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This thesis systematically investigates the performance of a novel high retention (HR) – 
enzymatic membrane bioreactor (EMBR) for effective degradation of a broad spectrum of trace 
organic contaminants (TrOCs) commonly detected either in sewage-impacted water or in 
wastewater treatment plant effluent. In the last decade, laccase (EC 1.10.3.2), a copper-
containing oxidoreductase enzyme, has been studied extensively for the degradation of 
recalcitrant pollutants. Laccase-catalysed degradation of TrOCs such as pharmaceuticals, 
pesticides, personal care products, industrial chemicals and steroid hormones has gained 
significant attention. These TrOCs occur ubiquitously in municipal wastewater and sewage-
impacted water bodies. This can potentially be harmful to aquatic ecosystems and human 
health. 
Initially, performance of laccase was assessed in batch enzymatic bioreactors due to the 
concern of enzyme washout in a continuous-flow treatment system. In an attempt to prevent 
enzyme washout, an enzymatic membrane bioreactor (EMBR) was developed by coupling an 
ultrafiltration (UF) membrane to an enzymatic bioreactor. Interestingly, during the operation 
of the EMBR, adsorption of some hydrophobic TrOCs (log D >3) onto the enzyme gel layer 
over the membrane surface resulted in enhanced degradation of the adsorbed compounds. This 
observation indicates the complementarity of simultaneous laccase and TrOC retention within 
EMBR. Hence, in this thesis, a novel high retention enzymatic membrane bioreactor (HR-
EMBR) system was developed for enhanced TrOC degradation by coupling an enzymatic 
bioreactor with a high retention membrane separation process such as nanofiltration (NF) or 
membrane distillation (MD).  
To serve as the proof of concept, the first step of this research compared the performance of a 
conventional UF- and high retention NF- EMBRs for the degradation of a broad spectrum of 
29 TrOCs under identical operating conditions such as TrOC-loading rate and hydraulic 
retention time. The results revealed that the overall removal (i.e., biodegradation + membrane 
retention) of TrOCs in NF-EMBR was better as compared to that achieved by UF-EMBR. This 
is because the NF membrane achieved TrOC rejection ranging from 90 to 99%. Furthermore, 
mass balance analysis shows that, as compared to the UF-EMBR, significantly better 
degradation (up to 65%) was achieved by laccase in NF-EMBR. Improved degradation 
following simultaneous TrOC and laccase retention was mainly due to the prolonged contact 
time. Formation of secondary radicals or coupling agents, which are formed following laccase-
catalysed degradation of phenolic TrOCs, are highly reactive and could directly oxidize or 
polymerize other TrOCs. Notably, the results of this study suggest that UF membrane can 
contribute to the removal of TrOCs depending on their hydrophobicity and charge, thereby 
improving the overall performance of UF-EMBR. The overall removal by the NF-EMBR was 
considerably better due to enhanced TrOC degradation as well as effective TrOC removal. 
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Permeate flux of UF/NF membranes reduced gradually, this can be attributed to: (i) membrane 
fouling due to the adsorption of laccase on membrane surface forming an enzyme gel-layer; 
and/or (ii) concentration polarization due to the accumulation of TrOCs and transformation 
products on membrane surface. Membrane cleaning with water was suitable for effective flux 
recovery. 
In vitro treatment with laccase mainly depends on two factors: (i) redox-potential; and (ii) 
availability of electron donating (EDG) or withdrawing (EWG) functional groups in the 
chemical structure of TrOCs. Depending on its source, the catalytic potential of laccase for 
TrOC removal may significantly vary. In the next part of this research work, efficacy of two 
different laccases from genetically modified Aspergillus oryzae and Trametes versicolor was 
analysed in by coupling an enzymatic bioreactor with the MD process, which is another format 
of high retention membrane. Following effective TrOC retention (>99%) by the MD 
membrane, enhanced laccase-catalysed degradation of the selected TrOCs was achieved in 
MD-EMBR as compared to previously developed UF-EMBRs. Importantly, although 
degradation by both laccases was TrOC-specific, performance of laccase from A. oryzae was 
superior to that obtained by laccase from T. versicolor. This could be attributed to the higher 
redox-potential (up to 15%) of laccase from A. oryzae than laccase from T. versicolor.  
Although MD-EMBR can produce TrOC-free permeate, enzymatic degradation of certain 
groups of TrOCs (e.g., those containing strong EWGs) was incomplete. The spectrum of 
efficiently degraded TrOCs can be extended by introducing a naturally occurring or synthetic 
redox-mediator that acts as an electron shuttle between the TrOCs and laccase. Hence, the 
performance of three redox-mediators, namely syringaldehyde, violuric acid and 1-
hydroxybenzotriazole was assessed for improving the degradation of TrOCs in MD-EMBR. 
Each redox-mediator achieved TrOC-specific improvement in degradation, but violuric acid 
was the most efficient and versatile redox-mediator. However, when a mixture of 
syringaldehyde and violuric acid was tested, instead of inducing a synergistic effect, 
degradation of at least six pharmaceutically active TrOCs reduced. Despite the improved TrOC 
degradation, a mediator-specific increase in toxicity of bioreactor media as well as rapid 
laccase inactivation was observed following their addition in the enzymatic bioreactor of MD-
EMBR. Nevertheless, the effluent of the MD-EMBR (i.e., membrane permeate) was non-toxic. 
This is because the high retention MD membrane could retain all the constituents of enzymatic 
bioreactor. 
To address the issue of laccase inactivation in presence of redox-mediators, an integrated 
persulfate- and laccase- based oxidation process was envisioned. Based on the results achieved 
in batch tests, effect of persulfate concentration (1-10 mM) and incubation time (up to 24 h) as 
well as persulfate activation pathways were elucidated. The results revealed that the combined 
laccase/persulfate-assisted oxidation process achieved improved degradation of TrOCs 
resistant to laccase only. The developed process was also effective for estrogenicity reduction 
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without causing significant laccase inhibition. A NF membrane when coupled with the 
laccase/persulfate-assisted oxidation process allowed continuous-flow operation. This is 
because NF membrane effectively retained both persulfate and laccase. Importantly, 
degradation of non-phenolics further improved by 10 to 65% in laccase/persulfate-NF system 
as compared to laccase only. This could be attributed to the prolonged contact time between 
laccase/PS and TrOCs; as well as the contribution of oxidative coupling agents in degradation. 
The toxicity and estrogenicity bioassays confirmed that membrane permeate was non-toxic and 
safe for disposal. 
Physicochemical properties of raw water collected from surface water and groundwater are 
diverse. Raw water matrix contains different dissolved organic and inorganic (e.g., metal ions) 
impurities. The freshwater bodies may contain both TrOCs and metal ions (e.g., iron) due to 
sewage contamination as well as acid mine drainage (AMD) intrusion. Different treatment 
options including the stand-alone and integrated MD system were examined for efficient 
treatment of sewage- and AMD-impacted water. The stand-alone MD system successfully 
retained (85-100%) bulk organics, TrOCs and metal ions (iron, magnesium, calcium and 
lithium). However, accumulation of organics and metal ions caused severe membrane fouling, 
consequently reducing the permeate flux by up to 75% within 5 d of operation. Based on the 
performance of laccase and persulfate in batch tests, a PS-assisted oxidation process was 
selected to be coupled with the MD system. The PS-MD system reduced the accumulation of 
bulk organics and TrOCs, but membrane scaling mainly caused by iron still affected permeate 
flux. Nevertheless, the MD membrane effectively retained all impurities, and consistently 
produced pollutant-free permeate (i.e., treated effluent). 
Keywords: Biodegradation; Effluent toxicity; Enzymatic membrane bioreactor; Estrogenicity; 
High retention membranes; Laccase; Membrane distillation; Membrane fouling; 





A PhD journey is always full of exciting challenges and opportunities. My PhD journey was 
not any different. During this life-changing experience of almost three and half years, I built 
myself up (on daily basis) with all the motivation and courage to maintain a smooth progress. 
This could not have been possible without the support and guidance of many people.  
I started applying for fully-funded PhD positions after completing my Masters’ degree in 2014 
but without any luck for more than one year. This tested my patience and motivation to do PhD 
from abroad. Only when I started considering PhD from a local University, an opportunity 
came out of the blue to join the Strategic Water Infrastructure Laboratory (SWIL) of the 
University of Wollongong (UOW). I am thankful to Prof. Dr. Sher Jamal Khan (IESE, NUST, 
Pakistan) for the support, and to recommend me for the PhD position at SWIL. 
The role of the supervisor, which starts from the application process until graduation, is very 
important during PhD. I express my gratitude to my Principal Supervisor and mentor A/Prof 
Faisal I. Hai for supporting my application to successfully acquire the Research Training 
Program Scholarship from Australian Commonwealth Government. My Principal Supervisor 
taught me a lot in the last three and half years, which helped me to improve my critical thinking, 
problem solving and technical writing skills. I appreciate all the contributions of my Principal 
Supervisor in the form of his time, ideas and funding without which it would not be possible 
to complete my thesis. 
I am thankful to my Co-supervisors Prof William E. Price and Prof Long D. Nghiem for their 
insightful guidance, encouragement and support. I also appreciate them for providing 
constructive feedback on my research outcomes and writing throughout my PhD studies.  
I would like to acknowledge the help and support of the Technical officers (School of Civil, 
Mining and Environmental Engineering), especially Dr. Ling (Linda) Tie for providing the 
common lab supplies as well as for help in sample analysis and troubleshooting. I thank Mr. 
Frank Crabtree, Mr. Fernando Escribano and Mr. Travis Marshall for their help in 
troubleshooting my experimental setups.  
The members of the SWIL groups have contributed immensely to my personal and professional 
time at the University of Wollongong. The group has been a source of friendships as well as 
good advice and collaboration. I am grateful to Dr. Loung N. Nguyen for providing differnt 
trainings, particularly on fungal culturing at the start of PhD studies. Dr. Jinguo Kang, who 
passed away in 2018, is thanked for his assistance in GC-MS analysis. It was great loss, and he 
will always remain in our thoughts (may his soul rest in peace). I thank Quỳnh Anh Nguyễn 
(Allie) for help with DNA extraction, and Lei Zhang for training on Electrokinetic analyser. I 
would like to thank all my friends and colleagues, Sultan Alharbi, Ashley Ansari, Hop Phan, 
Biplob Pramanik, Wenhai Luo, Minh, Xiaoye Song, Zulqarnain Fida, Naveed Ahmed, Arbab 
x 
 
Tufail for their moral support. Winning the UniClubs Cup in 2016 with my colleagues is one 
of the highlights of my life in UOW. I wish you all the best in your professional careers. 
I would like to thank my colleagues Dr. Nadeem Majeed, Dr. Sidra Iftekhar, Rasikh Habib, 
Shamas Tabraiz, and Dr. Tahir Maqbool from Pakistan for their sincere help and support 
throughout my PhD studies. 
My time in Wollongong was made worth remembering in large part due to the many friends 
that became a part of my life in the later stage of my PhD. I am grateful for the time spent with 
our housemates Mr. and Mrs. Tajmmal Kabir. They helped my family (upon arrival) to adjust 
in Wollongong. I am indebted to Mr. and Mrs. Tajmmal Kabir for the care that they showed 
towards our well-being. I will always remember our academic and political discussions during 
my night strolls with Tajmmal.  
‘Mens sana in corpore sano (healthy mind in a healthy body)’. I am thankful to all the people 
with whom I played cricket in the later part of my PhD studies. I am especially thankful to 
Imran Zafar and Dawood Hassan for spending their valuable time as well as for providing 
sincere advice on different aspects of life. I appreciate Wollongong District Cricket Club for 
providing with an opportunity to improve my skills and to contribute in winning the 
Premiership (2018/19).  
I am very thankful to my brothers and their wives - Muhammad Farooq Aziz & Gamze Kart 
Aziz; Muhammad Muzzammil Hassan & Sundas Hassan; and Muhammad Usman Ibrahim & 
Hafsa Usman, as well as my sister (Rehana Sadia) and Mother in-law (Hoorya Khan) for always 
believing in me and encouraging me to follow my dreams. Although I could not visit my home 
country throughout my PhD studies due to reasons beyond my control, I am thankful to all of 
you for always remaining in-touch, and for your unconditional support. 
And finally, to my wife Maiha Zahid, who has been by my side throughout my PhD studies, 
living every single minute of it, and without whom, I would not have had the courage to embark 
on this journey in the first place. I salute you for the efforts you had to put in with our daughter 
Abal Fatima in my absence for more than 2 years. I appreciate my daughter Abal for being 
such as good and calm little girl, which allowed me to complete the thesis writing. I dedicate 
this research work to my Parents for the efforts they put in during my brought-up and made me 
a capable person. 






Table of Contents 
 
Certification ............................................................................................................................... ii 
Thesis-related Publications ...................................................................................................... iii 
Additional-relevant Publications ............................................................................................... v 
Abstract ..................................................................................................................................... vi 
Acknowledgments..................................................................................................................... ix 
Table of Contents ...................................................................................................................... xi 
List of Figures ........................................................................................................................ xvii 
List of Tables ....................................................................................................................... xxiii 
List of Abbreviations ............................................................................................................ xxiv 
Chapter 1: Introduction .............................................................................................................. 1 
1.1. Background ......................................................................................................................... 1 
1.2. Knowledge gaps .................................................................................................................. 4 
1.3. Research objectives ............................................................................................................. 5 
1.4. Thesis outline ...................................................................................................................... 6 
1.5. Contribution to knowledge ................................................................................................. 8 
1.6. References ........................................................................................................................... 9 
Chapter 2: Literature Review ................................................................................................... 15 
2.1. Introduction ....................................................................................................................... 16 
2.2. Trace organic contaminants (TrOCs)................................................................................ 17 
2.2.1. Occurrence of TrOCs in environmental systems ....................................................... 18 
2.2.2. Wastewater ................................................................................................................. 19 
2.2.3. Surface water .............................................................................................................. 22 
2.2.4. Groundwater ............................................................................................................... 24 
2.2.5. Seawater ..................................................................................................................... 28 
2.3. TrOC removal by biological treatment processes ............................................................. 31 
2.3.1. TrOC removal by CAS process .................................................................................. 32 
2.3.2. TrOC removal by MBR.............................................................................................. 35 
2.3.3. TrOC removal by high retention (HR)-MBR ............................................................. 36 
2.3.3.1. HR-MBR configurations ...................................................................................... 37 
2.3.3.2. Mechanisms of TrOC removal by high retention membranes ............................. 38 
2.3.3.3. Aqueous phase removal of TrOCs by HR-MBR .................................................. 41 
2.3.3.4. Factors affecting TrOC removal by activated sludge in HR-MBR ..................... 43 
xii 
 
2.3.3.5. Fate of TrOCs in HR-MBR .................................................................................. 47 
2.4. TrOC degradation by white-rot fungi (WRF) ................................................................... 50 
2.4.1. Properties of WRF and their ligninolytic enzymes .................................................... 50 
2.4.2. Modes of TrOC degradation by WRF ........................................................................ 52 
2.4.2.1. Removal by Whole-cell WRF ............................................................................... 52 
2.4.2.2. WRF bioreactor configurations ........................................................................... 56 
2.4.2.3. Performance under non-sterile environment and bottlenecks ............................. 57 
2.4.2.4. Removal by crude ligninolytic enzymes ............................................................... 59 
2.4.2.5. Removal by purified ligninolytic enzymes ........................................................... 60 
2.4.2.6. Mechanisms of TrOC removal ............................................................................. 62 
2.4.2.7. Degradation pathways, identification of intermediates and toxicity ................... 64 
2.4.3. Impacts of physicochemical characteristics of wastewater on TrOC removal .......... 65 
2.4.4. TrOC removal by enzymatic membrane bioreactor (EMBR) .................................... 66 
2.4.5. Improvement in the performance of EMBR with redox-mediators ........................... 70 
2.5. Performance of emerging advanced oxidation process .................................................... 72 
2.6. References ......................................................................................................................... 74 
Chapter 3: TrOC removal by a high retention nanofiltration vs. ultrafiltration enzymatic 
membrane bioreactor (UF- vs. NF-EMBR) ............................................................................. 97 
3.1. Introduction ....................................................................................................................... 98 
3.2. Hypothesis....................................................................................................................... 100 
3.3. Materials and methods .................................................................................................... 100 
3.3.1. Enzyme solution, redox-mediator and trace organic contaminants ......................... 100 
3.3.2. Experimental setup ................................................................................................... 101 
3.3.3. Enzymatic membrane bioreactor operation and experimental protocols ................. 103 
3.3.3.1. Preliminary assessment of NF vs. UF coupled EMBRs .................................... 103 
3.3.3.2. Assessment of NF vs. UF coupled EMBRs for broad spectrum of TrOCs ........ 104 
3.3.4. Analytical methods ................................................................................................... 105 
3.3.4.1. TrOC analysis .................................................................................................... 105 
3.3.4.2. Laccase activity assay and ORP ........................................................................ 106 
3.3.4.3. Analysis of membrane properties and surface morphology .............................. 106 
3.4. Results and discussion .................................................................................................... 106 
3.4.1. Laccase and TrOC retention by the membranes ...................................................... 106 
3.4.2. Preliminary assessment of TrOC removal in UF vs. NF-EMBRs ........................... 108 
3.4.3 Laccase-catalyzed degradation of a broad set of TrOCs by NF-EMBR ................... 111 
3.4.3.1. Degradation of phenolic TrOCs ........................................................................ 111 
xiii 
 
3.4.3.2. Degradation of non-phenolic TrOCs ................................................................. 113 
3.4.3.3. Overall removal of TrOCs in EMBRs ................................................................ 115 
3.4.5. Effect of redox-mediator addition on TrOC degradation by NF-EMBR ................. 119 
3.4.5.1. Overall improvement in TrOC degradation ...................................................... 119 
3.4.5.2. Effect of mediator concentration on TrOC degradation ................................... 121 
3.4.6. Hydraulic performance of membranes ..................................................................... 123 
3.5. Effect on membrane surface charge and hydrophobicity ............................................ 125 
3.5. Conclusion ...................................................................................................................... 126 
3.6. References ....................................................................................................................... 126 
Chapter 4: TrOC removal by a membrane distillation – enzymatic membrane bioreactor (MD-
EMBR): Impact of laccase source ......................................................................................... 131 
4.1. Introduction ..................................................................................................................... 132 
4.2. Hypothesis....................................................................................................................... 134 
4.3. Materials and methods .................................................................................................... 134 
4.3.1. Trace organic contaminants ..................................................................................... 134 
4.3.2. Enzyme solutions and redox-mediators ................................................................... 134 
4.3.3. MD-EMBR experimental setup ............................................................................... 135 
4.3.4. Experimental protocol .............................................................................................. 136 
4.3.5. Analytical methods ................................................................................................... 137 
4.3.5.1. Analysis of TrOCs .............................................................................................. 137 
4.3.5.2. Laccase assay and ORP .................................................................................... 137 
4.4. Results and discussion .................................................................................................... 138 
4.4.1. TrOC retention by MD system ................................................................................. 138 
4.4.2. TrOC degradation vs. laccase source in MD-EMBR ............................................... 138 
4.4.3. Effect of redox-mediator addition ............................................................................ 141 
4.4.3.1. TrOC degradation ............................................................................................. 141 
4.4.3.2. Impact on enzymatic activity ............................................................................. 144 
4.4.3.3. Impact on contact time ...................................................................................... 145 
4.4. Hydraulic performance of membrane ......................................................................... 146 
4.5. Conclusion ...................................................................................................................... 148 
4.6. References ....................................................................................................................... 148 
Chapter 5: TrOC removal by a membrane distillation – enzymatic membrane bioreactor (MD-
EMBR): Impacts of redox-mediator types, concentrations and their mixtures ..................... 152 
5.1. Introduction ..................................................................................................................... 153 
5.2. Hypothesis....................................................................................................................... 155 
xiv 
 
5.3. Materials and methods .................................................................................................... 155 
5.3.1. TrOCs, laccase and mediators .................................................................................. 155 
5.3.2. The MD-EMBR System ........................................................................................... 157 
5.3.3. Experimental protocol .............................................................................................. 157 
5.3.3.1. Preliminary assessment with and without mediator addition ........................... 157 
5.3.3.2. Long-term performance with and without mediator addition ........................... 157 
5.3.4. Analytical methods ................................................................................................... 158 
5.3.4.1. TrOC analysis .................................................................................................... 158 
5.3.4.2. Laccase activity and contact angle .................................................................... 158 
5.3.4.3. Permeate toxicity analysis ................................................................................. 158 
5.4. Results and discussion .................................................................................................... 159 
5.4.1. Overall TrOC removal by MD-EMBR .................................................................... 159 
5.4.2. Preliminary assessment of TrOC degradation in MD-EMBR ................................. 160 
5.4.3. TrOC degradation in MD-EMBR during long-term continuous operation.............. 162 
5.4.3.1. Degradation of phenolic TrOCs ........................................................................ 162 
5.4.3.2. Degradation of non-phenolic TrOCs ................................................................. 163 
5.4.4. MD-EMBR performance with mediator addition .................................................... 165 
5.4.4.1. Preliminary screening of redox-mediators during preliminary assessment ..... 165 
5.4.4.2. TrOC degradation following VA and SA addition during long-term operation 170 
5.4.4.3. Effect of mediator mixture on TrOC degradation ............................................. 172 
5.4.5. Permeate toxicity ...................................................................................................... 175 
5.4.6. Permeate flux of MD-EMBRs.................................................................................. 176 
5.5. Conclusion ...................................................................................................................... 177 
5.6. References ....................................................................................................................... 178 
Chapter 6: Laccase – persulfate assisted degradation of TrOC by nanofiltration – enzymatic 
membrane bioreactor (NF-EMBR) ........................................................................................ 182 
6.1. Introduction ..................................................................................................................... 183 
6.2. Hypothesis....................................................................................................................... 185 
6.3. Materials and methods .................................................................................................... 185 
6.3.1. Trace organic contaminants, laccase solution and persulfate .................................. 185 
6.3.2. Performance of laccase and persulfate in batch bioreactor ...................................... 186 
6.3.3. Continuous nanofiltration-bioreactor setup and experimental protocol ................... 187 
6.3.1.1. Description of experimental setup ..................................................................... 187 
6.3.1.2. Experimental protocol ....................................................................................... 187 
6.3.4. Analytical methods ................................................................................................... 187 
xv 
 
6.3.4.1. TrOC analysis .................................................................................................... 187 
6.3.4.2. Laccase activity essay and PS concentration measurement .............................. 188 
6.3.4.3. Estrogenic activity and ecotoxicity .................................................................... 188 
6.4. Results and discussion .................................................................................................... 189 
6.4.1. TrOC removal in batch experiments ........................................................................ 189 
6.4.1.1. Preliminary performance of integrated laccase/PS system ............................... 189 
6.4.1.2. Effect of PS concentration ................................................................................. 192 
6.4.1.3. Effect of incubation time .................................................................................... 194 
6.4.1.4. Ecotoxicity and Estrogenic evaluation .............................................................. 195 
6.4.2. Continuous TrOC removal by laccase/PS-NFBR treatment system ........................ 196 
6.4.2.1. TrOC degradation ............................................................................................. 197 
6.4.2.2. Overall TrOC removal ....................................................................................... 198 
6.4.3. Hydraulic performance of the laccase/PS-NFBR..................................................... 200 
6.5. Conclusion ...................................................................................................................... 200 
6.6. References ....................................................................................................................... 201 
Chapter 7: Simultaneous removal of TrOCs and metals by a PS-assisted membrane distillation 
reactor .................................................................................................................................... 205 
7.1. Introduction ..................................................................................................................... 206 
7.2. Hypothesis....................................................................................................................... 208 
7.3. Materials and methods .................................................................................................... 208 
7.3.1. Chemicals ................................................................................................................. 208 
7.3.2. Experimental setup ................................................................................................... 209 
7.3.3. Experimental protocols ............................................................................................ 210 
7.3.3.1. MD process characterization ............................................................................ 210 
7.3.3.2. Performance of a stand-alone MD process ....................................................... 211 
7.3.3.3. Performance of an integrated MD process ....................................................... 212 
7.3.4. Analytical methods ................................................................................................... 212 
7.3.4.1. Analysis of basic quality parameters ................................................................. 212 
7.3.4.2. Analysis of TrOCs and metals ........................................................................... 213 
7.3.4.3. Membrane characterization and toxicity of MD permeate ............................... 214 
7.3.4.4. PS concentration and laccase activity ............................................................... 214 
7.4. Results and discussions ................................................................................................... 214 
7.4.1. Mass transfer coefficient (Km) of MD ...................................................................... 214 
7.4.2. Performance of a stand-alone MD system ............................................................... 215 
7.4.2.1. Removal of TrOCs ............................................................................................. 215 
xvi 
 
7.4.2.2. Removal of TOC, TN and metal ions ................................................................. 218 
7.4.3. Performance of an integrated MD system ................................................................ 219 
7.4.3.1. Degradation of TrOCs in batch tests ................................................................. 219 
7.4.3.2. Degradation of TrOCs by PS-assisted MD system ............................................ 221 
7.4.3.3. TOC and TN degradation by PS-assisted MD system ....................................... 224 
7.4.4. Hydraulic performance of the stand-alone and PS-assisted MD.............................. 225 
7.4.5. Toxicity of treated effluent ....................................................................................... 228 
7.5. Conclusions ................................................................................................................. 229 
7.6. References ................................................................................................................... 229 
Chapter 8: Conclusions and recommendations for future work ............................................ 233 
8.1. Conclusions ..................................................................................................................... 233 
8.2. Recommendations for future research ............................................................................ 236 






List of Figures 
Figure 1.1. A schematic representation of thesis structure and outline................................................... 8 
 
Figure 2.1. Sources and pathways of TrOC contamination in freshwater and seawater. Data source: [1, 
18, 26]. “AR”: artificial recharge .................................................................................................. 19 
Figure 2.2. Variations in the concentration (ng/L) of TrOCs in surface water bodies. Box plots 
represents interquartile range, median (horizontal line), min and max (whiskers), and average 
(black and white square box). Number of data points for each class/subclass is given in brackets 
on the x-axis. NSAIDs: Nonsteroidal anti-inflammatory drug; ALR: Anticonvulsant and Lipid 
regulator; and PCPs: Personal care products. Data is extracted from [46-54]. ............................. 24 
Figure 2.3. Variations in the concentration (ng/L) of TrOCs in groundwater. Box plots represents 
interquartile range, median (horizontal line), min and max (whiskers), and average (black and 
white square box). Number of data points for each class/subclass is given in brackets on the x-axis. 
NSAIDs: Nonsteroidal anti-inflammatory drug; ALR: Anticonvulsant and Lipid regulator; and 
PCPs: Personal care products. Data is extracted from [56, 57, 81-87]. ........................................ 28 
Figure 2.4. Average concentration (ng/L) of the five major classes of TrOCs in sea and coastal waters. 
Box plots represents interquartile range, median (horizontal line), min and max (whiskers), and 
average (black and white square box). Number of data points for each class/subclass is given in 
brackets on the x-axis. NSAIDs: Nonsteroidal anti-inflammatory drug; ALR: Anticonvulsant and 
Lipid regulator; and PCPs: Personal care products. Data is extracted from [103-108]. ............... 30 
Figure 2.5. Removal of different categories of TrOCs by an CAS-based treatment process. Data 
presented as average ±standard deviation. Data is extracted from [125, 126]. ............................. 33 
Figure 2.6. Removal of different categories of TrOCs by MBR. Data presented as average ±standard 
deviation. Data is extracted from [125, 126]................................................................................. 36 
Figure 2.7. Schematics of (a) Conventional membrane bioreactor (MBR); (b) membrane distillation 
bioreactor (MDBR); (c); forward osmosis- membrane bioreactor (FO-MBR); and (d) 
nanofiltration- membrane bioreactor (NF-MBR) .......................................................................... 38 
Figure 2.8. Qualitative predictive framework for the retention of TrOCs by NF or FO membrane. The 
case of an acidic compound is depicted here. A basic compound will become positively charged 
at pH<pkb. The transformation of neutral TrOCs to negatively charged at pH > pKa or positively 
charged at pH < pKb can improve their retention by NF and the FO membranes. Modified from 
[166, 170] ...................................................................................................................................... 41 
Figure 2.9. Aqueous phase removal of TrOCs by CAS, MBR and HR-MBR. Box-and-whisker plot is 
showing information about: the interquartile range; median (horizontal line in the box); min and 
max (whiskers); and average (block square in the box). Adapted from [126]. ............................. 43 
Figure 2.10. Effect of SRT on the aqueous phase removal of selected TrOCs by conventional MBR. (a) 
Significant SRT dependent improvement in TrOC removal; and (b) insignificant dependence of 
TrOC removal on SRT. Adapted from [126]. ............................................................................... 46 
Figure 2.11. Variations in the biodegradation of TrOCs in CAS (a), MBR (b) and HR-MBR (c). Box-
and-whisker plot is showing information about: the interquartile range; median (horizontal line in 
the box); min and max (whiskers); and average (block square in the box). Numbers in the 
parenthesis on the x-axis represent the no. of data points (no. of data points: HR-
MBR+MBR+CAS). Adapted from [126]. .................................................................................... 47 
Figure 2.12. Contribution of different mechanisms for TrOC removal in HR-MBR and conventional 
MBR. HR-MBR. Adapted from [126]. ......................................................................................... 48 
Figure 2.13. A qualitative framework to predict the contribution of different mechanisms of TrOC 
removal in HR-MBR categorized based on their physicochemical properties. ............................ 49 
Figure 2.14. Average removal of phenolic and non-phenolic TrOCs after treatment with 
purified/commercially available laccase. Error bar indicates average±standard deviation. Numbers 
xviii 
 
within parenthesis indicates number of data points. Data was collected from the following studies: 
[229, 303, 304, 306, 314, 324-328]. .............................................................................................. 62 
Figure 2.15. TrOC removal mechanisms by WRF-based treatment processes. Adapted from [329]. .. 63 
Figure 2.16. Removal of TrOCs in batch enzymatic bioreactor and continuous-flow EMBR. Numbers 
within parenthesis indicates number of data point (nEMBR +nbatch laccase). Error bars represent standard 
deviation among data points. E1: Estrone; E2: 17β – Estradiol; EE2: 17α – ethinylestradiol. The 
data is extracted from the studies listed in Table 2.9. ................................................................... 70 
 
Figure 3.1. Schematics of the lab-scale cross-flow filtration system attached to an enzymatic bioreactor 
operated in full recirculation mode (a) and continuous-flow mode (b). Arrows show the direction 
of flow. Laccase retention was first confirmed with a short term (i.e., 24 h) study in full 
recirculation mode. Further operation of EMBRs were conducted in continuous-flow mode for 
assessing the impact of TrOC retention on their degradation. Cf, CEBR and Cp are the concentration 
(µg/L) of a specific TrOC in the feed, enzymatic bioreactor and permeate, respectively. Vf, VEBR 
and Vp represent the volume of feed, enzymatic bioreactor and permeate, respectively. A picture 
of lab-scale EMBR is shown in Appendix Figure 3-2. ............................................................... 102 
Figure 3.2. Laccase activity in the enzymatic bioreactor and permeate of UF-EMBR and NF-EMBR 
during their operation in full recirculation mode for 24 h. The standard deviation of duplicate 
samples was less than 2%. .......................................................................................................... 107 
Figure 3.3. Overall removal (i.e., degradation + membrane retention) of TrOCs in UF- and NF-EMBRs 
operated separately at an HRT of 16 h and TrOC loading rate of 1.44 mg/L d. Data presented as 
average ± standard deviation (n = 6). .......................................................................................... 108 
Figure 3.4. Degradation of TrOCs in UF- and NF-EMBRs operated separately at an HRT of 16 h and 
TrOC loading rate of 1.44 mg/L d. Data presented as average ± standard deviation (n = 6). .... 110 
Figure 3.5. Time course of TrOC degradation by laccase in continuous-flow UF- and NF-EMBRs. Each 
data point denotes average of two samples with a variation of less than 5%. ............................ 111 
Figure 3.6. Degradation of TrOCs in enzymatic bioreactor coupled to the UF or NF membrane for 
showing the effect of effective TrOC retention on degradation. Both enzymatic membrane 
bioreactors were operated at an initial laccase activity of 180 µM(DMP)/min, TrOC concentration of 
5 µg/L, HRT of 16 h and cross-flow velocity of 40.2 cm/s. The temperature of the enzymatic 
bioreactor was kept at 25 ºC. Data is presented as average ± standard deviation (n=4). ............ 112 
Figure 3.7. Enzymatic degradation in both UF- and NF-EMBR as function of TrOC molecular weight, 
showing that the extent of degradation was significantly higher for TrOCs with a molecular weight 
above 200 g/mol. ......................................................................................................................... 115 
Figure 3.8. Overall TrOC removal in enzymatic bioreactor coupled to the UF or NF membrane. Data is 
presented as the average ± standard deviation (n=4). ................................................................. 116 
Figure 3.9. Permeate to supernatant (P/S) ratio of the selected TrOCs to show their partial retention by 
the UF membrane in UF-EMBR. Data is presented as average ± standard deviation (n=4). ..... 117 
Figure 3.10. SEM images of the NF and UF membranes, confirming the formation of enzyme gel-layer 
on the surface of membranes. The formartion of an enzyme gel-layer on the surface of membranes 
could improve overall performance of EMBRs via TrOC adsorption ........................................ 118 
Figure 3.11. Effect of adding a naturally occurring redox-mediator, violuric acid VA, on the degradation 
of TrOCs in NF-EMBR. VA was added at a concentration of 10 µM at the start of the experiment. 
Data is presented as the average ± standard deviation (n=4). ..................................................... 120 
Figure 3.12. Effect of different mediator concentration on the degradation of selected TrOCs in NF-
EMBR. Data is presented as the average ± standard deviation (n=4). ........................................ 122 
Figure 3.13. Improvement in TrOC degradation by adding single dose VA at different concentration 
separately at the start of NF-EMBR operation. VA showed compound-specific and concentration 
dependent improvement. The overall removal of TrOCs in NF-EMBR was >95%. The NF-EMBR 
were operated for a period of 68 h in continuous mode at an initial HRT of 16 h...................... 123 
xix 
 
Figure 3.14. Variations in the permeate flux presented as a normalized flux as a function of operating 
time. The reduction in the permeate flux was attributed to: (i) membrane fouling following the 
adsorption of laccase on membrane surface forming an enzyme gel-layer (see Figure 3.10), and/or 
(ii) concentration polarization due to the accumulation of TrOCs and transformation products on 
membrane surface. Cleaning the membranes with clean water for one hour was enough to recover 
the permeate flux by more than 90%. ......................................................................................... 124 
Figure 3.15. Effect of laccase on the properties of the NF and UF membranes. Error bars represent the 
standard deviation among triplicate measurements. Although change in properties of the NF 
membrane did not affect TrOC removal by NF-EMBR, the formation of an enzyme-gel layer on 
the surface of the UF membrane following laccase adsorption can improve the overall performance 
of UF-EMBR by adsorbing hydrophobic TrOCs (see Figure 3.9). ............................................. 125 
 
Figure 4.1. A simplified schematic of an MD process. The TrOC wastewater recirculation loop is kept 
at higher temperature as compared to cold water circulation loop. This creates a vapor pressure 
gradient across the MD membrane surface and allows water to diffuse from hot side to cold side.
 .................................................................................................................................................... 133 
Figure 4.2. A schematics representation of membrane distillation-enzymatic membrane bioreactor 
(MD-EMBR). .............................................................................................................................. 136 
Figure 4.3. Total mass of selected TrOCs in feed at the start (0 h) and the end (12 h) of experiment in 
the enzymatic bioreactor of MD-EMBR following complete TrOC retention (>99%) by MD. Error 
bars represent the standard deviation of duplicate samples. Error bars for samples taken at t=12 h 
are not visible for all the selected TrOCs because the standard deviation among those samples was 
less than 5%. Operating conditions: temperature of enzymatic bioreactor and distillate was 
maintained at 30 and 10 °C, respectively; cross-flow rate of water from enzymatic bioreactor and 
distillate was 1 L/min (corresponding to cross-flow velocity of 9 cm/s); and initial laccase activity 
in enzymatic bioreactor was 95-100 µMDMP/min. ....................................................................... 139 
Figure 4.4. The fate of TrOCs following treatment with laccases from A. oryzae (a) and T. versicolor 
(b) in the bioreactor of MD-EMBR. The fate of each compound was analyzed by developing a 
mass balance among the total input, mass in concentrate, enzymatic degradation, 
adsorption/evaporation and permeates. MD system completely retained (>99%) all the selected 
TrOCs. Operating conditions of MD-EMBR are given in the caption of Figure 4.3. ................. 140 
Figure 4.5. Enzymatic degradation of selected TrOCs in enzymatic bioreactor after 12 h of treatment in 
MD-EMBR with and without the addition of redox-mediator addition. Error bars represent the 
standard deviation of duplicate samples. Two mediators (HBT and SA) are added separately at 1 
mM. Operating conditions of MD-EMBR are given in the caption of Figure 4.3. ..................... 143 
Figure 4.6. Oxidation reduction potential (ORP) and enzyme inactivation with and without the addition 
of redox-mediators. Two mediators, namely HBT and VA, were added separately at 1 mM 
concentration. Operating conditions of MD-EMBR are given in the caption of Figure 1. Time 
course of enzymatic activity during all experiments is given in Appendix Figure 4-1. .............. 144 
Figure 4.7. Effect of reaction time on the removal of selected TrOCs in the enzymatic bioreactor of 
MD-EMBR with and without the addition of two mediators. HBT and SA were added at 1 mM 
concentration separately. Operating conditions of MD-EMBR are given in the caption of Figure 
4.2. .............................................................................................................................................. 146 
Figure 4.8. Average permeate flux obtained during the operation of enzymatic membrane distillation 
(E-MD) with different combinations of enzymes and mediators. Numbers within parenthesis in x-
axis indicate number of data points. MD without the addition of enzyme and mediators served as 
a control. Feed and distillate temperature were controlled at 30 and 10 °C, respectively during all 
experiments. The cross-flow rate of both feed and distillate side was set at 1 L/min (corresponding 




Figure 5.1. Overall removal (membrane retention + enzymatic degradation) of 30 TrOCs arranged by 
usage category in the MD-EMBR. The data from the preliminary short-term experiment (t = 12 h 
and n=2) as well as from the long-term experiment (t = 60 h and n=4)) is presented. Error bars are 
not visible because the standard deviation was less than 5%. MD-EMBR operating conditions: the 
initial TrOC concentration and laccase activity was 20 µg/L and 95–100 µM(DMP)/min, 
respectively; temperature of the enzymatic bioreactor and the permeate tank were kept at 30 and 
10 °C, respectively; and cross-flow rate of media from the enzymatic bioreactor and distillate was 
1 L/min (corresponding to a cross-flow velocity of 9 cm/s). ...................................................... 160 
Figure 5.2. Preliminary performance of the MD-EMBR for the degradation of 30 TrOCs by laccase. 
Error bars indicate the standard deviation of duplicate samples. Experimental conditions are given 
in the caption of Figure 5.1. ........................................................................................................ 162 
Figure 5.3. Laccase-catalyzed degradation of 30 TrOCs in MD-EMBR during long-term continuous 
operation of MD-EMBR (60 h; and 2×HRT). Error bars indicate the standard deviation among 
four samples. Experimental conditions are given in the caption of Figure 5.1. .......................... 164 
Figure 5.4. Enzymatic degradation of 30 TrOCs during the preliminary screening of three redox-
mediators, namely HBT, VA and SA (separately at 0.5 mM) in the MD-EMBR operated for 12 h. 
Error bars indicate the standard deviation of duplicate samples. Operating conditions of the MD-
EMBR are given in the caption of Figure 5.1. ............................................................................ 166 
Figure 5.5. Impact of redox-mediator concentration (0.25 and 0.5 mM) on the degradation of TrOCs in 
the MD-EMBR operated for 12 h. Error bars indicate the standard deviation of duplicate samples. 
Operating conditions of the MD-EMBR are given in the caption of Figure 5.1. Only those TrOCs 
showing mediator concentration-dependent improvement in their degradation are shown here. For 
remaining TrOCs, results are given in Appendix Figure 5-1. ..................................................... 168 
Figure 5.6. Effect of mediator type and concentration on oxidation reduction potential (ORP) and 
laccase inactivation in the MD-EMBR operated for 12 h. Operating conditions of the MD-EMBR 
are given in the caption of Figure 5.1. ........................................................................................ 169 
Figure 5.7. Enzymatic degradation of 30 TrOCs following the addition of two redox-mediators viz SA 
and VA separately at 0.5 mM in MD-EMBR operated for a period of 60 h (i.e., 2×HRT). SA or 
VA was introduced only at the start of MD-EMBR operation. Data presented as average±standard 
deviation (n=4). Operating conditions of the MD-EMBR are given in the caption of Figure 5.1.
 .................................................................................................................................................... 171 
Figure 5.8. Fate of TrOCs during MD-EMBR operation with and without the addition of redox-
mediators. Operating conditions of the MD-EMBR are given in the caption of Figure 5.1. ...... 172 
Figure 5.9. Effect of individual mediators and their mixture on the degradation of selected non-phenolic 
TrOCs, showing reduced performance when mediator mixture was used. Data presented as 
average±standard deviation (n=4). Effect of mediator mixture (i.e., SA and VA) on all the tested 
TrOCs (i.e., phenolic and non-phenolic) is shown in Appendix Figure 5-2. .............................. 173 
Figure 5.10. Oxidation reduction potential (ORP) and laccase inactivation percentage with and without 
the addition of redox-mediators. Data presented as average±standard deviation (n=2 for ORP; and 
n=5 for laccase inactivation). Time course of enzymatic activity during all experiments is given in 
Appendix Figure 5-3. .................................................................................................................. 174 
Figure 5.11. Contact angle of the membrane before and after using it for EMBR operation of 60 h. Error 
bars represent the standard deviation of three repeated measurements. ..................................... 177 
 
Figure 6.1. Degradation of the selected TrOCs by laccase and laccase/PS in batch tests after an 
incubation time of 24 h. PS (potassium persulfate) was added at 5 mM concentration, while the 
initial laccase activity was 90-95 µM(DMP)/min. Results presented as average ± standard-deviation 
(n=3). Note: performance of PS alone at 1 mM concentration was assessed in parallel, and no 
TrOC removal observed. ............................................................................................................. 190 
Figure 6.2. Degradation of the selected TrOCs by laccase and laccase/PS in batch tests for understanding 
the PS activation pathways. PS (potassium persulfate) was added at 5 mM concentration, while 
xxi 
 
the initial laccase activity was 90-95 µM(DMP)/min. Results presented as average ± standard-
deviation (n=3). ........................................................................................................................... 192 
Figure 6.3. Effect of PS concentrations on TrOC degradation in batch laccase/PS system. PS 
concentration ranged from 1-10 mM, while the initial laccase activity was 90-95 µM(DMP)/min. 
Results presented as average ± standard-deviation (n=3). .......................................................... 193 
Figure 6.4. Laccase inactivation (a) and depletion of PS (b) at the end of batch tests with and without 
the addition PS at different concentrations. Error bars represents the standard deviation between 
duplicate samples. ....................................................................................................................... 194 
Figure 6.5. Effect of incubation time on TrOC degradation in batch laccase/PS system assessed 
separately at 2- and 5-mM PS concentration. Initial laccase activity was 90-95 µM(DMP)/min. 
Results presented as average ± standard-deviation (n=3). .......................................................... 195 
Figure 6.6. Performance of the laccase/PS-NFBR treatment system for the degradation of the selected 
TrOCs. Overall TrOC degradation (a) as well as time course of TrOC degradation (b) is shown 
here. PS (potassium persulfate) was added at 5 mM concentration, while the initial laccase activity 
was 90-95 µM(DMP)/min. The laccase/PS-NF treatment system was operated at a TrOC loading rate 
of 0.72 mg/L.d and HRT of 16 h. Results presented as average ± standard-deviation calculated 
based on the triplicate samples that were collected at 24, 36, 48 and 64 h. ................................ 198 
Figure 6.7. Overall removal (degradation + membrane retention) of TrOCs by the laccase/PS-NFBR 
system. Error bars represents the standard deviation (n=12). Experimental conditions are presented 
in the caption of Figure 6.6. ........................................................................................................ 199 
Figure 6.8. Hydraulic performance of the NF membrane expressed as normalised flux during the 
operation of the laccase/PS-NFBR treatment system. ................................................................ 200 
 
Figure 7.1. Schematic representation of the laboratory-scale DCMD setup used in this study .......... 210 
Figure 7.2. Permeate flux (a) and mass transfer coefficient (b) of the MD system determined 
experimentally with Milli-Q water as feed at a temperature of 40, 45 and 50 ºC. Temperature of 
the distillate reservoir was kept at 20 ºC, while the cross-flow velocity was maintained at 1 L/min.
 .................................................................................................................................................... 215 
Figure 7.3. Performance of the stand-alone MD for the removal of the selected TrOCs arranged based 
on pKH /log. Two different compositions of the synthetic wastewater were prepared to assess the 
performance of the stand-alone MD. For the control run, synthetic wastewater was prepared by 
adding a mixture of TrOCs in ultrapure Milli-Q water. For the MD-WW0 run, synthetic wastewater 
was prepared by dosing MBR permeate with TrOC mixture. Operating conditions: the initial TrOC 
concentration was 5 µg/L; temperature of the MD feed and the distillate (permeate) tank was kept 
at 40 and 20 ºC, repectivley; and cross-flow rate was 1 L/min (corresponding to cross-flow velocity 
of 9 cm/s). Mean removal efficiency and standard deviation (n=4 for control run, and n=10 for 
MD-WW0 run) are presented. ..................................................................................................... 216 
Figure 7.4. Performance of the stand-alone MD for the removal of the selected TrOCs arranged based 
on pKH /log in presence of metal salts at 10 (MD-WW10) and 100 mg/L (MD-WW100). Mean 
removal efficiency and standard deviation (n=4) are presented. Operating conditions are presented 
in the caption of Figure 7.3. ........................................................................................................ 218 
Figure 7.5. Performance of laccase and persulfate (PS) for degradation of the selected TrOCs in batch 
experiments. The performance of both laccase (95-100 µM/min) and PS (1 mM) was assessed for 
an incubation period of 24 h in presence of iron salt (10 mg/L) at 20 and 40 °C. Mean removal 
efficiency and standard deviation (n=2) are presented. .............................................................. 220 
Figure 7.6. Degradation of the selected TrOCs by PS (1 mM)-assisted MD system during the treatment 
of wastewater with (MD-WW10) and without (MD-WW0) the addition metal salts. Data is 
presented as average ± standard deviation (n=4 for MD-WW10 and n=10 for MD-WW0). Operating 
conditions are presented in the caption of Figure 7.3. ................................................................ 223 
Figure 7.7. Variations in the permeate flux of the stand-alone and PS-assisted MD systems as a function 
of time. Operating conditions are given in the caption of Figure 7.3. ........................................ 225 
xxii 
 
Figure 7.8. SEM images and EDS spectra of pristine MD membrane (a) and fouled membrane collected 
at the end of experiment with the stand-alone MD (b) and PS-assisted MD (c) systems. The 
membranes were used for the treatment of wastewater without the addition of metal salts. ...... 226 
Figure 7.9. SEM images and EDS spectra of the MD membrane. (a) PS-assisted MD membrane at the 
end of MD-WW10 run; (b) MD membrane at the end of MD-WW10 run (c) MD membrane at the 





List of Tables 
Table 2.1. Occurrence of a wide range of TrOCs in wastewater. The range of influent concentration, 
effluent concentration and removal efficiency of TrOCs is presented. Excretion rates of 
pharmaceuticals and steroid hormones are also given. Data is extracted from [16, 17, 29, 34]. .. 21 
Table 2.2. Occurrence (µg/Kg) of some TrOCs in the soil of different countries. Data is extracted from 
[18, 74-79] ..................................................................................................................................... 27 
Table 2.3. Occurrence of commonly detected TrOCs in marine sediments and marine biota [113]. ... 31 
Table 2.4. Factors affecting the retention of TrOCs by high retention membranes .............................. 39 
Table 2.5. Physicochemical properties of TrOCs and their aqueous phase removal by HR-MBR ...... 42 
Table 2.6. Characteristics of extracellular ligninolytic enzymes [250, 251]......................................... 51 
Table 2.7. Removal (%) of TrOCs by different species of WRF (whole-cell) under different operating 
conditions ...................................................................................................................................... 53 
Table 2.8. Performance of crude enzymes for the removal (%) of the selected TrOCs........................ 61 
Table 2.9. Details of the selected studies for the removal of TrOCs by EMBR ................................... 68 
Table 2.10. Properties of redox-mediators used to improve the performance of laccase-based treatment 
of TrOCs. Adapted from [295]. .................................................................................................... 71 
 
Table 3.1. Physicochemical properties of the selected 29 TrOCs ....................................................... 101 
 
Table 4.1. Physicochemical properties of selected TrOCs ................................................................. 135 
 
Table 5.1. Physicochemical properties of TrOCs selected for this experiment .................................. 156 
Table 5.2. Toxicity of the bioreactor mixture and permeate following treatment of TrOCs with different 
mediators in MD-EMBR, expressed as relative toxic unit (rTU). The limit of detection of the 
toxicity assay was 10% inhibition of luminescence (i.e., 1 rTU). ‘NA’: not available ............... 175 
 
Table 6.1. Selected physicochemical properties of the selected TrOCs ............................................. 186 
Table 6.2. Estrogenic activity and ecotoxicity of samples collected at the end of different treatment 
options. Number of samples, n = 2. ............................................................................................ 196 
 
Table 7.1. Physicochemical properties of the selected TrOCs ............................................................ 209 
Table 7.2. Description of different wastewater compositions treated by the stand-alone MD ........... 211 
Table 7.3. Characteristics of MBR permeate used for making the different compositions of wastewater 
to be treated by MD .................................................................................................................... 211 
Table 7.4. Removal of different pollutants during the treatment of wastewater by the stand-alone MD 
system ......................................................................................................................................... 218 
Table 7.5. Removal of pollutants during the treatment of wastewater by the PS-assisted MD system
 .................................................................................................................................................... 224 
Table 7.6. Toxicity, expressed as relative toxic unit (rTU), of different samples. The limit of detection 





List of Abbreviations 
ABTS   2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) 
ADI   Acceptable daily intake 
ALR   Anticonvulsant and Lipid regulator 
AMD   Acid mine drainage 
AOPs   Advanced oxidation processes 
AR   Artificial recharge 
CAS   Conventional activated sludge 
DCMD   Direct contact membrane distillation  
DEET   N, N-Diethyl-meta-toluamide 
DMP   2,6-dimethoxyphenol 
DO   Dissolved oxygen 
E1   Estrone 
E2   17β-Estradiol 
E3   Estriol  
EDCs   Endocrine disrupting chemicals 
EDGs   Electron donating functional groups 
EE2   17α-Ethynylestradiol 
EMBR   Enzymatic membrane bioreactor 
EQS   Chronic environmental quality standards 
EWG   Electron withdrawing functional groups 
FO  Forward osmosis  
GAC   Granular activated carbon 
GC-MS   Gas chromatography- mass spectrometry 
HBT   1-hydroxylbenzotriazole 
HPLC   High performance liquid chromatography 
HR-EMBR  High retention enzymatic membrane bioreactor 
HR-MBR  High retention membrane bioreactor 
HRT   Hydraulic retention time 
LC-MS   Liquid chromatography- mass spectrometry 
LiP   Lignin peroxidase 
xxv 
 
Log D   Water partitioning coefficient 
MBR   Membrane bioreactor 
MD   Membrane distillation 
MnP   Manganese peroxidase 
MWCO  Molecular weight cut off 
NF   Nanofiltration 
NSAIDs  Nonsteroidal anti-inflammatory drug 
PCPs   Personal care products 
PhACs   Pharmaceutically active compounds 
PNEC   Predicted no-effect concentration 
PPCPs   Phamaceuticals and personal care products 
PS   Persulfate 
RO   Reverse osmosis 
RQ   Risk quotient 
SA   Syringaldehyde 
SEM-EDS  Scanning electron microscopy – Energy dispersive X-ray spectroscopy 
SPE   Solid phase extraction 
TEMPO  2,2,6,6-tetramethylpiperidin-1-yloxy 
TN  Total nitrogen 
TOC  Total organic carbon 
TrOCs   Trace organic contaminants 
UF   Ultrafiltration 
VA   Violuric acid 
WRF   White-rot fungi 




Chapter 1: Introduction 
1.1. Background 
Due to the rapid population increase and urbanization, water demand for domestic, industrial and 
agricultural activities is increasing at an alarming rate [7, 8]. Less than 3% of all the water on earth 
is categorized as freshwater, most of it frozen in glaciers, ice and snow, and less than 1% present 
as fresh groundwater and soil moisture. Less than 0.01% of it is present as surface water in lakes, 
swamps and rivers. The situation is exacerbated by erratic rainfall patterns due to climate change, 
which impose new challenges to the already water-stressed areas [8-10]. In addition to effective 
water resource management, wastewater treatment and reuse are important strategies because 
wastewater can serve as an alternative non-conventional source of water for diverse end-user 
applications (e.g., irrigation and non-potable reuse), particularly in water scarce regions. The 
concept of water reuse dates back the 1920s [11-13]. Given the ever-increasing water demand and 
uncertain freshwater supply, the importance of water reuse cannot be overstated [14, 15]. Many 
countries around the world either have established stringent regulations to ensure water reuse or 
have initiated programs to promote water reuse. For instance, a few states of USA such as 
California, Florida and Washington have adopted regulations for mandatory connection to the 
reclaimed water network, if available [16], thus creating opportunities for investment in future 
water reuse projects. Importantly, the financial model of water reuse projects continue to evolve 
for attracting investments [17]. These projects are also eligible for subsidies [16]. For example, 
water recycling projects in Australia has received approximately $800 million in funding/subsidies 
from Water Smart Australia program initiated by Australian Government [18]. The market for 
advanced water reuse (i.e., direct and indirect potable) is growing rapidly in USA, Australia, 
Mexico, China, Spain and Saudi Arabia [14], and the total market is expected to reach $12 billion 
by 2025 [8, 19]. 
In the last decade, water reclamation and reuse have received particular attention to meet water 
demand during long term droughts and to improve and strengthen water supply portfolio. For safe 
water reuse applications, effective removal of a wide range of pollutants including bulk organics, 
salts, nutrients and trace organic contaminants (TrOCs) is essential. Among these pollutants, the 
effective removal of TrOCs is one of the most challenging aspects of wastewater treatment and 
reuse as conventional activated sludge (CAS)-based wastewater treatment plants were not 
designed for their removal [20, 21].  
TrOCs include a diverse group of chemicals such as pharmaceuticals, ingredients of personal care 
products, endocrine disrupting chemicals (EDCs), pesticides and industrial chemicals. Most 
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groups of TrOCs such as pharmaceuticals and ingredients of personal care products are of 
municipal origin and are used in homes and workplaces on daily basis, leading to their widespread 
occurrence in municipal wastewater [22-24]. A few other groups of TrOCs such as pesticides can 
contaminate municipal wastewater and freshwater bodies via leaching from roads and 
parks/gardens during rainfall events [23, 25]. According to a thorough literature survey, 
wastewater is the main source of TrOC occurrence in freshwater, hence, their removal in 
conventional wastewater treatment plants (WWTPs) is of prime significance [24, 26]. 
Conventional WWTPs cannot efficiently remove certain groups of TrOCs such as antibiotics, 
pesticides and some industrial chemicals [21, 27]. Presence of TrOCs in the treated effluent could 
cause severe ecological health concerns even at a trace concentration, i.e., in the range of hundreds 
of nanogram per lire to tens of microgram per lire [28-31]. Due to their potentially harmful effect 
on aquatic ecosystem and human health, development of a treatment process for effective removal 
of TrOCs has gained significant interest in the recent years.  
Different physicochemical and biological treatment technologies have been investigated for the 
removal of TrOCs from water and wastewater over the last decade, showing promising results [32-
35]. However, each treatment process has its own advantages and disadvantages. For instance, the 
use of physicochemical processes (e.g., coagulation and adsorption) may lead to the production of 
toxic sludge, and the disposal of the toxic sludge can be problematic [24]. Similarly, high retention 
membrane separation processes such as nanofiltration (NF), forward osmosis (FO) and membrane 
distillation (MD) can effectively retain TrOC but without their mineralization into non-toxic 
compounds [36-38]. Despite being the environmentally friendly and potentially cost-effective 
techniques, biological treatment processes (e.g., CAS process) are only effective for certain groups 
of TrOCs such as hydrophobic compounds and/or compounds with strong electron donating 
groups (EDGs) [39, 40]. For effective removal of TrOCs, high retention membrane separation 
processes such as nanofiltration (NF)/reverse osmosis [41, 42] and membrane distillation [38, 43, 
44] have been combined with membrane bioreactors (MBR) as a post-treatment step, providing 
effective removal to produce TrOC-free effluent stream. To avoid an additional high retention 
membrane separation process, the high retention (HR)-MBRs have been developed, which can 
achieve TrOC retention by membrane and subsequent biodegradation in a single step for the 
production of high quality effluent suitable for water reuse applications [40]. 
HR-MBR combines the high retention membranes such as nanofiltration (NF), forward osmosis 
(FO) or membrane distillation (MD) with a CAS process. Available studies report that HR-MBR 
provides effective removal of a wide range of TrOCs [45, 46]. One of the underlying rationales for 
the development of HR-MBR was that the effective retention of pollutants within the bioreactor 
may facilitate biodegradation due to the prolonged contact time between the activated sludge and 
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TrOCs. Despite the effective TrOC retention achieved by the high retention membranes [45], 
degradation of TrOCs by the activated sludge within the bioreactor has not been reported to 
consistently improve [45, 46]. This is because the degradation of TrOCs by the activated sludge 
depends on their intrinsic biodegradability that is governed by their physicochemical properties 
such as chemical structure and hydrophobicity [47]. Poor degradation of resistant TrOCs HR-MBR 
leads to their accumulation within the bioreactor of HR-MBR. To improve the degradation of 
TrOCs in HR-MBR, other microbes with better TrOC degradation capacity than the conventional 
activated sludge can be introduced. In this context, white-rot fungi (WRF) and their ligninolytic 
extracellular enzymes [48] are worth-noting.  
Depending on growth medium and culture conditions as well as on the type of WRF 
species/strains, WRF can secrete four different ligninolytic enzymes namely laccase, lignin 
peroxidase (LiP), manganese peroxidase (MnP) and versatile peroxidase (VP). In addition, 
cytochrome P450 monooxygenases, a group of intracellular enzymes, have also been reported to 
play a vital role in the degradation of TrOCs via hydroxylation, dehalogenation and heteroatom 
oxygenation mechanisms [49-51]. Whole-cell WRF and their ligninolytic enzymes have been 
reported to efficiently remove a wide range of TrOCs such as pharmaceuticals (e.g., ibuprofen, 
ketoprofen and diclofenac), ingredients of personal care products (e.g., triclosan and oxybenzone) 
and steroid hormones [52-55]. The capacity of WRF for TrOC removal has been commonly 
investigated under sterile conditions to avoid bacterial contamination. However, several studies 
have cast light on the aspect of bacterial contamination by operating bioreactors under non-sterile 
environment using either synthetic [55, 56] or real wastewater [57-62]. For example, Yang et al. 
[55] investigated the performance of whole-cell Trametes versicolor for the removal of bisphenol 
A and diclofenac in a membrane bioreactor under non-sterile conditions using a malt-based 
synthetic wastewater. They observed that the removal of diclofenac was reduced by 40-50% under 
non-sterile conditions as compared to its 99% removal achieved in sterile batch experiments. In 
that study, bacterial contamination was evident from microbial analysis. A few recent studies have 
investigated the removal of pharmaceuticals and endocrine disrupting compounds from municipal 
and hospital wastewater by whole-cell Phanerochaete chrysosporium or Trametes versicolor [57-
63]. In all these studies, bacterial contamination restricted long term operation of the bioreactors 
as the overall removal of the TrOCs gradually reduced as compared to that obtained under sterile 
conditions. 
Use of the harvested enzyme instead of a live whole-cell preparation allows decoupling of fungal 
growth and pollutant degradation steps, and this can be a suitable strategy to avoid bacterial 
contamination issues. Importantly, harvested enzymes can achieve TrOC degradation under mild 
conditions, while realizing higher rates and reaction specificity [64]. Degradation of TrOCs, 
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particularly by laccase has been extensively investigated in recent years [53, 65, 66]. Despite the 
promising performance of laccase for TrOC degradation, a few research gaps need to be addressed 
for improving the efficacy of enzymatic bioreactors. These research gaps are explained in section 
1.2, and are addressed in Chapter 3-7 of this thesis (see Section 1.4).” 
1.2. Knowledge gaps 
Initial studies have assessed the performance of laccase-catalyzed TrOC degradation in batch 
enzymatic bioreactors due to the concern of enzyme washout in a continuous-flow system. In an 
attempt to prevent enzyme washout, an enzymatic membrane bioreactor (EMBR) was developed 
by coupling an ultrafiltration (UF) membrane to an enzymatic bioreactor [53, 67]. Membrane 
coupling to an enzymatic bioreactor offers several advantages over other alternatives such as: (i) 
more effective enzyme retention compared to packed bed reactors; (ii) avoid mass transfer 
limitation linked with enzyme immobilization; and (iii) easy to replenish enzyme for prolonged 
operations [64, 68]. Notably, during the operation of a UF-EMBR, adsorption of some 
hydrophobic TrOCs (e.g., amitriptyline, oxybenzone and octocrylene) onto the enzyme gel layer 
over the membrane surface resulted in enhanced degradation of the adsorbed compounds [53]. In 
another study, removal of four non-phenolic TrOCs, namely atrazine, sulfamethoxazole, 
diclofenac and carbamazepine was improved by 15–25% following the addition of granular 
activated carbon (GAC) in a UF-EMBR. This was probably because simultaneous adsorption of 
laccase and TrOCs on GAC promoted the interaction of TrOCs with the active sites of laccase 
[69]. Results from these studies indicate the complementarity of simultaneous laccase and TrOC 
retention within an EMBR in contrast to only laccase retention by UF membranes utilized in the 
previously developed UF-EMBRs. However, the impact of simultaneous retention of both laccase 
and TrOCs by integrating an enzymatic bioreactor with a high retention membrane separation 
process (e.g., NF and MD) has not been systematically assessed, and performance governing 
factors have not been elucidated.  
Degradation of TrOCs in an enzymatic bioreactor can be improved by adding different natural and 
synthetic redox-mediators that are low molecular weight compounds capable of exchanging 
electrons between laccase and TrOCs [66, 70, 71]. Studied report that the addition of redox-
mediators can extend the spectrum of efficiently degraded TrOCs [53, 72]. However, inhibition of 
laccase activity following the addition of redox-mediators has been observed. For instance, Hata 
et al. [73] observed 90% reduction in laccase activity within fist 8 h of incubation in the presence 
of 1-hydroxibenzotriazole (HBT). Rapid decline in laccase activity was also observed following 
the addition of HBT, syringaldehyde (SA) and 2,2-azino-bis(3-ethylbenzothiazoline-6-sulfnoic 
acid (ABTS) separately [74]. Rate of laccase inactivation depends on the relative stability of the 
radicals generated by redox-mediators. Despite rapid inactivation of enzymes, redox-mediators 
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can compensate by enhancing the rate of reaction, eventually achieving rapid and enhanced 
removal of TrOCs. Hence, it is worthwhile to assess the effect of redox-mediator types and 
concentration on TrOC removal and laccase stability in a high retention (HR)-EMBR capable of 
retaining both laccase and TrOCs. The conventional UF-EMBRs requires continuous mediator 
dosing for achieving stable TrOC removal because redox-mediator pass through the UF membrane 
during filtration of bioreactor media. A high retention membrane processes integrated with an 
EMBR is expected to retain redox-mediators and may allow long-term operation of EMBR without 
mediator re-injection.  
Advanced oxidation processes (AOPs) such as photolysis and persulfate oxidation produce highly 
reactive radicals (e.g., hydroxyl and sulfate radicals) that can directly oxidize a wide range of 
TrOCs [75]. A combination of an AOP and laccase-catalyzed degradation process may act 
synergistically and could achieve effective TrOC degradation. Because an integrated AOP-laccase 
assisted membrane bioreactor system for TrOC removal has not been assessed previously, it will 
contribute to the body of knowledge on the fate of TrOCs in integrated treatment processes. It will 
also help to elucidate the role of a high retention membrane separation process during continuous 
treatment.  
Laccase-catalyzed degradation of TrOCs, particularly in the presence of mediators, produces 
reactive radicals and transformation products that may increase the toxicity of the treated effluent 
[76, 77]. In addition, estrogenic activity is another important parameter to evaluate the safety of 
treated effluent for disposal and reuse [78, 79]. To predict the risk associated with the disposal of 
treated effluent, bioassays have been developed and reported for quantifying the toxicity and 
estrogenicity [80, 81]. However, studies on TrOC degradation do not always report the toxicity 
and estrogenic activity, particularly when treating a mixture of a broad spectrum of TrOCs at an 
environmentally relevant concentration.  
Physicochemical properties of raw water collected from surface water and groundwater are 
diverse. Raw water matrix contains different dissolved organic (e.g., humic substances) and 
inorganic (e.g., heavy metals) impurities. A treatment process capable of effectively removing both 
heavy metals and TrOCs from wastewater should be critically assessed. A few lab-scale studies 
on the removal of TrOCs and heavy metals are available [84, 85], but the impact of impurities such 
as metal salts on pollutant retention and membrane fouling remains largely unexplored. 
1.3. Research objectives  
The primary objective of this thesis is to develop and assess a high retention (HR)- enzymatic 
membrane bioreactor (EMBR) system for achieving enhanced TrOC removal. The main idea was 
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to gain an in-depth understanding of removal mechanisms and the factors affecting the 
performance of HR-EMBR. The specific research objectives are as follows: 
i. To elucidate the impact of simultaneous laccase and TrOC retention on degradation by 
comparing the performance of a nanofiltration (NF)-EMBR with a ‘control’ ultrafiltration 
(UF)-EMBR under identical operating conditions. 
 
ii. To systematically assess the performance of two high retention membranes including 
membrane distillation (MD) and nanofiltration (NF) coupled to an EMBR separately for 
understanding the role of membrane in TrOC and heavy metal removal as well as for 
analyzing the hydraulic performance and stability of the developed treatment systems. 
 
iii. To critically assess the impact of redox-mediator (both natural and synthetic) type, 
concentration and mixture on TrOC degradation, laccase stability and effluent toxicity in 
both NF- and MD-EMBRs.  
 
iv. To elucidate the factors affecting the performance of an integrated laccase/persulfate 




1.4. Thesis outline  
This thesis is divided into eight chapters (Figure 1.1), and the research objectives outlined above 
in Section 1.2 has been addressed in Chapters 3-7.  
Chapter 1 describes the background, research gaps and research objectives of this study. 
In Chapters 2, a comprehensive literature review of the occurrence of TrOCs in wastewater, 
freshwater bodies and seawater. In addition, status and evolution of current activated sludge-based 
biological processes such as MBR and HR-MBR are critically explained to understand the fate of 
TrOCs during wastewater treatment. The current knowledge related to the application of WRF and 
their ligninolytic enzymes (particularly laccase) for TrOC degradation is provided, and the 
performance governing factors along with research gaps are identified.  
Chapter 3 is arguably the most critical chapter of this thesis because it serves as a proof of the 
concept – simultaneous retention of TrOC and laccase within enzymatic bioreactor facilitate 
degradation. This is achieved by comparing the performance of a NF-EMBR and a ‘control’ UF-
EMBR under identical operating conditions.  
In Chapter 4, another configuration of HR-EMBR (i.e., MD-EMBR) is assessed for enhanced 
TrOC degradation, and the impact of laccase source on the extent of degradation are elucidated. 
The purpose of this chapter is to demonstrate that other high retention membrane separation 
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processes, in addition to NF membrane, can be integrated with an enzymatic bioreactor for 
achieving improved TrOC degradation.  
In Chapter 5, long-term performance of MD-EMBR for the removal of 30 TrOCs having diverse 
physicochemical properties (e.g., EDGs/EWGs, hydrophobicity and phenolic/non-phenolic 
moieties) is examined. The effect of dosing redox-mediators, separately and as a mixture, on TrOC 
degradation, laccase stability and effluent toxicity is elucidated. 
In Chapter 6, a novel integrated laccase/persulfate oxidation process is examined for the first time. 
The effect of persulfate concentration and incubation time on TrOC degradation, toxicity and 
estrogenicity is elucidated in both batch bioreactor and continuous-flow NF-EMBR. 
In Chapter 7, simultaneous removal of both TrOCs and the selected heavy metals by MD process 
is assessed. The effect of metal ions and organic impurities on membrane retention and fouling is 
systematically studied. The MD process was selected for simultaneous TrOC and heavy metal 
removal because the literature suggests better performance of MD process as compared to the NF 
membrane. 
Finally, the Chapter 8 summarizes the key findings of this study and outlines recommendations 
for the future research. 
In this thesis, Chapters 3-7 are structured as a scientific publication, with their own introduction, 
materials and methods, conclusion and reference sections; and its own supplementary information 
placed at the end of the thesis. However, where suitable, reference to a section in a previous chapter 



























Figure 1.1. A schematic representation of thesis structure and outline 
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enzymatic membrane bioreactor (HR-EMBR) has not been studied previously, the findings of this 
thesis contribute significantly by identifying the performance governing factors as well as by 
providing an in-depth understanding of the fate of TrOCs during laccase catalyzed degradation in 
EMBR. 
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2.1. Introduction  
In this section, rationale for carrying out this research is outlined, and the arrangement of the 
literature review is explained. Due to their ineffective removal by conventional wastewater 
treatment plants (WWTPs), widespread occurrence of trace organic contaminants (TrOCs) has 
been reported in freshwater bodies (See Section 2.2 and 2.3). For their effective removal, a high 
retention membrane bioreactor (HR-MBR) was developed, which combines the high retention 
membranes such as nanofiltration (NF) or membrane distillation (MD) with an activated sludge. 
Activated sludge-based HR-MBR provides effective removal of a wide range of trace organic 
contaminants (TrOCs), via membrane retention and biodegradation, and can produce high quality 
TrOC-free effluent stream for safe disposal and reuse. One of the underlying rationales for the 
development of activated sludge- based HR-MBR was that the effective retention of pollutants 
within the bioreactor may facilitate biodegradation due to the prolonged contact time between the 
activated sludge and TrOCs. Despite the effective TrOC retention by the high retention 
membranes, degradation of TrOCs by activated sludge within the bioreactor has not been reported 
to consistently improve (see Section 2.3.3.4). This is because the degradation of TrOCs by the 
activated sludge depends on their intrinsic biodegradability. To improve the degradation of TrOCs 
in HR-MBR, other microbes with better TrOC degradation capacity than conventional activated 
sludge can be introduced. In this context, white-rot fungi (WRF) and their extracellular ligninolytic 
enzymes (such as laccase) are worth-noting. They can achieve effective degradation of TrOCs that 
are resistant to an activated sludge-based treatment process (see Section 2.4.2). However, bacterial 
contamination may hamper the growth and enzymatic activity of whole-cell WRF in any reactor 
configuration. Use of the harvested enzymes, particularly laccase instead of a whole-cell 
preparation allows decoupling of fungal growth and pollutant degradation steps, and this can be a 
suitable strategy to avoid bacterial contamination issues. Initially, only batch enzymatic 
bioreactors were assessed for the degradation of TrOCs to prevent enzyme washout with the treated 
effluent (see Section 2.4.2). This led to the development of a laccase-based EMBR that couples 
an enzymatic bioreactor with an ultrafiltration (UF) membrane having a suitable molecular cutoff 
for effective enzyme retention (see Section 2.4.4). UF membranes in practice cannot effectively 
retain TrOCs. Thus, TrOCs that are not readily degraded by laccase can still pass through the UF 
membrane, consequently requiring an additional post-treatment process (e.g., high retention 
membrane separation processes) for their effective removal.  
It is important to note that the formation of an enzyme gel-layer on the surface of the membrane 
in previously developed UF-EMBR effectively adsorbed a few significantly hydrophobic TrOCs 
(log D >3). This resulted in improved degradation of the adsorbed TrOC following their retention 
by the enzyme gel-layer (see Section 2.4.4). Hence, it was envisaged that the use of high retention 
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membranes, which will retain both laccase and TrOCs, can facilitate the degradation of resistant 
TrOCs in HR-EMBR. Importantly, HR-EMBR will produce high quality TrOC-free effluent 
without an additional post-treatment process. In light of the discussion above, literature review is 
structured accordingly in four different sections. In Section 2.2, recent occurrences and fate of 
TrOCs in surface water, groundwater and seawater are systematically presented and discussed. In 
addition, the factors influencing the occurrence of TrOCs in different environmental systems are 
elucidated. Section 2.3 discusses the performance of biological processes (such as conventional- 
and HR-MBRs), and critically analyses the factors governing the removal of TrOCs. Section 2.3 
is critical to understand the fate of TrOCs during biological treatment, and it facilitates in 
identifying the research gaps that led to the development of enzymatic-MBRs. In Section 2.4, 
performance of WRF and their ligninolytic enzymes for TrOC removal is critically evaluated. 
TrOC removal by enzymatic membrane bioreactor (EMBR) is particularly discussed, and the role 
of membrane in removal is elucidated. In addition to exploring the efficiency of enzymatic 
degradation, this thesis explores the combined application of enzymatic and emerging advanced 
oxidation processes (AOPs). In line with this, performance of emerging AOPs such as persulfate 
oxidation process is reviewed and presented in Section 2.5. 
2.2. Trace organic contaminants (TrOCs) 
A broad spectrum of organic compounds has become an integral part of our daily life. These 
compounds are used in immense quantities for a variety of purposes including industrial processes, 
food production and preservation as well as for the healthcare of human and animals [1-3]. 
Occurrence of these compounds in environmental systems has become a topic of growing interest 
over the last decade due to their potential detrimental impacts on both aquatic life and human 
health [4, 5]. Among these compounds, TrOCs, also known as emerging organic pollutants, are of 
particular interest due to their widespread occurrence in wastewater as well as in different 
environmental systems such as groundwater, surface water and seawater. TrOCs from both natural 
and anthropogenic sources can be divided into different categories including pharmaceuticals, 
personal care products, pesticides, industrial chemicals, steroid hormones and food preservatives 
[6, 7]. Concentration of TrOCs in environmental system could be very low (i.e., in the range of a 
few µg/L to ng/L). This not only affects the analytical procedures associated with their detection 
[8], but may also influence the efficacy of water and wastewater treatment processes.  
Conventional wastewater treatment plants (WWTPs) have not been designed for effective TrOC 
removal [9]. Following the discharge of the treated effluent, TrOCs may induce ecotoxicity and 
endocrine disrupting effects in an aquatic ecosystem [10-14]. Although occurrence, fate and 
impacts of TrOCs have been extensively studied in last 15 years, their environmental significance 
is still not fully understood. Different organizations including the World Health Organization 
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(WHO), the European Union (EU), the International Program of Chemical Safety (IPCS) or the 
North American Environmental Protection Agency (EPA) have realized these issues and are 
developing legal frameworks to protect environmental systems, particularly freshwater sources 
[15]. A wealth of studies have been published in the last decade on the occurrence of TrOCs in 
surface water [8, 16, 17] and groundwater [18], as well as their fate in biological and 
physicochemical treatment processes [6, 9, 16]. In this section, recent occurrences and fate of 
TrOCs in surface water, groundwater and seawater are systematically presented and discussed. In 
addition, the factors influencing the occurrence of TrOCs in different environmental systems are 
elucidated.  
2.2.1. Occurrence of TrOCs in environmental systems 
With ever growing population, pharmaceutical production for human use has increased many folds 
in recent years [19, 20]. According to one estimate, thousands of new pharmaceuticals are being 
invented every year [21]. Per capita consumption of pharmaceuticals in developing countries 
varies from 50-150 g/year. However, worldwide average of pharmaceutical consumption is on the 
lower side (15 g/capita.year) due to their less consumption in developed countries [22]. Upon 
consumption, pharmaceuticals and animal medicines are excreted into the wastewater, making it 
the most significant source of TrOC in environmental systems [23]. Similarly, other sources of a 
broad spectrum of TrOCs and their intermediates in different environmental systems include but 
are not limited to hospital wastewater, industrial effluents, aquaculture and livestock activities, 
solid waste dumping and agricultural runoff [18, 24, 25]. Notably, domestic use of pharmaceuticals 
and personal care products remains the largest contributor of TrOC contamination in wastewater 
and subsequently in environmental systems. Sources and pathways of TrOCs in the surface water, 
groundwater and seawater are shown in Figure 2.1. Domestic, industrial and hospital wastewater 
in addition to the effluent from combined sewage treatment plant are the examples of point source, 
and TrOC loading from these sources can be measured and monitored. On the other hand, diffuse 
sources such as urban/agriculture/livestock runoff, biosolids, artificial recharge and leachate 
originating from a large geographical area cannot be quantified accurately (Figure 2.1). 
Uncertainty of TrOC loading in the freshwater and seawater sources originating from diffuse 
sources is the major challenge to measure, assess, control and monitor their detrimental impacts 




Figure 2.1. Sources and pathways of TrOC contamination in freshwater and seawater. Data 
source: [1, 18, 26]. “AR”: artificial recharge 
2.2.2. Wastewater 
Reported concentrations of TrOCs in the influent and effluent of WWTPs summarized in Table 
2.1 indicate significant variations among the selected compounds. Variations in the influent 
concentration of TrOCs can be attributed to several factors such as the production rate, annual 
sales, excretion rate, agricultural practices and average daily water consumption per person. On 
the other hand, effluent concentration of TrOCs may vary, depending on the relevant 
environmental regulations and effectiveness of WWTPs. Since most of the operational WWTP 
were not designed for effective TrOC removal, poor TrOC removal is not entirely unexpected [27, 
28]. According to Table 2.1, influent concentration of TrOCs varies between 1 and 10 µg/L, while 
the concentration of some pharmaceuticals such as atenolol, caffeine, naproxen and diclofenac, 
one industrial chemical (DEHP), one pesticide (triclosan) and one surfactant (nonylphenol) is 
relatively high (up to 1 mg/L) in raw wastewater. TrOCs with high concentration in raw wastewater 
are mostly pharmaceuticals, probably because of their elevated production amounts and 
use/consumption in our daily life. It is important to note that the prescription may not be required 
for a few pharmaceuticals such as ibuprofen and caffeine. Thus, their occurrence at high 
concentration can be attributed to the ease of accessibility.  
Concentration of steroid hormones has been reported to be generally low (<1 µg/L) in raw 
wastewater (Table 2.1). Average excretion rate for steroid hormones ranges between 0.4 and 81 
µg/capita.day (Table 2.1). Effluent concentration of most TrOCs in WWTP varies from 1 to 10 
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µg/L and governed by the efficacy of WWTPs. However, a few TrOCs such as acetaminophen, 
caffeine, DEHP, atenolol and triclosan are discharge into water bodies at high concentrations (up 
to 40 µg/L) due to their abundance in wastewater and/or their persistence to conventional 
wastewater treatment process. Steroid hormones are generally well removed in conventional 
WWTPs, but their very low concentration (up to 1 ng/L) is enough to induce estrogenic effects in 
aquatic life [29].  
In general, production of TrOCs and their use/consumption pattern in a country govern the level 
TrOC contamination in wastewater. Many studies have correlated the concentration of 
pharmaceuticals in wastewater with their production as well as with the population of a country. 
For instance, Kasprzyk-Hordern et al. [23] and Choi et al. [30] studied the occurrence of 
pharmaceuticals such as acetaminophen, carbamazepine, sulfamethoxazole, codeine in the 
wastewater of UK and Korea, respectively. They observed that the concentration of 
pharmaceuticals in wastewater followed the production rate of these TrOCs in their respective 
countries. However, a few studies reported that the concentration of some TrOC in wastewater did 
not correlate well with population and their production rates [31, 32], possibly because TrOCs can 
find their way into wastewater steams from other sources such as storm water runoff a (Figure 
2.1). Since pharmaceuticals require oral ingestion, their occurrence in domestic wastewater also 
depends on their excretion through urine and feces. Excretion rate of ibuprofen, carbamazepine, 
naproxen, clofibric acid and gemfibrozil is generally low (1-10%). On the other hand, the highest 
excretion rate (>70%) has been reported for paracetamol and atenolol (Table 2.1). However, it is 
important to note that high or low excretion rate does not necessarily mean high or low 
concentration of these TrOCs in wastewater. In addition to the ambient environmental conditions, 
outbreak of a certain disease in a community could also influence the concentration of 
pharmaceuticals and personal care products in raw wastewater. Moreover, concentration of 
pesticides in wastewater could be influenced by seasonal variations [16, 33]. Similarly, rainfall 
effects the flow pattern of wastewater in combined sewerage system, resulting in the change of 
wastewater composition containing TrOCs. For instance, Kasprzyk-Hordern et al. [23] observed 
an increase (up to 2 folds) in the concentration of pharmaceuticals in domestic wastewater during 




Table 2.1. Occurrence of a wide range of TrOCs in wastewater. The range of influent 
concentration, effluent concentration and removal efficiency of TrOCs is presented. Excretion 





Concentration (µg/L)  
Removal 
efficiency  
   (%) Influent Effluent (%) 
Pharmaceuticals      
β-blocker Atenolol 50-95 0.14-35.1  0.33-7.60 0-80 
  Metoprolol 5-30 0.019-1.48  0.003-0.30 3-56 
  Propranolol 2.5-10 0-0.5 0.30-0.71 40-45 
  Sotalol 0-17.5 0.320-0.711 0.21-0.24 25-35 
Analgesic and 
anti-inflammatory 
Acetaminophen ≤5  5.64-44 21-70 0-0.03  
  Diclofenac 0.5-39  0.001-90.5  <0.001-0.69 0-81 
  Ibuprofen 5-10  0.004-590  0-55 70-100 
  Ketoprofen -  0.004-9.01  <0.001-3.42 10-100 
  Mefenamic acid -  0.015-1.15  0.005-0.40 0-75  
  Naproxen ≤0.5  <0.01-50.7  0.002-5.1  43-99 
  Salicylic acid    0.58-65.4  0-0.54  90-100  
Anticonvulsant Carbamazepine 3-5   0.035-3.8 <0.01-4.50 0-65 
Lipid regulator Bezafibrate 40-69  0.05-1.39  0.03-0.67 10-70  
  Clofibric acid ≤6    0-0.74  ND-0.33 0-93  
 Gemfibrozil ≤1     0.10-17.1  <0.01-5.24  0-90 
 Antibiotic Erythromycin 5-25  0.14-10.0  0.02-2.84  0-82.  
  Sulfamethoxazole 20  <0.01-0.98  <0.01-1 15-90  
  Trimethoprim ≤39 0.06-6.80  <0.01-3.05 0-80 
Nervous stimulant Caffeine 1-5  0.22-209  0-43.50  50->99  
Personal care 
products 
         
Musk fragrance Galaxolide -  0.03-25  0.06-2.77  85-88 
  Tonalide  - 0.05-1.93   0.05-0.32 80-85  
Disinfectant Triclosan  - 0.03-23.9  0.01-6.88 71->99 
Insect repellant  DEET -  2.56-3.19  0.61-15.8  66-80   
UV filter Benzophenone  - 0.079-0.90  0.079-0.23   64-98 
Steroid hormone        
  Estrone (E1) 19 a 0.01-0.17  0.001-0.08  75-90  





 0.41 a 0.001-0.003  0.001-0.002  45-100  






Concentration (µg/L)  
Removal 
efficiency  
 Surfactants        
 Nonylphenol  - 0.03-101.6  0.03-7.8  25-99  
  Octylphenol  - 0.2-8.7  0.004-1.3  0-95 
Industrial 
Chemicals 
         
Plasticizers Bisphenol A  - 0.013-2.14  0.03-1.10  65-99 
  DBP  - 0-11.8  0-4.13  75-80 
  DEHP  - 0.003-70.0  0.0001-54.0  25-97  
  DMP  - 0-6.49   0-1.52 85-95 
Fire retardant TCEP  -  0.06-0.50  0.06-2.40   0 
  TCPP  - 0.18-40.  10-21  0 
 Pesticides            
Herbicide Atrazine - 0.02-28  0.004-0.73  0-25  
  Diuron -  0.03-1.96  0.002-2.53  25-70  
  Diazinon - 0-0.684  0.0007-4.16  0 
Fungicide Clotrimazole - 0.012-0.08  ND-0.005  85-95  
Insecticide Tebuconazole -  0-1.89  0.0005-0.69  0-60  
“–“: not available; ND: not detected 
a µg/capita.day 
 
2.2.3. Surface water 
Compared to other sources (Figure 2.1), major source of TrOCs in surface water has been reported 
to be the discharge of the treated effluent from WWTPs [17, 35]. After the discharge of TrOCs 
into freshwater bodies, different natural attenuation processes such as photolysis, aerobic 
biodegradation, sorption onto sediments and dilution play an important role. However, in-stream 
attenuation rate varies for each process, and is dependent on the physicochemical characteristics 
of TrOCs and local environmental conditions. For instance, Kunkel and Radke [36] observed 
different attenuation rates for 10 pharmaceuticals in a river, and the physicochemical properties 
were credited for these variations. Similarly, while investigating the relationship between natural 
attenuation rates and physicochemical properties of 225 TrOCs [37], high attenuation rates were 
obtained for: (i) compound having medium to low volatility (−4<log Kaw<−2); and (ii) hydrophilic 
compounds (0<Kow<4.5). By contrast, Acuñaet al. [38] did not observe any meaningful correlation 
between attenuation rate and physicochemical properties of TrOCs. Hence, more studies are 
needed to understand the factor affecting the natural attenuation of TrOCs in environmental 
systems.  
Photolysis is an important natural attenuation process for TrOCs in surface water bodies. However, 
Kunkel and Radke [36] found that some TrOCs such as bezafibrate, metoprolol and naproxen 
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could not be attenuated via photolysis. Despite the efficacy and rapidness of photolysis process, 
resultant transformation byproducts could be toxic and resistant to further photolysis or 
biodegradation. For instance, Donner et al. [39] showed that the transformation byproducts formed 
during photolysis were more toxic than their parent compound (i.e., carbamazepine). Water 
dilution and sorption onto sediments also contribute in attenuating a wide range of TrOCs. 
Significance of water dilution can be realized from the fact that high concentration of TrOCs in 
surface water bodies has been reported during dry weather [40, 41]. Concentration of TrOCs in 
surface water was less in samples collected during summer season than those collected during 
winter season [42]. Enhanced biodegradation rate due to high temperature in summer and/or 
elevated wetter summer season could be another reason of relatively lower TrOC concentration in 
summer than winter [42]. Rainfall, in some cases, can also contribute as a source of TrOCs in 
surface water bodies. This is because they can leach from municipal solid waste dumping sites 
during the rainfall and ends up in either combined sewerage system or surface water bodies [43, 
44].  
Contamination of surface water bodies with pesticides may depend on the characteristic of 
receiving water body such as: flows rate and depth; distance from land; soil characteristics; and 
crop type [45]. While studying the pathways of TrOCs for Swist river basin (Germany), 
Christoffels et al. [44] detected the presence of pharmaceuticals in combined sewer overflows, and 
they also observed the presence of fungicides and insecticides in the runoff originating from an 
orchard, thus, highlighting the significance of diffuse sources for TrOCs. Figure 2.2 illustrates the 
variations in the concentration (ng/L) of each class of TrOCs from recent studies. Pharmaceuticals 
are the most commonly detected class of TrOCs followed by industrial chemicals. Nonsteroidal 
anti-inflammatory drugs (NSAIDs) such as acetaminophen, diclofenac and ibuprofen are the most 


























































































































Figure 2.2. Variations in the concentration (ng/L) of TrOCs in surface water bodies. Box plots 
represents interquartile range, median (horizontal line), min and max (whiskers), and average 
(black and white square box). Number of data points for each class/subclass is given in brackets 
on the x-axis. NSAIDs: Nonsteroidal anti-inflammatory drug; ALR: Anticonvulsant and Lipid 
regulator; and PCPs: Personal care products. Data is extracted from [46-54]. 
Average concentration of pharmaceuticals varies from 75 to 140 ng/L (Figure 2.2) and the highest 
average concentration (140 ng/L) is observed for NSAIDs possibly due to their abundance in 
domestic wastewater (Table 2.1). On the other hand, average concentration of industrial chemicals 
(1150 ng/L) and personal care products (410 ng/L) in surface water is alarmingly high. 
Concentration of steroid hormones ranges from 1 to 10 ng/L, and is high enough to induce 
estrogenic effects [50].  
2.2.4. Groundwater 
Groundwater is the major source of freshwater for domestic and industrial use in many countries. 
It constitutes approximately 30% of total freshwater resources in this world. Since 70% of 
freshwater resources are frozen, groundwater represents 97% of freshwater available for human 
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use [55]. It also suggests that groundwater is key for sustainable water supplies in the world. 
Despite the high attenuation of some TrOCs in soil strata, some studies confirmed the presence of 
TrOCs in groundwater, making it an issue of significant concern [18, 56-58]. Currently, the 
occurrence of TrOCs in groundwater has been well documented only for Europe and America [56, 
58-61]. Concentration of TrOCs may not be as high as in surface water bodies but still more 
emphasis is needed to characterize them better in other parts of the world.    
TrOCs can contaminate groundwater from variety of sources such as wastewater, contaminated 
surface water, landfill leachate, artificial recharge, percolation of agriculture/storm water runoff 
and leakages from sewers and septic tanks (Figure 2.1). Concentration of TrOCs from septic 
tank/sewer leakage and landfill leachate generally varies from 10 to 104 and 10 to 103 ng/L, 
respectively, making them the major sources of groundwater contamination. Application of 
pesticides in agriculture lands may contaminate groundwater because they can percolate down 
with irrigation water [62]. After the discharge of WWTP effluent containing TrOCs in surface 
water bodies, TrOCs can also find their way into groundwater due to lateral and vertical hydraulic 
exchange [63]. For instance, Gasser et al. [64] reported the transfer of TrOCs from surface water 
to groundwater by using carbamazepine as a marker. Artificial recharge (AR) using surface and 
reclaimed water is another source of TrOCs in groundwater, especially when the reclaimed water 
has poor quality and residence time in soil is short. Common AR processes include but are not 
limited to well injection and river bank filtration [65]. TrOCs during the river bank filtration of 
WWTP effluent could find their way into shallow groundwater aquifer, and the concentrations of 
a few compounds such as carbamazepine and sulfamethoxazole were reported to be above 20 ng/L 
in groundwater along the bank of the stream [66].  
TrOCs pass through subsurface and unsaturated zone before reaching the groundwater. During the 
transfer of TrOCs in soil, natural attenuation helps to reduce their concentration [67]. Attenuation 
of TrOCs in underground environment is possible via: (i) adsorption; and (ii) biodegradation. 
Physicochemical properties of TrOCs such as hydrophobicity, molecular weight and chemical 
structure governs their adsorption on soil strata. TrOCs with octanol–water partition coefficient 
(KOW) of less than 1.5 tend to be highly mobile and are more likely to be detected in groundwater 
[68]. For instance, sulfamethoxazole (log KOW=0.9) and caffeine (log KOW=-0.07) have been 
commonly detected in groundwater due to their poor adsorption on soil [18]. A few TrOCs such 
as triclosan (log KOW= 4.76) are only adsorbed by both silt loam and sandy loam soil, while a few 
TrOCs such as caffeine (log KOW=-0.07) are only adsorbed by sandy loam soil. These results 
suggest that caffeine is more likely to reach groundwater than triclosan. Teijón et al. [69] found 
that low sorption potential of naproxen on sandy loam material with low organic content resulted 
in its ubiquitous occurrence in sandy loam aquifer. It also suggests that properties of TrOCs and 
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soil characteristics both govern the mobility of compounds in soil. Occurrence of TrOCs such as 
pharmaceuticals and personal care products in the soil of different countries along with their 
physicochemical properties is presented in Table 2.2. Concentration of a few TrOCs such as 
triclosan and ibuprofen is up to 35.5 µg/Kg due to high sorption capacity (log Kow > 3). Despite 
having poor sorption coefficient (log Kow > -0.9), concentration of oxytetracycline was 9.6 µg/Kg 
in the soils of China. It validates that other factors such as soil properties may also influence the 
occurrence of TrOCs in soil. Moreover, oxytetracycline, ibuprofen and triclosan in soil exceeds 
the predicted no effect concentration (PNEC) of these TrOCs in the soil of China and Mexico. In 
Europe, TrOCs with a log Kow value of greater than 4 are considered an environmental risk [70].  
It is believed that degradation of TrOCs is faster in aerobic conditions than anaerobic conditions, 
probably due to the difference in aerobic and anaerobic microbial communities [71]. Degradation 
of TrOCs in groundwater is generally poor and/or incomplete due to the unavailability of diverse 
microbial species in groundwater. However, while investigating the degradation of 27 
pharmaceuticals under oxic and anoxic conditions, Burke et al. [72] reported effective degradation 
of some TrOCs such as propyphenazone, doxycycline and phenazone only in oxic conditions. On 
the other hand, some TrOCs including clindamycin, roxithromycin and clarithromycin were only 
degraded in anoxic conditions. Increase in temperature during summer season could facilitate the 
removal of a few TrOCs such as iopromide, metoprolol, and diclofenac in the hyporheic zone [73]. 
These observations presented here suggests that environmental parameters and redox conditions 





Table 2.2. Occurrence (µg/Kg) of some TrOCs in the soil of different countries. Data is extracted from [18, 74-79] 
Compounds Class/Use Concentration (µg/Kg) Log Kow PNEC (µg/Kg) 
  USAa Chinab Mexicoc Malaysiad Indiae   
Carbamazepine Anticonvulsant  ND-1.4 0.02-0.06 0.1-16.4 - - 2.45 48.6 
Trimethoprim Antibiotic ND-0.64 0.64-2.15 - 3.1-60.1 - - - 
Ibuprofen NSAID - 1.51-5.03 ND-0.3 - - 3.97 3 
Diclofenac NSAID - 0.35-1.16 <0.1 - - 4.51 735 
Sulfadiazine Antibiotic - 1.15-16 ND - - 0.28 - 
Triclosan  Personal care product ND n.d-16.7 0.4-35.5 - - 4.8 3.74 
Oxytetracycline Antibiotic - ND-9.6 - - - -0.9 0.3 
Norfloxacin Antibiotic - 61.9 - - 0.011 1.03 47-12611 
Salicylic acid NSAID - 4.5 - - - 2.26 2079 
Ciprofloxacin Antibiotic -  - - 0.014 3.1 248915 
Ofloxacin Antibiotic -  - - 0.019 -0.39 569 
Naproxen NSAID - - 0.20-2.40 - - 3.18 2357 
ND: not detected; NSAID: Nonsteroidal anti-inflammatory drug; Kow: Octanol-water portioning coefficient; PNEC: Predicted no-effect 
concentration; and “–“: not reported 
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Box and whisker plot (Figure 2.3) for the five classes of TrOC shows that pharmaceuticals are 
most commonly detected in groundwater, followed by the ingredients of personal care 
products. Average concentration of pharmaceuticals ranged from 100 to 1000 ng/L. 
Pharmaceuticals are of particular interest because of their widespread occurrence in wastewater 
and surface water (see Table 2.1 and Figure 2.2). Concentration of pesticides and personal 
care products is on the higher side (above 100 ng/L) in groundwater (Figure 2.3) as compared 
compared to surface water. This difference is because some studies reported the occurrence of 
TrOCs in the vicinity of a landfill site and septic tank [56, 80]. Concentration of steroid 
hormones is generally low (less than 10 ng/L) except for one study that reported a 17α-



















































































































Figure 2.3. Variations in the concentration (ng/L) of TrOCs in groundwater. Box plots 
represents interquartile range, median (horizontal line), min and max (whiskers), and average 
(black and white square box). Number of data points for each class/subclass is given in brackets 
on the x-axis. NSAIDs: Nonsteroidal anti-inflammatory drug; ALR: Anticonvulsant and Lipid 
regulator; and PCPs: Personal care products. Data is extracted from [56, 57, 81-87].  
2.2.5. Seawater 
According to one estimate, one fifth of the world population lives in coastal areas. 21 out of 33 
megacities of the world such as Mumbai (India), Guangzhou (China) and New York (USA) 
are situated in coastal areas [88]. Corcoran [89] estimated that above 80% untreated wastewater 
in coastal areas is discharged in to oceans without any treatment. Septic tanks are used for 
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wastewater collection in many Asian countries, and wastewater is subsequently released to 
coastal waters without any treatment [90]. A few cities such as Los Angeles discharge their 
treated effluent into oceans via marine outfalls [91, 92]. Following disposal in freshwaters, 
treated effluent also ends up in oceans, thereby putting an additional load of TrOC in seawater. 
According to one estimate, 150 tons of pharmaceuticals are received by the ocean via Yangtze 
River in China [93]. Ships, cruise liners and boats discharge their treated effluent in oceans 
[94]. Moreover, leachate from the landfill sites in coastal areas could also contaminate oceans. 
For instance, Rodríguez-Navas et al. [95] reported that the leachate from a landfill site situated 
in Mallorca Island (Spain) is adding 27 µg/L of pharmaceuticals in ocean on daily basis.  
Aquaculture is one of the largest industry of the world, and more than 500 million people are 
associated with this industry [96]. A range of pharmaceuticals are used in aquaculture activities 
to prevent the outbreak of diseases. According to one estimate, more than 75% of the 
pharmaceuticals used during aquaculture find their way into oceans via food pellets and 
excretion [97]. Like surface water and groundwater, other sources of TrOCs in oceans include 
surface runoff, agriculture runoff and leaching from domestic/hospital waste [98, 99].  
Unlike freshwater, occurrence and fate of TrOCs in oceans has been investigated only recently 
as >70% of the studies dealing with this topic are published in last ten years. However, more 
investigations are required for many parts of the world, especially South America, Asia and 
Africa. Interestingly, there is only one study reporting the occurrence of TrOCs in India, the 
2nd largest population of the world [100]. Pharmaceuticals have been the most commonly 
reported class of TrOCs, while data availability is very limited for other classes such as personal 
care products, industrial chemical and pesticides. Scope of the studies included in this section 
varies significantly. Some studies deal with a particular class of TrOCs [101], while others 
focus on the development of detection methods and validation [102]. Occurrence of TrOCs in 
oceans is presented in Figure 2.4, which shows that pharmaceuticals have been commonly 
detected. Among pharmaceuticals, NSAIDs are ubiquitously detected followed by ALR. 
Concentration of pharmaceuticals ranged from 1 to 1000 ng/L, while the concentration for 
other classes ranged from 0.1 to 1000 ng/L. It is also observed that the concentration of TrOCs 
is usually greater than the predicted no-effect concentration (PNEC) of 10 ng/L.  
Dilution and adsorption are the two natural attenuation process in oceans. However, 
concentration of a few TrOCs such as ketoprofen, gemfibrozil and caffeine can be higher than 
PNEC, suggesting that dilution could not reduce the concentration of TrOCs to acceptable 
levels. For instance, concentration of gemfibrozil (77–758 ng/L) and ketoprofen (185–805 






















































































































Figure 2.4. Average concentration (ng/L) of the five major classes of TrOCs in sea and coastal 
waters. Box plots represents interquartile range, median (horizontal line), min and max 
(whiskers), and average (black and white square box). Number of data points for each 
class/subclass is given in brackets on the x-axis. NSAIDs: Nonsteroidal anti-inflammatory 
drug; ALR: Anticonvulsant and Lipid regulator; and PCPs: Personal care products. Data is 
extracted from [103-108]. 
Adsorption of TrOCs in marine environment is influenced by acid dissociation constant (pKa) 
and pH of the seawater because these factors can change the octanol-water partition coefficient 
(log Kow) of TrOCs. For instance, log Kow of propranolol and fluoxetine was observed to 
increase linearly with pH [109, 110]. Similarly, typical pH=8 of seawater facilitates the 
lipophilicity of ionisable TrOCs onto marine sediments and marine organisms. For instance, 
McEneff et al.  [111] reported incomplete dissociation of trimethoprim (pKa= 6.6) in marine 
environment. In some studies, log D has been used to predict the adsorption/sorption of TrOCs 
onto marine sediments/biota. For example, Fu et al. [112] observed that TrOCs with high log 
D (>3) are more likely to adsorb onto marine sediments. Occurrence of a few commonly 











17β – estradiol 11–63 2.9–11.4  
17α – ethinylestradiol 0.15–130 3– 38 
Trimethoprim 0.1–734000 0.6 
Tetracycline 0.6–7.1 1.9–9.5 
Sulfamethoxazole 0.4–820000 2.3-20 
Diclofenac 0.1–10 1.3–5.3 
Naproxen 0.6–15.8 - 
Ibuprofen 98–100 - 
Acetaminophen 0.1–25.5 - 
Atenolol 0.1–0.3 0.3–13 
Propranolol 0.1–0.9 - 
Clofibric Acid 0.1–0.1  
Gemfibrozil 0.1–0.9 - 
Caffeine 1.9–12.2 - 
Simvastatin 2–4 - 
Triamterene 0.3–10.8 - 
Carbamazepine 0.1–88.8 - 
“-“: not reported 
 
2.3. TrOC removal by biological treatment processes 
As discussed above in Section 2.2, TrOCs are ubiquitously detected in municipal wastewater, 
industrial wastewater, hospital wastewater and landfill leachate. Due to their ineffective 
removal by WWTPs (Table 2.1), widespread occurrence of TrOCs has been reported in 
freshwater bodies [46-54]. Concentrations of TrOCs in the effluent of WWTPs and sewage-
impacted waterbodies range between hundreds of nanogram per litre (ng/L) and tens of 
microgram per litre (μg/L) [114, 115]. Even at the reported trace concentrations, several 
categories of TrOCs (e.g., pharmaceuticals) are biologically active compounds, and cause acute 
and/or chronic ecological risks such as: (i) interference with the endocrine systems of the 
aquatic life; and (ii) accumulation in plants and animals. Thus, effective removal of TrOCs, 
particularly from municipal wastewater is essential for safe disposal of WWTP effluents. 
Among different physicochemical and biological treatment processes investigated over the last 
few decades [116, 117], biological treatment processes, particularly conventional activated 
sludge (CAS) and membrane bioreactor (MBR) have been by far the most commonly 
investigated processes. Physicochemical treatment processes such as coagulation-flocculation, 
advanced oxidation processes (AOPs) and membrane separation processes (e.g., nanofiltration, 




Biodegradation is the dominant mechanism of TrOC removal in CAS-based biological process. 
During biological treatment, microorganisms convert and/or biomineralize TrOCs into simple 
organic and/or inorganic molecules (carbon dioxide and water). Microorganisms generate 
energy by utilizing organic compounds as a primary source of food. A part of this energy is 
used by the microorganisms for their cell growth, and the remaining energy is used for cell 
maintenance [119]. Since some TrOCs such as antibiotics and pesticides can be toxic to 
microorganisms, an additional growth substrate may be required to maintain microbial growth 
and diversity for adequate biodegradation. This process of adding an additional substrate is 
known as ‘cometabolism’ [120, 121]. In this section, performance of biological processes (such 
as conventional- and HR-MBRs) are discussed, and the factors governing the removal of 
TrOCs is critically analysed. This section is critical to understand the fate of TrOCs during 
biological treatment, and it facilitates in identifying the research gaps that led to the 
development of enzymatic-MBRs 
2.3.1. TrOC removal by CAS process 
In the CAS process, growth of microorganism takes place in an aeration tank under aerobic 
conditions. Among other conventional biological processes, the CAS process is the most 
widely applied treatment process for the treatment of municipal wastewater [122]. Although 
CAS-based WWTPs have not been designed for effective TrOC removal, it can achieve above 
80% removal for some specific groups TrOCs such as bisphenol A, caffeine and surfactants. 
Several different mechanisms such as photolysis, volatilization, biodegradation and sorption 
onto activated sludge have been reported to contribute in TrOC removal, but major portion of 
these compounds are removed via biodegradation. The extent of TrOC removal depends on 
their physicochemical properties of TrOCs and operational parameters of the CAS process 
[123, 124]. This aspect is comprehensively discussed in Section 2.3.3.4. Performance of the 
CAS process for the removal of 86 TrOCs categorized based on their use/class is presented in 





Figure 2.5. Removal of different categories of TrOCs by an CAS-based treatment process. Data presented as average ±standard deviation. Data is 





The CAS process can achieve greater than 95% removal for all the selected surfactants. 
Effective removal of surfactant by the CAS process has been attributed to both sorption onto 
the activated sludge and biodegradation [122]. Margot et al. [127] reported that biodegradation 
remained the dominant mechanism of removal for surfactants. However, notably, they 
observed that sorption is mainly responsible for the removal of a cationic surfactant, namely 
dialkyldimethylammonium chloride [127].  
All the EDCs are shown separately in Figure 2.5, because they can be harmful even a very low 
concentration. Of the 23 EDCs, complete elimination of four EDCs, namely 2-OHE1, a-OHE1, 
androstenedione and androsterone has been reported following treatment with the CAS 
process. Average removal of the remaining EDCs ranges from 75 to 90% except for the one 
syenthetic estrogen D-equilin (less than 5%) [128]. Due to their simple chemical structure, high 
sorption potential and biodegradability, EDCs are either adsorbed onto activated sludge or 
biodegraded by the activated sludge [123, 129]. According to the available literature, 
availability of dissolved oxygen is one of the key factors for effective EDC removal. For 
instance, Furuichi et al. [130] reported better removal of EDCs under aerobic conditions as 
compared to anaerobic conditions.  
The CAS process has been reported to achieve significant removal (70-95%) for several PCPs 
such as methyl dihydrojasmonate, methylparaben, oxybenzone, galaxolide, tonalide and 
salicylic acid. Although removal of DEET, cashmeran, celestolide and 2,4-D is not as high as 
others TrOCs in this category, the CAS process can still achieve up to 60% removal. Notably, 
sorption was reported to be the dominant mechanism for PCPs with above 70% removal in the 
CAS process. Indeed, Margot et al. [127] estimated that the contribution of sorption in the 
overall removal of two PCPs (galaxolide and tonalide) can be as high as 80%. Removal of 
pesticides in the CAS process has been reported to range between 50 and 60% (Figure 2.5). 
Among the selected pesticides, atrazine is the most recalcitrant pesticide and was poorly 
removed (25%) by the CAS process (Figure 2.5). 
Reported removals for different classes of pharmaceuticals such as beta-blockers, NSAIDs and 
antibiotics indicate that there is no apparent correlation in their removal. Beta-blockers such as 
atenolol and propranolol were poorly removed (<25 %) by the CAS process. Although atenolol 
and propranolol contain an electron donating group (EDG), their hydrophilic nature and poor 
affinity for biosolids could be the reason of their poor biodegradation in CAS process [124]. 
Among analgesics and anticonvulsants pharmaceuticals (Figure 2.5), ibuprofen, naproxen, and 
paracetamol were well removed (>70%) by the CAS process, probably because their chemical 
structure contains strong EDGs. Similarly, removal of a few antibiotics, namely ciprofloxacine, 
norfloxacin and ofloxacin as well as a few NSAIDs such as gemfibrozil and clofebric acid has 
been reported to be ranged between 50-60% in the CAS process. All nervous simulants and 
metabolites were observed to be completely removed (95-99 %) in the CAS process (Figure 
2.5). In general, highly polar pharmaceuticals containing EWGs such as carbamazepine, 
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diclofenac, primidone and erythromycin are resistant to the biodegradation by the activated 
sludge in the CAS process and cannot be biodegraded by microorganisms. In addition, these 
TrOCs have the tendency to inhibit microbial activity [122, 131, 132]. Although it is difficult 
to classify the TrOC removal based on different categories, removal trends (Figure 2.5) can be 
written as follows: surfactants > nervous stimulants > metabolites > EDCs > personal care 
products > pesticides > pharmaceuticals except metabolites and stimulants. 
2.3.2. TrOC removal by MBR 
Membrane bioreactor (MBR) is considered as an effective improvement of the CAS process 
due to its robust and compact design as well as excellent effluent quality [133-135]. In 
conventional MBR, activated sludge is responsible for the degradation of the pollutants such 
as bulk organics, nutrients and TrOCs, while micro- or ultra-filtration (MF/UF) based 
membrane separation process effectively retains the activated sludge within the bioreactor 
[136-138]. Conventional MBR can achieve efficient aqueous phase removal of bulk organics 
from wastewater [139-141]. As far as TrOC removal is concerned, MBR may achieve better 
removal for certain groups of TrOCs as compared to the CAS process, possibly due to high 
concentration of the mixed liquor suspended solids (MLSS) and long solids retention time 
(SRT) [16, 124, 142]. MBR has been investigated extensively for the removal of TrOCs in the 
last decade, and its performance for the removal of TrOCs is shown in Figure 2.6. TrOCs are 
arranged in their respective class such as EDCs, pesticides and antibiotics. It is interesting to 
note that removal of some TrOCs such as fenoprop, triclosan, atenolol and carbamazepine 
varies from one study to another possibly due to different operating and environmental 
conditions.  
Like the CAS process (Figure 2.5), average removal efficiency for EDCs is generally high and 
ranges from 80 to 99% in MBR. Above 90% removal has been observed to be achieved by 
MBR for two PCPs namely salicylic acid and octocrylene, while the removal for other personal 
care products range between 50 and 70%. As expected, pesticides have not been effectively 
removed by MBR except for triclosan and 2, 4-D. Atrazine was the most poorly removed 
compound with removal of less than 25% among all pesticides, while triclosan removal could 
be as high as 99% (Figure 2.6). Although different classes of pharmaceuticals showed TrOC-
specific removal, removal of beta blockers and NSAIDs range from 70 and 90%. Some 
pharmaceuticals such as carbamazepine, trimethoprim and roxithromycin are poorly removed 
(<50%) in MBR. Compared to the CAS process (Figure 2.5), approximately 10-20% 
improvement in the removal of pharmaceuticals could be achieved in MBR.  
Similar to other biological processes, removal of TrOCs in biological systems is also influenced 
by operational parameters and physicochemical properties of TrOCs such as chemical structure 
and hydrophobicity [124] as explained in Section 2.3.3.4. General trend in MBR based on 
different TrOC categories is as follows: EDCs > stimulants > NSAIDs > Analgesics > PCPs > 
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Antibiotics > beta-blokers > pesticides. Despite the effectiveness of MBR for the removal of a 
broad spectrum of TrOCs, knowledge is limited to understand the compound specific removal 
mechanisms and degradation pathways in addition to the fate of byproducts and their impacts 


































































































































































































































































































































































































































































Figure 2.6. Removal of different categories of TrOCs by MBR. Data presented as average 
±standard deviation. Data is extracted from [125, 126]. 
2.3.3. TrOC removal by high retention (HR)-MBR 
Ineffectiveness of the CAS process and conventional MBR for the removal of certain groups 
of TrOCs is a significant concern. For effective removal of TrOCs, high retention membrane 
separation processes such as nanofiltration (NF)/reverse osmosis [145, 146] and membrane 
distillation [147-149] have been combined with conventional MBRs as a post-treatment step. 
To avoid an additional high retention membrane separation process, the high retention (HR)-
MBRs have been developed, which can achieve TrOC retention by membrane and subsequent 
biodegradation in a single step for the production of high quality effluent suitable for water 
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reuse applications [150]. HR-MBR combines the high retention membranes such as 
nanofiltration (NF), forward osmosis (FO) or membrane distillation (MD) with an activated 
sludge process. Available studies report that HR-MBR provides effective removal of a wide 
range of TrOCs and can produce high quality TrOC-free effluent stream [151, 152]. One of the 
underlying rationales for the development of HR-MBR was that the effective retention of 
pollutants within the bioreactor may facilitate biodegradation due to the prolonged contact time 
between the activated sludge and TrOCs. Despite the effective TrOC retention by the high 
retention membranes [151, 153], degradation of TrOCs by activated sludge within the 
bioreactor has not been reported to consistently improve [151, 152]. This is because the 
degradation of TrOCs by the activated sludge depends on their intrinsic biodegradability that 
is governed by their physicochemical properties such as chemical structure and hydrophobicity 
[6].  
A few excellent reviews on the main features, overall performance and technological 
constraints of HR-MBR have been published recently [150, 154-156]. However, removal of 
TrOCs by HR-MBR and factors affecting the removal of TrOCs by the activated sludge, 
particularly in HR-MBR have not been critically reviewed and discussed. This section aims to 
critically analyze the removal of TrOCs by the high retention membranes and activated sludge 
in HR-MBR. In addition, mechanisms of TrOC removal by HR-MBR are systematically 
elucidated. Based on the contribution of each mechanism of TrOC removal, a qualitative 
predictive framework is proposed.  
2.3.3.1. HR-MBR configurations 
In addition to the use of high retention membranes that allows effective retention of pollutants 
including TrOCs, HR-MBRs may have different features compared to the conventional MBR 
configuration (Figure 2.7a). Three configurations of HR-MBR, namely membrane distillation 
(MD)-MBR (Figure 2.7b), forward osmosis (FO)-MBR (Figure 2.7c) and nanofiltration (NF)-
MBR (Figure 2.7d) have been investigated to-date [151, 152, 157].  
Mechanisms of TrOC removal by HR-MBR include: (i) membrane retention; (ii) 
biodegradation; (iii) sorption; (iv) air stripping/volatilization; and (v) photolysis [6, 21, 158]. 
Removal of TrOCs by volatilization depends on the Henry’s constant (H), which is the ratio of 
the concentration of a target pollutant in air to its concentration in wastewater. It has been 
reported that the removal of target pollutants via volatilization can be significant (5-10%) if 
their H values are higher than 0.005 [159-161]. Since the values of H for TrOCs generally fall 
in the range of 10-6 to 10-10, TrOC removal in HR-MBR via volatilization is insignificant. 
Similarly, contribution of photolysis is negligible due to the high mixed liquor suspended solids 
(MLSS) concentration in the bioreactor [152, 162]. Hence, biodegradation, sorption and 
membrane retention mechanisms primarily contribute in varying extent for TrOC removal by 
HR-MBR as discussed in the following sub-sections. 
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Figure 2.7. Schematics of (a) Conventional membrane bioreactor (MBR); (b) membrane 
distillation bioreactor (MDBR); (c); forward osmosis- membrane bioreactor (FO-MBR); and 
(d) nanofiltration- membrane bioreactor (NF-MBR)  
2.3.3.2. Mechanisms of TrOC removal by high retention membranes 
Retention by high retention membrane appears to be the most dominant mechanism for removal 
of TrOCs that are resistant to degradation by the activated sludge. Therefore, understanding 
the mechanisms of TrOC removal by MD, NF and FO membranes is vital. TrOC 
retention/removal by high retention membranes depends on: (i) the type of high retention 
membrane; (ii) influent characteristics; and (iii) operating conditions (Table 2.4). TrOC 
retention by NF and FO membranes has been reported to be influenced by a number of factors 
(Table 2.4) such as physicochemical properties (e.g., hydrophobicity, charge and molecular 
weight) of TrOCs, operating parameters and membrane properties as explained below [163-
166]. On the other hand, TrOC retention by MD membranes depends on the volatility (pKH) 
and hydrophobicity (log D) of pollutants [147, 150], thereby making TrOC retention by MD 
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membrane simpler as compared to NF and FO membranes. In a stand-alone MD process, 
‘pKH/log D’ ratio of less than 2.5 corresponds to ineffective TrOCs retention (50-70%), while 
TrOCs with a high pKH/log D ratio (>2.5) are effectively retained (90-99%) by MD membranes 
[147]  




FO membrane NF membrane 
Fouling * * * 
Diffusion of solute - * * 
Hydrophobicity * * * 
Membrane MWCO - * * 
Charge on TrOCs - * * 
Membrane surface 
charge 
- * * 
Polarity  - * * 
Molecular width  - * * 
Volatility of TrOCs * * * 
Temperature and pH  * * * 
“ –”  : no effect according to available reports 
 
Mechanisms of TrOC retention by NF and FO membrane consist of: (i) the net sorption of a 
solute on the membrane surface; (ii) the transport of solute inside the membrane; and (iii) the 
sieving property of the membrane [150, 167, 168]. Influence of other factors including 
hydrophobicity and charge repulsion on sorption and solute transport has also been observed 
[169, 170]. In general, size exclusion mechanism is responsible for the retention of non-ionic 
and hydrophilic (log D <3) TrOCs, and the extent of retention depends on the molecular weight 
cut-off (MWCO) of membranes. For example, a tight NF membrane (MWCO <200 g/mole) 
achieved 97% retention of carbamazepine (log D = 1.89) from a filtered lake water containing 
a mixture of 22 TrOCs, while only 50% removal was observed by a loose NF membrane 
(MWCO >300 g/mole) [171]. In another study by Xie et al. [172], retention of carbamazepine 
by a cellulose triacetate FO membrane remained in between 80 and 90% at different pH values 
(i.e., 3.5-7.5). Similarly, carbamazepine retention by cellulose triacetate and thin film 
composite polyamide FO membranes was reported to be 90-95% [173].  Effective retention 
(80-99%) of other hydrophilic TrOCs such as metronidazole (log D = -0.14), clofibric acid (log 
D = -1.06) and N, N-Diethyl-meta-toluamide (DEET, log D = 2.42) by NF and FO membranes 
has been reported [145, 174-177]. Hydrophobic TrOCs (log D >3) such as steroid hormones, 
bisphenol A and 4-tert-octylphenol have also been reported to be effectively retained (>80%) 
by both NF and FO membranes [164, 177, 178]. Notably, hydrophobicity of TrOCs can 
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influence their retention because hydrophobic TrOCs can adsorb onto the membrane surface, 
thus initially resulting in their effective retention. However, as the filtration continues, their 
retention may reduce due to their subsequent diffusion into the permeate [164, 177]. Compared 
to hydrophilic TrOCs, hydrophobic TrOCs, regardless of their size, can diffuse into the 
permeate to attain an equilibrium between the concentration of hydrophobic TrOCs on/near the 
membrane surface and the permeate. This gradually reduces the extent of TrOC retention by 
the NF and the FO membranes [179-181]. Once an equilibrium between the concentration of 
TrOCs on/near membrane surface and permeate is established, the role of adsorption in TrOC 
retention diminishes, and charge repulsion and size exclusion mechanisms govern the retention 
of TrOCs by NF and FO membranes [168, 182].  
NF and FO membranes are negatively charged at pH=7 owing to the protonation of their 
functional groups [168, 171]. Hence, membrane surface charge and its interaction with charged 
TrOCs such as diclofenac, naproxen and ibuprofen will govern the extent of their retention. 
Poor rejection of positively charged hydrophobic TrOCs such as steroid hormones by NF/FO 
membrane can be attributed to the attraction between positively charged TrOCs and negatively 
charged membrane surface. This consequently increases the concentration of solute at the 
surface of membrane, thus increasing their diffusion into permeate. On the other hand, effective 
retention of negatively charged hydrophilic TrOCs is due to the charge repulsion mechanism, 
which keeps TrOCs away from the membrane surface [179, 183, 184]. Notably, the 
transformation of neutral TrOCs to negatively charged TrOCs at pH>pKa can improve their 
retention by NF and the FO membranes. For example, an increase of 50 and 65% in the 
retention of sulfamethoxazole (pKa = 5.6) and ibuprofen (pKa = 4.47), respectively, by a thin 
film composite NF membrane was observed when the feed pH was changed from 5 to 10 [167].  
In another study, retention of ibuprofen (pKa = 4.47) and naproxen (pKa = 4.2) by an FO 
membrane was observed to be increased by 10-15% due to the increase in the pH of feed from 
6 to 8 (i.e., pH>pKa) [173]. Based on the discussion regarding the factors affecting the retention 






Figure 2.8. Qualitative predictive framework for the retention of TrOCs by NF or FO 
membrane. The case of an acidic compound is depicted here. A basic compound will become 
positively charged at pH<pkb. The transformation of neutral TrOCs to negatively charged at 
pH > pKa or positively charged at pH < pKb can improve their retention by NF and the FO 
membranes. Modified from [166, 170] 
2.3.3.3. Aqueous phase removal of TrOCs by HR-MBR  
As mentioned before, three configurations of HR-MBR, namely membrane distillation 
bioreactor (MDBR), forward osmosis (FO-MBR) and nanofiltration (NF-MBR) have been 
investigated to-date [151, 152, 157, 185]. Depending on the physicochemical properties of 
TrOCs and the type of HR-MBR configuration, removal of TrOCs by HR-MBRs can range 
between 90-99% (Table 2.5).  
The advantage of an integrated biodegradation and membrane separation process is that HR-
MBR can achieve better TrOC removal as compared to the standalone HR-membrane. For 
instance, Wijekoon et al. [147] studied the rejection of a mixture of 30 TrOCs by a standalone 
MD process, and observed partial retention (50-70%) of a few volatile TrOCs (pKH <9) such 
as 4-tert-octylphenol (pKH= 5.06), benzophenone (pKH= 5.88) and amitriptyline (pKH= 8.18). 
On other hand, when the performance of MDBR was studied for the removal of a mixture of 
30 TrOCs, effective removal (95-99%) was achieved by MDBR for all the selected 30 TrOCs 
including those partially removed by the standalone MD process [147, 152].  
Compared to ineffective or unstable removal of a few hydrophobic TrOCs such as bisphenol 
A (40-80%), oxybenzone (70-75%), estrone (80%), and 17α – ethynylestradiol (70-90%) by a 
standalone FO process [168], FO-MBR has been reported to achieve above 99% removal for 
hydrophobic TrOCs [151, 186]. Better performance of MDBR and FO-MBR for TrOC removal 
as compared to the standalone MD and FO process can be attributed to the efficient degradation 
of volatile and hydrophobic TrOCs such as 4-tert-octylphenol, benzophenone, triclosan, 















(H) b  
pKH b 
Log D at 
pH=7 a 
Removal efficiency (%) 
  g/mole     FO-MBR c MDBR d NF-MBR e 
Primidone C12H14N2O 218.25 12.26 ± 0.40 1.164E-14 13.93 0.83 >99 >99 - 
Ketoprofen C16H14O3 254.28 4.23 ± 0.10 2.005E-14 13.70 0.19 >99 >99 94 
Naproxen C14H14O3 230.26 4.84 ± 0.30 2.096E-13 12.68 0.73 >99 >99 98 
Gemfibrozil C15H22O3 250.33 4.75 7.677E-13 12.11 2.07 >95 >99 99 
Metronidazole C6H9N3O3 171.15 14.44 ± 0.10 2.073E-12 11.68 -0.14 >95 >99 99 
Diclofenac C14H11Cl2NO2 296.15 4.18 ± 0.10 3.098E-12 11.51 1.77 >95 90 45-95 
Fenoprop C9H7Cl3O3 269.51 2.93 3.284E-12 11.48 -0.13 83-99 95 - 
Ibuprofen C13H18O2 206.28 4.41 ± 0.10 4.066E-11 10.39 0.94 >99 >99 100 
Ametryn C9H17N5S 27.33 3.71±0.41 4.418E-10 9.35 2.97 >99 >99 - 
Clofibric acid C10H11ClO3 214.65 3.18 ±0.10 2.909E-10 9.54 -1.06 >99 >99 75 
Carbamazepine C15H12N2O  236.27 13.94 ± 0.20 8.168E-10 9.09 1.89 50-99 95 18-75 
Octocrylene C24H27N 361.48 -  3.382E-09 8.47 6.89 80-90 90 95 
Amitriptyline C20H23N 277.40 9.18 ± 0.28 6.596E-09 8.18 2.28 >99 >99 83-100 
Atrazine C8H14ClN5 215.68 2.27 ± 0.10 5.223E-08 7.28 2.64 75-90 >99 16-80 
Propoxur  C11H15NO3 209.24 1.49 ± 0.70 5.265E-07 6.28 1.54 >99 >99 - 
Benzophenone C13H10O 182.22 - 1.316E-06 5.88 3.21 >99 95 >99 
N, N-Diethyl-meta-toluamide (DEET) C12H17NO 191.3 - 1.410E-06 5.85 2.42 40-90 - 60 
Estriol C18H24O3 298.33 10.25 ± 0.70 1.644E-11 10.78 1.89 >99 >99 - 
17α – Ethynylestradiol C20H24O2 269.40 10.24 ± 0.60 3.399E-10 9.47 4.11 >99 >99 - 
Oxybenzone C14H12O3 228.24 7.56±0.35 5.851E-10 9.23 3.89 >99 >99 - 
Estrone C18H22O2 270.37 10.25 ± 0.40 9.286E-10 9.03 3.62 >99 >99 95 
17β – Estradiol C18H24O2 272.38 10.27 1.173E-09 8.93 4.15 >99 >99 - 
17β – Estradiol-17-acetate C20H26O3 314.42 10.26 ± 0.60 2.151E-09 8.67 5.11 >99 >99 - 
Bisphenol A C15H16O2 228.29 10.29 ± 0.10 2.197E-09 8.66 3.64 >99 >99 95-97 
Salicylic acid C7H6O3 138.12 3.01 ± 0.10 6.653E-09 8.18 -1.13 >99 95 70 
Triclosan C12H7Cl3O2 289.54 7.80 ± 0.35 6.537E-07 6.18 5.28 >99 >99 82 
4-tert-Butylphenol  C10H14O 150.22 10.13 ± 0.13 7.136E-06 5.15 3.40 >99 >99 88 
4-tert-Octylphenol  C14H22O 206.32 10.15 ± 0.15 8.670E-06 5.06 5.18 >99 >99 - 
a Data extracted from SciFinder Scholar; b Henry’s law constant (H)  = Vapour pressure × molecular weight/water solubility; and pKH = - log10 H. c Wijekoon, Hai, Kang, Price, Guo, Ngo, Cath and Nghiem 
[152]; d Alturki, McDonald, Khan, Hai, Price and Nghiem [188]; Holloway, Regnery, Nghiem and Cath [187]; Lay, Zhang, Zhang, McDougald, Tang, Wang, Liu and Fane [189] Luo, Hai, Kang, Price, Nghiem 
and Elimelech [186]; and Luo, Phan, Xie, Hai, Price, Elimelech and Nghiem [151]; e Phan, McDonald, Hai, Price, Khan, Fujioka and Nghiem [157]; and Wang [153] 
“–”: not available 
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Both MDBR and FO-MBR was reported to achieve effective removal of a range of TrOCs (Table 
2) [150, 190]. Indeed, a comparison of the aqueous phase removal of TrOCs by CAS, conventional 
MBR and HR-MBR reveals that median TrOC removal by HR-MBR is almost 90%, while median 
values for CAS and MBR are approximately 60 and 65%, respectively (Figure 2.9).  































Figure 2.9. Aqueous phase removal of TrOCs by CAS, MBR and HR-MBR. Box-and-whisker 
plot is showing information about: the interquartile range; median (horizontal line in the box); min 
and max (whiskers); and average (block square in the box). Adapted from [126]. 
2.3.3.4. Factors affecting TrOC removal by activated sludge in HR-MBR 
2.2.3.4.1. Effect of TrOC molecular structure 
Degradation of TrOCs by activated sludge depends on their intrinsic biodegradability and sorption 
potential. The extent of TrOC degradation can vary depending on the chemical structure of the 
target compound [186, 191]. In general, simple structured TrOCs without branched/multi chain 
alkyl groups are readily biodegraded compared to structurally complex TrOCs due to their 
resistance to microbial degradation. Similar to conventional MBR, TrOCs containing strong 
electron withdrawing functional groups (EWG) such as carboxyl, halogen and amide are resistant 
to biodegradation, and their degradation is also poor and/or unstable in HR-MBR [152, 157]. For 
instance, atrazine, carbamazepine and diclofenac are resistant to biodegradation due to the 
presence of EWGs (i.e., halogen and amide) in their structures [191, 192].  
Based on their biodegradation, TrOCs can be divided into three categories: (i) low or unstable 
removal (5-30%) for TrOCs containing strong EWGs such as atrazine, carbamazepine and 
primidone; (ii) consistently high removal (80-90%) of hydrophobic TrOCs containing electron 
donating groups (EDGs) such as steroid hormones; and (iii) poor to moderate removal (30-80%) 
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of hydrophilic TrOC containing both EWGs and EDGs [152, 157, 193]. Limited degradation of 
some TrOCs by the activated sludge highlights the significance of high retention membranes in 
effective TrOC removal for producing a high-quality effluent. Specific groups of TrOCs that are 
poorly degraded by the activated sludge accumulate within the bioreactor of HR-MBR. Thus, there 
is a need to introduce microbes such as fungi with strong degradation capacity. 
2.2.3.4.2. Effect of TrOC sorption on activated sludge 
Hydrophobic TrOCs (log D>3) can adsorb onto the activated sludge by following mechanisms: (i) 
chemical binding to bacterial proteins and nucleic acids; (ii) sorption onto polysaccharide 
structures outside the bacterial cell; (iii) adsorption onto bacterial lipid structure [129]. With a few 
exceptions, HR-MBR can achieve as high as 99% removal of hydrophobic TrOCs via 
biodegradation and sorption [152, 187]. Additionally, non-hydrophobic interactions such as 
hydrogen bonding, electrostatic interactions and ion exchange can also instigate sorption of 
hydrophilic TrOCs onto activated sludge. For instance, Wijekoon et al. [152] observed that 
sorption significantly contributed to the removal of a hydrophilic TrOC salicylic acid (log D = -
1.22).  
Sorption on activated sludge contributes to improvement of overall aqueous phase removal of 
TrOCs in conventional MBRs [160, 189, 194-196]. For instance, halogenated TrOCs are widely 
reported to be persistent to microbial degradation. However, the increase in halogen-content 
increases the hydrophobicity of halogenated TrOCs [197]. Thus, efficient removal of halogenated 
TrOCs, particularly of triclosan, have been reported to be achieved by even conventional MBRs 
due to its sorption onto activated sludge [6, 191, 198]. Although sorption also contributes to the 
removal of TrOCs within the bioreactor of HR-MBRs, the overall TrOC removal by HR-MBR is 
less dependent on sorption because of the high retention membranes, which can retain even the 
TrOCs demonstrating low sorption on sludge.  
Following sorption onto the activated sludge, the extent of TrOCs degradation depends on their 
intrinsic biodegradability [6]. For instance, Wijekoon et al. [152] observed higher concentrations 
of two highly hydrophobic TrOCs, namely triclosan and octocrylene in the sludge samples of an 
MDBR as compared to other hydrophobic TrOCs such as bisphenol A and steroid hormones. This 
is because of the presence of strong EWGs in the molecular structure of triclosan and octocrylene 
i.e., halogen and carbonyl, respectively [6, 191].  
2.2.3.4.3. Effect of mixed liquor suspended solids concentration 
Conceptually, mixed liquor suspended solid (MLSS) concentration may affect the removal of 
TrOCs in a biological process by influencing the rate of biodegradation. However, biodegradation 
also depends on TrOC physicochemical properties and diversity of microbial communities [199-
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201]. Indeed biodegradation of TrOCs containing EDGs in their molecular structure (i.e., easily 
biodegradable) has been reported to be 80-99% in conventional MBRs at the tested MLSS 
concentrations ranging from 2-15 g/L [202-205]. Similarly, effective degradation (90-99%) of 
TrOCs containing EDGs such as naproxen, ketoprofen, bisphenol A and t-octylphenol has been 
achieved in NF-MBR, FO-MBR and MDBR over MLSS concentrations of 2-5 g/L [151, 152, 
157]. Holloway et al. [187] also achieved 95-99% degradation of TrOCs containing strong EDGs 
such as naproxen, oxybenzone, ibuprofen and caffeine by operating an FO-MBR at a MLSS 
concentration of 3-4 g/L.  
Degradation of hydrophilic TrOCs containing EWGs in conventional MBR has been reported to 
be poor irrespective of operating MLSS concentrations [199, 206-209]. Similarly, poor and 
unstable degradation (15-40%) by the activated sludge in HR-MBR has been reported for 
hydrophilic TrOCs containing EWGs such as carbamazepine, DEET and atrazine [157, 186].  
2.2.3.4.4. Effect of solids retention time 
Solids retention time (SRT) governs the microbial makeup of a bioreactor. Conceptually, long 
SRT may improve the extent of TrOC removal by providing adequate time for the development of 
special TrOC degrading microbial communities [200, 210, 211]. Indeed, biodegradation of a few 
resistant TrOCs such as sulfamethoxazole, diclofenac, mefenamic acid and carbamazepine 
improved significantly following an increase in the SRT of conventional MBR (Figure 2.10). The 
biodegradation of resistant TrOCs containing strong EWGs varied depending on the type of HR-
MBR configuration. For instance, FO-MBR (SRT = 20 days) achieved better degradation of 
carbamazepine, atrazine, clofibric acid, fenoprop and diclofenac as compared to MDBR (SRT = 
88 days) [151, 152, 157]. Disrupted metabolic activities associated with the treatment in 
thermophilic conditions may have resulted in less effective degradation of resistant TrOCs by 
MDBR [120, 152]. However, a systematic study is necessary to determine the actual reasons of 
these observations. 
As expected, no improvement was observed in the degradation of easily biodegradable TrOCs 
containing EDGs such as naproxen, ketoprofen and ibuprofen by increasing the SRT of a 
conventional MBR beyond 15 days [198, 204, 212, 213]. Similarly, no observable effect of SRT 
on the degradation of TrOCs such as naproxen, ketoprofen, ibuprofen, bisphenol A and 4-tert-
octylphenol has been reported in HR-MBRs over a wide range of SRTs [152, 157, 187, 214].  
2.2.3.4.5. Effect of operating temperature 
To date lab-scale FO- and NF-MBRs have been operated at the room temperature i.e., 18-21 ºC, 
while the operating temperature of MDBR falls in the thermophilic range i.e., 40-60 ºC [152, 157, 
215, 216]. As noted in the previous section, relatively less degradation of a few hydrophilic TrOCs 
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such as carbamazepine, atrazine, clofibric acid, fenoprop and diclofenac has been observed in 
MDBR as compared to FO-MBR [151, 152]. This can be attributed to the higher operating 
temperature of MDBR, which can disrupt microbial activities. Particularly, high operating 
temperature (>35 ºC) can affect TrOC degradation by reducing the abundance of nitrifying bacteria 
[217-219]. In conventional MBR, improvement in TrOC removal has been reported to concur with 
the achievement of efficient nitrification [220]. To provide further insight into this aspect, the 
effect of thermophilic conditions on the microbial diversity and TrOC removal in various formats 






















Figure 2.10. Effect of SRT on the aqueous phase removal of selected TrOCs by conventional 
MBR. (a) Significant SRT dependent improvement in TrOC removal; and (b) insignificant 
dependence of TrOC removal on SRT. Adapted from [126]. 
(b) Insignificant         
      effect of SRT 
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2.3.3.5. Fate of TrOCs in HR-MBR  
Effective retention of TrOCs (90-99%) within the bioreactor of HR-MBR by the high retention 
membranes may facilitate their biodegradation due to the prolonged contact time between the 
activated sludge and TrOCs. Indeed, comparing data from independent studies, degradation of 
some TrOCs seems to be more stable in HR-MBR as compared to conventional MBR and CAS 




















































































































































































































































































































































































































































































Figure 2.11. Variations in the biodegradation of TrOCs in CAS (a), MBR (b) and HR-MBR (c). 
Box-and-whisker plot is showing information about: the interquartile range; median (horizontal 
line in the box); min and max (whiskers); and average (block square in the box). Numbers in the 
parenthesis on the x-axis represent the no. of data points (no. of data points: HR-
MBR+MBR+CAS). Adapted from [126]. 
The degradation improvement for these TrOCs in HR-MBR is discernible, however, not very high. 
An assessment of the relative contribution of different mechanisms of TrOC removal suggests that 
membrane retention and biodegradation govern the effectiveness of treatment by HR-MBR 
(Figure 2.12). According to the available literature, TrOC removal in HR-MBR via sorption onto 
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activated sludge ranges between 1-10% and 2-30% for hydrophilic and hydrophobic TrOCs, 
respectively. 
 
Figure 2.12. Contribution of different mechanisms for TrOC removal in HR-MBR and 
conventional MBR. HR-MBR. Adapted from [126]. 
The fate of TrOCs during wastewater treatment by HR-MBR is governed by the TrOC 
physicochemical properties (e.g., chemical structure and hydrophobicity), which influence their 
biodegradation. The hardly biodegradable TrOCs will not appear in the treated effluent because of 
the extra barrier provided by the high retention membranes. However, when not subsequently 
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biodegraded, their accumulation on sludge would complicate sludge disposal and reuse. Based on 
the contribution of each mechanism of TrOC removal, a qualitative framework for the removal of 
TrOCs in HR-MBR is proposed in Figure 2.13.  
 
Figure 2.13. A qualitative framework to predict the contribution of different mechanisms of TrOC 
removal in HR-MBR categorized based on their physicochemical properties.  
An in-depth assessment of the available literature on HR-MBR performance suggests that, as 
compared to CAS and conventional MBRs (using micro- or ultrafiltration membrane), aqueous 
phase removal of TrOCs in HR-MBR is significantly better. However, a strong evidence of 
improvement in TrOC degradation in HR-MBR is not available. In fact, poor degradation of 
resistant TrOCs HR-MBR leads to their accumulation within the bioreactor of HR-MBR. To 
improve the degradation of TrOCs in HR-MBR, other microbes with better TrOC degradation 
capacity than the conventional activated sludge can be introduced. In this context, white-rot fungi 
and their extracellular enzymes [221] are worth-noting. White-rot fungi (WRF) and their enzymes 
have been reported to achieve effective degradation of TrOCs that are resistant to activated sludge-
based treatment process [222-224]. Performance of white-rot fungi and their enzymes for the 




2.4. TrOC degradation by white-rot fungi (WRF) 
White-rot fungi (WRF) are a type of fungus that can degrade lignin, a class of complex natural 
organic polymers found in the cell wall of plants, by using their extracellular enzymatic system, 
called as ligninolytic enzymes [225, 226]. WRF and their ligninolytic enzymes have also been 
studied for the treatment of a variety of recalcitrant compounds such as polycyclic aromatic 
hydrocarbons, dyes, and chlorophenols [222, 227, 228]. In particular, removal of TrOCs using 
WRF or their extracellular enzymes has gained much attention over the last decade [229-231]. 
TrOCs such as pharmaceuticals, personal care products, industrial chemicals and steroid hormones 
have been commonly detected in municipal wastewater and surface water bodies as discussed in 
Section 2.2. Their occurrence in environmental systems can be harmful to aquatic ecosystem and 
human health even at trace concentrations [5, 16].  
Whole-cell WRF and their ligninolytic enzymes have been reported to efficiently remove a wide 
range of TrOCs such as pharmaceuticals (e.g., ibuprofen, ketoprofen and diclofenac), personal 
care products (e.g., triclosan and oxybenzone) and steroid hormones [229, 232-234]. Moreover, a 
number of influencing factors for such treatment systems have been identified. These factors 
include physicochemical properties of TrOCs, type of WRF species and their individual 
ligninolytic extracellular enzymes as well as culture medium and environmental conditions [222, 
235]. The potential of WRF for the removal of TrOCs has been investigated mostly in batch mode. 
There are only a few studies on continuous-flow reactor configurations [234, 236-239]. Despite a 
significant research effort, efficient removal of TrOCs by WRF mediated treatment, their removal 
mechanisms and degradation pathways remain largely to be elucidated. There have been a few 
excellent reviews on bioremediation of recalcitrant compounds by WRF and their enzymes [222, 
235, 240-242]. In this section, performance of WRF and their ligninolytic enzymes as well as the 
performance governing factors is critically analysed and discussed. In addition, the performance 
of conventional enzymatic membrane bioreactor (EMBR) is elucidated. The key research gaps are 
identified, indicating the need of high retention (HR)-EMBR. 
2.4.1. Properties of WRF and their ligninolytic enzymes  
WRF species degrade recalcitrant compounds including TrOCs by using their intracellular or 
extracellular enzymes [222, 243]. The key features of WRF that make them an attractive treatment 
option for TrOC removal include but are not limited to (i) the non-specificity and non-selectivity 
of their enzyme systems, enabling them to degrade complex individual and mixture of pollutants; 
(ii) the secretion of extracellular enzymes, enabling them to degrade pollutants with low water 
solubility; (iii) the ability of their plasma membrane-dependent redox system to degrade pollutants 
in a nutrient deficient reaction mixture over a wide range of pH; and (iv) the ability of intracellular 
enzyme to degrade some pollutants [225, 244, 245]. Depending on growth medium and culture 
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conditions as well as on the type of WRF species/strains, WRF can secrete four different 
ligninolytic enzymes namely laccase, lignin peroxidase (LiP), manganese peroxidase (MnP) and 
versatile peroxidase (VP). In addition, cytochrome P450 monooxygenases, a group of intracellular 
enzymes, have also been reported to play a vital role in the degradation of TrOCs via 
hydroxylation, dehalogenation and heteroatom oxygenation mechanisms [222, 246, 247].  
Characteristics of ligninolytic extracellular enzymes such as molecular mass, isoelectric point and 
redox potential are outlined in Table 2.6. Stability and catalytic potential of ligninolytic enzymes 
may vary due to difference in their redox-potential as well as due to the extent of glycosylation. In 
general, enzymes having high redox-potential are favorable for enzyme catalyzed reactions [246, 
248, 249]. Redox-potential of ligninolytic enzymes is as follows: LiP>MnP=VP>laccase (Table 
2.6).  













Laccase 50 – 80 0.3 – 0.8 
10 – 20 (N- 
Glycosylated) 
3 – 4 O2 
Lignin peroxidase 35 – 48 1 – 1.2 
20 – 30 (N- 
Glycosylated) 
3.1 – 4.5 H2O2 
Manganese 
peroxidase 
38 – 62 0.8 – 1 
5 – 15 (N- 
Glycosylated) 
3 – 7.2 H2O2 
Versatile 
peroxidase 
40 – 47 >1 N.A. 3.4 – 4.9 H2O2 
“N.A.”: not available  
 
Glycosylation, a complex enzymatic process, is responsible for the formation of biopolymers such 
as polynucleotides at the cellular level [252, 253]. Glycosylation in extracellular enzymes can 
influence their shape, structure, composition and the formation of substrate binding sites as well 
as their properties such as redox-potential, enzymatic activity and catalytic potential [254, 255]. 
Stability of enzymes tends to improve with the increase of glycosylation but it may not always 
improve the catalytic potential of an enzyme [256, 257]. Deglycosylation of extracellular enzymes 
has been observed to adversely affect the enzymatic activity, stability and catalytic potential of 
enzymes [255, 258, 259]. Notably, the catalytic potential or redox-potential of LiP is higher than 
other ligninolytic enzymes, possibly because the level of glycosylation in LiP is greater than other 
ligninolytic enzymes [246, 250]. Isoelectric point is important to estimate the charge on fungal 
enzymes at different pH [260]. Isoelectric point of ligninolytic enzymes mostly falls in acidic pH 
range i.e. 3-7, indicating that ligninolytic enzymes are negatively charged at pH ≥7.0 [261]. 
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2.4.2. Modes of TrOC degradation by WRF  
Different WRF and their ligninolytic enzymes have been investigated under different experimental 
conditions for the removal of TrOCs - either by whole-cell WRF culture or by using the crude 
and/or purified enzyme extracts. Different modes of TrOC degradation via WRF and their 
ligninolytic enzymes are critically discussed as follows.  
2.4.2.1. Removal by Whole-cell WRF 
Although whole-cell WRF cultures, either in submerged or solid media, have been used for the 
removal of TrOCs, submerged whole-cell WRF cultures have been more commonly reported. 
Since WRF species harbor different enzyme systems, the extent of TrOC removal achieved by 
different WRF species also varies. TrOC removal performance by different WRF species is 
presented in Table 2.7. Notably, temperature and pH for these studies were in the range of 25-
30oC and 4.5-5, respectively, with glucose used as the common electron donor. 
T. versicolor, also known as Coriolus versicolor [262, 263], has been investigated in several 
studies for the removal of TrOCs both in batch and continuous-flow bioreactors  [234, 237, 264-
268]. Depending on the strain, T. versicolor may contain laccase, LiP and MnP, with laccase being 
the predominant enzyme in some strains. It can be observed from Table 2.7 that T. versicolor 
achieved significant removal (>70%) for most of the tested TrOCs. TrOCs such as steroid 
hormones, nonylphenol and octocrylene can induce endocrine disrupting effects [269, 270]. Their 
removal by T. versicolor in literature ranges from 80 to 99% regardless of the operating conditions. 
Conversely, poor and unstable removal was reported for particular pharmaceuticals, namely 
ciprofloxacine (35%), salicylic acid (0-5%), azithromycin (26%), tetracyclin (0-5%) and 
carbamazepine (negligible to 90%). Low and/or unstable removal of these compounds can be 
attributed to the presence of strong electron withdrawing functional groups (EWGs) in their 
chemical structure [222]. Compared to the pharmaceuticals, the removal of personal care products 
has been communicated in only a limited number of studies [266, 267]. However, T. versicolor 
has been shown to achieve high removal of ingredients of personal care products such as triclosan, 

















Stirred tank  Inoculum= 1.2 g/L  Diclofenac  0.8 >99 
[271] 
(Batch-fed) Reactor volume = 2 L, HRT= 24 h Ibuprofen 0.8 75-99 
 Mixing speed = 200 rpm Naproxen  0.8 >99 
 pH = 4.5; Temperature= 30oC    
 Electron donor= glucose     
 Operating time= 30 days    
Stirred tank  Reactor volume = 1.5 L Diclofenac  1 92 
[272] 
(Continuous)  HRT= 24 h Ibuprofen 1 95 
 pH = 4.5; Temperature= 30oC Naproxen  1 95 
 Electron donor= glucose  Carbamazepine  0.5 25-60 
 Operating time= 50 days Diazepam 0.25-0.5 0 
T. versicolor 
(Laccase, LiP, MnP) 
Fixed bed Inoculum= 3.2 g/L 17β-estradiol (E1)   
[264] 
(Continuous) Reactor volume = 0.13 L 17α-
ethynylestradiol 
3-18.8 >95 
 HRT= 120 days  7.3 >95 
 pH = 4.5; Temperature= 22oC    
 Electron donor= glucose    
 Operating time= 26 days    
Fluidized bed Inoculum= 3.8 g Carbamazepine 0.05-9 61-94 
[268] 
(Batch-fed) Reactor volume = 1.5 L    
 pH = 4.5; Temperature= 25oC    
 Electron donor= glucose    
 Operating time= 15 days    
Fluidized bed Inoculum= 1.5 g/L Ibuprofen 2.34 100 
[237] 
(Batch-fed) Reactor volume = 10 L Acetaminophen 1.56 100 
 pH = 4.5; Temperature= 25oC Ketoprofen 0.08 100 
 Electron donor= glucose Ciprofloxacine 84.71 35 
 Operating time= 8 days Azithromycin 4.31 100 
 Real hospital wastewater  Propranolol 0.06 100 
 Non sterile conditions Carbamazepine 0 -50 
Fluidized bed Inoculum= 1.4 g/L Acetaminophen 109 100 
[273] 
(Continuous) Reactor volume = 10 L Naproxen 1.62 100 
 pH = 4.5; Temperature= 25oC Ibuprofen 35.5 100 













 Operating time= 8 days Diclofenac 0.477 100 
 Real hospital wastewater  Codeine 0.606 100 
 Non sterile conditions Phenazone 0.497 96 
  Salicylic Acid 0.606 0 
  Ofloxacin 3.34 98 
  Ciprofloxacine 13.0 99 
  Sulfamethoxazole 1.41 100 
  Trimethoprim 0.853 100 
  Metronidazole 0.912 85 
  Azithromycin 1.37 26 
  Clarithromycin 2.20 80 
  Erithromycin 0.008 100 
  Tetracyclin 0.011 0 
  Caffeine 149 39 
  Carbamazepine 0.056 0 
  Atenolol 2.99 75 
  Metoprolol 0.019 95 
Membrane 
bioreactor 
Inoculum= 3.5 g/L Diclofenac  
0.3-1.5 55 
[234] 




 pH = 5.4; Temperature= 27oC    
 Operating time= 90 days    
 Non sterile conditions    
Membrane 
bioreactor 
Inoculum= 3 g/L Ibuprofen 
0.005 95 
[266] 




 pH = 4.5; Temperature= 27oC Ketoprofen 0.005 90 
 Operating time= 110 days Diclofenac  0.005 50 
 Non sterile conditions Carbamazepine 0.005 20 
  Metronidazole 0.005 40 
  Gemfibrozil 0.005 95 
  Amitriptyline 0.005 85 
  Estriol (E3) 0.005 >95 













  17-β-estradiol –
acetate 
0.005 >95 
  17-α 
ethinylestradiol 
0.005 >95 
  Triclosan 0.005 95 
  Benzophenone 0.005 80 
  Oxybenzone 0.005 92 
  Octocrylene 0.005 94 
Erlenmeyer 
flask 
Inoculum= 2-3 mg/test Triclosan 
10 98 
[267] 
(Batch-fed) pH = 4.5; Temperature= 28oC 17-α 
ethinylestradiol 
10 94 
 Operating time= 14 days Nonylphenol  10 90 





Inoculum= 2-3 mg Triclosan 
10 98 
[267] 
(Batch-fed) pH = 4.5; Temperature= 28oC 17-α 
ethinylestradiol 
10 62 
 Operating time= 14 days Nonylphenol 10 93 





Inoculum= 2-3 mg Triclosan 
10 98 
[267] (Batch-fed) pH = 4.5; Temperature= 28oC 17-α 
ethinylestradiol 
10 78 
 Operating time= 14 days Nonylphenol  10 85 
B. adusta 
(Laccase, LiP, MnP) 
Erlenmeyer 
flask 
Inoculum= 2-3 mg Triclosan 
10 98 
[267] (Batch-fed) pH = 4.5; Temperature= 28oC 17-α 
ethinylestradiol 
10 78 




Other WRF species such as P. chrysosporium [271, 272], B. adusta , D. squalens and P. ostreatus 
containing different combinations of ligninolytic enzymes have also been investigated for the 
removal of TrOCs (Table 2.7). However, these studies reported the removal of only a few TrOCs 
such as ibuprofen, diclofenac and triclosan. Despite the difference in enzyme secretion pattern of 
these WRF, efficient removal (in the range of 70 to 99%) was achieved for most tested TrOCs, 
with uncertain/unstable removal reported for carbamazepine, which is a known persistent 
pharmaceutical. It is important to note that a direct comparison of TrOC removal data from 
different studies may not be valid due to the differences in operating conditions and bioreactor 
configurations as well as difference in their enzymatic systems. However, Table 2.7 serves the 
purpose of providing a general overview. 
2.4.2.2. WRF bioreactor configurations 
Different bioreactor configurations have been explored for the continuous treatment of TrOCs in 
WRF-based systems (Table 2.7). Since whole-cell WRF based treatment systems are still in their 
development phase, the bioreactor design and configurations are of significant importance. Hence, 
the salient features of the bioreactor configurations studied to-date for the removal of TrOCs, 
namely, stirred tank bioreactors [271, 272], bubble column bioreactors, fluidized or packed bed 
bioreactors [274-276] and membrane bioreactors [277-280] are briefly discussed here to provide 
a general overview.  
Among all the bioreactor configurations, stirred tank bioreactor has been the most common type 
of bioreactor used for the treatment of TrOCs in WRF based treatment systems. This bioreactor 
type has been explored mostly in batch and sterile modes [271, 272]. In this bioreactor, aeration is 
provided usually at the bottom of the bioreactor, which is dispersed via mechanical agitation. 
Mechanical mixing also ensures the uniform mixing of the growth medium and wastewater in the 
bioreactor [274]. Enhanced production of ligninolytic enzymes could be achieved in stirred tank 
bioreactors as compared to other bioreactor configurations. For instance, Babič and Pavko [281] 
investigated the production of laccase and MnP from D. squalens in stirred tank bioreactor and 
bubble column bioreactor under different operating conditions such as incubation time and 
agitation speed: they observed that laccase production was as much as 70% higher in the former, 
although the production of MnP was comparable [281]. Agitation speed and high shear rate may 
influence the morphology of the fungal biomass. In a study by Cao et al. [282], impact of two 
bioreactor configurations, namely stirred tank bioreactor and airlift bioreactor, on the morphology 
of P. sanguineus was investigated. They found that the morphology of the fungal biomass was 
adversely impacted in the stirred tank bioreactor, which uses strong mechanical mixing. Consistent 
with the finding of Cao et al. [282], it has been reported that excessive agitation may lead to the 
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rupturing of fungal hyphae [274, 283, 284]. Therefore, agitation/mixing speed in bioreactors is an 
important parameter governing fungal morphology and enzymatic activity.   
Fluidized bed bioreactor is another type that has been used for the removal of TrOCs from 
municipal and synthetic wastewater [237, 273]. In this type of bioreactor, fungal biomass rapidly 
moves around the solid carrier (‘bed’), allowing uniform mixing of the reaction media [285]. 
However, aggregation of fungal biomass may cause poor fluidization, resulting in spouting of bed. 
Biomass aggregation can be avoided by intermittent and partial purging of the biomass [286].  
A bubble column bioreactor coupled with a microfiltration membrane has been recently explored 
for the removal of TrOCs [234, 266]. Such fungal membrane bioreactor was expected to offer 
some additional advantages over bubble column reactors [227, 287, 288] such as: (i) formation of 
biofilm on the membrane surface that may enhance the removal of recalcitrant TrOCs; (ii) 
maintenance of high fungal biomass concentration improving biodegradation rate; and (iii) 
effective prevention of enzyme washout. Nevertheless, bacterial contamination may hamper the 
growth and enzymatic activity of whole-cell WRF in any bioreactor configuration. Impacts of 
bacterial contamination on WRF are discussed in the next section.  
2.4.2.3. Performance under non-sterile environment and bottlenecks 
The capacity of WRF for TrOC removal has been commonly investigated under sterile conditions 
to avoid bacterial contamination. However, several studies have cast light on the aspect of bacterial 
contamination by operating bioreactors under non-sterile environment using either synthetic [234, 
266] or real wastewater [237, 268, 273, 289-291]. For example, Yang et al. [234] investigated the 
performance of whole-cell Trametes versicolor for the removal of bisphenol A and diclofenac in 
a membrane bioreactor under non-sterile conditions using a malt-based synthetic wastewater. They 
observed that the removal of diclofenac was reduced by 40-50% under non-sterile conditions as 
compared to its 99% removal achieved in sterile batch experiments. In that study, bacterial 
contamination was evident from microbial analysis. A few recent studies have investigated the 
removal of pharmaceuticals and endocrine disrupting compounds from municipal and hospital 
wastewater by whole-cell Phanerochaete chrysosporium or Trametes versicolor [237, 268, 273, 
289-292]. In all these studies, bacterial contamination restricted long term operation of the 
bioreactors as the overall removal of the TrOCs gradually reduced as compared to that obtained 
under sterile conditions. Two probable modes of bacterial interruption to fungal enzymatic 
expression can be perceived: (i) loss of enzyme secretion capacity of fungi owing to the growth 
disruption under competition for substrate and bacterial colonization of the mycelia, and (ii) 
destabilization or consumption of secreted enzyme by bacteria [234, 285, 293]. Bacteria are fast 
growing prokaryotes as compared to eukaryotic WRF and can easily outperform WRF in substrate 
utilization [293, 294].  
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In addition to bacteria, other species of fungi can interrupt WRF growth and enzymatic activity. 
For instance, Badia-Fabregat et al. [291] analyzed the composition of microbial communities in a 
fluidized bed bioreactor treating hospital wastewater. They observed other fungal species (e.g. 
Trichoderma asperellum and Trichoderma spp.) to overtake the originally inoculated fungi 
(Trametes versicolor) in the bioreactor. This is the only study demonstrating the dominance of 
fungal species other than the inoculated fungi in the bioreactor. Therefore, more research is needed 
to analyze the presence of different competing species that can suppress the growth of inoculated 
WRF to formulate strategies to control their proliferation in the bioreactor. A number of strategies 
for the control of microbial contaminations have been reviewed previously [295]. However, these 
strategies could only extend the operation of fungal bioreactors without bacterial contamination 
for a few weeks. Some of the strategies to avoid bacterial contamination are outlined below: 
(i) Operation under acidic pH: Optimum pH for the growth and reproduction of fungi ranges 
from 4.5-5. Conversely, bacteria grow at or near neutral pH. Bacterial growth can be 
suppressed by maintaining the pH in the range of 4.5-5. However, this is a temporary 
solution to the problem of bacterial contamination because some bacteria can eventually 
adapt to acidic environment [293].  
(ii) Immobilization or attached growth of fungi: Immobilization of fungal strains onto different 
carriers under non-sterile conditions shows promising results. For instance, by 
immobilizing C. versicolor onto a plastic support, Hai et al. [287] was able to prevent 
bacterial contamination for an extended period of time while operating the reactor under 
non-sterile conditions for the treatment of an azo dye. 
(iii) Nitrogen limited feed: Bacterial contamination can be avoided by using a media deficient 
of nitrogen. However, this strategy can only help during the startup of the bioreactor. 
Bacterial contamination would occur with the passage of operating time as bacteria would 
start consuming carbon and nitrogen available in fungal mycelium [293].    
(iv) Coupling of bioreactor with micro-screen: Bioreactors can be coupled with a micro-screen 
which would retain fungal biomass but allow the washout of bacteria with effluent. 
Moreover, this strategy will benefit from using shorter hydraulic retention times, which 
will enhance the washout of bacteria from the reactor [296].  
(v) Use of disinfecting agents: Inactivation of bacteria without imposing any harmful effects 
on fungal biomass can be a promising strategy. Depending on the wastewater 
characteristics, it is important to carefully select the type, dose and contact time of the 
disinfectant. Disinfection of wastewater using ozone has been used successfully to 
selectively inactivate bacteria [297, 298].  
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(vi) Biomass replacement: Periodic biomass replacement and purging strategy can be used to 
carry out long term operation of fungal bioreactors. In this strategy, biomass in the 
bioreactor is purged and renewed in different fractions (e.g., ½ or ¼th of the initial biomass 
volume) at different frequencies [292, 299].   
(vii) Pretreatment of wastewater: Coagulation-flocculation pretreatment of non-sterile 
wastewater can help to reduce the initial bacterial count which would allow an extended 
operation of the fungal bioreactor [292].  
2.4.2.4. Removal by crude ligninolytic enzymes  
Individual extracellular ligninolytic enzyme has been tested for the removal of a wide range of 
pollutants. Use of the harvested enzyme instead of a whole-cell preparation allows decoupling of 
fungal growth and pollutant degradation steps, and this can be a suitable strategy to avoid bacterial 
contamination issues. The capacity of both crude and purified/commercially available extracellular 
enzymes for TrOC removal has been reported previously [229, 266, 300-307]. However, whole-
cell fungi may achieve relatively better removal of a broader spectrum of pollutants than 
extracellular enzymes due to the availability of extracellular, intracellular and/or mycelium bound 
enzymes in addition to sorption of pollutants onto fungal biomass.  
Crude extracellular enzymes have been investigated for the degradation of TrOCs in both batch 
and continuous-flow mode. For instance, Wen et al. [308] achieved significant degradation of two 
pharmaceuticals, oxytetracycline (84%) and tetracycline (72%), by using crude MnP (40 U/L) 
extracted from P. chrysosporium. Similarly, crude enzyme solution extracted from T. versicolor 
containing MnP (30 U/L) and laccase (1500 U/L) was tested for the degradation of 10 
pharmaceuticals at an initial concentration of 10 µg/L each [301]. They achieved complete 
degradation of five pharmaceuticals, viz diclofenac, ibuprofen, naproxen, indomethacin and 
fenoprofen, while the rest were partially removed. LiP extracted  from P. chrysosporium was tested 
for the degradation of diclofenac and carbamazepine at different pH [309]. It was observed that 
degradation of carbamazepine was mostly less than 10%, while a complete degradation was 
achieved for diclofenac at pH 3-4.5. Similarly, crude extract from T. versicolor was used for the 
removal of 30 TrOCs [302]. The results revealed that all steroid hormones were almost completely 
removed (>95%), while removal of two TrOCs namely diclofenac and triclosan ranged from 50 to 
60% with poor removal of the remaining TrOCs (<20%). In another study [310], crude enzyme 
extract from P. ostreatus achieved low removal (<20 %) for two TrOCs, namely oxybenzone and 
naproxen.  
Since WRF also secretes natural mediators along with extracellular enzymes, crude enzyme may 
achieve better removal as compared to purified and/or commercially available enzymes. For 
instance, Tran et al. [301] highlighted that complete removal (>99%) of some pharmaceuticals 
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such as diclofenac, indomethacin and ibuprofen was due to the presence of some natural mediators 
in crude laccase solution. Removal of selected TrOCs by individual crude enzymes has been 
systematically presented in Table 2.8. It can be seen that the extent of TrOC removal is different 
for each type of extracellular enzyme. Moreover, crude enzyme extract from different fungi may 
perform differently. For instance, Weng et al. [311] collected crude LiP from two WRF species, 
namely, P. sordida and P. chrysosporium for the treatment of EDCs and found that LiP from P. 
sordida was more effective than LiP from P. chrysosporium. Similarly, removal of DEET, an 
insect repellent, by T. versicolor was 55% in real wastewater as compared to its 20% removal in 
acetate buffer. High removal of DEET in real wastewater was attributed to the presence of other 
compounds (such as phenolic compounds) that may act as redox-mediators [312], as further 
discussed in Section 2.4.5.  
2.4.2.5. Removal by purified ligninolytic enzymes 
Purified or commercially available extracellular ligninolytic enzymes, mostly laccase from 
different WRF, has been used for the treatment of TrOCs in both batch and continuous bioreactors. 
Average removal of the selected TrOCs by purified laccase reported in recent studies is presented 
in Figure 2.14. Purified laccases are more effective for the removal of phenolic compounds such 
as oxybenzone, triclosan and steroid hormones. Removal of non-phenolic compounds such as 
carbamazepine, naproxen and ketoprofen is generally poor/unstable. Their degradation depends 
on their physicochemical properties such as hydrophobicity and chemical structure as well as the 
oxidation reduction potential (ORP) of the enzyme [222, 313]. Indeed, based on the results of the 
recent studies incorporated in Figure 2.14, removal of phenolic compounds ranges from 70 to 
99%, while the removal of non-phenolics is generally less than 20%. However, relatively higher 
removal of some non-phenolic compounds, namely, diclofenac (40-50%), octocrylene (>80%) and 
ibuprofen (30-45%) has been reported because these compounds contain both electron donating 
and electron withdrawing functional groups. Although both crude and purified enzymes 
demonstrated degradation of a range of pollutants, crude enzymes achieved better removal of some 
TrOCs such as diclofenac and naproxen as compared to purified enzymes [229, 266, 300, 302, 
303, 306], possibly due to the presence of natural mediators in crude enzyme solution secreted by 
WRF. For instance, Tran et al. [301] achieved almost complete removal of three pharmaceuticals 
namely diclofenac, ibuprofen and naproxen after treatment with crude enzyme extracted from T. 
versicolor, whereas purified laccase from T. versicolor and A. oryzae achieved 20-50% removal 




Table 2.8. Performance of crude enzymes for the removal (%) of the selected TrOCs 























Carbamazepine  5 – 37 0.01-0.1 24-48 <10 5 2 14-20 0.01-4.7 24-48 
Ibuprofen <5 – 38 0.01-0.1 24-48 - - - 20 0.01 48 
Naproxen 20-100 0.01-0.5 24-48 - - - 95 0.01 48 
Diclofenac   60-100 0.01-0.1 3-48 >99 5 2 100 0.01 48 
Gemfibrozil  20-25 0.01-0.1 24-48 - - - 30 0.01 48 
ketoprofen  <5 -12 0.01-0.1 24-48 - - - 22 0.01 48 
Clofebric acid  10-20 0.01-0.1 24-48 - - - <10 0.01 48 
Benzophenone  <5 0.1 24 - - - - - - 
DEET 20-55 0.01 4 - - - - - - 
Octocrylene  20 0.1 24 - - - - - - 
Phenolic compounds          
Estrone 70-100 0.1-27 1-24 60 27 24 >99 5 8 
17β-Estradiol >99 0.01-5 1-24 40, 85 0.6, 27 1, 24 >99 2.96 1 
17α-Ethynylestradiol >99 0.1-2.96 1-24 20, 82 6.6, 30 8, 24 >99 2.96 1 
Oxybenzone  10-25 0.1-0.5 24 - - - - - - 
Nonylphenol 100 22 1 - - - - - - 
Triclosan 70-90 0.1-144 24 - - - - - - 





Utilization of crude enzymes for the treatment of TrOCs may considerably reduce the cost of the 
treatment process. However, extracellular extract i.e., the crude enzyme solution also contains 
significant amount of the unspent growth media, and dosing crude enzyme means additional 




































































































































































































































































 Non-phenolic TrOCs  
Figure 2.14. Average removal of phenolic and non-phenolic TrOCs after treatment with 
purified/commercially available laccase. Error bar indicates average±standard deviation. Numbers 
within parenthesis indicates number of data points. Data was collected from the following studies: 
[229, 303, 304, 306, 314, 324-328].  
2.4.2.6. Mechanisms of TrOC removal 
Removal mechanisms during treatment with WRF whole-culture include: (i) sorption onto the 
fungal biomass; (ii) degradation by extracellular enzymes; and (iii) degradation by mycelium 
bound or intercellular enzymes. A schematic of fungal mediated treatment process with possible 
removal mechanisms is presented as Figure 2.15. Hydrophobicity (log D) of TrOCs is a key 
property that governs biosorption onto fungal biomass and could facilitate enhanced removal of 
some compounds. For instance, a batch study to investigate the contribution of biosorption and 
63 
 
degradation by extracellular enzymes confirmed that hydrophobic TrOCs (log D>4) were highly 
removed by both mechanisms [300]. Moreover, they also confirmed that biosorption of 
significantly hydrophobic compounds facilitated the biodegradation of these compounds. On the 
other hand, a few studies have reported that removal of some TrOCs such as 17β-Estradiol, 17α-
ethynylestradiol, triclosan and nonylphenol by whole-cell WRF and extracellular enzymes is 
comparable (see Table 2.7 and 2.8), indicating a negligible impact of biosorption on their removal.  
 
Figure 2.15. TrOC removal mechanisms by WRF-based treatment processes. Adapted from [329]. 
Biodegradation by whole-cell can be due to intracellular, extracellular and mycelium-associated 
enzymes. This can lead to significant differences in removal by whole-cell WRF and harvested 
enzyme. For instance, carbamazepine, containing a strong EWG, was significantly removed by 
some WRF species, namely P. ostreatus (100%) [247] and T. versicolor ATCC 42530 (76%) 
[301], while crude [247, 301, 302] and purified laccase [229, 306] could only achieve 5-15% 
carbamazepine removal. Similarly, ibuprofen and naproxen were almost completely removed by 
whole-cell WRF [237, 265, 273]. In contrast, their removal by crude and purified laccase was in 
the range of 10 to 40% [229, 266, 306, 314]. Since both naproxen and ibuprofen are hydrophilic 
compounds (log D <3), role of biosorption in their removal would be limited. However, almost 
complete removal of these compounds by whole-cell WRF substantiates the role of mycelium 
bound and/or or intercellular enzymes. Indeed, the role of intercellular enzyme (i.e., cytochrome 
P450) in the degradation of naproxen, diclofenac and carbamazepine has been demonstrated [247, 
265, 330]. These studies showed that naproxen, diclofenac and carbamazepine were partially 
removal (15-50%) in the presence of cytochrome P450 inhibitor during whole-cell WRF treatment. 
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Therefore, it can be concluded that high removal of some TrOCs in whole-cell WRF treatment is 
due to the synergetic effects of extracellular, intercellular and/or mycelium bound enzymes. 
Moreover, secretion of natural mediators may also help in enhancing the removal of these 
compounds.    
2.4.2.7. Degradation pathways, identification of intermediates and toxicity 
TrOCs degradation pathways and their intermediate products have been identified for some 
compounds such as carbamazepine, diclofenac, triclosan and ibuprofen. However, each WRF 
species may follow a different degradation pathway.  
Fungal mediated treatment of diclofenac starts with the conversion of the hydroxyl group in its 
structure into an intermediate product, namely, hydroxy diclofenac. Hydroxy diclofenac can be 
amenable to further fungal biodegradation [330, 331]. In vivo and in vitro experiments for the 
degradation of diclofenac showed that laccase (T. versicolor)-catalyzed degradation leads to the 
formation of biodegradable compounds such as: (i) hydroxelated metabolites (appeared in both in 
vivo and in vitro experiments); and (ii) 4-(2,6 dichlorophenylamino)-1,3-benzenedimethanol 
metabolite (appeared only in in vivo experiments) [331]. Diclofenac and its metabolites both 
disappeared after 24 h of incubation, reducing the ecotoxicity of the treated effluent. Degradation 
of ketoprofen was reported to initiate by the intercellular cytochrome P450 that converts 
ketoprofen into (2-[3-(4-hydroxybenzoyl)phenyl]-propanoic acid) and (2-[(3-hydroxy(phenyl)-
methyl)phenyl]-propanoic acid) via hydroxylation and reduction of the ketone group, respectively 
[331]. Moreover, it was also observed that the role of extracellular enzyme (laccase) in the 
degradation of ketoprofen was insignificant.  
Both laccase and cytochrome P450 can catalyze the degradation of naproxen in WRF based 
treatment. Formation of two intermediates, namely 6-desmethylnaproxen and 1-(6-
methoxynaphthalen-2-yl)ethanone), was observed possibly via P450-mediated desmethylation and 
laccase catalysis, respectively [265, 272]. Moreover, naproxen and associated intermediates were 
completely removed from the reaction media and the treated effluent was non-toxic [265].  
Ibuprofen conversion predominantly starts with the formation of hydroxy-ibuprofen via 
hydroxylation. Marco-Urrea et al. [332] investigated the degradation pathways of ibuprofen by 
WRF T. versicolor. They observed that oxidation of isopropyl chain resulted in the formation of 
1-hydroxy ibuprofen and 2-hydroxy ibuprofen. These intermediates were then degraded by T. 
versicolor to 1,2-dihydroxy ibuprofen, which was not further degraded. Hence, the ecotoxicity of 
treated effluent was higher than that of the initial solution [332]. 
Degradation pathways for carbamazepine by different whole-cell WRF including T. versicolor and 
P. ostreatus have also been studied. These have identified several stable intermediate products 
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namely, 10,11-dihydro-10,11-dihydroxy-carbamazepine, acridine, acridone and 10,11-epoxy-
carbamazepine. Interestingly, the treated effluent showed less toxicity [247, 268].  
Intermediates or metabolites of triclosan during whole-cell treatment depends on WRF species. 
Major intermediates of triclosan during the treatment with C. polyzona WRF were dimer, trimer 
and tetramer [333], while 2-O-(2,4,4-trichlorodiphenyl ether)-b-D-xylopyranoside, 2-O-(2,4,4-
trichlorodiphenyl ether)-b-D-glucopyranoside and 2,4-dichlorophenol were identified as major 
intermediates following its treatment with T. versicolor [334]. 
2.4.3. Impacts of physicochemical characteristics of wastewater on TrOC removal 
Performance of WRF in wastewater treatment depends on several factors such as environmental 
conditions and physiochemical properties of the wastewater as well as the properties of TrOCs. 
Influence of TrOC properties on their overall removal in a WRF mediated treatment process has 
been comprehensively reviewed previously by Asif et al. [329]. Briefly, physicochemical 
properties of water/wastewater such as pH, temperature and the presence of dissolved organic 
and/or inorganic compounds may influence the performance of both WRF and their ligninolytic 
enzymes. Because information about these properties are vital to design and optimize WRF- and 
enzyme-based treatment systems, these are discussed in this section.  
The operating temperature not only affects the stability of WRF/enzymatic systems but also the 
rate of reaction. It is believed that the rate of reaction increases with  increase in temperature [309]. 
However, depending on the WRF strain, rapid thermal inactivation of ligninolytic enzymes has 
been observed at temperature above 40oC [335, 336]. Only a few studies have investigated the 
impact of temperature on enzymatic activity and removal efficiency in a reaction media. For 
instance, increase in temperature of the reaction media from 20 to 25oC enhanced the removal 
efficiency of chlorophenols in laccase-mediated treatment system [337]. Similarly, Ullah et al. 
[338] investigated the removal of pentachlorophenol by varying the temperature from 10 to 45 oC 
and found that the optimal temperature was 25oC to achieve maximum laccase activity and 
pentachlorophenol removal. Temperature range of 37-40 oC has been reported to achieve optimal 
activity of MnP and LiP [308, 339].  
The pH for optimum activity can vary depending on the source of enzyme. For instance, laccases 
extracted from Pleurotus ostreatus [340], Trametes versicolor  [341], and Albatrella dispansus 
[342] have been reported to show maximum laccase activity at a temperature of 35, 50 and 70 oC, 
respectively. However, in general, the optimum temperature for most fungal laccases and 
peroxidases ranges from 25-30oC and 35-40oC, respectively [308, 337, 339]. Depending on the 
source fungus, the optimum pH for high and stable laccase activity ranges from 3.5 – 6.0 [343]. 
For example, the optimum pH for activity of laccase  from Trametes versicolor [344, 345], 
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Physisporinus rivulosus [346] and Agaricus blazei [347] was 3.0-4.5, 4.0 and 5.5, respectively. 
Best removal of TrOCs ubiquitously detected in wastewater such as triclosan, diclofenac, 
ketoprofen and bisphenol A was achieved at pH range of 4.0-6.0 [233, 303, 311, 315, 348, 349]. 
The optimum pH varies for different types of TrOCs due to the difference between the redox-
potential of the TrOC and enzymes [350, 351]. In general, removal of TrOCs at varying pH results 
in a bell-shaped curve because TrOC removal reduces with the increase in the pH of the reaction 
mixture [303, 348]. Reduction in the removal of TrOCs with the increase in pH can be attributed 
to: (i) the change in the redox-potential of enzymatic reactions; and (ii) the binding of hydroxide 
ions to Type II and Type III copper sites of laccase at alkaline pH, thereby blocking the internal 
electron transfer [352, 353].  
Fungal/enzymatic bioreactors have mostly been studied for the treatment of synthetic wastewater 
spiked with TrOCs in absence of potential inhibiting compounds prevalent in real wastewater [222, 
324]. However, wastewater derived interfering compounds can affect the stability and catalytic 
efficiency of WRF and ligninolytic enzymes [354, 355]. Many compounds such as sulphides, 
halides [350, 356], natural/synthetic organics [357-362] and heavy metals [231, 363] can inhibit 
the catalytic activity of laccases [364]. Moreover, each compound may have different mode of 
laccase inhibition. For instance, fatty acids inhibit laccase catalytic potential by blocking the 
binding sites for phenolic substrates [365-367]. On the other hand, spectrophotometric assays, 
electron spin resonance spectroscopy and catalytic voltammetry analysis confirmed that anionic 
inhibitors such as halides and sulphides could block the access to the active copper sites in laccase 
[368-370]. Among anionic inhibitors, fluoride and azide are the most effective and can rapidly 
reduce the catalytic activity of laccase by 50% even at µM concentrations [371]. Although 
inhibition of laccases by halides can proceed in the following order: fluoride > chloride > bromide, 
the concentration of halides required to inhibit laccases varies, with no fixed correlation with their 
inhibition potential. For instance, chloride concentration ranging from 100 µM – 100 mM may 
cause a 50% drop in activity of laccase from different species [242, 372].  
2.4.4. TrOC removal by enzymatic membrane bioreactor (EMBR) 
Enzyme washout had been the major limitation of enzyme applications in continuous-flow 
reactors. These limitation can be solved by immobilizing enzyme onto a support material [319, 
373] or by coupling the enzymatic bioreactor with a membrane [229, 374]. Compared to enzyme 
immobilization, an EMBR offers several benefits over immobilized enzyme including ease of 
operation and maintenance as well as limited mass transfer limitation.  
Lloret et al. [243] investigated the removal of two estrogens (estrone and 17β-estradiol) by using 
a suspension of a commercially available laccase from M. thermophila in the EMBR. The UF 
membrane (MWCO of 10 kDa), which was submerged in the enzymatic bioreactor, effectively 
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retained the enzyme. The EMBR effectively removed to (64 – 100%) estrone and 17β-estradiol at 
an enzymatic activity of 500 U/L. In addition to the high removal efficiency, the EMBR effectively 
reduced estrogenic activity to 97%. Similarly, Nguyen et al. [229] investigated the removal of 30 
TrOCs in UF-EMBR using purified laccase from A. oryzae. They observed that the removal of 
phenolic TrOCs with EDGs ranged from 70 to 99%, while the removal of phenolic TrOCs with 
EWGs was in the range of 25 to 50%. On the other hand, removal of tested non-phenolic 
compounds were generally poor (i.e. 5-20%) expect for a few non-phenolic TrOCs namely, 
benzophenone (75%), amitriptyline (95%), octocrylene (99%) and diclofenac (45%) [229]. A list 
of EMBR studies for the removal of TrOCs is presented in Table 2.9. 
Denaturation of enzyme (i.e., loss of enzymatic activity) has been observed during the operation 
of EMBR. Denaturation of enzyme may be due to various factors including physicochemical and 
biological inhibitors. Denaturation of enzyme can lead to the reduction in the removal of TrOCs 
by the EMBR system. Reduction in enzymatic activity has been observed in several studies [229, 
303, 375]. Thus, periodic enzyme addition may be necessary to maintain stable enzymatic activity 
and TrOC removal. Hata et al. [375] re-injected laccase every 8 h to the bioreactor to enhance the 
performance of the laccase-catalyzed treatment system. Similarly, Nguyen et al. [229] re-injected 




Table 2.9. Details of the selected studies for the removal of TrOCs by EMBR 










Wastewater composition References 
UF Polyethersulfone 
(10 kDa) 
500, 100 0.25 1, 4 7 26 
TrOCs (4 mg/L each) in water buffered with 




500 0.25 2, 4 4, 7 25 
TrOCs (4 mg/L each) in water buffered with 
100 mM sodium acetate at pH 4 and with 100 




90 1.5 8 6.8 28 TrOCs (0.5 mg/L each) in Milli-Q water [303] 
UF Polyacrylonitrile 
(6 kDa) 
180 1.5 8 6.8 28 TrOCs (0.005 mg/L each) in Milli-Q water [229] 
UF Polyacrylonitrile 
(6 kDa) 
90 1.5 8 6.8 28 
TrOCs (0.25 and 0.5 mg/L each) in Milli-Q 
water 
[306] 
Laccase-grafted ceramic  
membrane (0.2 and 1.4 µm) 
NA 2 24 7 25 TrOCs (20 mg/L each) in deionized water [377] 
Laccase on TiO2 coated on 
PVDF membrane 
0.42 0.04 24 5.5 22 
TrOCs (35 mg/L each) in water buffered with 
100 mM acetate 
[378] 






Interestingly, during the operation of UF-EMBR, removal of some TrOCs such as naproxen, 
oxybenzone and pentachlorophenol was better as compared to batch experiments as explained 
here [306, 374]. Although a direct comparison between batch and continuous experiments may 
not be valid, TrOC removal data obtained from batch enzymatic bioreactor and UF-EMBR 
(Figure 2.16) indicates two distinct pattern: (i) significant improvement (40-90%) in the 
removal of some phenolic TrOCs such as amitriptyline, benzophenone and octocrylene and 
some phenolic TrOCs such as oxybenzone, pentachlorophenol, and salicylic acid during the 
operation of UF-EMBR, and (ii) 5-20% reduction in the removal of some phenolic compounds 
such as estrone, 17β – estradiol and bisphenol A.  
Improvement in the removal of some non-phenolic and phenolic compounds was attributed to 
retention of these compounds on enzyme gel-layers formed on the surface of the membrane 
during EMBR operation [229]. Since laccase is negatively charged at pH ≥6, formation of an 
enzyme gel-layer may have converted the membrane surface from an uncharged to a partially 
charged membrane. Although ultrafiltration membrane used by Nguyen et al. [229] was not 
expected to retain TrOCs via size exclusion mechanism, enhanced removal of some TrOCs can 
be attributed to: (i) adsorption of hydrophobic TrOCs (log D>3) onto enzyme gel-layers; and 
(ii) non-hydrophobic interaction (e.g., electrostatic interaction) between ionizable TrOCs and 
negatively charged membrane surface. For instance, removal of the significantly hydrophobic 
nonphenolic TrOCs such as benzophenone (log D=3.46), octocrylene (log D=5.18) and 
oxybenzone (log D=3.21) in EMBR improved, possibly due to their adsorption onto enzyme 
gel-layer (Figure 2.16). However, significantly hydrophobic solutes adsorbed on membrane 
surface could diffuse in permeate to attain the equilibrium. This phenomenon has commonly 
been reported for nanofiltration and forward osmosis membranes [379, 380] but could be 
possible in ultrafiltration membranes as well [381, 382]. The evidence (Figure 2.16) suggests 
that diffusion in to permeate can be the reason of reduction in the removal of a few hydrophobic 
phenolic TrOCs such as estrone, 17β – estradiol and bisphenol A. Moreover, reduction in their 
removal can also be attributed to the continuous loading of TrOCs in EMBR [229, 243].  
Electrostatic interactions between charged membrane and ionizable TrOCs are strongly 
influenced by solution pH and dissociation constant (pKa) of compounds [383]. For instance, 
Nghiem et al. [167, 384] observed that the rejection rate of hydrophilic pharmaceuticals (log 
<3) via charge repulsion by a negatively charged loose NF membrane was increased at pH>pka 
due to the transformation of compounds from neutral to negatively charged species. Since 
EMBR was operated near neutral pH i.e., 6.8-7 [229, 306], removal of hydrophilic compounds 
such as ibuprofen (pKa=4.41), naproxen (pKa =4.84), ketoprofen (pKa =4.23) was possibly 
improved due to their conversion from neutral to negatively charged species. It was also 
confirmed that the retained TrOCs were subsequently degraded in EMBR [229], indicating that 
retention of both enzyme and TrOCs is important to enhance the removal of TrOCs in EMBR. 
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Despite all the possible explanations, change in membrane properties and impacts on TrOC 








































































































































































































































































































































































Figure 2.16. Removal of TrOCs in batch enzymatic bioreactor and continuous-flow EMBR. 
Numbers within parenthesis indicates number of data point (nEMBR +nbatch laccase). Error bars 
represent standard deviation among data points. E1: Estrone; E2: 17β – Estradiol; EE2: 17α – 
ethinylestradiol. The data is extracted from the studies listed in Table 2.9. 
As noted in section 2.3, activated sludge-based HR-MBR provides excellent removal of TrOC 
based on the effluent quality, however the biodegradation of TrOC in the bioreactor is 
comparable to that achieved by CAS process and/or MBR, leading to the accumulation of 
TrOCs in the bioreactor of HR-MBR. Therefore, WRF or their ligninolytic enzymes having 
stronger biodegradation capacity than the activated sludge should be investigated for the 
biodegradation of TrOCs. Based on the impact of membrane retention in conventional UF-
EMBR, it can be postulated that that the coupling of an enzymatic bioreactor with a high 
retention membrane process may facilitate the degradation of recalcitrant compounds by 
retaining both enzyme and TrOCs.  
2.4.5. Improvement in the performance of EMBR with redox-mediators  
Laccase catalyzes mono-electronic oxidation of TrOCs. However, the extent of removal 
depends on the ORP of the enzyme and individual TrOCs. Poor removal of non-phenolic 
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TrOCs can be attributed to: (i) presence of a strong EWG in the structure of non-phenolic 
compounds, causing steric hindrance; and (ii) higher ORP of non-phenolic compounds than 
laccase [313]. Removal of non-phenolic compounds can be enhanced by introducing a low-
molecular weight redox-mediator. In a redox-mediator catalyzed system, highly reactive 
radicals are formed due to the oxidation of a mediator by laccase, and these radicals then serve 
as an electron transfer shuttle between TrOCs and laccase, facilitating enhanced removal of 
recalcitrant compounds. Three oxidation mechanisms, namely hydrogen atom transfer (HAT), 
ionic mechanisms and electron transfer have been reported for mediators. For instance, 1-
hydroxybenzotriazole (HBT) and syringaldehyde (SA) follow HAT mechanism, while 2,2-
azino-bis(3-ethylbenzothiazoline)-6-sulfnoic acid (ABTS) and 2,2,6,6-
tetramethylpiperidinyloxyl (TEMPO) follow electron transfer and ionic mechanisms, 
respectively [310, 385]. 
Properties of different redox-mediators used to enhance the removal of different TrOCs are 
summarized in Table 2.10. Although the mediators perform differently, two mediators namely 
HBT and SA have been commonly used to broaden the spectrum of compounds significantly 
degraded by laccase. Studies involving these mediators confirmed that they not only improved 
the ORP of reaction media but also the extent of removal. Only a few studies elucidated the 
performance of different mediators based on the type of substrate (i.e., phenolic vs. non-
phenolic). For instance, N=OH type mediators (VA and HBT) were found to achieve the best 
removal of non-phenolic TrOCs such as clofibric acid, naproxen and carbamazepine, while SA 
and ABTS performed  better for phenolic compounds such as salicylic acid and steroid 
hormones [229, 303, 306]. 
Table 2.10. Properties of redox-mediators used to improve the performance of laccase-based 
treatment of TrOCs. Adapted from [295]. 
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Mediator type, concentration and compound properties influence the performance of a redox-
mediator. For instance, removal of diclofenac improved from 40 to 80% by increasing the 
concentration of SA from 0.1 to 0.5 mM [314]. Similarly, Nguyen et al. [306] achieved an 
improvement of 35% in the removal of diclofenac in an EMBR by increasing the dose of SA 
from 0.01 mM to 0.1 mM. However, beyond a threshold concentration increasing redox-
mediator dose may not improve the removal of TrOCs. For instance, Ashe et al. [310] observed 
that increasing the concentration of VA and ABTS from 0.5 to 1 mM could not enhance the 
removal of oxybenzone and naproxen. They also observed that removal of atrazine was reduced 
by 15-25 % when the concentration of VA and HBT was increased from 0.1 to 0.25 mM. This 
may be attributed to the complex interactions between laccase and the radicals generated due 
to degradation of the mediator by laccase, as discussed below. 
It has been observed in almost all the studies that enzymatic activity significantly drops with 
the addition of mediators. For instance, Hata et al. [375] observed 90% decline in enzymatic 
activity within fist 8 h of incubation in the presence of HBT. Similarly, rapid decline in 
enzymatic activity was also observed with the addition of VA, HBT or ABTS [310]. Rate of 
enzyme inactivation depends on the relative stability of the radicals generated by mediators. In 
the absence of any known enzyme inhibitor, rapid enzyme inactivation in mediator catalyzed 
system can be attributed to: (i) the blockage of active sites of the enzyme by charged radicals 
and metabolites; and (ii) the reaction of metabolites with enzyme-active sites to convert them 
into non-productive complexes [386, 387].  
Despite rapid inactivation of enzymes, redox-mediators can compensate by enhancing the rate 
of reaction, eventually achieving rapid and enhanced removal of TrOCs. However, periodic 
replenishment of enzyme is needed to maintain the removal efficiency of TrOCs, constraining 
the long-term operation of mediator-enzyme based wastewater treatment processes. Therefore, 
selection of mediator type and its concentration is vital for effective and long-term operation 
of such systems.  
2.5. Performance of emerging advanced oxidation process 
In addition to exploring the efficiency of enzymatic degradation, this thesis has explored 
combined application of enzymatic and emerging advanced oxidation processes (AOPs). In 
line with this, performance of emerging AOPs such as persulfate (PS) oxidation process is 
reviewed and is briefly presented in this section. 
Due to their molecular properties, conventional biological processes are not effective for a wide 
range of TrOCs (see Section 2.3). On the other hand, despite the effective removal of TrOCs 
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by NF/RO membrane filtration, an additional step is required for the treatment of the produced 
concentrate. In this context, it is noteworthy that advanced oxidation processes (AOP) may 
achieve effective degradation of TrOCs, and may degrade pollutants causing membrane 
fouling. Notably, post treatment of biologically treated wastewater by AOPs may 
simultaneously achieve disinfection and TrOC removal [388]. Among the advanced oxidation 
processes, ozonation has been mostly investigated for TrOC removal [389, 390]. However, 
ozone residuals may interact with membrane material, and can reduce the membrane lifetime 
[391]. Activated PS is an emerging advanced oxidation process that can degrade both natural 
organic matter and recalcitrant TrOCs [392, 393].  
PS is stable at room temperature, but can be activated by various agents such as transition 
metals (e.g., iron), heat, and ultraviolet (UV) light to form one or more sulphate radicals (SO4
– 
•), which are highly reactive [392]. PS activation by heat and UV light produce two SO4
– • 
radicals (Equation 1), while only one SO4
– • radical is generated following activation by 
transition metals such as Fe2+ (Equation 2). This indicates that activation by heat or UV light 
may provide more efficient treatment compared to activation by a transition metal [392, 394].  
𝑆2𝑂8 
2− + ℎ𝑒𝑎𝑡 𝑜𝑟 𝑈𝑉 𝑙𝑖𝑔ℎ𝑡 →  2 𝑆𝑂4 








Depending on wastewater characteristics, persulfate or SO4
–• radicals may react with water 
and/or organics to form secondary radicals that can also contribute to degradation of organic 
impurities [392, 395]. SO4
–• radicals can react with water to form hydroxyl (OH–•) radicals, but 
the abundance of the SO4
–• and OH–• radicals is governed by the pH of reaction media. Under 
acidic conditions (pH<7), SO4
–• radicals are the dominant species, while OH–• is the primary 
reactive species under basic conditions (pH>7). At neutral pH, both SO4
–• and OH–• radicals 
contribute equally to pollutant degradation [396].  
Literature on the degradation of TrOCs by activated PS is scarce, and to date has been generally 
focused on PS activation routes in the presence of a single TrOC. Previously, the combined 
peroxymonosulfate (50 µM) – Fe2+ (50 µM) process achieved above 99% degradation of 
atrazine, outperforming atrazine removal by coagulation [397]. Heat activated PS has been also 
reported to achieve 40-100% removal of a few investigated TrOCs such as atrazine, aniline, 
monochlorobenzene and 2,4-dichlorophenol [392]. Deng et al. [398] reported only 12% 
degradation of carbamazepine following 2 h treatment with heat-activated PS at a PS 
concentration and operating temperature of 1 mM and 40ºC, respectively. In a study by Ji et al. 
[399], PS (1 mM) activated by heat at 40ºC achieved 20% atrazine degradation after an 
incubation time of 120 h. Ji et al. [400] observed complete degradation of the antibiotic 
sulfamethoxazole within 8 h at 50ºC. These previous experiments were done in batch mode. 
74 
 
Instead of a single TrOC, performance of activated PS for the degradation of a wide range of 
TrOCs in their mixture should be assessed. In addition to TrOC degradation, PS activated by 
UV light was reported to control fouling during the treatment of surface water by an 
ultrafiltration membrane [401]. In another study by Chen et al. [397], fouling of an 
ultrafiltration membrane caused by humic substances and sodium alginate was significantly 
reduced by peroxymonosulfate activated by Fe2+.  
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Chapter 3: TrOC removal by a high retention 
nanofiltration vs. ultrafiltration enzymatic 

















This chapter is based on the following publications: 
Asif, M.B., Hai, F.I., Dhar, B.R., Ngo, H.H., Guo, W., Jegatheesan, V., Price, W.E., Nghiem, 
L.D., Yamamoto, K. 2018. Impact of simultaneous retention of micropollutants and laccase 
on micropollutant degradation in enzymatic membrane bioreactor. Bioresource Technology, 
267, 473-480. 
Asif, M.B., Hou, J., Price, W.E., Chen, V., Hai, F.I. 2019. Nanofiltration vs ultrafiltration- 
coupled enzymatic membrane bioreactor (EMBR): Can the choice of a membrane influence 








Trace organic contaminants (TrOCs) such as pharmaceuticals, pesticides, steroid hormones and 
industrial chemicals are commonly detected in different environmental systems including 
surface water and groundwater due to the discharge of secondary treated wastewater [1, 2]. In 
addition, agricultural run-off, combined sewer overflow and stormwater run-off can 
significantly increase the concentration of TrOCs in freshwater bodies [2, 3]. Since TrOCs can 
be potentially harmful to the aquatic ecosystem and human health [4], an efficient treatment 
system is required for effective TrOC removal.  
Conventional activated sludge process and membrane bioreactors (using micro- or 
ultrafiltration membranes) have been reported to be ineffective for the removal of TrOCs [5, 
6]. Bioreactors equipped with high retention membranes (e.g., nanofiltration or membrane 
distillation) can be a promising alternative. Among different types of high retention membrane 
separation processes, nanofiltration (NF) membranes have been studied extensively for the 
removal of TrOCs from secondary treated wastewater and freshwater [7-10]. Following 
membrane separation, an additional process is required for the treatment of the membrane- 
concentrate containing high concentrations of TrOCs. Instead of providing a separate treatment 
process for the degradation of TrOCs, it is a sensible approach to integrate a TrOC degradation 
process with the NF membrane. In this context, an enzymatic bioreactor can be combined with 
an NF membrane, which will provide complete retention and TrOC biodegradation in a single 
step. TrOC degradation by fungal enzymes in enzymatic bioreactors is a promising eco-friendly 
technique. Enzyme-catalyzed degradation of TrOCs by fungal enzymes does not produce 
secondary toxic sludge, which is a key attribute of physicochemical treatment processes [11, 
12]. Among different fungal enzymes (e.g., lignin peroxidases and manganese peroxidase), 
laccase is interesting as it does not require an external co-factor such as hydrogen peroxide 
(H2O2) to catalyze the degradation or oxidation of TrOCs [13]. Laccase-catalyzed degradation 
process typically involves the transfer of an electron from a substrate to the active sites of 
laccase followed by conversion of dissolved oxygen to water [14, 15]. The characteristics of 
active sites of laccase have been studied by using a combination of spectroscopic and 
crystallography techniques [16, 17]. Briefly, laccase active sites consist of four copper atoms, 
and can be classified into following categories: (i) Type 1 containing one copper atom; (ii) 
Type II containing one copper atom; and (iii) Type III containing a pair of copper atoms. 
During the degradation process, reduction of Type I copper site occurs due to the transfer of an 
electron from a substrate to the laccase. This promotes the transfer of an electron to Type II 
and Type III active sites where dissolved oxygen is reduced, and release of water takes place 
[15, 17].  
Performance of laccase is governed by the operating conditions (e.g., pH and temperature) and 
molecular properties of pollutants (e.g., molecule structure and hydrophobicity). Typically, 
laccase can efficiently catalyze the degradation of TrOCs containing strong electron donating 
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functional groups (EDGs) such as hydroxyl (–OH) and amine (–NH) functional groups. By 
contrast, degradation of TrOCs containing strong electron withdrawing functional groups 
(EWGs) such as amide (–NH2) and halogen (–X) is incomplete [11, 18, 19]. To improve the 
degradation of resistant TrOCs, a low molecular weight redox-mediator can be introduced in 
the enzymatic bioreactor. Redox-mediators are readily oxidized by laccase and produce highly 
reactive radicals that can either directly degrade or polymerize resistant TrOCs [20].     
Performance of laccase for TrOC removal has been predominantly studied by operating the 
enzymatic bioreactor in batch mode to avoid enzyme washout. This issue has been addressed 
by coupling an ultrafiltration (UF) membrane to an enzymatic bioreactor to effectively retain 
the enzyme [21, 22]. Notably, the UF membrane integrated with an enzymatic membrane 
bioreactor (EMBR) can effectively retain laccase but are not expected to retain TrOCs via size 
exclusion. During the filtration of bioreactor media, an enzyme gel-layer was reported to be 
formed on the membrane surface, which partially retained the resistant TrOCs. Due to the 
prolonged contact time between TrOCs and laccase, the retained TrOCs were demonstrated to 
be degraded by laccase. This improved the overall performance of UF-EMBR [23]. Based on 
this observation, it can be envisaged that the simultaneous retention of laccase and TrOCs could 
facilitate degradation. However, this has not been systematically investigated by integrating an 
enzymatic bioreactor with a high retention NF membrane, which will retain both laccase and 
TrOCs, or a conventional UF membrane, which will only retain laccase but not TrOCs. 
To-date, the performance of the NF based enzymatic membrane bioreactor (NF-EMBR) has 
been reported only once in available literature [24]. In the first study by Escalona et al. [24], 
removal of an industrial chemical (bisphenol A) by NF-EMBR was studied over a short 
duration of only 5 h by operating the NF-EMBR in full batch or recirculation mode [24]. 
Because the available studies focused on only one compounds, it is imperative to investigate 
the degradation of a broad spectrum of pollutants at the environmentally relevant concentration 
for elucidating the role of simultaneous TrOC and laccase retention on the performance of an 
EMBR.  
In this chapter, the degradation of a set of 29 chemically diverse TrOCs in an enzymatic 
bioreactor coupled to the NF membrane (NF-EMBR) was assessed. To demonstrate the impact 
of effective TrOC retention on degradation, the performance of a “control” UF based EMBR 
that can only retain laccase but not TrOCs, was investigated and compared to that achieved by 
NF-EMBR. Importantly, the factors governing the performance of NF and UF membranes as 
well as laccase were studied. This facilitated in elucidating the mechanism responsible for 
better TrOC degradation in the NF-EMBR. To further improve the degradation of TrOCs, 
impact of a naturally occurring redox-mediator (violuric acid) at different concentrations was 
systematically studied. Finally, variations in membrane flux and changes in membrane 




▪ Simultaneous retention of laccase and TrOCs by the high retention NF membrane will 
facilitate degradation 
▪ Physciochemical properties, particularly chemical structure may govern TrOC removal 
by laccase and membranes 
3.3. Materials and methods 
3.3.1. Enzyme solution, redox-mediator and trace organic contaminants  
Laccase from genetically modified Aspergillus oryzae supplied by Novozymes Australia Pty. 
Ltd. (Sydney, NSW, Australia) was used. According to the supplier, w/w composition of 
enzyme solution was as follows: 66% water, 25% propylene glycol, 4% glucose, 3% laccase 
and 2% glycine. The purpose of adding propylene glycol, glucose and glycine is to stabilize 
the enzyme solution. The enzyme solution had an enzymatic activity of 190,000 µM(DMP)/min, 
which was measured before the commencement of this experiment by using 2,6-dimethoxy 
phenol (DMP) as substrate at room temperature and pH =4.5 (see Section 3.3.4.2). 
A naturally occurring redox-mediator, namely violuric acid (VA), was used because it has been 
reported to significantly improve degradation of TrOCs that are resistant to laccase-catalyzed 
degradation [25, 26]. Analytical grade VA was purchased from Sigma Aldrich (Sydney, NSW, 
Australia). A stock solution of VA was prepared in Milli-Q water and stored at -4 ºC in dark. 
Various categories of TrOCs such as pharmaceuticals, personal care products, pesticides, 
steroid hormones and industrial chemicals are ubiquitously detected in freshwater bodies [2]. 
Therefore, synthetic wastewater was prepared by adding a mixture of 29 TrOCs in Milli-Q 
water at a concentration of 5 µg/L to stimulate the composition of TrOCs in environmental 
systems. These TrOCs include ten pharmaceuticals, seven pesticides, five naturally-occurring 
steroid hormones, three industrial chemicals, three ingredients of personal care products and 
one phytoestrogen (see Appendix Table 3-1). Relevant physicochemical properties of TrOCs 
are given in Table 3.1. Analytical grade TrOCs (purity >98%) were purchased from Sigma 
Aldrich (Sydney, NSW, Australia), and a stock solution containing the mixture of 29 TrOCs 

















Non-phenolic TrOCs      
Clofibric acid C10H11ClO3 214.65 -1.06 3.18 -ve 
Metronidazole C6H9N3O3 171.15 -0.14 14.44 Neutral 
Fenoprop C9H7Cl3O3 269.51 -0.13 2.93 -ve 
Ketoprofen C16H14O3 254.28 0.19 4.23 -ve 
Naproxen C14H14O3 230.26 0.73 4.84 -ve 
Primidone C12H14N2O 218.25 0.83 12.26 Neutral 
Ibuprofen C13H18O2 206.28 0.94 4.14 -ve 
Propoxur  C11H15NO3 209.24 1.54 12.28 Neutral 
Diclofenac C14H11Cl2NO2 296.15 1.77 4.18 -ve 
Carbamazepine C15H12N2O 236.27 1.89 13.94 Neutral 
Gemfibrozil C15H22O3 250.33 2.07 4.75 -ve 
Amitriptyline C20H23N 277.4 2.28 9.18 Neutral 
N, N-Diethyl-meta-toluamide 
(DEET) 
C12H17NO 191.3 2.42 1.37 -ve 
Atrazine C8H14ClN5 215.68 2.64 2.27 -ve 
Ametryn C9H17N5S 227.33 2.97 3.71 -ve 
Benzophenone C13H10O 182.22 3.21 7.5 Neutral 
Octocrylene C24H27N 361.48 6.89 - - 
Phenolic TrOCs      
Salicylic acid C7H6O3 138.12 -1.13 3.01 -ve 
Estriol C18H24O3 298.33 1.89 10.25 Neutral 
Enterolactone C18H18O4 288.38 2.53 9.93 Neutral 
Pentachlorophenol C6HCl5O 266.34 2.85 4.68 Neutral 
4-tert-Butylphenol  C10H14O 150.22 3.4 10.13 Neutral 
Estrone C18H22O2 270.37 3.62 10.25 Neutral 
Bisphenol A C15H16O2 228.29 3.64 10.29 Neutral 
17α– Ethinylestradiol  C20H24O2 269.4 4.11 10.24 Neutral 
17β–Estradiol C18H24O2 272.38 4.15 10.27 Neutral 
17β-Estradiol-17-acetate C20H26O3 314.42 5.11 10.26 Neutral 
4-tert-Octylphenol  C14H22O 206.32 5.18 10.15 Neutral 
Triclosan C12H7Cl3O2 289.54 5.28 7.8 Neutral 
Note: Data collected from SciFinder database, Taheran et al. [9]; and Fujioka et al. [27] 
 
3.3.2. Experimental setup 
A laboratory-scale cross-flow filtration system coupled to an enzymatic bioreactor (3 L) was 
used in this experiment (Figure 3.1). A detailed description of the filtration system is given 
elsewhere [27]. Briefly, this system mainly consists of a stainless-steel enzymatic bioreactor, 
high-pressure pump (Hydra-Cell, Wanner Engineering Inc., Minneapolis, MN, USA), stainless 
steel membrane cell, and bypass and back-pressure valves (Swagelok, Solon, OH, USA). The 
membrane cell with a channel height of 2 mm holds the flat-sheet NF or UF membrane with a 
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surface area of 40 cm2. A digital flow meter (FlowCal, GJC Instruments Ltd, Chester, CH, UK) 
was connected to the permeate line for monitoring the permeate flux. The cross-flow velocity 
and temperature were maintained at 40.2 cm/s and 25 °C, respectively in all experiments. 
 
Figure 3.1. Schematics of the lab-scale cross-flow filtration system attached to an enzymatic 
bioreactor operated in full recirculation mode (a) and continuous-flow mode (b). Arrows show 
the direction of flow. Laccase retention was first confirmed with a short term (i.e., 24 h) study 
in full recirculation mode. Further operation of EMBRs were conducted in continuous-flow 
mode for assessing the impact of TrOC retention on their degradation. Cf, CEBR and Cp are the 
concentration (µg/L) of a specific TrOC in the feed, enzymatic bioreactor and permeate, 
respectively. Vf, VEBR and Vp represent the volume of feed, enzymatic bioreactor and permeate, 
respectively. A picture of lab-scale EMBR is shown in Appendix Figure 3-2. 
Commercially available flat-sheet UF and NF membranes were used in this experiment. The 
UF membrane was purchased from Sterlitech (WA, USA). The active layer of the UF 
membrane is made of polyvinylidene fluoride (PVDF), and its molecular weight cut-off 
(MWCO) is 30,000 Da. The UF membrane was not expected to retain TrOCs by size exclusion, 
because the molecular weight of the selected TrOCs ranged between 138-361 Da (Table 3.1). 
On the other hand, the NF membrane (NF90, Dow chemicals, MI, USA) had an MWCO of 200 
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Da. It was a polyamide thin film composite (TFC) membrane that has been studied extensively 
for the rejection of recalcitrant pollutants from surface water and secondary treated wastewater 
[9]. However, the performance of the polyamide-TFC NF membrane has not been studied for 
the removal of TrOCs following its integration with an enzymatic bioreactor. 
3.3.3. Enzymatic membrane bioreactor operation and experimental protocols 
Each experiment was initiated with membrane compaction. The NF membrane was compacted 
at a pressure and cross-flow velocity of 10 bar and 40.2 cm/s, respectively, using Milli-Q water 
until the permeate flux stabilized at around 7 L/m2 h. Similarly, the UF membrane was also 
compacted but without applying any pressure. This is because the cross-flow velocity of 40.2 
cm/s was enough to generate a permeate flux equivalent to that achieved by the NF membrane. 
A series of experiments were conducted by operating UF/NF-EMBR separately to assess: 
TrOC degradation by laccase; and TrOC removal by the UF and NF membrane. This exeriment 
has two parts – (i) proof of the concept preliminary run: the performance of NF vs. UF coupled 
EMBRs for the degradation of only five TrOCs; and (ii) comprehensive run: the performance 
of NF vs. UF coupled EMBRs for the degradation of a broad spectrum of TrOCs. Experimental 
protocoals for both runs are explained separately in the following sections. 
3.3.3.1. Preliminary assessment of NF vs. UF coupled EMBRs 
The working volume of the enzymatic bioreactor was kept at 3 L in all experiments. In full 
recirculation mode, UF/NF-EMBRs were operated for a period of 24 h, and the membrane 
permeate was continuously returned back to the enzymatic bioreactor. The NF-EMBR was 
operated at a pressure of 8 bar and cross-flow velocity of 40.2 cm/s, which corresponds to an 
initial permeate flux of 6.9 L/m2 h bar. Laccase was directly added to the enzymatic bioreactor 
to achieve an initial laccase activity of 180-185 µM(DMP)/min. This laccase activity was selected 
based on that reported for previously developed UF-EMBRs [22, 28]. Stock solution containing 
the TrOC mixture was added to the enzymatic bioreactor to obtain a concentration of 1000 
µg/L of each TrOC. However, the actual initial measured concentrations of atrazine, 
carbamazepine, sulfamethoxazole, diclofenac and oxybenzone were 1100±20, 1050±40, 
1120±80, 1070±40 and 1000±30 μg/L (n=4), respectively.  
All operating parameters for UF-EMBR were identical to that of NF-EMBR except the applied 
pressure as explained above. The EMBRs were first operated to confirm retention of laccase 
and TrOCs by the membrane and check the stability of laccase during EMBR operation. 
Duplicate samples were collected from the membrane permeate at 2, 4, 8 and 24 h for 
measuring laccase activity and TrOC removal.  
All the operating conditions in continuous-flow mode were same as described above for full 
recirculation mode, except that the synthetic wastewater containing the mixture of TrOCs was 
continuously fed into the enzymatic bioreactors at a loading rate of 1.44 mg/L.d for each TrOC. 
A peristaltic pump (Masterflex, Vernon Hills, IL, USA) was used for continuous feeding. 
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Based on the initial permeate flux of the membranes (i.e., 6.9 L/m2 h bar), the hydraulic 
retention time (HRT) of the EMBRs was 16 h. The EMBRs were each operated continuously 
for a period of 48 h (i.e., 3×HRT). During each run, duplicate samples were collected from the 
enzymatic bioreactor and membrane permeate at specific intervals (i.e., 6, 12, 16, 24, 32, 38 
and 48 h) for measuring laccase activity and TrOC removal. At the end of UF/NF-EMBR 
operation, the clean water flux was measured for 1 h using Milli-Q water to assess membrane 
fouling and flux recovery. 
3.3.3.2. Assessment of NF vs. UF coupled EMBRs for broad spectrum of TrOCs 
The NF-EMBR and UF-EMBR (“control”) were operated under continuous mode to 
systematically investigate the effect of TrOC retention on their degradation. Under continuous 
mode, the synthetic wastewater containing the mixture of TrOC in ultrapure Milli-Q water was 
continuously fed to UF/NF-EMBR separately for a period of 68 h using peristaltic pumps 
(Masterflex, Vernon Hills, IL, USA). Based on the initial permeate flux of the membranes, the 
HRT for both EMBRs was approximately 16 h. Duplicate samples from enzymatic bioreactor 
were collected at 32 and 68 h for analysis to assess TrOC degradation by laccase. At same 
intervals (i.e., 32 and 68 h), duplicate samples from permeate were also collected to analyze 
the overall removal of TrOCs (i.e., biodegradation+membrane retention). At the end of each 
experiment, UF and NF membranes were backwashed with ultrapure Milli-Q water for 1 h, 
and the clean water flux of the membranes was measured to assess flux recovery.  
Redox-mediators are low molecular weight phenolic compounds that can facilitate the 
degradation of TrOC by acting as an electron shuttle between laccase and target pollutant [20]. 
In this experiment, the NF-EMBR was operated with and without mediator dosing to 
investigate the influence of mediator dosing on TrOC degradation. A single dose of violuric 
acid (VA) was introduced at different concentrations (i.e., 10, 25, 50 and 100 µM) separately 
to the NF-EMBR. Duplicate samples from enzymatic bioreactor and permeate were collected 
at 32 and 68 h for TrOC analysis. 
3.3.3.2.4. Laccase stability and maintenance in EMBRs 
During the operation of EMBRs, laccase activity may diminish due to various physical, 
chemical and biological inhibitors such as shear stress caused by membrane filtration [13, 29]. 
Moreover, the transformation products formed following TrOC degradation in an EMBR can 
also inhibit laccase by blocking the active sites of enzymes [30]. Therefore, laccase activity 
was regularly monitored during the operation of EMBRs. Based on laccase activity drop (see 
Appendix Figure 3-3), a protocol of re-injecting a small dose of laccase (250 µL per litre of 
bioreactor media) was developed to maintain a laccase activity of 170-185 µM(DMP)/min for 
stable TrOC degradation. 
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3.3.4. Analytical methods 
3.3.4.1. TrOC analysis 
During prelimnary assessment with five compounds, quantification of TrOCs was carried out 
by using High-performance liquid chromatography (HPLC) (Shimadzu, Kyoto, Japan) at the 
detection wavelength of 280 nm using a method reported previously [31]. Briefly, the HPLC 
system was equipped with a UV-Vis detector and C-18 column (300×4.6 mm) having a pore 
size of 5 μm (Supelco Drug Discovery, Sigma Aldrich, Sydney, NSW, Australia). Milli-Q 
water buffered with 25 mM KH2PO4 and HPLC grade acetonitrile were used as the mobile 
phase for TrOC quantification. Two eluents, namely eluent A (20% acetonitrile + 80% buffer, 
v/v) and eluent B (80% acetonitrile + 20% buffer, v/v), were passed through the C-18 column 
at a flow rate of 0.7 mL/min for 30 min in time dependent gradients as follows: [Time (min), 
A (%)]: [0, 85], [8, 40], [10, 0], [22, 0], [24, 85]. The gradient of eluent B was then 
automatically adjusted as follows: [Time (min), B (%)]: [0, 15], [8, 60], [10, 100], [22, 100], 
[24, 15]. The limit of detection (LOD) for this method was approximately 10 µg/L.  
During experiment with as broad spectrum of 29 compounds, TrOC concentration was 
measured using a method previously described by Hai et al. [32]. This method involves the 
extraction of TrOC by solid-phase extraction technique followed by their quantification using 
a GC/MS system (QP5000, Shimadzu, Japan). TrOCs present in the feed, supernatant and 
permeate samples were extracted using 6 mL 200 mg Oasis HLB cartridges (Waters, Milford, 
MA, USA). The TrOC extraction procedure was as follows: (i) pre-conditioning of HLB 
cartridge with 5 mL dichloromethane and methanol solution (1:1 v/v), 5 mL methanol and 5 
mL Milli-Q water; (ii) loading of acidified (pH 2-2.5) samples onto the cartridges at a flow rate 
of 1–4 mL/min; and (iii) drying of cartridges with nitrogen for 30 min. The TrOCs were 
subsequently eluted from the cartridge using 5 mL of methanol followed by dichloromethane 
and methanol mixture (1:1 v/v) at a flow rate of 1–4 mL/min. The effluent was subsequently 
evaporated at 40 oC under a gentle stream of nitrogen. The residual after evaporation was re-
dissolved in 200 µL methanol containing an internal standard (5 mg bisphenol A-d16) before 
its transfer into 1.5 mL vials. The mixture present in 1.5 mL vials was again evaporated under 
gentle stream of nitrogen. Finally, the extracts were derivatized by adding 100 µL of N,O-
bis(trimethylsilyl)trifluoroacetamide (1% trimethylchlorosilane) and pyridine (dried with KOH 
solid), then heated on a heating block (60–70 oC) for 30 min. The derivatives were cooled to 
room temperature and analyzed using the Shimadzu QP5000 GC–MS (Shimadzu, Kyoto, 
Japan). The limit of detection (LOD) for this method is compound specific and ranged from 1-
20 ng/L as listed in Appendix Table 3-1. Removal efficiency by laccase (Rdegradation) and the 
membrane (Rmembrane) was measured as:  
Rdegradation = 100 × (1 – CEBR/Cf) (1) 




where, Cf, CEBR and Cp are the concentration (ng/L) of a specific TrOC in feed, enzymatic 
bioreactor and permeate, respectively. The mass of TrOCs degraded by laccase was calculated 
as follows:  
Cf × Vf  = (CEBR × VEBR) + (Cp × Vp) + biodegradation/biotransformation (3) 
where, Vf, VEBR and Vp represents the volume of feed, enzymatic bioreactor and permeate, 
respectively. 
3.3.4.2. Laccase activity assay and ORP 
Laccase activity was measured by using a method previously reported by Paszczynski et al. 
[33]. Briefly, the change in absorbance of 2,6-dimethoxyl phenol (DMP) in sodium citrate 
buffer (pH = 4.5) was recorded over a duration of 2 min at room temperature using a UV-Vis 
spectrometer (DR3900, HACH, Loveland, Colorado, USA). A molar extinction coefficient of 
49.6/mM cm was used to calculate laccase activity. Oxidation-reduction potential (ORP) of 
laccase with and without the addition of redox-mediator was measured using an ORP meter 
(WP-80D dual pH-mV meter, Thermo Fisher Scientific, Australia).  
3.3.4.3. Analysis of membrane properties and surface morphology  
Surface charge and hydrophobicity was analyzed to assess the effect of laccase on membrane 
properties. Membrane hydrophobicity in terms of contact angle was measured by the standard 
sessile drop method using a Rame-Hart Goniometer (Model 250, Rame-Hart, Netcong, New 
Jersey, USA) as previously described [34].  
For assessing the change in surface charge of the membranes, the zeta potential was measured 
at room temperature using a SurPASS elctrokinetic analyzer (Anton Par GmbH, Graz, Austria). 
Analytical grade potassium hydroxide and hydrochloric acid were used to adjust the pH of the 
electrolyte solution. The zeta potential was calculated from the steaming potential using the 
Fairbrother-Mastin approach [34].  
NF and UF membranes collected at the end of experiments were air-dried in a desiccator. After 
coating the membranes with a gold layer by using a sputter coater (SPI Module, West Chester, 
PA, USA), the surface morphology of the membranes was characterized with scanning electron 
microscopy (SEM) (JCM-600, JEOL, Tokyo, Japan).  
3.4. Results and discussion 
3.4.1. Laccase and TrOC retention by the membranes 
Coupling a membrane to the enzymatic bioreactor can prevent washout of the enzyme along 
with treated effluent. The flat-sheet UF and NF membranes used in this experiment have not 
been tested before for laccase retention. Hence, effective retention of laccase was studied by 
operating UF/NF-EMBRs in full recirculation mode. Laccase activity in NF-EMBR permeate 
remained undetected throughout operation as shown in Figure 3.2, thus confirming effective 
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retention of laccase by the NF membrane. On the other hand, no laccase activity was detected 
in the permeate during the first 4 h of UF-EMBR operation in full recirculation mode, but a 
small laccase activity of 5-7 µM(DMP)/min (i.e., still above 95% laccase retention) was measured 
in UF-permeate samples for the rest of the experiment. In previously developed UF-EMBR, 
hollow fiber UF membranes with molecular weight cutoff (MWCO) of 6-10 kDa effectively 
retained laccase in the enzymatic bioreactor [21, 22]. Although the MWCO of the flat-sheet 
UF membrane (30 kDa) used in this experiment was smaller than the size of laccase (56 kDa), 
slight passage of laccase through the UF membrane can be attributed to its diffusion into the 
permeate following the formation of a laccase gel-layer on the active side of membrane that 
was visible to the naked eye. The enzyme gel-layer formed on the UF membrane can be seen 
in the picture given in Appendix Figure 3-4. In addition, membrane pore size may be non-
uniform, and presence of pores with diameter greater than the average pore size can increase 
the effective MWCO of a membrane. Furthermore, depending on water matrix (e.g., ionic 
strength and pH) and membrane properties (e.g., surface charge, hydrophobicity and pore size), 
chemicals may permeate even through the membrane with a smaller MWCO. Similar 
observations were made when two enzymes, namely, lysozyme and protease were concentrated 
using polysulfone and polyethersulfone ultrafiltration membranes, respectively [35, 36].  












































































Figure 3.2. Laccase activity in the enzymatic bioreactor and permeate of UF-EMBR and NF-
EMBR during their operation in full recirculation mode for 24 h. The standard deviation of 
duplicate samples was less than 2%. 
The results of NF-EMBR operation in full recirculation mode confirmed above 95% retention 
of the TrOCs by the NF membrane. Conversely, TrOC rejection by the UF membrane varied 
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between 1% (Sulfamethoxazole) and 5% (diclofenac). The rejections of TrOCs by both 
membranes are shown in Appendix Figure 3-5.  
3.4.2. Preliminary assessment of TrOC removal in UF vs. NF-EMBRs  
In this experiment, NF-EMBR achieved 92 to over 99% removal of the TrOCs (Figure 3.3). 
In general, NF membranes can remove TrOCs via the following mechanisms: (i) size 
exclusion; (ii) adsorption; and (iii) electrostatic interaction [9, 37]. TrOCs having a molecular 
weight higher than 200 g/mol have been reported to be effectively rejected by the NF90 
membrane [38]. Because the molecular weight of the selected TrOCs during preliminary 
assessment was above 200 g/mole, effective rejection (92-99%) could be attributed to size 
exclusion mechanism. Moreover, charge repulsion between the negatively charged NF 
membrane (Table 3.1) and negatively charged TrOCs (i.e., diclofenac, sulfamethoxazole and 
atrazine) could be responsible for their rejection by the NF membrane in the NF-EMBR. 
Adsorption of hydrophobic TrOCs (log D>3.2), which are generally neutral at pH=7, on 
membrane surface has been reported to result in effective rejection by the NF membrane at the 
initial stage of operation. However, their rejection could reduce gradually with time due to the 
diffusion of hydrophobic TrOCs into permeate [9, 39]. In this experiment, the NF-EMBR 
achieved above 99% removal of a hydrophobic TrOC, namely oxybenzone (log D = 3.99), 
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Figure 3.3. Overall removal (i.e., degradation + membrane retention) of TrOCs in UF- and 
NF-EMBRs operated separately at an HRT of 16 h and TrOC loading rate of 1.44 mg/L d. 
Data presented as average ± standard deviation (n = 6). 
The overall removal of the TrOCs by the NF-EMBR (as indicated by TrOC concentration in 
the membrane permeate) was 10-80% higher than that by the UF-EMBR (Figure 3.3). UF 
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membranes are not expected to remove TrOCs via size exclusion. However, it was observed 
that TrOCs were partially retained by the UF membrane. This aspect has been comprehensively 
discussed in Section 3.4.3.3. 
During preliminary assessment of TrOC degradation by laccase in EMBRs, remaining TrOCs 
following degradation will mostly pass through the membrane (for UF membrane) or be 
significantly retained (for NF membrane). The NF membrane is expected to retain TrOCs more 
effectively than the UF membrane, but the current experiment seeks to assess if the application 
of NF can also enhance degradation. The UF/NF-EMBRs were continuously operated for a 
duration of 3×HRT under identical conditions to provide a common basis for comparing the 
degradation of TrOCs in UF- and NF-EMBRs. The degradation of TrOCs by laccase in UF/NF-
EMBR was calculated using Equation (1). Among the selected TrOCs, efficient degradation 
(80-99%) of oxybenzone was achieved by laccase in both UF- and NF-EMBRs (Figure 3.4). 
In addition, its degradation was observed to be above 50% within the first 6 h of EMBR 
operation, which suggested that oxybenzone was easily amenable to degradation by laccase. 
Since phenols are typical substrates of laccase [11, 13], high removal of oxybenzone by laccase 
could be attributed to the presence of a phenolic moiety in its molecule. Indeed, oxybenzone 
removal by batch and continuous-flow enzymatic bioreactors has been reported to range from 
60-99% [40, 41]. Gago-Ferrero et al. [42] reported the formation of three degradation products, 
namely benzophenone-1, 4-hydroxybenzophenone and 4,4′-dihydroxybenzophenone, 
following laccase-mediated degradation of oxybenzone. Interestingly, despite being inherently 
amenable to laccase-catalyzed degradation, its degradation was 19% better in NF-EMBR as 
compared to UF-EMBR (Figure 3.4). This could be attributed to the effective retention of 
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Figure 3.4. Degradation of TrOCs in UF- and NF-EMBRs operated separately at an HRT of 
16 h and TrOC loading rate of 1.44 mg/L d. Data presented as average ± standard deviation (n 
= 6).  
During preliminary assessment, compared to the UF-EMBR, better degradation (15-30%) of 
the non-phenolic TrOCs was achieved by the NF-EMBR (Figure 3.4). For example, 
degradation of atrazine and carbamazepine was 29 and 35%, respectively, by the NF-EMBR, 
while their degradation was approximately 10% in UF-EMBR. Similarly, degradation of 
sulfamethoxazole and diclofenac was 10-30% better as compared to that achieved by UF-
EMBR (Figure 3.4).  
Literature on the performance of an NF based enzymatic membrane bioreactor for TrOC 
removal is scarce. To date, only one study [24] has reported the performance of laccase in an 
NF-EMBR in the recirculation mode (rather than the continuous flow, which is required for 
scaling up) for a period of only 5 h and targeting only one TrOC (i.e., bisphenol A). To improve 
from the previous study by Escalona [24], in this chapter, degradation of a mixture of TrOCs 
by laccase was assessed by operating the NF-EMBR in continuous-flow mode for a longer 
duration of 3 × HRT (i.e., 48 h). Indeed, long term operation of a bioreactor is critical to achieve 
steady state TrOC degradation (Figure 3.5). The results of the preliminary assessment suggest 
that a NF membrane-coupled enzymatic bioreactor cannot only produce high quality effluent 
due to effective TrOC retention, but also achieve improved TrOC biodegradation (i.e., reduced 
concentrate disposal). However, it is imperative to investigate the degradation of a broad 




Figure 3.5. Time course of TrOC degradation by laccase in continuous-flow UF- and NF-
EMBRs. Each data point denotes average of two samples with a variation of less than 5%. 
3.4.3 Laccase-catalyzed degradation of a broad set of TrOCs by NF-EMBR 
During assessment of EMBRs for the degradation of a broad spectrum of TrOC, laccase was 
again effectively retained (>95%) by both the membranes (Appendix Figure 3-6). TrOCs were 
retained effectively only by the NF membrane, and this was confirmed by filtering a TrOC 
mixture in Milli Q water through the membrane (Appendix Figure 3-7). Hence, the operating 
conditions of the UF/NF-EMBRs were suitable to systematically investigate the impacts of 
effective TrOC retention within the enzymatic bioreactor on their laccase-catalyzed 
degradation.  
Laccase-catalyzed degradation occurs due to the transfer of a single electron from a substrate 
to laccase [20]. With some exceptions, phenolic TrOCs have been reported to be effectively 
degraded by laccase [13, 43]. On the other hand, degradation of non-phenolic TrOCs by laccase 
can be highly variable and may depend on the difference of ORP between laccase and the non-
phenolic TrOCs as well as the TrOC molecular properties such as the presence of an EWGs or 
EDGs [11, 44]. Therefore, here the degradation of the phenolic and non-phenolic TrOCs is 
discussed separately.  
3.4.3.1. Degradation of phenolic TrOCs  
In this experiment, laccase achieved efficient degradation (>80%) for four out of 12 phenolic 
TrOCs, namely 17ß–estradiol-17-acetate, 4-tert-octylphenol, triclosan and salicylic acid in 
both UF- and NF-EMBRs (Figure 3.6). Efficient degradation of these TrOCs by laccase has 

































































































































































































































































 UF-EMBR  NF-EMBR
 Phenolic TrOCs Non-phenolic TrOCs
 
Figure 3.6. Degradation of TrOCs in enzymatic bioreactor coupled to the UF or NF membrane 
for showing the effect of effective TrOC retention on degradation. Both enzymatic membrane 
bioreactors were operated at an initial laccase activity of 180 µM(DMP)/min, TrOC concentration 
of 5 µg/L, HRT of 16 h and cross-flow velocity of 40.2 cm/s. The temperature of the enzymatic 
bioreactor was kept at 25 ºC. Data is presented as average ± standard deviation (n=4). 
As mentioned above, phenolic pollutants are typical substrates of laccase. However, the 
concomitant presence of EWGs in the molecule of phenolic TrOCs can cause steric hindrance, 
thereby delaying the access of a pollutant to the active sites of laccase for effective degradation 
[44]. For phenolic TrOCs containing EWG(s), the extent of degradation by laccase in NF-
EMBR was observed to vary depending on the type of EWGs. For example, NF-EMBR 
achieved 80% degradation of estrone that contains the carbonyl (=O) functional group as an 
EWG in its molecular structure. On the other hand, degradation of pentachlorophenol, 
containing a halogen (–X) functional group as an EWG, was observed to be 60% in NF-EMBR.  
Notwithstanding the above-mentioned variations in the degradation of the phenolic TrOCs 
containing EWG(s), NF-EMBR achieved from 5 up to 60% better degradation for eight out of 
the 12 investigated phenolic TrOCs as compared to the UF-EMBR (Figure 3.6). When an NF 
membrane is attached to an enzymatic bioreactor, the HRT of the bioreactor can be decoupled 
from the organic retention time due to effective TrOC retention. This leads to increased contact 
time between laccase and TrOC and can thus facilitate TrOC degradation. Indeed, in a study 
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by Lloret et al. [21], enhanced removal (33-37%) of two phenolic TrOCs, namely estrone and 
17ß–estradiol, was achieved by increasing the HRT of an enzymatic bioreactor coupled to a 
UF membrane by 2 h. It is important to note that prolonged contact time might not be the only 
reason for improved degradation of TrOCs in the NF-EMBR: phenolic TrOCs (e.g., bisphenol 
A), which could act as a redox-mediator, can also improve the degradation of TrOCs in NF-
EMBR. This aspect is discussed further in Section 3.4.3.2. 
Degradation of six phenolic TrOCs including four steroid hormones (17ß–estradiol and 17α–
ethinylestradiol and estriol) and two industrial chemicals (4-tert-butylphenol and bisphenol A) 
by laccase was 70-90% in NF-EMBR, while UF-EMBR achieved 10-40% degradation (Figure 
3.6). Although these TrOCs have been generally reported to be well removed by laccase in 
batch enzymatic bioreactors [46, 47], the lower performance of UF-EMBR in this experiment 
can be attributed to the continuous TrOC loading that has been reported to affect the extent of 
TrOC degradation [21, 23]. Continuous TrOC loading in UF-EMBR could affect the extent of 
TrOC degradation due to kinetic limitations. Under sustained TrOC loading, TrOCs occupy all 
the active sites of laccase, eventually reducing the percent degradation [23, 44]. Notably, the 
NF-EMBR was better suited to withstand the continuous loading of the phenolic TrOCs to the 
enzymatic bioreactor.  
3.4.3.2. Degradation of non-phenolic TrOCs 
In this experiment, the following three trends were observed in the degradation profile of 17 
non-phenolic TrOCs (Figure 3.6): (i) From 5 up to 65% better degradation of six 
pharmaceuticals (i.e., ketoprofen, naproxen, primidone, gemfibrozil, amitriptyline and 
metronidazole) and five pesticides, namely fenoprop, clofibric acid, propoxur, 
pentachlorophenol, N, N-diethyl-meta-toluamide (DEET) and ametryn, in NF-EMBR as 
compared to UF-EMBR; (ii) efficient degradation (>80%) of two ingredients of personal care 
products (i.e., benzophenone and octocrylene) in both UF- and NF-EMBR; and (iii) poor 
removal (5-15%) of a pesticide (i.e., atrazine) and three pharmaceuticals (i.e., carbamazepine, 
diclofenac and ibuprofen) in both UF- and NF-EMBR.  
Only around 5-15% degradation of atrazine, carbamazepine, diclofenac and ibuprofen by the 
EMBRs can be attributed to the presence of strong EWGs such as amide (–NH2), carboxylic 
(–COOH) and halogen (–X) functional groups (see Appendix Table 3-1), which makes them 
resistant to laccase-catalyzed degradation [11, 19, 47]. On the other hand, benzophenone and 
octocrylene, which were well removed by laccase in this experiment, were also reported to be 
efficiently degraded by laccase in a continuous-flow enzymatic bioreactor [23].   
The significantly better degradation of 11 non-phenolic TrOCs following their retention within 
the NF-EMBR can be attributed to the increased reaction time between laccase and the 
pollutants. Asif et al. [26] reported high TrOCs degradation in membrane distillation (MD)-
EMBR, where the studied TrOCs and laccase were retained by MD membrane. However, in 
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that experiment the performance of the MD-EMBR was not compared to a suitable “control” 
i.e., an EMBR that will retain laccase but not the TrOCs [26]. By comparing UF- vs. NF- 
EMBR, this experiment demonstrates that effective TrOC retention within the bioreactor 
facilitates their degradation. 
It is important to note that TrOCs containing hydroxyl and amine functional groups such as 
bisphenol A and steroid hormones can also play an important role in the degradation of non-
phenolic TrOCs by acting as redox-mediators [46, 48]. The secondary radicals or coupling 
agents, which are formed following the oxidation of TrOCs containing hydroxyl and amine 
functional groups, are highly reactive and could directly oxidize or polymerize other TrOCs. 
For instance, lignin is a plant polymer with a highly complex chemical structure. The 
degradation pathway for lignin reveals that laccase directly oxidizes the phenolic components 
of lignin, and produces highly reactive phenoxyl radicals, which then oxidize the non-phenolic 
components of lignin [44, 49]. Similarly, Hachi et al. [48] demonstrated that the degradation 
of acetaminophen by laccase formed a coupling agent (i.e., dimer). This coupling agent reacted 
with carbamazepine to form oligomers, thereby improving carbamazepine removal from 10 to 
40% [48]. In another study by Jahangiri et al. [50], removal of triclosan was reported to improve 
in a batch enzymatic bioreactor following the addition of the phenolic compound 
acetaminophen. Enhanced removal of triclosan was attributed to the formation of 
acetaminophen-triclosan cross-coupling products [50]. In the current experiment, the synthetic 
wastewater that was continuously fed to the UF/NF-EMBR contained a mixture of 29 TrOCs 
including 12 phenolic and 17 non-phenolic TrOCs. Since these TrOCs were effectively retained 
by the NF membrane but not by the UF membrane (see Section 3.4.3.3), it is possible that the 
radicals or coupling agents formed after the oxidation of some phenolic TrOCs by laccase 
contributed to better degradation of the non-phenolic TrOCs in NF-EMBR as compared to UF-
EMBR. A close look at the trend of laccase-catalyzed degradation in both UF- and NF-EMBR 
indicates that the improvement in degradation could be correlated with the molecular weight 
of TrOCs. In the current experiment, the extent of improvement in degradation was 
significantly higher for TrOCs with a molecular weight above 200 g/mol (Figure 3.7). This is 
probably because the presence of more branches and/or functional groups in TrOCs with high 
molecular weight would create more opportunities of their interaction with laccase, secondary 
radicals and coupling agent [51].  
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Figure 3.7. Enzymatic degradation in both UF- and NF-EMBR as function of TrOC molecular 
weight, showing that the extent of degradation was significantly higher for TrOCs with a 
molecular weight above 200 g/mol.  
3.4.3.3. Overall removal of TrOCs in EMBRs 
TrOC degradation in the enzymatic bioreactor ranged between 10-99% (Figure 3.6). However, 
the overall TrOC removal (calculated based on TrOC concentration in membrane permeate) by 
the NF-EMBR was 90-99%, demonstrating the significant contribution of the NF membrane 
to the overall removal.  
As explained in Section 3.4.2, NF membranes can reject TrOCs via following mechanisms: (i) 
size exclusion; (ii) electrostatic interaction; and (iii) adsorption. In general, the NF membrane 
used in this experiment has been reported to effectively retain TrOCs with a molecular weight 
of greater than 200 g/mol (i.e., MW > MWCO) via size exclusion mechanism [38]. With a few 
exceptions, the molecular weight of the TrOCs investigated was greater than 200 g/mol, and 
indeed they were effectively removed (>90%) by the NF-EMBR (Figure 3.8). The exceptions 
include salicylic acid (138.12 g/mol), metronidazole (171.15 g/mol), benzophenone (182.22 
g/mol), DEET (191.27 g/mol) and 4-tert-butylphenol (150.22 g/mol). Removal of these TrOCs 
also ranged between 95-99% in NF-EMBR (Figure 3.8). Since salicylic acid, atrazine and 
DEET are negatively charged (pKa < pH) at the operating pH of the NF-EMBR (i.e., 6.7-6.9), 
charge repulsion between the negatively charged NF membrane and anionic TrOCs is likely 
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Figure 3.8. Overall TrOC removal in enzymatic bioreactor coupled to the UF or NF membrane. 
Data is presented as the average ± standard deviation (n=4). 
TrOC adsorption on the membrane surface is also a mechanism of removal by NF membranes. 
Hydrophobic TrOCs (log D > 3) can adsorb on the membrane surface, thereby resulting in their 
high initial rejection by the NF membrane [9, 53], but this may reduce with time due to their 
diffusion into membrane permeate [9, 54]. Nevertheless, in this experiment, the hydrophobic 
TrOCs were efficiently degraded by laccase in the enzymatic bioreactor (80-99%, Figure 3.6). 
Thus, the overall removal of hydrophobic TrOCs (log D > 3) was above 99%. Previous studies 
reported that a combination of activated sludge [55] or enzymatic bioreactor [26] with a high 
retention membrane (e.g., MD membrane) can improve the overall removal of TrOCs 
compared to a stand-alone high retention membrane system. However, this is the first study 
that demonstrates the performance of an NF-based EMBR for a set of 29 TrOCs. 
UF membranes cannot reject TrOCs via size exclusion. Thus, as expected, the overall TrOC 
removal by the NF-EMBR was 10-80% higher than the UF-EMBR (Figure 3.8). However, it 
is noteworthy that, for the UF-EMBR, the overall removal efficiency of a few TrOCs was 
significantly better than that suggested by biodegradation efficiency (Figure 3.6). This 
indicates that the UF membrane provided partial retention of those TrOCs. To facilitate the 
discussion on TrOC removal by the UF membrane, the ratio of the concentration of selected 
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TrOCs in membrane permeate and bioreactor (i.e., permeate/bioreactor ratio) is shown in 
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Figure 3.9. Permeate to supernatant (P/S) ratio of the selected TrOCs to show their partial 
retention by the UF membrane in UF-EMBR. Data is presented as average ± standard deviation 
(n=4).  
Indeed, the permeate/bioreactor concentration ratio for significantly hydrophobic TrOCs (log 
D>3) including 17ß–estradiol-17-acetate, triclosan and 17α-ethinylestradiol was significantly 
below 1 and ranged between 0.3-0.6 (Figure 3.9). Previously, Nguyen et al. [23] observed 
adsorption of TrOCs on the enzyme gel-layer formed on the surface of a polyacrylonitrile 
hollow fiber UF membrane following the filtration of media within an EMBR. They also 
reported that the adsorbed TrOC was subsequently degraded by laccase in UF-EMBR, and this 
prevented the accumulation of TrOCs on the membrane surface. In this experiment, the 
formation of enzyme gel-layer on membranes surface during EMBR operation was confirmed 





Figure 3.10. SEM images of the NF and UF membranes, confirming the formation of enzyme 
gel-layer on the surface of membranes. The spiral formations on the SEM images with the 
annotation ‘NF- and UF- used’ represents enzyme gel-layer. These spiral formations are not 
present on the clean NF and UF membrane. The formation of an enzyme gel-layer on the 
surface of membranes could improve overall performance of EMBRs via TrOC adsorption  
In a study by Garcia-Ivars et al. [56], partial retention of anionic pharmaceuticals such as 
naproxen, diclofenac and ibuprofen by a flat-sheet ceramic UF membrane was attributed to 
charge repulsion mechanism. Similarly, in this experiment, despite being hydrophilic (log D 
<3), the partial retention of a few anionic TrOCs by the UF membrane was observed. These 
hydrophilic anionic TrOCs include naproxen (permeate/bioreactor ratio= 0.8), primidone 
(permeate/bioreactor ratio= 0.86), ibuprofen (permeate/bioreactor ratio= 0.9), propoxur 
(permeate/bioreactor ratio= 0.88) and diclofenac (permeate/bioreactor ratio= 0.94). Despite the 
higher MWCO of the UF membrane than the MW of TrOCs, data from the current experiment 
confirms that the flat-sheet PVDF UF membrane along with the enzyme layer on it can retain 
anionic TrOCs to some extent via charge repulsion mechanism.  
The discussion here suggests that UF membrane can contribute to the removal of TrOCs 
depending on their hydrophobicity and charge, thereby improving the overall performance of 
UF-EMBR. However, the overall removal by the NF-EMBR was considerably better due to 
enhanced TrOC degradation (Figure 3.6) as well as effective TrOC removal (Figure 3.8) in a 
single step. 
Laccase-catalysed degradation of the target pollutants may produce degradation products or 
metabolites that could be more toxic than the parent pollutants. However, the previous studies 
suggest that toxicity of EMBR permeate after the enzymatic treatment of a mixture of TrOCs 
does not increase, particularly when a high retention membrane separation process, e.g., 
membrane distillation, is integrated with an enzymatic bioreactor [23, 26]. In the current 
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experiment, a high retention NF membrane combined with the enzymatic bioreactors 
effectively retained TrOCs (Figure 3.8). Thus, the permeate of NF-EMBR was expected to be 
non-toxic.  
3.4.5. Effect of redox-mediator addition on TrOC degradation by NF-EMBR 
3.4.5.1. Overall improvement in TrOC degradation 
As noted in section 3.4.3.1, efficient degradation (>80%) of three non-phenolic and eight 
phenolic TrOCs was observed during operation of the NF-EMBR (Figure 3.6). To improve 
the spectrum of efficiently degraded TrOCs, redox-mediators can be introduced to the reaction 
mixture. In a laccase-mediator system, laccase oxidizes the mediator to produce highly reactive 
radicals. Due to high redox-potential of these radicals, they can directly degrade or polymerize 
TrOCs, particularly those resistant to laccase-catalyzed degradation [20]. 
In this experiment, a naturally occurring redox-mediator (violuric acid, VA) was studied for 
improving the degradation of TrOCs by NF-EMBR.Laccase can readily oxidize VA to form 
highly reactive aminoxyl (=N–O) radicals. The aminoxyl radicals degrade the target pollutants 
by following hydrogen atom transfer (HAT) mechanism [25, 57]. The driving force of HAT 
mechanism is the enthalpy balance between the forming bond (H–ON) and the dissociated C–
H bond [20]. 
Improvement in the degradation of TrOCs following the addition of a single dose of VA at a 
concentration of 10 µM is presented in Figure 3.11. Redox-mediators capable of degrading a 
substrate following the HAT mechanism has been reported to be particularly effective for non-
phenolic compounds, which are originally poorly removed by laccase [25, 58]. In this 
experiment, VA improved the degradation of six non-phenolic compounds by 10-50% (Figure 
3.11). For example, diclofenac degradation increased from 13% in NF-EMBR to 42% in 
laccase-VA mediated NF-EMBR. Similarly, VA addition improved the degradation of the 
pesticide atrazine by 40%. The highest improvement (50%) was observed for ametryn (Figure 
3.11). Laccase cannot efficiently degrade non-phenolic TrOCs with higher redox-potential [11, 
44]. The redox-potential of the media in enzymatic bioreactor increased from 300 to 390 mV 
following the addition of VA at a concentration of 10 μM (Appendix Figure 3-8), which is 
one of the reasons of the improved degradation in NF-EMBR. The concentration of redox-
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Figure 3.11. Effect of adding a naturally occurring redox-mediator, violuric acid VA, on the 
degradation of TrOCs in NF-EMBR. VA was added at a concentration of 10 µM at the start of 
the experiment. Data is presented as the average ± standard deviation (n=4). 
Laccase achieved almost complete (>99%) degradation of three phenolic TrOCs viz 4-tert-
octylphenol, triclosan and salicylic acid in NF-EMBR. However, biodegradation of some 
phenolic compounds by laccase-only was incomplete. Six steroid hormones (estrone, 17β-
estradiol, estriol 17α–ethinylestradiol and 17β-estradiol-17–acetate, enterolactone), two 
industrial chemicals (4-tert-octylphenol and bisphenol A) and a pesticide (pentachlorophenol) 
were degraded by laccase with an efficiency between 20 and 90%, and their degradation did 
not improve at a VA dose of 10 μM (Figure 3.11). Our observation is consistent with that by 
Nguyen et al. [23] who reported that the degradation of phenolic TrOCs such as estrone, estriol, 
17β-estradiol 17–acetate, 4-tert-butylphenol and bisphenol A did not improve in UF-EMBR 
following the addition of another aminoxyl radical producing redox-mediator (i.e., 1-
hydroxybenzotriazole, HBT) at a concentration of 10 μM. This is probably because the laccase-
VA system did not produce enough reactive aminoxyl radicals at such a trace concentration 
(i.e., 10 μM) that would improve the degradation of the phenolic TrOCs tested here. Indeed, 
increasing the concentration of VA from 10 to 25 μM in NF-EMBR resulted in enhanced 
degradation for six phenolic TrOCs (see Section 3.4.5.2).  
It is noteworthy that redox-mediators have been reported to exhibit substrate specificity [26, 
59]. In this experiment, VA (10 μM) was more effective in improving the degradation of the 
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non-phenolic TrOCs, although it should be noted that the overall degradation of the phenolic 
compounds within the bioreactor was still significantly better than the non-phenolic TrOCs.  
3.4.5.2. Effect of mediator concentration on TrOC degradation 
The concentration of redox-mediators can influence the performance of the laccase-mediator 
system because TrOC degradation is affected by the abundance of highly reactive radicals. 
Hence, a single dose of VA at different concentrations (i.e., 10, 25, 50 and 100 µM) was added 
separately to the NF-EMBR. To show different trends of improvement, degradation of 10 
selected TrOCs at different VA concentrations is presented in Figure 3.12.  
Increasing the concentration of VA from 10 to 25 µM further improved the degradation of 
TrOCs by up to 10-25% (Figure 3.12). Although VA did not improve the degradation of 
phenolic TrOCs at 10 µM, an improvement of 10-25% was observed in the degradation of 
estrone, estriol, 17β-estradiol 17–acetate, 17β-estradiol, 4-tert-butylphenol and bisphenol A 
after adding VA at 25 µM concentration in NF-EMBR (Figure 3.12). Improvements were also 
noted in the case of non-phenolic compounds such as propoxur, ibuprofen, diclofenac, ametryn 
and atrazine. Despite a discernable increase in ORP (see Appendix Figure 3-8), no further 
degradation improvement was observed by increasing the concentration of VA from 25 to 100 
µM (Figure 3.12). Depending on mediator type, laccase source and the target pollutant, the 
improvement in TrOC degradation may reach a plateau beyond a certain mediator 
concentration [60, 61]. For instance, Ashe et al. [25] observed no improvement in atrazine and 
naproxen removal beyond 500 μM of VA in a batch enzymatic bioreactor. In another study, 
increasing VA concentration from 250 to 500 μM provided similar degradation for a few 
phenolic TrOCs such as bisphenol A and 4-tert-butylphenol [62]. The current experiment 
confirms that TrOC degradation would not significantly improve i.e., reach a plateau beyond a 



















































































































Figure 3.12. Effect of different mediator concentration on the degradation of selected TrOCs 
in NF-EMBR. Data is presented as the average ± standard deviation (n=4). 
Although addiation a redox-mediator improved TrOC degradation, the radicals formed 
following the oxidation of redox-medaitors can cause toxicity. In prvious studies, addition of 
syringaldehyde [61] and 2,2'-azino-bis-3-ethylbenzothiazoline-6-sulphonic acid [25] has been 
reported to increase the toxicity treated effluent. Notably, following VA addition at 
concentration ranging from 0.5–1 mM, toxicity of the treated effluent has been reported to not 
increase significantly [25, 62]. For instance, Asif et al. [62] studied the improvement in TrOC 
degradation by adding a single dose of 0.5 mM VA in an membrane distillation (MD) – EMBR, 
and observed that the toxicity of reaction media with and without VA was up to 1.8 and 3.9 
rTU, respectivley. Despite the increase in toxicity following the addition of 0.5 mM VA, they 
reported that the toxicity of MD-EMBR permeate was below the limit of detection [62]. 
Because a high retention NF membrane that can effectively retained TrOCs and their 
metabolities was combined with an enzymatic bioreactor in this experiment, permeate of NF-
EMBR with and without VA addition was expected to be non-toxic. 
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In light of mediator performance at different concentrations, VA at a concentration of 25 µM 
was the best for achieving improved TrOC degradation by the NF-EMBR. Three phenolic and 
14 non-phenolic TrOCs were not completely degraded even with redox-mediator dosing. 
However, the final treated effluent, i.e, NF-permeate achieved over 95% removal of all TrOCs 
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Figure 3.13. Improvement in TrOC degradation by adding single dose VA at different 
concentration separately at the start of NF-EMBR operation. VA showed compound-specific 
and concentration dependent improvement. The overall removal of TrOCs in NF-EMBR was 
>95%. The NF-EMBR were operated for a period of 68 h in continuous mode at an initial HRT 
of 16 h.  
3.4.6. Hydraulic performance of membranes 
Variations in permeate flux during the operation of the laccase based EMBRs are presented as 
normalized permeate flux in Figure 3.14. Typically, a steep fall in the permeate flux of the NF 
and UF membranes has been observed at the initial stage of their operation [24, 56]. Indeed, 
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the permeate flux reduced rapidly in the first few hours of UF/NF-EMBR runs in this 
experiment (Figure 3.14). Given the MWCO of the membranes, i.e., 200 Da for the NF and 
30,000 Da for the UF, the reduction in permeate flux for the NF membrane was steeper. The 
initial permeate flux of the UF membrane decreased by approximately 15%, and stabilized after 
10 h of UF-EMBR operation. On the other hand, a progressive fall in the flux of the NF 
membrane was observed during the first 30 h of NF-EMBR operation. Despite this, the 
permeate flux at the end of NF-EMBR operation was still 65% of the initial flux (Figure 3.14). 
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Figure 3.14. Variations in the permeate flux presented as a normalized flux as a function of 
operating time. The reduction in the permeate flux was attributed to: (i) membrane fouling 
following the adsorption of laccase on membrane surface forming an enzyme gel-layer (see 
Figure 3.10), and/or (ii) concentration polarization due to the accumulation of TrOCs and 
transformation products on membrane surface. Cleaning the membranes with clean water for 
one hour was enough to recover the permeate flux by more than 90%. 
The reduction in permeate flux in UF/NF-EMBR can be attributed to: (i) membrane fouling 
due to the adsorption of laccase on membrane surface forming an enzyme gel-layer (Figure 
3.10); and/or (ii) concentration polarization due to the accumulation of TrOCs and 
transformation products on membrane surface [24, 63]. To assess whether the reduction in 
permeate was reversible or irreversible, permeate flux was measured after backwashing the UF 
and NF membranes with Milli-Q water for 1 h. Membrane cleaning recovered the permeate 
flux of the NF and UF membranes by 92 and 96%, respectively. The flux recovery was not 
100% probably due to the irreversible adsorption of laccase on the membrane surface. This is 
also evident from changes in membrane properties, i.e., contact angle and zeta potential as 
discussed in the following section. 
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3.5. Effect on membrane surface charge and hydrophobicity  
The UF and NF membranes were negatively charged at the operating pH of the UF/NF-EMBRs 
(i.e., approximately 7) as shown in Figure 3.15. The virgin NF membrane is negatively charged 
due to the protonation of carboxylic and amino functional groups of the active membrane layer 
[34]. On the other hand, the virgin PVDF UF membrane is usually not charged but it becomes 
negatively charged due to the adsorption of hydroxyl ions that originates from the self-
ionization of water [64, 65].  













































Figure 3.15. Effect of laccase on the properties of the NF and UF membranes. Error bars 
represent the standard deviation among triplicate measurements. Although change in properties 
of the NF membrane did not affect TrOC removal by NF-EMBR, the formation of an enzyme-
gel layer on the surface of the UF membrane following laccase adsorption can improve the 
overall performance of UF-EMBR by adsorbing hydrophobic TrOCs (see Figure 3.9). 
The negative charge on the surface of UF and UF membranes in response to their operation 
with enzyme solution reduced as compared to the virgin membranes (Figure 3.15). These 
changes in membrane surface charge can be attributed to the adsorption of laccase on the 
membrane surface as shown in Figure 3.10. It was reported that adsorption of solutes on the 
membrane surface can change the surface roughness and chemistry of membrane active layer, 
thereby altering their streaming potential [66].  
Hydrophobicity of a membrane depends on its surface properties and water associating 
chemical groups [34]. Based on the contact angle, the UF membrane was significantly 
hydrophobic, while the NF membrane was moderately hydrophobic (Figure 3.15). However, 
hydrophobicity of both the UF and NF membrane reduced, which again confirms the 
adsorption of laccase on the membrane surface. Results of this experiment indicate that laccase 
adsorption can alter the properties of the membranes to some extent although above 90% flux 
recovery can be achieved by flushing the membrane with ultrapure Milli Q water. While no 
effect of change in properties of the NF membrane was observed on TrOC removal, the 
formation of an enzyme-gel layer on the surface of the UF membrane following laccase 
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adsorption can improve the overall performance of UF-EMBR by adsorbing hydrophobic 
TrOCs (see Section 3.4.3.3).  
3.5. Conclusion 
Enzymatic degradation of a broad spectrum of TrOCs including 12 phenolic and 17 non-
phenolic compounds was compared by operating ultrafiltration (UF)- and nanofiltration (NF)-
based enzymatic membrane bioreactors (EMBR). This helped to assess the effect of effective 
TrOCs retention within enzymatic bioreactor on their degradation by laccase. Initially, 
comparative performance of UF- and NF-EMBRs were assessed for five TrOCs to prove the 
concept. Overall removal of TrOCs by UF-EMBR varied from 20-85%, while NF-EMBR 
achieved 92-99.9% TrOC removal. Notably, the effective retention of the TrOCs within the 
enzymatic bioreactor by the NF membrane improved (15-30%) their degradation as compared 
to UF-EMBR. This observation confirmed the hypothesis that simultaneous retention of 
laccase and TrOCs by the high retention NF membrane facilitates degradation During the 
assessment of EMBRs for a broad spectrum of TrOCs, the overall removal of TrOCs in NF-
EMBR was better because the NF membrane achieved TrOC rejection ranging from 90-99%. 
Furthermore, mass balance analysis shows that compared to the UF-EMBR, significantly better 
degradation (up to 65%) was achieved by laccase in NF-EMBR. However, physciochemical 
properties, particularly chemical structure governed TrOC removal by laccase and membranes. 
Laccase achieved efficient degradation of TrOC containing strong electron donating functional 
groups (such as bisphenol A and natural hormones), while those containing strong EWGs (such 
as carbamazepine and diclofenac) remained resistant to laccase-catalysed degradation. A 
redox-mediator (violuric acid, VA) was dosed to NF-EMBR for further improving the 
degradation of TrOCs. VA achieved improved degradation for four phenolic and six non-
phenolic TrOCs in NF-EMBR, at a concentration of 25 µM, beyond which the extent of 
degradation did not improve significantly. Change in membrane properties due to laccase 
adsorption along with concentration polarization can reduce the permeate flux of the UF and 
NF membrane, although flux can be recovered effectively by cleaning the membrane with 
water.  
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Trace organic contaminants (TrOCs) include a wide array of natural or anthropogenic 
chemicals including pesticides, pharmaceuticals and personal care products. Recent studies 
have confirmed the potentially harmful effects of TrOCs on the growth and reproduction 
patterns of aquatic flora and fauna as well as on human health due to prolonged ingestion [1, 
2]. Conventional wastewater treatment processes cannot effectively remove certain groups of 
TrOCs, resulting in their widespread occurrence in freshwater sources [3, 4]. Therefore, the 
scientific community is in constant pursuit of an effective wastewater treatment process for 
TrOC removal.  
Different physicochemical and biological wastewater treatment processes have been 
investigated over the years for TrOC removal [5-8]. TrOC degradation by biocatalysts such as 
laccase, peroxidase and proteases is a promising eco-friendly technique [9, 10]. Enzymatic 
transformation of TrOCs is governed by a number of factors such as pH, temperature, TrOC 
properties and characteristics of enzymes [11]. Laccase is an oxidase enzyme that can degrade 
a broad spectrum of TrOCs over a wide range of pH by utilizing the dissolved oxygen in water 
[12, 13]. Particularly mention worthy is the ability of laccase to oxidize the phenolic TrOCs 
including aromatic/aliphatic amines, diphenols and methoxy-substituted monophenols [11]. 
Molecular structure, namely distribution of the functional groups, i.e., electron withdrawing 
functional group (EWGs) and electron donating functional groups (EDGs), governs the extent 
of TrOC removal by laccase. The oxidation of TrOCs containing EWGs such as amide (–NH2), 
halogen (–X) and nitro groups (– NO2) is slower as compared to those containing EDGs [11, 
14]. TrOC oxidation can be enhanced by introducing a redox-mediator, which can act as an 
electron shuttle between the target compounds and enzyme. Depending on the type of redox-
mediator, laccase source and TrOC structure, laccase-mediator systems can achieve significant 
improvement in the removal of target compounds [15, 16]. However, literature on the impact 
of laccase source and their combination with redox-mediators is limited and require further 
attention. 
Enzyme washout is a major constraint in the large-scale application of an enzymatic bioreactor. 
To mitigate this problem, laccase can be immobilized onto or entrapped within different 
supports [11, 17]. Alternatively, enzymatic bioreactor can be coupled with a membrane having 
a suitable molecular cutoff. For example, Nguyen et al. [13] and Lloret et al. [18] achieved 
complete retention of laccase with ultrafiltration (UF) membranes. The use of enzymatic 
membrane bioreactor (EMBR) can avoid the mass transfer limitations associated with laccase 
immobilization onto support media. Although TrOCs are not expected to be retained by UF 
membranes, Nguyen et al. [13] observed the formation of an enzyme gel layer on the surface 
of the membrane that effectively adsorbed non-phenolic hydrophobic TrOCs such as 
octocrylene, amitriptyline and benzophenone. This resulted in enhanced degradation of these 
compounds. However, enzyme gel layer could not adsorb hydrophilic non-phenolic TrOCs 
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such as atrazine and carbamazepine, and their overall removal was less than 10% [13]. Hence, 
it was postulated that the use of high retention membranes, which will retain both laccase and 
TrOCs, can facilitate the degradation of resistant TrOCs.  
In recent years, high retention membranes, namely membrane distillation [19], nanofiltration 
[20] and forward osmosis [21-23], have been integrated with the conventional activated sludge 
bioreactors to achieve complete TrOC retention, resulting in their high aqueous phase removal. 
However, these short-term studies have revealed accumulation of membrane-retained 
recalcitrant compounds in the bioreactor, indicating the need for enhancement of 
biodegradation. Although laccase has been reported to achieve better biodegradation than 
conventional activated sludge, more efforts are required to explore the performance of high 
retention membrane – enzymatic bioreactor. 
In Chapter 3, performance of ultrafiltration (UF) – and nanofiltration (NF) – enzymatic 
membrane bioreactor (EMBR) operated under identical operating conditions (e.g., hydraulic 
retention time and TrOC loading rate) is demonstrated. As compared to UF-EMBR, NF-EMBR 
achieved better degradation of TrOCs. Membrane distillation (MD) is another format of high 
retention membrane separation process with a completely different working principle and can 
potentially be integrated with an enzymatic bioreactor for enhanced TrOC degradation. In MD, 
a vapor-liquid interface is developed around a hydrophobic micro-porous membrane that 
allows the water to pass through the membrane via diffusion due to vapor pressure gradient. A 
simplified schematic of MD is presented in Figure 4.1. Compared to conventional distillation 
processes such as fractional distillation, the MD process requires low temperature and could 
be operated by using low grade heat or solar energy [24, 25]. Since the mass transfer in the MD 
process occurs in gaseous phase, it can theoretically achieve 100% retention of all non-volatile 
compounds [26]. Previously, the standalone MD process has been investigated for seawater 
desalination [27], industrial wastewater treatment [28], municipal wastewater treatment [29] 
and TrOC removal [26]. 
 
Figure 4.1. A simplified schematic of an MD process. The TrOC wastewater recirculation loop 
is kept at higher temperature as compared to cold water circulation loop. This creates a vapor 
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pressure gradient across the MD membrane surface and allows water to diffuse from hot side 
to cold side. 
This chapter is based on the experiment conducted to investigate the performance of a 
membrane distillation – enzymatic membrane bioreactor (MD-EMBR) for enhanced 
degradation of five hardly degradable TrOCs. A series of experiments were performed to 
elucidate the performance of two commercially available laccases – one from genetically 
modified Aspergillus oryzae (A. oryzae) and the other from Trametes versicolor (T. versicolor). 
In addition, impacts of two N=OH type redox-mediators, namely 1-hydrozybenzotriazole 
(HBT) and violuric acid (VA) on TrOC degradation as well as on enzyme stability were also 
studied. 
4.2. Hypothesis 
▪ The high retention membrane distillation – enzymatic membrane bioreactor may 
achieve enhanced TrOC degradation  
▪ Depending on the source of commercially available laccases, the extent of TrOC 
degradation may be different 
4.3. Materials and methods 
4.3.1. Trace organic contaminants 
Four pharmaceutical and personal care products, namely sulfamethoxazole, carbamazepine, 
diclofenac and oxybenzone, and one pesticide (atrazine) were selected for this experiment due 
to their widespread occurrence in environmental systems [4]. Analytical grade (>98% purity) 
standards of these TrOCs were purchased from Sigma–Aldrich (Australia). The 
physicochemical properties including molecular weight, chemical structure, hydrophobicity 
(log D) and volatility (pKH) of the tested TrOCs are given in Table 4.1. A stock solution (2 
g/L) of these compounds was prepared and stored at -18 oC in the dark.  
4.3.2. Enzyme solutions and redox-mediators 
Commercially available laccase purified from T. versicolor (CAS No. 80498-15-3) purchased 
from Sigma–Aldrich (Australia) was used in this experiment. Laccase from genetically 
modified A. oryzae (Novozym 51030) was the second source of laccase, and it was supplied 
by Novozymes Pty. Ltd, Australia. These laccases have been investigated recently for the 
removal of a broad spectrum of TrOCs, showing promising results [13, 15, 30]. Properties of 
laccase from A. Oryzae are already presented in Section 3.3.1 (Chapter 3). Laccase from T. 
versicolor was received in powdered form. After dissolving 10 mg of T. versicolor laccase in 
1 L Milli-Q water, T. versicolor laccase showed an activity of 8.5 µM(DMP)/min at pH 4.5 and 
20°C. 
Two N=OH type mediators, namely HBT and VA were selected for this experiment. HBT and 
VA are particularly effective for improving the degradation of non-phenolic compounds. Both 
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HBT and VA follow hydrogen atom transfer (HAT) mechanism, producing highly stable and 
reactive aminoxyl radicals [14]. Mediators were also purchased from Sigma–Aldrich 
(Australia), and separate stock solutions (50 mM) for HBT and VA were kept at 4 oC before 
use. 
Table 4.1. Physicochemical properties of selected TrOCs 













253.28 -0.22 1.52×10-12 11.81 
Carbamazepine 
 
236.27 1.89 8.17×10-10 9.08 
Diclofenac 
 
296.15 1.77 2.06×10-09 8.68 
Oxybenzone 
 
228.24 3.99 1.58×10-08 7.80 
Atrazine 
 
215.68 2.64 5.22×10-08 7.28 
Note: Henry’s law constant (H) at 25oC (atm m3/mol) = Vapor pressure × molecular weight/water solubility. 
The pKH value is defined as pKH= -log10H. Chemical structure, molecular weight (MW), log D, vapor pressure 
and water solubility values were taken from SciFinder Scholar. 
 
4.3.3. MD-EMBR experimental setup  
A laboratory scale MD-EMBR setup consisting of a glass enzymatic bioreactor (1.5 L) and an 
external direct contact membrane distillation (DCMD) module was used (Figure 4.2). The 
enzymatic bioreactor was covered with aluminum foil to avoid TrOC photolysis. An immersion 
heating unit (Julabo, Germany) was immersed in the water bath to maintain the temperature at 
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30±0.2 oC. Moreover, air diffuser connected with an air pump (ACO-002, Zhejiang Sensen 
Industry Co. Ltd., Zhejiang, China) was placed at the bottom of the bioreactor to maintain 
homogeneity, and to keep dissolved oxygen (DO) above 3 mg/L.  
To minimize heat losses, acrylic glass material was used to prepare the DCMD module. The 
feed and distillate flow channels (Dimensions: 145 mm×95 mm×3 mm) were engraved on each 
acrylic block. Water from the enzymatic bioreactor and the distillate container was 
continuously passed from the DCMD module and then recirculated back to the enzymatic 
bioreactor and distillate container, respectively. A temperature sensor was placed at the inlet 
of the DCMD module to monitor the temperature of the feed. Distillate temperature was 
maintained at 10±0.1 oC using a chiller (SC100-A10, Thermo Scientific, USA). A stainless-
steel heat exchanging coil connected with the chiller was immersed in the distillate container 
placed on a precision balance (Mettler Toledo Inc, USA) to monitor permeate flux. The 
recirculation flow rate of both feed and the distillate was kept at 1 L/min (corresponding to the 
cross-flow velocity of 9 cm/s) using two rotameters.  
Hydrophobic microporous polytetrafloroethylene (PTFE) membranes (GE, Minnetonka, MN) 
were used during all experiments. Properties of PTFE membrane are given elsewhere [19, 31]. 
Briefly, nominal pore size, thickness, active layer thickness and porosity of the PTFE 
membrane was 0.22 µm, 175 µm, 70% and 5 µm, respectively.  
 
Figure 4.2. A schematics representation of membrane distillation-enzymatic membrane 
bioreactor (MD-EMBR). 
4.3.4. Experimental protocol  
Initially, the MD-EMBR system was operated without the addition of enzyme and mediators 
to determine the loss in TrOC concentrations due to adsorption and/or evaporation. Laccase 
from T. versicolor was tested alone and then both redox-mediators, HBT and VA (at 1 mM 
concentration), were added separately to investigate the improvement in the degradation of 
TrOCs. Similarly, laccase from genetically modified A. oryzae was also tested with and without 
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the addition of HBT and VA separately. At the start of each experiment with laccase, 1 mL and 
0.1 g of A. oryzae and T. versicolor, respectively, were added to 1.5 L Milli-Q water separately 
for achieving an initial enzymatic activity of 95-100 µM(DMP)/min. TrOCs were each added at 
a nominal concentration of 1 mg/L. However, the actual measured concentrations of 
sulfamethoxazole, diclofenac, carbamazepine, atrazine and oxybenzone were 948±90, 923±76, 
873±137, 855±140, 771±210 µg/L (n=8), respectively. The difference in theoretical and 
measured concentrations of TrOCs may be attributed to the purity of each compound, since the 
actual purity of a compound may differ from that claimed by the manufacturer [32]. Samples 
from the enzymatic bioreactor and distillate were taken at every three hours over a period of 
12 hours to monitor TrOC removal and enzymatic activity. The enzymatic degradation of the 
TrOCs was determined as 𝑅(%) = 100 × (1 −
𝑚𝑡
𝑚0
), where mo and mt are initial mass (0 h) and 
mass at the time of sampling, respectively. 
4.3.5. Analytical methods 
4.3.5.1. Analysis of TrOCs 
TrOC concentration in the enzymatic bioreactor and permeate was measured at different time 
intervals using HPLC (Shimadzu, Kyoto, Japan) at the detection wavelength of 280 nm. The 
HPLC system was equipped with a UV-Vis detector and C-18 column (300×4.6 mm) having a 
pore size of 5 mm (Supelco Drug Discovery, Sigma Aldrich, Australia). Milli-Q water buffered 
with 25 mM KH2PO4 and HPLC grade acetonitrile were used as the mobile phase for TrOC 
quantification. Two eluents, namely eluent A (20% acetonitrile + 80% buffer, v/v) and eluent 
B (80% acetonitrile + 20% buffer, v/v), were passed through the C-18 column at a flow rate of 
0.7 mL/min for 30 min in time dependent gradients as follows: [Time (min), A (%)]: [0, 85], 
[8, 40], [10, 0], [22, 0], [24, 85]. The limit of detection (LOD) for this method was 
approximately 10 µg/L. Since any residual enzymatic activity in samples may interfere with 
the accuracy of the results, samples were diluted (2 folds) with methanol to inactivate laccases 
[15]. Before TrOC analysis, known standards of each TrOC were analyzed to determine the 
time at which the peak of specific TrOC appears. After that, standards prepared from stock 
solution containing the mixture of selected TrOCs were analyzed to prepare the calibration 
curve (peak area vs concentration). Coefficient of determination (R2) for all the calibration 
curves was greater than 0.99. 
4.3.5.2. Laccase assay and ORP 
Laccase activity was measured at an interval of three hours using a previously developed 
method [15]. A detailed description of laccase activity assay and ORP is already given in the 





4.4. Results and discussion 
4.4.1. TrOC retention by MD system  
TrOC removal by an MD-EMBR system is governed by enzymatic transformation and 
retention by MD membrane. In this experiment, the MD membrane achieved complete 
retention (>99%) of the tested TrOCs, i.e., concentration of TrOCs in membrane permeate was 
below the detection limit of 10 µg/L during all experiments. Since mass transfer in MD occurs 
in vapor phase, volatility (pKH) of target pollutants controls their transport from feed to 
distillate. The retention of TrOCs has been investigated recently in MD-only and MD coupled 
with conventional bioreactor (MDBR) systems [19, 26], but not an enzymatic bioreactor. In 
these studies, retention of volatile TrOCs (pKH <9) by MD system varied from 50-90%, while 
retention of most non-volatile TrOCs (pKH >9) varied from 95-99%. Among the incompletely 
removed moderately-volatile TrOCs in previous studies was oxybenzone [19, 26]. Complete 
retention of all TrOCs including oxybenzone in the current experiment can be attributed to the 
lower operating temperature (i.e., 30 oC vs. 40 oC) of the enzymatic bioreactor, which 
consequently lowered the vapor pressure.  
The MD system was also operated without the addition of laccase to quantify the loss in the 
mass of tested TrOCs due to adsorption and/or evaporation. Sulfamethoxazole and diclofenac 
lost approximately 4.5 and 2.5% of its initial mass, respectively, at the end of control run, while 
the remaining compounds lost less than 1%. A negligible loss in the mass of TrOCs due to 
adsorption and/or evaporation during the control run suggests that membrane retention and 
enzymatic degradation were the main mechanisms of TrOC removal in MD-EMBR. 
4.4.2. TrOC degradation vs. laccase source in MD-EMBR 
Oxidation of TrOCs by laccase is principally controlled by two factors: (i) the nature of 
functional groups attached to the core part of the molecule i.e., EDGs and EWGs; and (ii) 
relative redox potential of laccase and TrOCs. Laccase can efficiently degrade phenolic 
compounds. On the other hand, oxidation of non-phenolic compounds by laccase is possible 
but it may be restricted by kinetic limitations [11, 14]. Notably, depending on the fungal 
species, growth medium and level of glycosylation, the catalytic potential of laccase for TrOC 
removal may be different. Thus, effect of laccase source on TrOC degradation was assessed. 
In this experiment, significant enzymatic degradation of TrOCs was observed following their 
complete retention by the MD membrane in MD-EMBR (Figure 4.3).  
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Figure 4.3. Total mass of selected TrOCs in feed at the start (0 h) and the end (12 h) of 
experiment in the enzymatic bioreactor of MD-EMBR following complete TrOC retention 
(>99%) by MD. Error bars represent the standard deviation of duplicate samples. Error bars 
for samples taken at t=12 h are not visible for all the selected TrOCs because the standard 
deviation among those samples was less than 5%. Operating conditions: temperature of 
enzymatic bioreactor and distillate was maintained at 30 and 10 °C, respectively; cross-flow 
rate of water from enzymatic bioreactor and distillate was 1 L/min (corresponding to cross-
flow velocity of 9 cm/s); and initial laccase activity in enzymatic bioreactor was 95-100 
µMDMP/min.  
The fate of each compound was analyzed by developing a mass balance considering the total 
input mass, mass in concentrate at the end of experiment, mass in permeate, adsorption and/or 
evaporation losses, and enzymatically degraded portion (Figure 4.4). It was observed that 
biodegradation was the main mechanism of TrOC removal in the enzymatic bioreactor. 
Laccase from T. versicolor and A. oryzae achieved 40-80% and 45-99% TrOC degradation, 
respectively (Figure 4.4). Laccase from A. oryzae demonstrated better overall performance 
possibly due to its higher ORP, as discussed further later.  
This is the first demonstration of a laccase-based membrane distillation – enzymatic membrane 
bioreactor (MD-EMBR). Thus, the results are compared with previous UF-EMBR studies to 
highlight the synergistic effect of integrating a high retention membrane with an enzymatic 
bioreactor. Given the high TrOC retention by the MD membrane, depending on the level of 
biodegradation, TrOC concentration in the bioreactor and the MD-permeate may be 
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significantly different. By contrast, in an UF-EMBR, due to the limited TrOC retention by the 
cake-layer on UF membrane, the TrOC concentration in the bioreactor and in permeate are 
usually close i.e., permeate to supernatant ratio is usually within 0.8-1.0 as reported by Nguyen 
et al. [13]. Therefore, for simplicity we compare overall removal by UF-EMBR 





































































 Concentrate   Adsorption and/or evaporation
 Enzymatic degradation
 (a) A. oryzae
 (b) T. versicolor
 
Figure 4.4. The fate of TrOCs following treatment with laccases from A. oryzae (a) and T. 
versicolor (b) in the bioreactor of MD-EMBR. The fate of each compound was analyzed by 
developing a mass balance among the total input, mass in concentrate, enzymatic degradation, 
adsorption/evaporation and permeates. MD system completely retained (>99%) all the selected 
TrOCs. Operating conditions of MD-EMBR are given in the caption of Figure 4.3. 
The highest degradation (80-99%) was achieved for a phenolic compound oxybenzone 
containing two EDGs, namely methoxy and hydroxyl groups. Previously, Nguyen et al. [13] 
also observed high overall removal (>80%) of oxybenzone in an UF-EMBR. Conversely, in 
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comparison to the very low overall removal (>10%) of carbamazepine (containing a strong 
EWG amide) in previous studies [13, 33], its degradation was 43% with laccase from T. 
versicolor and 53% with laccase A. oryzae in the MD-EMBR. In general, diclofenac is well 
removed (>60%) by laccase in UF-EMBR due to the presence of two EDGs, namely aromatic 
amine and aniline functional groups, providing active sites for enzymatic attack [13, 18]. In 
this experiment, degradation of diclofenac by laccases from T. versicolor and A. oryzae was 
observed to be 82 and 90%, respectively.  
Despite the presence of two EDGs (methyl and amine functional groups), atrazine, a non-
phenolic pesticide, is resistant to laccase based treatment systems due to the steric hindrance 
caused by chloride, a strong EWG [16, 34]. Enhanced degradation of atrazine by laccases from 
T. versicolor (54%) and A. oryzae (67%) compared to its previously reported overall removal 
of less than 5% in UF-EMBR [13] highlights the importance of complete TrOC retention for 
efficient enzymatic degradation of recalcitrant TrOCs. Sulfamethoxazole, a significantly 
hydrophilic compound (log D = -0.22), contains amine (EDG) and sulfonamide (EWG) groups. 
Depending on the source of fungal laccase and bioreactor type, sulfamethoxazole degradation 
has been reported to vary significantly (20-80%). For instance, Nguyen et al. [35] achieved less 
than 20% degradation of sulfamethoxazole by laccase from A. oryzae in an UF-EMBR. 
Conversely, Rodarte-Morales et al. [36] reported around 80% degradation of sulfamethoxazole 
with laccases from Bjerkandera sp., Phanerochaete chrysosporium and Bjerkandera adusta in 
a batch bioreactor. In this experiment, MD-EMBR achieved approximately 40 and 46% 
degradation of sulfamethoxazole with laccases from T. versicolor and A. oryzae, respectively. 
Integration of a DCMD system with conventional thermophilic bioreactor (MDBR) was 
investigated by Wijekoon et al. [19]. As expected, the performance of MDBR and MD-EMBR 
(this experiment) is comparable based on the permeate quality. However, it is indeed important 
to compare the extent of biodegradation achieved in the bioreactors. The comparison of MD-
EMBR with MDBR [19] and UF-EMBR [13, 30] suggests better TrOC removal in the 
bioreactor of MD-EMBR. For instance, degradation of diclofenac in this experiment ranges 
from 80-90% (Figure 4.4), while MDBR achieved 25% degradation [19]. Similarly, while the 
conventional activated sludge in MDBR achieved 10% removal of carbamazepine, its 
enzymatic degradation in MD-EMBR ranged between 43 and 55%.  
4.4.3. Effect of redox-mediator addition 
4.4.3.1. TrOC degradation 
Oxidation of phenolic and non-phenolic compounds by laccase can be possible via mono-
electronic oxidation subject to their ORP. Low removal of non-phenolic compounds by laccase 
is due to: (i) their higher ORP than laccase; and/or (ii) steric hindrance caused by EWGs such 
as chloride and amide functional groups [37]. Several different redox-mediators such as HBT 
and VA have been studied to improve the ORP of laccase, consequently improving TrOC 
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degradation [13, 16]. In a laccase-mediator system, laccase reacts with redox-mediators to 
produce reactive radicals that can improve the effectiveness of laccase-based treatment 
systems. Moreover, effectiveness of this system depends on mediator type and concentration, 
chemical structure of the substrate and ORP of laccase [38]. The efficacy of N=OH type 
mediators for non-phenolic TrOC degradation is evident from literature [16, 37]. Therefore, 
two N=OH type redox-mediators, namely HBT and VA, at 1 mM concentration were added 
separately in the enzymatic bioreactor at the start of the experiment. Both mediators follow 
hydrogen atom transfer (HAT) mechanism and produce highly reactive aminoxyl radical [14].  
Regardless of the laccase source, the tested mediators achieved the highest degradation for 
oxybenzone and diclofenac (Figure 4.5), probably because these compounds were already well 
removed by laccase (Figure 4.4). Overall, an improvement of 5-10% in TrOC degradation was 
achieved in T. versicolor-HBT system, while T. versicolor-VA yielded 10-20% improvement. 
Separate addition of HBT and VA with laccase from A. oryzae improved the degradation of 
TrOCs by 12-15 and 15-20%, respectively. Importantly, redox-mediator addition significantly 
improved carbamazepine and atrazine removal as compared to oxybenzone that was already 
well removed in the absence of any redox-mediator (Figure 4.5).   
In line with the results of this experiment, degradation of oxybenzone and diclofenac in the 
range of 80-99% has been reported following the addition of HBT and VA at 1 mM 
concentration in batch bioreactors [16, 39]. Similarly, Nguyen et al. [13] achieved 80-85% 
degradation of oxybenzone following the continuous addition of HBT at a low concentration 
of 0.01 mM in an UF-EMBR. It also suggests that high concentration (e.g., 1 mM in this 
experiment) of mediators may not be required to improve the degradation of those TrOCs that 
are well degraded by laccase.  
Improvement in the degradation of non-phenolic compounds has been observed to depend on 
the type and concentration of redox-mediators [11]. Indeed, improvement in the degradation of 
non-phenolic TrOCs including carbamazepine, sulfamethoxazole and atrazine was in the range 
of 10-15 and 15-20% due to the addition of HBT and VA, respectively, (Figure 4.5). Based on 
the overall performance of both laccase sources with VA or HBT (Figure 4.5), the laccase 
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Figure 4.5. Enzymatic degradation of selected TrOCs in enzymatic bioreactor after 12 h of 
treatment in MD-EMBR with and without the addition of redox-mediator addition. Error bars 
represent the standard deviation of duplicate samples. Two mediators (HBT and SA) are added 
separately at 1 mM. Operating conditions of MD-EMBR are given in the caption of Figure 
4.3. 
Increase in the ORP of the reaction media has been suggested as one of the reasons for 
enhanced TrOC removal in laccase-mediator system [14]. In this experiment, ORP of A. oryzae 
laccase was higher than T. versicolor laccase (Figure 4.6). Moreover, significant increase in 
ORP was also observed following the addition of mediators, and its highest value was obtained 
for VA regardless of the laccase source. Even though ORP of laccase-VA was higher than 
laccase-HBT, the results (Figure 4.7) suggest slightly better degradation of sulfamethoxazole 
and oxybenzone by laccase-HBT. Therefore, ORP is not the sole factor responsible for 

























































































Figure 4.6. Oxidation reduction potential (ORP) and enzyme inactivation with and without the 
addition of redox-mediators. Two mediators, namely HBT and VA, were added separately at 
1 mM concentration. Operating conditions of MD-EMBR are given in the caption of Figure 1. 
Time course of enzymatic activity during all experiments is given in Appendix Figure 4-1. 
4.4.3.2. Impact on enzymatic activity 
Gradual enzyme denaturation can occur during the operation of an EMBR due to different 
physical, biological and chemical inhibitors [40]. Moreover, rapid denaturation of enzymes has 
also been observed following the dosing of redox-mediators [16]. In this experiment, despite 
the absence of any chemical inhibitor, a continuous drop in enzymatic activity was observed 
due to hydrodynamic stress during all experiments (see Appendix Figure 4-1). Enzyme 
inactivation was significantly increased with the addition of HBT and VA (Figure 4.6). Purich 
[40] suggested that the substrate and charged metabolites can inactivate enzyme in a number 
of ways such as: (i) substrate can block the active sites of the enzymes due to the electrostatic 
interactions between enzyme and charged metabolites; and (ii) metabolites can react with 
enzyme to convert it into nonproductive complexes.  
The extent of inactivation in presence of mediators was different for laccase from T. versicolor 
and A. oryzae. A direct relation between ORP and enzyme inactivation was observed (Figure 
4.6). For example, the highest inactivation was induced by VA having the highest ORP (>0.6 
V). High ORP of laccase-mediator system indicates that radicals generated due to the oxidation 
of mediator by laccase can rapidly degrade TrOCs but at the same time they can inactivate 
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laccase quicker. Therefore, for the development of a long-term laccase-mediator based 
treatment process, mediator type, concentration and the characteristics of target compounds 
need to be considered. 
4.4.3.3. Impact on contact time 
Besides the assessment of the final degradation efficiency at the end of each experiment (i.e., 
12 h), TrOC concentration in the enzymatic bioreactor was measured at an interval of three 
hours. In absence of mediators, regardless of the laccase source, the TrOC concentrations 
showed a gradual drop over the entire operation period (Figure 4.7). On the other hand, in the 
presence of redox-mediators, the maximum degradation of most TrOCs was achieved within 
six hours (Figure 4.7).  
Only oxybenzone degradation was completed within three hours irrespective of redox-mediator 
addition. Thus, not only that 10-20% improvement in TrOC degradation was achieved (Figure 
4.5) but that was achieved rapidly (Figure 4.7) following the addition of redox-mediators. The 
cease of TrOC oxidation after six hours was apparently due to the inactivation of the laccase 
as noted in the previous section. Reactive radicals produced due to the oxidation of redox-
mediators by laccase can react with the aromatic amino residues available on the outer surface 
of the enzyme, resulting in the inactivation of enzyme [41]. Improved TrOC degradation at the 
expense of high laccase inactivation has been reported previously in batch tests involving 
laccase-mediator systems [33, 42]. The results presented in this chapter extends such 
observation in case of an MD-EMBR for the first time. 
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Figure 4.7. Effect of reaction time on the removal of selected TrOCs in the enzymatic 
bioreactor of MD-EMBR with and without the addition of two mediators. HBT and SA were 
added at 1 mM concentration separately. Operating conditions of MD-EMBR are given in the 
caption of Figure 4.2. 
4.4. Hydraulic performance of membrane  
Temperature difference between the feed and the distillate side has major influence over the 
permeate flux in MD process. Ideally, the temperature at the feed and distillate side is kept at 
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>50 and 20-25ºC, respectively to produce adequate permeate flux (approximately 10 L/m2 h) 
[24]. However, thermal stability of laccase at elevated temperature should be taken in to 
account before selecting the working temperature of enzymatic bioreactor in MD-EMBR. A 
few studies have covered the aspect of thermal stability of laccase under different experimental 
conditions. For instance, Nguyen et al. [43] observed stable laccase activity up to 40 °C when 
the enzyme solution was not spiked with TrOCs (i.e., ‘non-reacting’ laccase solution). 
Conversely, in presence of TrOCs, Nair et al. [44] and Kim and Nicell [45] observed rapid drop 
in laccase activity beyond 30°C. Therefore, in this experiment, the temperature of the 



















































































































Figure 4.8. Average permeate flux obtained during the operation of enzymatic membrane 
distillation (E-MD) with different combinations of enzymes and mediators. Numbers within 
parenthesis in x-axis indicate number of data points. MD without the addition of enzyme and 
mediators served as a control. Feed and distillate temperature were controlled at 30 and 10 °C, 
respectively during all experiments. The cross-flow rate of both feed and distillate side was set 
at 1 L/min (corresponding to a cross-flow velocity of 9 cm/s).   
The stability of the permeate flux was continually monitored during all experiments (see 
Appendix Figure 4-2). Permeate flux was stable during all experiments, and no significant 
decline was observed. Average permeate flux of 4.61±0.24, 3.78±0.35 and 3.74±0.46 L/m2 h 
was obtained for MD only (control), MD-EMBR with T. versicolor and/or mediators and MD-
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EMBR with A. oryzae and/or mediators, respectively (Figure 4.8). Permeate flux depends 
more on the temperature of the feed side due to the exponential effect of increase in temperature 
on flux [24]. Thus, relatively low permeate flux in this experiment was expected. 
4.5. Conclusion  
In this chapter, removal of trace organic contaminants (TrOCs) by an integrated membrane 
distillation – enzymatic bioreactor (MD-EMBR) was assessed. Experiments were performed 
using laccase from two different sources, namely Trametes versicolor and genetically modified 
Aspergillus oryzae to assess the impact of laccase source on TrOC degradation. Permeate flux 
of MD-EMBR was stable during all experiments. A mass balance revealed that enzymatic 
degradation was the major contributor in the overall removal of TrOCs. The MD system 
ensured complete retention (>99%) of both enzymes and TrOCs. Of particular interest was that 
the complete retention of the TrOCs resulted in improved TrOC degradation by both laccases. 
Oxybenzone and diclofenac degradation in the MD-EMBR ranged between 80 and 99%. 
Compared to UF-EMBR (Section 3.4.2, Chapter 3), up to 40% improvement in the removal of 
resistant non-phenolic TrOCs (e.g., carbamazepine) was observed. Laccase from A. oryzae 
demonstrated better TrOC degradation and enzymatic stability as compared to laccase from T. 
versicolor. This could be attributed to the higher (15%) redox-potential of laccase from Laccase 
from A. oryzae than laccase from T. versicolor. Performance of MD-EMBR system was further 
improved with the addition of one natural (violuric acid, VA) and one synthetic (1-
hydrozybenzotriazole, HBT) redox-mediator at 1 mM concentration. With the addition of 
redox-mediators, TrOC degradation was improved by 10-20%. Although HBT and VA both 
affected laccase stability, they increased the reaction rate, which resulted in rapid degradation 
of the selected compounds.  
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Membrane distillation (MD) is a low temperature distillation process in contrast to 
conventional distillation processes such as fractional or steam distillation. It essentially relies 
on the transport of water in the vapor phase from a feed solution through a microporous 
hydrophobic membrane to the permeate or distillate. Among different MD configurations, 
direct contact membrane distillation (DCMD) has been predominantly studied due to the ease 
of its operation [1, 2]. In DCMD, the temperature of the feed solution is maintained at 15-20 
ºC higher than the permeate to create an adequate vapor pressure difference, which allows 
water to pass through a microporous membrane in vapor form via diffusion [1, 3]. Since mass 
transfer occurs in gaseous phase, MD can theoretically achieve complete rejection of all non-
volatile compounds [4, 5].  
Due to efficient separation efficiency, low fouling propensity and potentially low energy 
requirement (subject to the availability of low grade heat), stand-alone MD has been studied 
for applications such as protein recovery in dairy processing [6], treatment of industrial [7] and 
municipal wastewater [8, 9], as well as for the removal of trace organic contaminant (TrOCs), 
such as pharmaceuticals and personal care products, pesticides and industrial chemicals, from 
wastewater [5, 10]. Recently, TrOC removal has also been investigated by coupling an 
activated sludge based bioreactor to MD that achieved excellent (95-99%) TrOC retention [9]. 
Since effective retention of TrOCs by the MD theoretically decouples organic retention time 
from hydraulic retention time (HRT) of a bioreactor, the degradation of TrOCs is expected to 
improve due to prolonged contact time between the recalcitrant compounds and the 
microorganisms [11]. However, it was found that the biodegradation of resistant TrOCs, such 
as those containing strong electron withdrawing functional groups (EWGs), by the activated 
sludge in the MD-coupled bioreactor did not improve, and eventually these TrOCs accumulated 
in the bioreactor [9, 12]. Hence, to realize the full potential of a combined biological – MD 
process, it is necessary to find the means to improve biodegradation of TrOCs retained in the 
bioreactor by the MD membrane. In this context, it is noteworthy that the oxidoreductase 
enzyme laccase (EC 1.10.3.2) can degrade TrOCs that are less susceptible to degradation by 
the activated sludge process [13, 14].  
Laccase can catalyze the degradation of a broad spectrum of pollutants including aromatic 
hydrocarbons, aliphatic amines and TrOCs by using dissolved oxygen as a co-factor [14-16]. 
TrOC degradation by laccase depends on several factors including pH, temperature, chemical 
structure of TrOCs and laccase properties [12, 14, 17]. In general, effective laccase-catalyzed 
degradation of TrOCs containing electron donating functional groups (EDGs) such as amine 
(–NH2), alkoxy (–OR) or hydroxyl (–OH) was observed. On the other hand, degradation of 
TrOCs containing electron withdrawing functional groups (EWGs) such as halogen (–X), 
amide (–CONR2) or nitro (–NO2) has been reported to be poor or unstable [14, 18]. Degradation 
of TrOCs can be improved by adding different natural and synthetic redox-mediators that are 
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low molecular weight compounds capable of exchanging electrons between laccase and TrOCs 
[19-21]. 
Larger scale application of enzymatic treatment systems is restricted by the lack of a bioreactor 
system, which can prevent washout of enzymes along with treated effluent. In an attempt to 
prevent enzyme washout, an enzymatic membrane bioreactor (EMBR) was developed by 
coupling an ultrafiltration (UF) membrane to an enzymatic bioreactor [22, 23]. Interestingly, 
during the operation of the EMBR, adsorption of some hydrophobic TrOCs (e.g., amitriptyline, 
oxybenzone and octocrylene) onto the enzyme gel layer over the membrane surface resulted in 
enhanced degradation of the adsorbed compounds [22]. In another study, removal of four non-
phenolic TrOCs, namely atrazine, sulfamethoxazole, diclofenac and carbamazepine were 
improved by 15–25% following the addition of granular activated carbon (GAC) in EMBR. 
This was probably because simultaneous adsorption of laccase and TrOCs on GAC promoted 
the interaction of TrOCs with the active sites of laccase [11]. Results from previous studies 
indicate the complementarity of simultaneous laccase and TrOC retention within EMBR in 
contrast to only laccase retention by UF membranes utilized in the previously developed 
EMBRs [22, 24]. This has led to the development of high retention (HR) – EMBR. Indeed, as 
demonstrated in Chapter 3, TrOC degradation by a high retention nanofiltration (NF) – EMBR 
was better than those achieved by ultrafiltration (UF)-EMBRs, which retains laccase but not 
TrOCs. Apparently, the effective retention of the TrOCs by the high retention NF membrane 
also improved their biodegradation [25].  
In a recent study, Asif et al. [24] combined an enzymatic bioreactor with the MD (MD – 
enzymatic membrane bioreactor or MD-EMBR), which retained both laccase and the tested 
TrOCs (carbamazepine, sulfamethoxazole, diclofenac, atrazine and oxybenzone). During a 
short term (12 h) batch operation of the MD-EMBR (see Chapter 4), degradation of the 
investigated TrOCs by laccase was found to improve significantly as compared to that achieved 
by an activated sludge-based MD bioreactor [9, 24]. The initial observations were promising 
but it is necessary to assess the performance of MD-EMBR for a wide range of TrOCs during 
continuous operation. In addition, although enhanced degradation was achieved by MD-EMBR 
[24], degradation of most tested TrOCs was incomplete, requiring the introduction of an 
additional agent capable of TrOC oxidation. As shown in Chapter 4, two redox-mediators, 
namely 1-hydrozybenzotriazole (HBT) and violuric acid (VA) were introduced separately in 
the enzymatic bioreactor at a concentration of 1 mM, which improved TrOC degradation by 
10-20%. However, there is a need to systematically study the impacts of redox-mediator type 
and concentration as well as mediator mixtures for improving the degradation of a broad 
spectrum of TrOCs.     
In this chapter, the performance of a laccase-based membrane distillation – enzymatic 
membrane bioreactor (MD-EMBR) is discussed for the removal of TrOCs having diverse 
physicochemical properties (e.g., EDGs/EWGs, hydrophobicity and phenolic/non-phenolic 
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moieties). In addition, the effect of dosing redox-mediators, separately and as a mixture, on 
TrOC degradation and laccase stability is elucidated. Redox mediators can improve 
degradation but may increase the toxicity of the treated effluent [26, 27], therefore, the toxicity 
of the bioreactor media and MD permeate (i.e., final effluent) to bacteria was monitored to 
clarify the applicability of this treatment process. Finally, during continuous operation, TrOC 
retention by MD can decrease over time due to ‘membrane wetting’ or loss of hydrophobicity 
[1, 3]. Accordingly, the effect of laccase and redox-mediators on the MD performance was also 
investigated.  
5.2. Hypothesis  
▪ Redox-mediator type and concentration may affect the extent of TrOC degradation, 
enzyme stability 
▪ Mixture of different redox-mediators may achieve better improvement in TrOC 
degradation than a single redox-mediator 
5.3. Materials and methods 
5.3.1. TrOCs, laccase and mediators 
A synthetic wastewater containing a mixture of 30 TrOCs in Milli-Q water was prepared for 
this experiment. These compounds were selected to represent different common classes of 
TrOCs, viz pharmaceutical and personal care products, industrial chemicals, steroid hormones 
and pesticides, which are commonly detected in different environmental systems [28]. A 
complete list along with their chemical structures appears in Appendix Table 3-1. Relevant 
physicochemical properties of the selected TrOCs such as hydrophobicity (log D) and volatility 
(pKH) are given in Table 5.1. The list of the selected TrOCs in this chapter and in Chapter 3 
are same except for oxybenzone, i.e., list of TrOCs in Cgapter 3 did not include oxybenzone. 
Analytical grade TrOCs were purchased from Sigma Aldrich (Australia). A stock solution (25 
mg/L) containing the mixture of 30 TrOCs was prepared in methanol and kept in dark at -18 
ºC prior to use. Laccase from genetically modified Aspergillus oryzae (Novozymes Australia 




Table 5.1. Physicochemical properties of TrOCs selected for this experiment 













  g/mole  mg/L  (mmHg)  
Primidone C12H14N2O 218.25 0.83 1500 6.08 × 10
-11 13.93 
Ketoprofen C16H14O3 254.28 0.19 554,000 3.32 × 10
-8 13.70 
Naproxen C14H14O3 230.26 0.73 435,000 3.01 × 10
-7 12.68 
Gemfibrozil C15H22O3 250.33 2.07 263,000 6.13 × 10 
-7 12.11 
Metronidazole C6H9N3O3 171.15 -0.14 29,000 2.67 × 10
-7 11.68 
Diclofenac C14H11Cl2NO2 296.15 1.77 20,000 1.59 × 10
-7 11.51 
Fenoprop C9H7Cl3O3 269.51 -0.13 230,000 2.13 × 10
-6 11.48 
Ibuprofen C13H18O2 206.28 0.94 928,000 1.39 × 10
-4 10.39 
Ametryn C9H17N5S 27.33 2.97 140 1.72 × 10
-6 9.35 
Clofibric acid C10H11ClO3 214.65 -1.06 100,000 1.03 × 10
-4 9.54 
Carbamazepine C15H12N2O  236.27 1.89 220 5.78 × 10
-7 9.09 
Octocrylene C24H27N 361.48 6.89 0.36 2.56 × 10
-9 8.47 
Amitriptyline C20H23N 277.40 2.28 83 1.50 × 10
-6 8.18 
Atrazine C8H14ClN5 215.68 2.64 69 1.27 × 10
-5 7.28 
Propoxur  C11H15NO3 209.24 1.54 800 1.53 × 10
-3 6.28 
Benzophenone C13H10O 182.22 3.21 150 8.23 × 10
-4 5.88 
DEET C12H17NO 191.3 2.42 1000 5.6 × 10
-3 5.85 
Enterolactone C18H18O4 288.38 2.53 200 3.29 × 10
-13 15.20 




C20H24O2 269.40 4.11 3.9 3.74 × 10
-9 9.47 
Oxybenzone C14H12O3 228.24 3.89 2700 5.26 × 10
-6 9.23 
Estrone C18H22O2 270.37 3.62 5.9 1.54 × 10
-8 9.03 




C20H26O3 314.42 5.11 1.9 9.88 ×10
-9 8.67 
Bisphenol A C15H16O2 228.29 3.64 73 5.34 × 10
-7 8.66 
Salicylic acid C7H6O3 138.12 -1.13 2240 8.2 × 10
-5 8.18 
Pentachlorophenol C6HCl5O 266.34 2.85 4800 3.49 × 10
-4 7.59 
Triclosan C12H7Cl3O2 289.54 5.28 19 3.26 ×10
-5 6.18 
4-tert-Butylphenol  C10H14O 150.22 3.40 1000 0.0361 5.15 
4-tert-Octylphenol  C14H22O 206.32 5.18 62 1.98 × 10
-3 5.06 
 
Two N=OH type redox-mediators, namely 1-hydroxybenzotriazole (HBT) and violuric acid 
(VA), and one phenolic redox-mediator, namely syringaldehyde (SA), were used. A separate 
stock solution (50 mM) of each mediator was prepared in ultrapure Milli-Q water and stored 
at 4 ºC in the dark. SA and VA produce highly reactive phenoxyl and aminoxyl radicals, 
respectively. They can mediate TrOC degradation by following a hydrogen atom transfer 
pathway [16, 27].  
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5.3.2. The MD-EMBR System  
A laboratory scale MD-EMBR system was used comprising a glass enzymatic bioreactor (1.5 
L) and an external direct contact membrane distillation (DCMD) module. A schematic of the 
experimental setup as well as the description of the DCMD module and MD membrane are 
available in Section 4.3.3 (Chapter 4).  
5.3.3. Experimental protocol 
5.3.3.1. Preliminary assessment with and without mediator addition  
A series of preliminary short-term (12 h) experiments was carried out to evaluate the 
performance of MD-EMBR for TrOC degradation. At the start of the experiment, a mixture of 
the selected TrOCs (each at 20 µg/L) in Milli-Q water was added to the bioreactor. Laccase 
was added to the bioreactor for achieving an initial enzymatic activity of 95–100 µM(DMP)/min. 
The media from the glass enzymatic bioreactor and water from the permeate tank were 
recirculated in their respective flow channels separated by the membrane. A chiller (SC100-
A10, Thermo Scientific, Waltham, MA, USA) was used to regulate the temperature of the 
permeate tank at 10 ± 0.1 °C. The permeate tank was also placed on a precision balance (Mettler 
Toledo Inc., Columbus, OH, USA) to monitor permeate flux. The recirculation flow rate of 
both feed and the distillate was controlled at 1 L/min (corresponding to the cross-flow velocity 
of 9 cm/s) using two rotameters. 
Duplicate samples from the enzymatic bioreactor (100 mL each) and permeate tank (500 mL 
each) were taken after operating the MD-EMBR for 12 h. After evaluating the laccase-
catalyzed degradation of TrOCs in MD-EMBR, the possible improvement in TrOC degradation 
was assessed with the addition of three redox-mediators (HBT, VA and SA) at two different 
concentrations (0.25 and 0.5 mM) via separate runs. Again, duplicate samples from the 
enzymatic bioreactor and permeate tank were collected for the quantification of TrOCs. 
Samples collected from the enzymatic bioreactor were diluted to 500 mL with Milli-Q water 
and were filtered through 0.45 µm glass fiber filter paper (Filtech, Wollongong, NSW, 
Australia). The pH of samples was adjusted to 2–2.5 using 4 M H2SO4 before solid phase 
extraction (SPE) and GC/MS analysis. For toxicity analysis, undiluted samples from the 
enzymatic bioreactor and permeate tank were collected in 2 mL amber vials at the end of each 
experiment and stored at 4 °C until analysis. 
5.3.3.2. Long-term performance with and without mediator addition  
A series of long-term experiments were conducted to investigate TrOC retention (by MD 
membrane) and enzymatic degradation with and without the addition of redox-mediators (i.e., 
SA and VA) to assess the stability of the developed process. Laccase activity and TrOC 
concentration in the enzymatic bioreactor were identical to that during preliminary short-term 
experiments. It is noteworthy that laccase activity in the enzymatic bioreactors may gradually 
diminish due to various physicochemical and biological inhibitors such as shear stress caused 
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by membrane filtration [29]. Hence, the laccase activity was maintained at 95-100 µM(DMP)/min 
by injecting a small dose of laccase (275 and 400 µL per liter of reactor volume for laccase and 
laccase-mediator, respectively) every 12 h to sustain MD-EMBR operation.  
The MD-EMBR was first operated for a period of 60 h (i.e., 2× HRT) in a continuous mode 
(i.e., continuous withdrawal of treated effluent) without the addition of mediators. The 
enzymatic bioreactor was replenished with synthetic wastewater every time the water recovery 
reached 70% (i.e., approximately around every 24 h). Samples from feed, enzymatic bioreactor 
and treated effluent (i.e., MD-permeate) were collected after 30 and 60 h of MD-EMBR 
operation for TrOC quantification. The effect of individual mediators and their mixture on 
TrOC degradation was investigated in additional runs. A single dose of an individual redox-
mediator (at 0.5 mM) or their mixture was added to the enzymatic bioreactor at the beginning 
of a run. Again, two sets of feed, supernatant and permeate samples for TrOC quantification 
were collected.  
5.3.4. Analytical methods 
5.3.4.1. TrOC analysis 
TrOCs were analyzed by solid phase extraction (SPE) and quantitative determination by a 
Shimadzu GC/MS (QP5000) system [9, 30]. A detailed description of this method is given in 
Section 3.3.4.1 (Chapter 3). The limit of detection (LOD) for this method is compound 
specific and ranged from 1-20 ng/L as listed in Appendix Table 3-1. Removal efficiency by 
enzymatic bioreactor (R1) and MD-EMBR (R2) was calculated as shown in equation (1) and 
(2), respectively:   








Where, Cf, Csu and Cp are the concentration (ng/L) of a specific TrOC in the feed, supernatant 
and permeate, respectively. Mass of each TrOC degraded by laccase was calculated as follows:  
Cf × Vf  = (Csu × Vsu) + (Cp × Vp) + mass degraded by laccase (3) 
where, Vf, Vsu and Vp represents the volume of feed, supernatant and permeate, respectively. 
5.3.4.2. Laccase activity and contact angle 
See Section 3.3.4.2 and 3.3.4.3 (Chapter 3)  
5.3.4.3. Permeate toxicity analysis 
Samples for toxicity analysis were collected from the enzymatic bioreactor and permeate tank 
at end of each experiment. Toxicity, expressed as a relative toxicity unit (rTU), was analyzed 
by measuring the inhibition of luminescence in the naturally bioluminescent bacteria, 
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Photobacterium leiognathi, as previously described [26, 31]. Briefly, an aliquot of a naturally 
bioluminescent bacteria, Photobacterium leiognathi, was incubated with a serial dilution of the 
sample extracts in a phosphate buffered saline solution. After 30 min, luminescence was 
measured on a Fluostar Omega plate reader (BMG Labtech, Germany) and the inhibition of 
luminescence was calculated relative to a negative control. The IC20, the concentration of the 
sample required to inhibit bacterial luminescence by 20%, was then computed for each sample 
by linear regression of the response between 0 and 40% inhibition. All results are presented as 
a relative toxicity unit (rTU), the reciprocal of the IC20. The limit of detection of this method 
was 1 rTU. 
5.4. Results and discussion 
5.4.1. Overall TrOC removal by MD-EMBR 
Retention by the MD membrane and degradation in the enzymatic bioreactor are two major 
mechanisms for TrOC removal in the MD-EMBR system. In theory, MD membranes can retain 
all but the volatile organic compounds. During the preliminary experiment, the concentration 
of non-volatile (pKH > 9; Table 5.1) TrOCs in the permeate of the MD-EMBR was below the 
limit of detection of GC/MS. This is consistent with the observation reported previously, where 
an MD membrane was coupled with an activated sludge bioreactor [9]. On the other hand, the 
MD system achieved 90–99% removal (Figure 5.1) of relatively volatile TrOCs having pKH < 
9. This compares favorably to their previously reported moderate to high removal (54–99%) 
by a standalone MD system [5].  
In order to assess the stability of the developed process for TrOC removal, the MD-EMBR was 
operated separately for an extended duration of 60 h (2× HRT). The removal of TrOCs was 
consistently above 94% and ranged between 94 and above 99% (Figure 5.1). Importantly, 
effective TrOC removal (90->99%) was achieved after the operation of the MD-EMBR for 12 
h and 60 h, indicating no deterioration in the quality of membrane permeate. These results 
suggest that the coupling of enzymatic degradation process to the MD system was favorable 
for achieving high TrOC removal.  
The results obtained after the long-term operation of MD-EMBR indicate that TrOC 
retention/removal by the MD membrane is not only governed by the vapor pressure (indicated 
by Henry’s constant, H or, pKH = -log H; Table 5.1), but is controlled by both the vapor 
pressure and the water partition coefficient (log D; Table 5.1) of the target TrOC. In a stand-
alone MD system, a low (<2.5) ‘pKH /log D’ ratio suggests poor removal of the target 
compound [5]. By contrast, the MD membrane coupled to an activated sludge bioreactor may 
achieve high removal of the target compounds irrespective of their pKH /log D ratio. This is 
because a compound with a low pKH /log D ratio tends to be adsorbed on the bioreactor 
particles [9]. Although the enzymatic bioreactor was free of any suspended particles that can 
potentially adsorb TrOCs, MD-EMBR still achieved 94 to over 99% removal for the 30 TrOCs 
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tested (Figure 5.1). It is noteworthy that compared to their partial removal (54-70%) in a stand-
alone MD system [5], the MD membrane in this experiment achieved over 99% removal of 
some TrOCs including 4-tert-octylphenol (pKH /log D = 0.98), octocrylene (pKH /log D = 1.21), 
4-tert-butylphenol (pKH /log D = 1.51), benzophenone (pKH /log D = 1.83) and oxybenzone 
(pKH /log D = 2.1). This significant improvement can be attributed to the efficient degradation 














































































































































































































































































































Figure 5.1. Overall removal (membrane retention + enzymatic degradation) of 30 TrOCs 
arranged by usage category in the MD-EMBR. The data from the preliminary short-term 
experiment (t = 12 h and n=2) as well as from the long-term experiment (t = 60 h and n=4)) is 
presented. Error bars are not visible because the standard deviation was less than 5%. MD-
EMBR operating conditions: the initial TrOC concentration and laccase activity was 20 µg/L 
and 95–100 µM(DMP)/min, respectively; temperature of the enzymatic bioreactor and the 
permeate tank were kept at 30 and 10 °C, respectively; and cross-flow rate of media from the 
enzymatic bioreactor and distillate was 1 L/min (corresponding to a cross-flow velocity of 9 
cm/s). 
5.4.2. Preliminary assessment of TrOC degradation in MD-EMBR 
Laccase degrades a substrate via a radical-catalyzed mechanism. In this process, transfer of one 
electron from a substrate to laccase occurs, and molecular oxygen is reduced to water. Laccase 
can efficiently degrade phenolic pollutants i.e., substrates containing a hydroxyl (–OH) group 
attached to a benzene ring. On the other hand, non-phenolic pollutants are less amenable to 
laccase-catalyzed degradation [14, 16]. Therefore, degradation achieved after the preliminary 
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experiment is presented in Figure 5.2 by arranging TrOCs based on the presence of phenolic 
moiety in their molecule.  
After the preliminary experiment, high degradation (87–99%) of 10 out 13 phenolic TrOCs 
was achieved by the MD-EMBR (Figure 5.2). These included five steroid hormones (estriol, 
estrone, 17β–estradiol, 17α–ethinylestradiol and 17β-estradiol-17-acetate (95–99%)), two 
industrial chemicals (4-tert-butylphenol, and 4-tert-octylphenol (87–99%)) and two personal 
care products (oxybenzone and triclosan (89–98%)). On the other hand, enzymatic degradation 
of some phenolic compounds, namely pentachlorophenol, enterolactone and salicylic acid, 
ranged from 55 to 75%. The enzymatic degradation of 17 non-phenolic TrOCs varied from 40 
to 99% (Figure 5.2). Laccase-catalyzed degradation of 13 compounds fell in the range of 40–
65%, while the degradation of the remaining four non-phenolic TrOCs ranged between 94 and 
98%. The well degraded non-phenolic TrOCs include metronidazole, benzophenone, 
amitriptyline and octocrylene. High laccase-catalyzed degradation (80–99%) in continuous flow 
UF-EMBR has been previously reported [22, 26] for benzophenone, amitriptyline and octocrylene. 
An overall degradation of only 40–65% was achieved by the MD-EMBR for a number of non-
phenolic TrOCs (Figure 5.2), however, these removal efficiencies in fact compare favorably 
with those reported in the literature [17, 19, 26]. For instance, laccase-catalyzed degradation of 
carbamazepine, clofibric acid, fenoprop and atrazine has been reported to be less than 10% in 
both batch and continuous-flow ultrafiltration based enzymatic bioreactors [19, 22, 32]. By 
contrast, 40–45% degradation of these TrOCs by the MD-EMBR was observed during 
preliminary assessment. Importantly, degradation of TrOCs by laccase in the MD-EMBR 
seems to be governed by TrOC properties such as the presence of strong EDGs and/or EWGs. 
This has been explained comprehensively in Section 5.4.2.2 that elucidates TrOC degradation 

















































































































































































































































































 Preliminary Performance (t = 12 h)  
Non-phenolic TrOCs Phenolic TrOCs
 
Figure 5.2. Preliminary performance of the MD-EMBR for the degradation of 30 TrOCs by 
laccase. Error bars indicate the standard deviation of duplicate samples. Experimental 
conditions are given in the caption of Figure 5.1. 
5.4.3. TrOC degradation in MD-EMBR during long-term continuous operation  
5.4.3.1. Degradation of phenolic TrOCs 
Of the 13 phenolic TrOCs tested (Figure 5.3), laccase achieved significant degradation (95-
99%) of 10 compounds including five steroid hormones, three industrial chemicals (bisphenol 
A, 4-tert-butylphenol and 4-tert-octylphenol) and two ingredients of personal care products 
(triclosan and oxybenzone). The observation of efficient enzymatic degradation of these TrOCs 
in MD-EMBR is consistent with the literature regarding previously developed enzymatic 
bioreactors. For example, Lloret et al. [23] achieved 95-99% removal of two steroid hormones 
(estrone and 17β–estradiol) in a batch enzymatic bioreactor. Similarly, efficient degradation 
(>90%) of oxybenzone, bisphenol A, triclosan and 4-tert-butylphenol has been achieved by 
both batch or continuous-flow enzymatic bioreactors [17, 26]. Notably, a reduced removal (20-
35%) of three natural steroid hormones such as estrone, 17β-estradiol and estriol has been 
reported in continuous -low UF-EMBRs, as compared to that achieved by batch enzymatic 
bioreactor [22, 23]. This was attributed to the sustained-TrOC loading in UF-EMBRs. In this 
experiment, degradation of estrone, 17β-estradiol and estriol was greater than 99%, which 
indicates that effective retention of these TrOCs by the MD membrane facilitated their 
degradation by laccase in MD-EMBR.  
Although phenolic TrOCs are especially amenable to laccase-catalyzed degradation, moderate 
degradation of a few phenolic compounds has been previously attributed to the presence of 
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EWG(s) in their molecular structure [33]. Due to the steric hindrance caused by the 
concomitant presence of an EWG, phenolic TrOCs cannot access the active sites of laccase for 
efficient degradation [26, 33]. In line with this, a moderate degradation (44-65%) was observed 
for three phenolic TrOCs, namely salicylic acid, pentachlorophenol and enterolactone in this 
experiment, which contain an EWG (i.e., carbonyl or halogen) in their molecule (Figure 5.3).  
5.4.3.2. Degradation of non-phenolic TrOCs 
Laccase can oxidize non-phenolic TrOCs, but the extent of the degradation may not be 
significant [14]. In previous studies, two distinct trends were observed for the degradation of 
non-phenolic TrOCs by laccase: (i) poor removal (e.g., less than 5%) of those that only contain 
strong EWGs such as halogen (–X), amide (–CONR2) and carbonyl (–C=O) functional groups; 
and (ii) moderate to high removal of those that contain both EWGs and EDGs such as amine 
(–NH2) or alkoxy (–OR) functional group [14, 29, 34]. In this experiment, benzophenone, 
octocrylene and amitriptyline were significantly degraded (>95%) by laccase. On the other 
hand, a moderate degradation (45-75%) was observed for the remaining non-phenolic TrOCs 
(Figure 5.3).  
Of particular interest is the enhanced degradation of pharmaceuticals and pesticides (containing 
strong EWGs) that were previously reported to be poorly (<10%) degraded by laccase in both 
batch and continuous-flow enzymatic bioreactors [17, 26]. These TrOCs include ketoprofen 
(EWG carboxylic; 52% removal), clofibric acid (EWG halogen; 55% removal), carbamazepine 
(EWG amide; 62% removal), metronidazole (EWG nitro; 67% removal), atrazine (EWG 
halogen; 59% removal), fenoprop (EWG halogen, 48% removal) and N, N-Diethyl-meta-
toluamide (DEET; EWG amide; 69% removal) (Figure 5.3). Previously, significantly 
improved degradation of recalcitrant TrOCs such as carbamazepine, atrazine and diclofenac 
was attributed to simultaneous adsorption of laccase and TrOCs on granular activated carbon 
which allowed prolonged close contact between laccase and TrOCs [11]. Although approach 
in this experiment was different, the enhanced degradation of recalcitrant TrOCs in MD-EMBR 
can be ascribed to the increased contact time between laccase and TrOCs following their 
complete retention (95-99% removal) by the MD membrane. It is important to critically 
analyze the degradation of TrOCs after both 12 h (preliminary performance) and 60 h 
experiments (long-term performance). The comparison of TrOC degradation by the MD-













































































































































































































































































TrOC degradation during long-term continuous operation  
Phenolic TrOCsNon-phenolic TrOCs
 
Figure 5.3. Laccase-catalyzed degradation of 30 TrOCs in MD-EMBR during long-term 
continuous operation of MD-EMBR (60 h; and 2×HRT). Error bars indicate the standard 
deviation among four samples. Experimental conditions are given in the caption of Figure 5.1. 
It is also noteworthy that TrOCs containing EDGs such as hydroxyl and amine (e.g., steroid 
hormones, bisphenol A and triclosan) can act as bi-functional substrates or redox-mediators 
[33, 35]. Fragments of phenoxyl radicals or oxidative coupling agents (e.g., dimers) produced 
due to the oxidation of bi-functional substrates can facilitate the degradation of recalcitrant 
TrOCs via enzymatic and/or non-enzymatic reactions (e.g., polymerization or agglomeration). 
Indeed, Margot et al. [17] reported significantly higher diclofenac removal in presence of  the 
phenolic TrOC bisphenol A as compared to that observed for diclofenac as a single compound. 
Similarly, Nair et al. [36] observed above 90% removal of diclofenac in a mixture containing 
bisphenol A, 17α–ethinylestradiol and diclofenac as compared to its 70% removal in absence 
of the phenolic TrOCs. In another study, Hachi et al. [35] demonstrated that an oxidative 
coupling agent (i.e., dimer) produced due to the degradation of acetaminophen containing an 
EDG (i.e., amine) formed oligomers with carbamazepine. These oligomers were more 
susceptible to laccase-catalyzed oxidation than the parent compound, which led to enhanced 
carbamazepine degradation [35]. Furthermore, in nature, laccase oxidizes the aromatic rings of 
lignin and produce phenoxyl radical, which are responsible for the degradation of non-phenolic 
components of lignin [33, 37]. Thus, there is a strong body of evidence of TrOCs containing 
EDGs working as redox-mediators for enhancing degradation of non-phenolics, albeit from 
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batch tests only. The synthetic wastewater used in this experiment contained a mixture of 
TrOCs containing EDGs and EWGs, as would be expected in practical wastewater conditions. 
These TrOCs were well retained by the MD component during the continuous operation of the 
MD-EMBR (see Section 5.4.1). Therefore, it is possible that radicals or oxidative coupling 
agents formed due to the oxidation of TrOCs containing hydroxyl and amine functional groups 
also contributed in achieving enhanced degradation (as compared to that achieved by UF-
EMBRs) of resistant TrOCs containing EWGs by the MD-EMBR. A comparative performance 
of a high retention – and conventional EMBR is demonstrated in Chapter 3. 
5.4.4. MD-EMBR performance with mediator addition 
5.4.4.1. Preliminary screening of redox-mediators during preliminary assessment 
As noted in Section 5.4.2 (i.e., preliminary assessment of TrOC degradation in MD-EMBR), 
of the 30 TrOCs tested, MD-EMBR achieved high degradation (85–99%) for 14 compounds 
(10 phenolic and 4 non-phenolic compounds) but the degradation efficiency varied widely (40–
70%) for the rest of the compounds. To improve the degradation of the latter group, three redox-
mediators, namely SA, VA and HBT, were added at 0.25 and 0.5 mM concentrations each in 
separate runs. Depending on the redox-mediator type and concentration, degradation of 
phenolic compounds and non-phenolic compounds by the MD-EMBR was improved by 20–
30% and 10–50%, respectively (Figure 5.4) as explained below. 
To date, the impact of redox-mediator type on the improvement of TrOC degradation has been 
assessed mainly in small scale and batch tests [27, 38, 39]. For instance, Ashe et al. [27] 
investigated the performance of seven different redox-mediators including SA, HBT and VA 
for the degradation of four resistant TrOCs, namely atrazine, naproxen, oxybenzone and 
pentachlorophenol in 10 mL batch reactors. They achieved significant improvement (40–90%) 
at a concentration of 1 mM. Nguyen et al. [22] achieved enhanced (10–90%) removal of TrOCs 
in UF-EMBR using SA and HBT. However, this is the first experiment investigating the 













































































































































































































































































 Laccase  Laccase+HBT (0.5 mM)  Laccase+VA (0.5 mM)  Laccase+SA (0.5 mM)
Non-phenolic TrOCs
 
Figure 5.4. Enzymatic degradation of 30 TrOCs during the preliminary screening of three 
redox-mediators, namely HBT, VA and SA (separately at 0.5 mM) in the MD-EMBR operated 
for 12 h. Error bars indicate the standard deviation of duplicate samples. Operating conditions 
of the MD-EMBR are given in the caption of Figure 5.1. 
All the tested redox-mediators enhanced the degradation of TrOCs. However, the best overall 
performance was shown by VA (Figure 5.4). In line with the findings of Nguyen et al. [26], 
degradation of the phenolic TrOCs that were already highly degraded by laccase (Figure 5.2) 
remained almost the same after the addition of redox-mediators. For the remaining phenolic 
TrOCs, VA (at 0.5 mM), compared to HBT and SA achieved better removal for two 
compounds, namely salicylic acid (80%) and pentachlorophenol (90%). Both VA and SA 
achieved above 95% degradation of enterolactone, which compares favorably with 45–70% 
degradation achieved in absence of mediators (Figure 5.3). 
Of the 17 non-phenolic compounds, degradation of four compounds viz metronidazole, 
benzophenone, amitriptyline and octocrylene, was at least 90%, regardless of the mediator type 
(Figure 5.4). For the remaining compounds, VA (at 0.5 mM) achieved better degradation for 
10 compounds compared to SA and HBT. SA (at 0.5 mM) performed the best for the 
degradation of two compounds, namely naproxen and primidone. It is well-known that the 
herbicide atrazine is resistant to laccase catalyzed degradation [22]. Compared to other redox-
mediators, HBT was particularly efficient (>99%) for the degradation of atrazine. Although a 
superior ability of VA compared to other mediators for the degradation of non-phenolic TrOCs 
has been reported previously in a batch enzymatic bioreactor spiked with four TrOCs [27], the 
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effectiveness of VA for the degradation of a broad spectrum of non-phenolic TrOCs is 
demonstrated for the first time in this chapter. 
5.4.4.1.1. Impact of redox-mediator concentration  
Redox-mediator dose can affect TrOC degradation by changing the abundance, stability and 
reversibility of the generated radicals [40]. Therefore, the impact of two mediator 
concentrations (0.25 and 0.5 mM) on ORP, TrOC degradation, and enzyme stability was 
investigated during preliminary screening of redox-mediators. 
Concentration-dependent improvement in the degradation of 18 TrOCs (5 phenolic and 13 non-
phenolic compounds, Figure 5.5) was observed in MD-EMBR. The highest improvement in 
the degradation of TrOCs was achieved at 0.5 mM. Notably, increasing the concentration of 
SA, HBT and VA from 0.25 to 0.5 mM improved TOC degradation by up to 7, 15 and 25%, 
respectively (Figure 5.5). This corresponds well with the respective increase of 2, 5 and 15% 
of the reaction media ORP (Figure 5.6). On the other hand, degradation of 8 phenolic and 4 
non-phenolic TrOCs in MD-EMBR was comparable at all the tested mediator concentrations 
(Appendix Figure 5-1). For instance, HBT achieved over 99% degradation of atrazine in MD-
EMBR irrespective of the mediator concentration. This is consistent with HBT performance 
reported in case of UF-EMBR [22]. 
In general, the degradation of TrOCs that are easily amenable to laccase (Appendix Figure 5-
1) does not improve significantly (less than 5% in this chapter), while the degradation of resistant 
TrOCs  may improve with the increase in mediator concentration and may reach a plateau beyond 
a certain mediator concentration. However, the mediator concentration beyond which no 
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Figure 5.5. Impact of redox-mediator concentration (0.25 and 0.5 mM) on the degradation of 
TrOCs in the MD-EMBR operated for 12 h. Error bars indicate the standard deviation of 
duplicate samples. Operating conditions of the MD-EMBR are given in the caption of Figure 
5.1. Only those TrOCs showing mediator concentration-dependent improvement in their 


































































































































Figure 5.6. Effect of mediator type and concentration on oxidation reduction potential (ORP) 
and laccase inactivation in the MD-EMBR operated for 12 h. Operating conditions of the MD-
EMBR are given in the caption of Figure 5.1. 
5.4.4.1.2. Effect of mediators on enzyme stability  
In this experiment, a gradual inactivation of laccase was observed despite the absence of any 
known chemical inhibitors in the synthetic wastewater (Figure 5.6). In the absence of redox-
mediators, a 37% laccase inactivation was observed over a period of 12 h. This was possibly 
due to the blockage of the active enzyme sites by the charged metabolites and/or hydraulic 
stress during membrane filtration [38, 42]. Since the MD membrane can conceptually retain all 
non-volatile organics including the transformation products/radicals, laccase inactivation with 
or without the presence of redox-mediators can be expected. The extent of laccase inactivation 
increased further when the mediators were added (61, 66 and 73 for HBT, SA and VA, 
respectively, each at a concentration of 0.5 mM). The highly reactive radicals generated from 
mediators can enhance the degradation of TrOCs but at the same time may inactivate laccase 
[43]. Purich [21] suggested that the metabolites from the oxidation of substrate and/or 
mediators could react with enzyme to form non-productive complexes, thereby inactivating the 
enzyme. 
The extent of laccase inactivation also depends on the concentration of redox-mediators. For 
instance, Khlifi-Slama et al. [43] observed a gradual increase in the inactivation of laccase from 
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Trametes trogii following a stepwise increase in the concentration of HBT from 0.1–10 mM. 
In another study, increasing SA concentration from 0.1–1 mM resulted in aggravated 
inactivation of laccase from Trametes versicolor [39]. These results suggest that the degree of 
laccase inactivation is strongly influenced by redox-mediator concentration. Indeed, loss in 
laccase activity was increased by 7, 9 and 11% in MD-EMBR due to the increase in the 
concentration of HBT, SA and VA, respectively, from 0.25 to 0.5 mM (Figure 5.6). Although 
laccase activity was greatly affected in the presence of redox-mediators, it was compensated 
by the improvement in TrOC degradation (Figure 5.5). For example, the highest drop in 
laccase activity was observed in the presence of VA (Figure 5.6), but it outperformed SA and 
HBT in terms of enhanced TrOC degradation (Figure 5.5). 
5.4.4.2. TrOC degradation following VA and SA addition during long-term operation 
During long-term operation of MD-EMBR (Section 5.4.3), efficient degradation (95-99%) by 
MD-EMBR was observed for 13 out of the 30 TrOCs, while the remaining TrOCs were 
moderately removed (44-75%). While these removal rates compare favorably with that in 
previous reports, two naturally occurring redox-mediators, namely SA and VA, were selected 
based on their performance during preliminary screening (Section 5.4.4.1). SA and VA were 
added to the EMBR separately and as a mixture in an attempt to further improve removal of 
the recalcitrant TrOCs.  
Oxidation of VA and SA by laccase produces highly reactive aminoxyl and phenoxyl radicals, 
respectively, that have higher ORP than laccase. Moreover, these radicals act as an electron 
shuttle between the substrate and laccase, thereby improving the degradation of the substrate 
i.e., target pollutants [27]. In a study by Weng et al. [44], addition of SA increased the ORP of 
the enzyme solution, consequently improving the degradation of sulphonamide antibiotics. 
Similarly, an increase in ORP was accompanied by an improved degradation of atrazine, 
pentachlorophenol, naproxen and oxybenzone following the addition of VA at a concentration 
of 0.5-1 mM in a batch enzymatic bioreactor [27]. In the current experiment, the ORP of 
EMBR-media increased from 0.3 to 0.39 and 0.45 V following the addition of SA and VA, 
respectively. This was accompanied by significant improvement in TrOC removal: an increase 
of 5-54% depending on the molecular structure of TrOCs and redox-mediator type as discussed 













































































































































































































































































 Laccase  Laccase+SA(0.5 mM)  Laccase+VA (0.5 mM)
 Phenolic TrOCsNon-phenolic TrOCs
 
Figure 5.7. Enzymatic degradation of 30 TrOCs following the addition of two redox-mediators 
viz SA and VA separately at 0.5 mM in MD-EMBR operated for a period of 60 h (i.e., 2×HRT). 
SA or VA was introduced only at the start of MD-EMBR operation. Data presented as 
average±standard deviation (n=4). Operating conditions of the MD-EMBR are given in the 
caption of Figure 5.1.  
The performance of different mediators for enhanced TrOC degradation has been reported in 
only a few batch or UF-EMBR studies [26, 27, 38]. In previous studies, a continuous supply 
of redox-mediator was required to sustain UF-EMBR operation, because UF membranes 
cannot retain redox-mediators [26, 39]. A uniqueness of this chapter is that it demonstrates the 
effect of the single dose of mediators on TrOC degradation following the complete retention 
of laccase, TrOCs and mediators by the MD membrane. SA and VA demonstrated substrate 
specific improvements in the degradation of TrOC that were moderately degraded by laccase-
only (Figure 5.3). Of the 17 moderately degraded TrOCs (Figure 5.3), the laccase-VA system 
achieved better degradation for six compounds namely, ketoprofen, gemfibrozil, naproxen, 
primidone, carbamazepine and pentachlorophenol. By contrast, the laccase-SA system 
performed best for four compounds; fenoprop, clofibric acid, propoxur and atrazine (Figure 
5.7). Similar degradation efficiency was achieved by both SA and VA for the remaining TrOCs. 
A comparison of TrOC fate in laccase and laccase-mediator based MD-EMBR revealed that 
the molecular structures of TrOCs significantly influence the effectiveness of laccase-mediator 
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(b) Laccase+VA (0.5 mM)
 
Figure 5.8. Fate of TrOCs during MD-EMBR operation with and without the addition of 
redox-mediators. Operating conditions of the MD-EMBR are given in the caption of Figure 
5.1.  
5.4.4.3. Effect of mediator mixture on TrOC degradation 
Since in this experiment, SA and VA showed different patterns of TrOC-specific degradation-
improvement during long-term operation of MD-EMBR (Figure 5.7), it was envisaged that a 
mediator-mixture would have further beneficial effects. Degradation of the phenolic TrOCs, 
which were already well removed by laccase-only, remained unaffected when a SA-VA 
mixture was used. The whole set of data is provided in Appendix Figure 5-2. However, 
compared to either SA-laccase or VA-laccase, the SA-VA-laccase system did not improve the 
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degradation of any TrOCs (Figure 5.9). Furthermore, in comparison to TrOC degradation by 
laccase-only, the SA-VA-laccase system achieved somewhat reduced degradation of six 
pharmaceuticals, namely ketoprofen, naproxen, clofibric acid, primidone, carbamazepine and 











































































Figure 5.9. Effect of individual mediators and their mixture on the degradation of selected non-
phenolic TrOCs, showing reduced performance when mediator mixture was used. Data 
presented as average±standard deviation (n=4). Effect of mediator mixture (i.e., SA and VA) 
on all the tested TrOCs (i.e., phenolic and non-phenolic) is shown in Appendix Figure 5-2. 
The performance of mediator mixtures has rarely been studied for the removal of TrOCs. 
Previously, Jeon et al. [45] observed in batch tests that vanillin and acetovanillone mixture did 
not improve the degradation of pentachlorophenol, while enhanced pentachlorophenol 
degradation was found by adding a mixture of 2,2'-azino-bis(3-ethylbenzothiazoline-6-
sulphonic acid) (ABTS) and vanillin or acetovanillone [45]. It is possible that, in mixtures, 
some mediators can chemically interact with each other instead of acting as an electron shuttle 
for laccase. Moreover, simultaneous addition of some mediators can reversibly inhibit laccase, 
thereby inhibiting electron transfer between laccase and TrOCs [45, 46]. Indeed, laccase 
inactivation was significantly increased following the addition of SA-VA mixture (Figure 
5.10). The current work demonstrates for the first time through continuous operation of the 
MD-EMBR that although VA and SA outcompete many other mediators tested to date [27], 
using them together may be counterproductive. Further studies to screen redox-mediators and 
their mixtures are recommended, but that is beyond the scope of the current experiment.  
Laccase activity in enzymatic bioreactors may be affected by various physicochemical and 
biological factors [21, 29]. Transformation byproducts or charged metabolites formed 
following the degradation of TrOCs can block the active sites of the laccase. Moreover, 
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hydraulic stress during MD-EMBR operation can also cause laccase inactivation [38]. 
Although some laccase inhibition was observed during continuous operation of the MD-EMBR 
(Figure 5.10), a stable operation could be sustained by reinjecting as little as 275-400 µL 
laccase solution per liter of reactor (working) volume every 12 h.  









































































Figure 5.10. Oxidation reduction potential (ORP) and laccase inactivation percentage with and 
without the addition of redox-mediators. Data presented as average±standard deviation (n=2 
for ORP; and n=5 for laccase inactivation). Time course of enzymatic activity during all 
experiments is given in Appendix Figure 5-3. 
It may be noted that the MD membrane can theoretically retain all non-volatile compounds 
including redox-mediator derived highly active radicals along with laccase and TrOCs. The 
radicals enhance laccase-catalyzed TrOC degradation [35], but can also instigate laccase 
inactivation. It has been suggested that the highly reactive radicals produced due to the 
oxidation of mediators can react with laccase, consequently converting them into non-
productive complexes [21, 38, 47]. Indeed, the extent of laccase inactivation increased during 
MD-EMBR operation after mediator addition. This data is available in Appendix Figure 5-3. 
The average laccase inactivation was 53±11% (no. of laccase injections, n=4) during MD-
EMBR operation in absence of mediators, while the loss in laccase activity was 57±11, 62±16 
and 80±12% (n=4) after the addition of a single dose of VA, SA and SA-VA mixture, 
respectively (Figure 5.10). To date higher laccase inactivation in presence of mediators has 
mostly been reported in small scale batch enzymatic bioreactors. For instance, Nguyen yet al. 
[39] reported rapid laccase inactivation following the addition of SA at the tested 
concentrations of 0.1-1 mM in a batch enzymatic bioreactor. In another study, a complete loss 
of enzymatic activity was observed in a batch enzymatic bioreactor by adding VA at a 
concentration of 0.5 mM [27]. In the current experiment, although laccase activity was 
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significantly affected in the presence of redox-mediators, it was compensated for by the 
improvement in TrOC degradation (Figure 5.8).  
5.4.5. Permeate toxicity  
Laccase-catalyzed degradation of TrOCs, particularly in the presence of mediators, produces 
reactive radicals and transformation products that may increase the toxicity of the treated 
effluent [26, 48]. In this experiment, the overall bacterial toxicity of the media in the enzymatic 
bioreactor and MD-permeate (i.e., final effluent) was measured at the end of each EMBR run 
(Table 5.2). Of the three mediators tested during preliminary assessment, SA significantly 
increased the toxicity of the solution in the enzymatic bioreactor, whereas HBT and VA showed 
no effect on toxicity levels (Table 5.2). Compared to the background toxicity of the mixture of 
laccase and TrOCs in the enzymatic bioreactor of MD-EMBR (<1 to 1.8 rTU; n = 2), toxicity 
in the enzymatic bioreactor due to addition of HBT, VA and SA ranged from <1 to 1.7 rTU (n 
= 2), 3.3 to 3.9 rTU (n = 2) and 109 to 116 rTU (n = 2), respectively. 
Table 5.2. Toxicity of the bioreactor mixture and permeate following treatment of TrOCs with 
different mediators in MD-EMBR, expressed as relative toxic unit (rTU). The limit of detection 
of the toxicity assay was 10% inhibition of luminescence (i.e., 1 rTU). ‘NA’: not available 
Reaction media Toxicity in enzymatic 
bioreactor (rTU) 
Toxicity of the 
permeate (rTU) 
 12 h 60 h  
TrOCs + Laccase  <1 – 1.8 4.4 – 5.0  <1 
TrOCs + Laccase + HBT (0.5 mM) <1 – 1.7 –  
TrOCs + Laccase + VA (0.5 mM) 3.3 – 3.9 12.8 – 15 <1 
TrOCs + Laccase + SA (0.5 mM) 109 – 116 61.4 – 66.3 <1 
TrOCs + Laccase + SA (0.25 mM) + VA (0.25 
mM) 
NA 119.4 – 136 <1 
 
At the conclusion of long-term operation of MD-EMBR, the media in the enzymatic bioreactor 
showed an overall toxicity of 4.5-5, 12.8-15, 61.4-66.3, and 119.4-136 rTU (n=2) in presence 
of laccase, laccase-VA, laccase-SA and laccase-SA-VA, respectively. The observed increase 
in toxicity due to addition of VA and SA are consistent with previous studies [26, 27], however, 
the toxicity in relation to mediator mixtures is reported for the first time in this chapter. A 
significantly increased toxicity following the addition of SA-VA mixture was observed. 
Despite the increase of toxicity in the enzymatic bioreactor, MD-EMBR permeate toxicity was 
below the limit of detection (i.e., rTU <1) during all experiments, evidencing that in addition 
to laccase and TrOCs, the MD system retained reactive radicals and transformation products, 
which cause bacterial toxicity. This is an added advantage of integrating a high retention 
membrane with an enzymatic bioreactor. 
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5.4.6. Permeate flux of MD-EMBRs 
The driving force of permeate flux in MD is the difference between feed and distillate 
temperature. Ideally, feed and distillate temperature is maintained at over 50 and 20–25 °C, 
respectively to obtain a permeate flux of approximately 10 L/m2 h [1, 3]. In this experiment, 
however, to avoid thermal inhibition of laccase [49], temperature of the enzymatic reactor and 
permeate tank was kept at 30 and 10 °C, respectively. A stable permeate flux of around 4 L/m2 
h was observed during all experiments (Appendix Figure 5-4 and 5-5), suggesting that 
membrane fouling did not occur during the operation period. This level of flux is consistent 
with the feed temperature employed. Notably, during short-term operation (12 h), the average 
permeate flux for laccase only, laccase-HBT, laccase-VA and laccase-SA was 3.69 ± 0.44 L/m2 
h, 3.89 ± 0.63 L/m2 h, 3.92 ± 0.62 L/m2 h and 3.86 ± 0.66 L/m2 h, respectively, confirming 
negligible impact of different type of mediator addition on membrane flux (Appendix Figure 
5-4). In this experiment, the mass transfer coefficient (Km) of the DCMD, which was calculated 
based on the method described by Nghiem et al. [50], ranged from 1.22 to 1.28 (×10−3) L/m2 h 
Pa. This value is in good agreement with that in previous studies [3, 51]. Thus, this chapter 
shows both stable membrane hydraulic performance and improved enzymatic degradation of 
TrOCs following their complete retention by the MD membrane. 
During prolonged continuous operation, the performance of the MD process can be affected by 
the loss of hydrophobicity of the MD membrane [1, 3]. Therefore, the integrity of the MD 
membrane was assessed by measuring the contact angle of the membrane after each 
experiment. The contact angle i.e., the hydrophobicity was found to be not significantly 





















































Figure 5.11. Contact angle of the membrane before and after using it for EMBR operation of 
60 h. Error bars represent the standard deviation of three repeated measurements. 
5.5. Conclusion 
Laccase-catalyzed degradation of a broad spectrum of trace organic contaminants (TrOCs) by 
a membrane distillation (MD) – enzymatic membrane bioreactor (EMBR) was investigated. 
Initially, the preliminary performance of MD-EMBR was assessed in a series of 12 h 
experiment. Based on permeate quality, MD-EMBR achieved 90–99% TrOC retention. 
Degradation of TrOCs varied (40–99%) depending on their molecular properties such as 
electron withdrawing functional groups (EWGs), and electron donating functional groups 
(EDGs). High degradation (above 90%) of TrOCs containing EDGs in their chemical structure 
was observed in the MD-EMBR, while those containing EWGs in their molecular structure 
were moderately degraded (40–75%). During preliminary assessment, performance of three 
redox-mediators, namely syringaldehyde (SA), violuric acid (VA) and 1-hydroxybenzotriazole 
(HBT) was also screened. The results suggest that VA at 0.5 mM concentration was the most 
effective redox-mediator for improving the degradation of phenolic and non-phenolic TrOCs. 
In addition, it was observed that the degradation of non-phenolic compounds in laccase-
mediator system was strongly influenced by the tested concentration of the redox-mediators. 
TrOC degradation in the MD-EMBR during long-term operation was also studied for assessing 
the process stability. The MD component effectively retained TrOCs (94-99%) in the EMBR 
during long-term operation, facilitating their continuous biocatalytic degradation. The 
comparison of TrOC degradation by the MD-EMBR after 12 h and 60 h suggests that TrOC 
degradation was stable. The addition of two redox-mediators, namely SA and VA, further 
improved TrOC degradation. However, a mixture of redox-mediators showed a reduced 
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performance for a few pharmaceuticals such as primidone, carbamazepine and ibuprofen. This 
observation disapproved the hypothesis - mixture of different redox-mediators may achieve 
better improvement in TrOC degradation than a single redox-mediator. Redox-mediator 
addition increased the toxicity of the media in the enzymatic bioreactor, but the membrane 
permeate (i.e., final effluent) was non-toxic, suggesting an added advantage of coupling MD 
with EMBR. Hydraulic performance of MD-EMBR was stable during all experiments, and 
membrane wetting, or fouling was not observed. 
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Chapter 6: Laccase – persulfate assisted degradation 
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Laccases (EC 1.10.3.2) are copper containing oxidoreductase enzymes and can effectively 
catalyse the oxidation or degradation of a wide range of aromatic pollutants such as phenols by 
using molecular oxygen as a co-factor [1-3]. The active sites of laccase contain four copper 
ions as per following distribution: (i) one copper ion at the Type I active site; (ii) one copper 
ion at the Type II active site; and (iii) two copper ions at the Type III active site. The 
degradation of a substrate occurs at the TI active site that acts as the primary electron acceptor. 
The electron accepted by the Type I active site is transferred to the Type II and Type III active 
sites, where molecular oxygen is reduced to water [4-6].  
In the last decade, laccase-catalysed degradation of trace organic contaminants (TrOCs) such 
as pharmaceuticals, ingredients of personal care products and industrial chemicals has gained 
considerable attention [7, 8], because the occurrence of TrOCs in aquatic ecosystems could be 
potentially harmful to aquatic life and human health [9, 10]. Notably, laccase-catalysed 
degradation has been reported to be effective for a broad variety of TrOCs as compared to 
conventional biological processes [11, 12]. Recent studies have also demonstrated that the 
performance of the laccase-catalysed treatment system is mainly governed by the 
physicochemical properties of target TrOCs such as chemical structure and hydrophobicity [7, 
13]. In general, TrOCs containing a phenolic moiety or electron donating functional groups 
(EDGs) are effectively degraded (70-99%) by laccase, while degradation of TrOCs containing 
electron withdrawing functional groups has been reported to be unstable/poor [7, 11]. 
The application of laccase in continuous systems such as wastewater treatment plants remains 
a challenge, since laccase is easily washed out with the treated effluent. This loss of laccase in 
a continuous treatment system could be effectively controlled by integrating a membrane of 
appropriate pore size with enzymatic bioreactor. Indeed, Lloret et al. [14] and Nguyen et al. 
[15] developed an enzymatic membrane bioreactor (EMBR) by coupling an ultrafiltration (UF) 
membrane with an enzymatic bioreactor, and reported effective retention (>99%) of laccase by 
the ultrafiltration membrane. Interestingly, Nguyen et al. [13] observed the formation of an 
enzyme gel-layer formed on membrane surface following the continuous permeation of 
bioreactor media, which adsorbed a few hydrophobic TrOCs (log D>3) such as oxybenzone 
and improved their degradation by laccase in EMBR. They attributed enhanced degradation to 
the simultaneous adsorption of TrOCs and laccase on membrane surface, thus promoting the 
interaction of adsorbed pollutants with laccase active sites [13]. This observation led to the 
development of high retention (HR) nanofiltration (NF) - and membrane distillation (MD)-
EMBRs [5, 16]. During the operation of HR-EMBR, laccase and TrOCs are simultaneously 
retained by the high retention membrane separation process, thereby providing a prolonged 
contact time between laccase and TrOCs for enhanced degradation. In a recent study, Asif et 
al. [5] compared the performance of UF- and NF-EMBR for the treatment of synthetic 
wastewater containing a mixture of TrOCs including sulfamethoxazole, carbamazepine, 
diclofenac, atrazine, and oxybenzone under identical operating conditions. As compared to UF-
EMBR, they achieved 15–30% better degradation of the selected TrOCs in NF-EMBR [5]. 
Despite the effective removal (92-99%) of TrOCs achieved by NF-EMBR based on the 
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permeate quality, degradation of TrOCs (except for oxybenzone) by laccase in the bioreactor 
ranged between 30 and 80% [5]. The partially degraded TrOCs accumulate in the bioreactor of 
NF-EMBR over time, and could increase the toxicity of NF-concentrate, consequently making 
the process of NF-concentrate disposal complex. Therefore, considerable efforts are required 
to further improve the extent of TrOC degradation within the bioreactor of HR-EMBR.  
Degradation of TrOCs in enzymatic treatment systems could be improved by introducing a 
redox-mediator that is a low molecular weight phenolic compound and can act as electron 
carrier between laccase and target compounds [4]. In a study by Ashe et al. [17], efficacy of 
seven redox-mediators such as 1-hydrozybenzotriazole (HBT), violuric acid (VA), 
syringaldehyde (SA) and 2,2'-azino-bis-3-ethylbenzothiazoline-6-sulphonic acid (ABTS) for 
improving TrOC degradation was assessed in laccase-catalysed treatment system. They 
observed that effectiveness of redox-mediator strongly correlated with its type and 
concentration. For instance, ABTS achieved the highest degradation for phenolic TrOCs, while 
HBT and VA were the best redox-mediators for non-phenolic TrOCs [17]. In another study, 
performance of SA and HBT was compared and elucidated in a continuous-flow UF-EMBR. 
The tested redox-mediators were found to achieve TrOC-specific improvement in their 
degradation [13]. However, the feasibility of laccase-mediator based treatment systems is 
severely affected due to significant laccase inactivation, elevated toxicity of treated effluent 
and high replenishment costs [4].  
Instead of redox-mediators, an alternative and innovative approach could be to develop an 
integrated treatment system by combining an advanced oxidation process (AOPs) with laccase-
catalysed degradation process in a bioreactor. AOPs can be either hydroxyl radical-based such 
as ultraviolet (UV) photolysis [18], or sulphate radical-based such as activated persulfate (PS) 
assisted-oxidation process [19, 20]. In recent years, sulphate radical-based AOPs has gained 
significant attention due to its effectiveness for a wide range of TrOCs such as pharmaceuticals 
and personal care products in various conditions [20]. To-date, a combined laccase/AOP 
assisted treatment system has yet to be developed and studied.  
Persulfate (PS) is stable at room temperature (i.e., 20 oC), and requires an activator such as heat 
(as low as 30 oC), transition metals (e.g., iron) and UV light to generate highly reactive SO4
– • 
radicals. Depending on the type of activator, PS produces one (e.g., in presence of transition 
metals, see Equation 1) or two (e.g., in presence of heat or UV light, see Equation 2) SO4
– • 
radicals [20, 21]. It is worth mentioning that phenolic compounds [22], humic substances 
containing quinone functional groups [23], graphene [24], activated carbon [20], 
ultrasonication [20] and sub-surface minerals [25] have also been reported to activate PS. 
However, a thorough literature survey suggests that PS activation by using enzymes has not 
been assessed.  
𝑆2𝑂8 
2− + ℎ𝑒𝑎𝑡 𝑜𝑟 𝑈𝑉 𝑙𝑖𝑔ℎ𝑡 →  2 𝑆𝑂4 










PS activation, formation of reactive radicals, and identification of degradation products or 
metabolites has been predominantly studied, to-date. In addition, performance of PS has been 
reported for the degradation of a single TrOC at concentration significantly higher than its 
environmentally relevant concentration [20, 26]. The logical step forward should be to assess 
the performance of PS for a mixture of TrOCs, because the extent of degradation for a single 
TrOC may change in a reaction media containing a mixture of TrOCs. Importantly, toxicity 
and estrogenicity of the treated effluent should be analysed for safe disposal and reuse of the 
treated effluent.  
This chapter elucidates the degradation of a mixture of five TrOCs in a laccase/persulfate (PS) 
oxidation-assisted nanofiltration membrane bioreactor (NFBR) for the first time. Initially, 
batch experiments were performed to understand the effect of initial PS concentration and 
effect of incubation time as well as possible PS activation mechanisms. While discussing the 
removals achieved by batch and continuous-flow bioreactors, physicochemical properties of 
TrOCs were also considered to provide an in-depth understanding. Estrogenicity and toxicity 
of the bioreactor media and membrane permeate were analysed and discussed. Finally, the 
hydraulic performance of NFBR is presented to confirm the stability of the developed process. 
6.2. Hypothesis  
▪ Integrated laccase and PS oxidation processes may synergistically facilitate TrOC 
degradation 
▪ The extent of degradation in laccase/PS system is governed by TrOC properties and PS 
concentration 
▪ Enhanced TrOC degradation may result in reduced toxicity and estrogenic activity 
6.3. Materials and methods 
6.3.1. Trace organic contaminants, laccase solution and persulfate 
In this experiment, one industrial chemical (bisphanol A) and four pharmaceuticals and 
personal care products, namely diclofenac, sulfamethoxazole, carbamazepine and oxybenzone 
were selected based on their ubiquitous presence in wastewater and freshwater bodies [9]. For 
both batch and continuous experiments, a synthetic wastewater containing the mixture of the 
selected TrOCs each at a concentration of 500 μg/L in ultrapure Milli-Q water was prepared. 
All the TrOCs were of analytical grade (purity >98%), and were procured from Sigma–Aldrich 
(Sydney, NSW, Australia). A stock solution (2 g/L) was also prepared by dissolving the 
mixture of the selected TrOCs in pure methanol. The TrOC stock solution was kept at –18°C 
in the dark and used within one month. The main physicochemical properties of the selected 
TrOCs are presented in Table 6.1. 
The enzyme solution acquired from Novozymes Australia Pty. Ltd. (Sydney, NSW, Australia) 
was commercially available laccase from genetically modified Aspergillus oryzae. Properties 
of laccase are presented in Section 3.3.1 (Chapter 3). Reagent grade (purity ≥99%) potassium 
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persulfate (PS) was purchased from Sigma-Aldrich (Sydney, NSW, Australia). A stock 
solution (50 mM) of PS was prepared in ultrapure Milli-Q water and stored at 4ºC before use. 
Table 6.1. Selected physicochemical properties of the selected TrOCs  















228.29 120 10.29 3.64 
Carbamazepine 
 
236.27 220 13.94 1.89 
Sulfamethoxazole 
 
253.28 410 5.6 –0.22 
Diclofenac 
 
296.15 30 4.18 1.77 
Oxybenzone 
 
228.24 100 7.56 3.99 
6.3.2. Performance of laccase and persulfate in batch bioreactor  
The performance of laccase/PS was initially assessed in batch bioreactor at different PS 
concentration (i.e., 1, 2, 5 and 10 mM) for an incubation period of 24 h. All the experiments 
were conducted in 250 mL conical flasks. The concentrated laccase stock solution (70 μL) was 
diluted to a final volume of 100 mL in conical flasks for maintaining an initial enzymatic 
activity of 90-95 μM(DMP)/min. PS and the selected TrOC were added in conical flasks at an 
initial concentration of 1-10 mM and 500 μg/L, respectively. Actual initial measured TrOC 
concentrations of bisphenol A, diclofenac, sulfamethoxazole, carbamazepine and oxybenzone 
were 510±15, 485±10, 525±20, 510±10 and 480±5 μg/L (n=12), respectively. The initial pH 
of the reaction media was not adjusted during all experiments and was approximately 7. All 
the conical flasks were incubated in an orbital shaker incubator (Model 8500, Bioline Global 
Pty Ltd. Australia) at 80 rpm and 25ºC. Triplicate samples were collected at 2, 4, 8 and 24 h 
for TrOC analysis. Samples for measuring the laccase activity, PS consumption, estrogenic 
activity and ecotoxicity were also collected at the end of each batch experiment. To verify the 
contribution of laccase and PS in TrOC degradation, ‘control’ batch tests were performed in 
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parallel by studying the performance of laccase alone, PS alone, and PS-heat inactivated 
laccase.  
6.3.3. Continuous nanofiltration-bioreactor setup and experimental protocol    
6.3.1.1. Description of experimental setup  
For elucidating the performance of accase/PS in continuous-flow mode, a lab-scale cross-flow 
nanofiltration (NF) setup coupled to a bioreactor (3 L working volume) was used (Figure 3.1). 
A detailed description of the cross-flow NF setup is available in Section 3.3.2 (Chapter 3). A 
commercially available flat-sheet NF90 membrane (Dow/Filmtec, USA) was used. It was a 
thin-film composite membrane with polyamide based active layer, and its molecular weight 
cut-off (MWCO) was 200 Da. 
6.3.1.2. Experimental protocol 
The experiment was started by compacting the membrane at an initial hydraulic pressure of 10 
bar for at least 1 h or until the stabilization of permeate flow rate. The synthetic wastewater (3 
L volume) containing the mixture of the selected TrOCs each at a concentration of 500 µg/L 
was added in the bioreactor of NF filtration setup. Laccase and PS from their respective stock 
solutions were directly added in the bioreactor to maintain an initial laccase activity of 90-95 
µM(DMP)/min, and PS concentration of 5 mM. The NFBR system was then operated at a 
hydraulic pressure of 8 bar and cross-flow velocity of 40 cm/s. This resulted in an initial 
permeate flux of 6.8 L/m2 h bar. The synthetic wastewater containing TrOC mixture was 
continuously fed to the bioreactor via a peristaltic pump (Masterflex, USA) for a period of 64 
h (i.e., 4 × hydraulic retention time, HRT). Triplicate samples from the bioreactor and 
membrane permeate were collected at 0, 6, 12, 24, 36, 48, 64 h for TrOCs analysis. In addition, 
samples were obtained regularly every 12 h for measuring the laccase activity and PS 
consumption in the bioreactor and membrane permeate. At the end of experiment, samples 
from feed, bioreactor and membrane permeate were collected for the evaluation of estrogenic 
activity and ecotoxicity as explained in Section 6.3.4.3. Hydraulic performance of the NF 
membrane was studied by monitoring the permeate flux. At the conclusion of the experiment, 
the membrane was cleaned with Milli-Q water for 1 h to check flux recovery. 
Laccase activity has been observed to diminish during continuous operation due to different 
physicochemical and biological inhibitors as explained previously [5, 19]. A protocol was 
developed to replenish the laccase activity by adding approximately 150 µL per litre of 
bioreactor volume every 24 h. Importantly, PS at a concentration of 5 mM was added only once 
at the start of laccase/PS assisted NFBR operation.  
6.3.4. Analytical methods    
6.3.4.1. TrOC analysis 
TrOC in samples collected from batch and continuous-flow bioreactors was quantified by 
High-performance liquid chromatography (HPLC) (Shimadzu, Kyoto, Japan) using a method 
reported previously [5]. A detail description of this method is available in Section 3.3.4.1 
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(Chapter 3). Removal efficiency by laccase/PS (Rdegradation) and the membrane 
(Rdegradation+membrane retention) was measured using equation (3) and (4), respectively:  
Rbiodegradation = 100 × (1 – CBR/Cf) (3) 
R(degradation+membrane retention) = 100 × (1 – Cp/Cf) (4) 
where, Cf, CBR and Cp are the concentration (µg/L) of a specific TrOC in the feed, bioreactor 
and membrane permeate, respectively. The mass of TrOCs degraded by laccase/PS during 
continuous-flow NF-BR operation was calculated as follows:  
Cf × Vf = (CBR × VBR) + (Cp × Vp) + degradation/transformation (5) 
where, Vf, VBR and Vp represents the volume of feed, bioreactor and permeate, respectively. 
6.3.4.2. Laccase activity essay and PS concentration measurement 
Laccase activity was measured as described in Section 3.3.4.2 (Chapter 3). PS concentration 
may change following its addition in both batch and continuous-flow bioreactors. The change 
in PS concentration was measured during each experiment by using a previously developed 
spectrophotometric method [19, 27].  
6.3.4.3. Estrogenic activity and ecotoxicity  
Duplicate samples (110 mL each) collected from the batch bioreactors and triplicate samples 
(110 mL each) collected each from the continuous-flow bioreactor and membrane permeate 
were extracted using Oasis HLB cartridges and eluted in 5 mL methanol. This resulted in a 
relative concentration factor of 22 for each sample. Estrogenic activity was analysed by 
ERα-GeneBLAzer assay (Life Technologies, USA) as described previously [28, 29]. This is 
an estrogen receptor-mediated reporter gene assay that measures the presence of either 
estrogens or estrogen mimicking compounds. This assay was carried out in 384-well plate and 
run in both antagonist and agonist modes. A Fluostar plate reader (BMG Labtech, Germany) 
was used for measuring the fluorescence at wavelengths of 460 and 520 nm after excitation at 
410 nm. The data from the plate reader was presented as the ratio of fluorescence obtained at 
460 nm to that obtained at 520 nm. The results were compared with the concentration-effect 
curve of reference standards and expressed as 17β-estadiol (agonist) and 4-hydroxytamoxifen 
(antagonist) equivalent concentration. The limits of detection for agonistic activity were 0.35 
and 1.4 ng/L for 17β-estradiol (E2-EQ) in batch and continuous flow-experiments, 
respectively. The detection limit for anti-estrogenicity was 20 µg/L for 4-hydroxytamoxifen 
(4-OHTMX-EQ) in all experiments. The method for ecotoxicity assay has already been 





6.4. Results and discussion 
6.4.1. TrOC removal in batch experiments 
6.4.1.1. Preliminary performance of integrated laccase/PS system  
Laccase is particularly suitable for the degradation of phenolic compounds but can also catalyse 
the degradation of non-phenolic compounds. The extent of degradation for non-phenolics is 
dependent on the relative ORP of laccase and target compound [30, 31]. In this experiment, the 
non-phenolic TrOCs were poorly degraded (less than 15%) by laccase (Figure 6.1). At the end 
of the incubation period of 24 h, laccase achieved 7, 9 and 15% degradation of 
sulfamethoxazole, carbamazepine and diclofenac, respectively. This recalcitrance of non-
phenolic TrOCs could be attributed to their chemical structure. All the tested non-phenolic 
TrOCs contain strong EWGs. For example, carbamazepine and sulfamethoxazole contain 
amide (–NH2) functional group, and diclofenac contains both halogen (–X) and carboxylic (–
CH3) functional groups in its molecule (see Table 6.1). These EWGs make TrOCs resistant to 
laccase because they can release electrons to stabilise the electron deficiency caused by the 
degradation process [3, 32]. Indeed, poor or unstable removal of non-phenolics during laccase-
catalysed degradation is also evident from available literature with reported removal often 
ranging between 10 and 25% [3, 11, 33].  
Although phenols have been recognised as a typical substrate of laccase [7, 32], their effective 
removal by laccase is not always possible. Out of five tested TrOCs, two compounds 
(oxybenzone and bisphenol A) contain phenolic moiety in their chemical structures, and their 
degradation by laccase is TrOC-specific. Laccase achieved 57% and complete degradation for 
bisphenol A and oxybenzone, respectively (Figure 6.1). Almost complete degradation of 
bisphenol A by laccase in batch enzymatic bioreactors treating the mixture of bisphenol A and 
diclofenac was reported previously [15]. However, in this experiment, moderate degradation 
of bisphenol A could be due to the competitiveness among phenolic TrOCs for transferring an 






































































Figure 6.1. Degradation of the selected TrOCs by laccase and laccase/PS in batch tests after 
an incubation time of 24 h. PS (potassium persulfate) was added at 5 mM concentration, while 
the initial laccase activity was 90-95 µM(DMP)/min. Results presented as average ± standard-
deviation (n=3). Note: performance of PS alone at 1 mM concentration was assessed in parallel, 
and no TrOC removal observed. 
All TrOCs (except for oxybenzone) were not effectively degraded, thus indicating the need of 
improvement via supplementing the laccase-catalysed degradation process with an oxidizing 
agent capable of TrOC degradation. In the current experiment, performance of the laccase-
catalysed degradation process was assessed by adding 5 mM PS in batch enzymatic bioreactor 
for an incubation period of 24 h. This significantly improved (15-46%) the extent of TrOC 
degradation, indicating the complementarity of combining laccase and PS oxidation process. 
Compared to less than 20% degradation of non-phenolics by laccase, PS achieved 24, 36 and 
53% degradation of carbamazepine, diclofenac, and sulfamethoxazole, respectively (Figure 
6.1). On the other hand, PS addition provided 43% improvement in the degradation of a 
phenolic plasticizer bisphenol A that was moderately degraded (57%) by laccase. Notably, 
following treatment with and without PS addition, oxybenzone concentration was below the 
limit of detection (i.e., 10 µg/L). Performance of an integrated laccase/PS assisted oxidation 
process for TrOC removal is reported for the first time in this chapter. 
It is important to note that an additional agent such as transition metals, heat or UV light is 
required to activate PS for the generation of SO4
– • and/or OH– • radicals [20]. Despite the 
absence of any known activators in reaction media, enhanced TrOC degradation by laccase/PS 
process indicated that PS was activated and produced radicals in the batch laccase/PS system. 
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For understanding the possible routes of PS activation, mechanism of laccase-catalysed 
degradation process needs to be revisited. Oxidation of a substrate by laccase occurs following 
the transfer of an electron from the substrate to the Type I active site of laccase. This is followed 
by the transfer of electrons to Type II and III active sites, where reduction of the cofactor 
oxygen to water molecules occurs. During the reduction of O2, formation of peroxide 
intermediates has been observed [6]. The production of peroxide intermediates can activate PS 
to produce reactive radicals [34]. To produce SO4
– • radicals, PS needs an electron from any 
source [6]. Hence, there is a possibility that both oxygen and PS may have acted as the cofactor 
and may accept electron from Type II and III active sites of laccase for completing the catalytic 
cycle. In the current study, the possibility of PS acting as a final electron acceptor was 
investigated by removing the dissolved oxygen from reaction media via autoclaving (Figure 
6.2). Dissolved oxygen in the reaction media measured using a DO meter (YSI, USA) was less 
than 0.01 mg/L. In absence of oxygen, TrOC degradation occurred in laccase/PS system but 
the extent of degradation of all the tested TrOCs (except for oxybenzone) reduced by 5 to 20% 
as compared to that achieved by laccase/PS system in presence of oxygen. Notably, although 
TrOC degradation was affected in absence of oxygen, PS activation still happened as evident 
from the better TrOC degradation by laccase/PS system without oxygen as compared to laccase 
alone (Figure 6.2). An additional batch run was performed by adding heat-inactivated laccase 
and PS in the bioreactor for a period of 24 h. Like the performance of laccase/PS system, 
degradation of TrOCs reduced significantly (5-40%) in the heat-inactivated laccase /PS system 
(Figure 6.2). These results indicate that PS activation is possibly caused by the structural 
components (e.g., a polypeptide chain and carbohydrate moieties) of laccase [35]. This has not 
been reported in literature, to date. Notably, TrOC degradation was affected more in heat-
inactivated laccase/PS system as compared to that achieved by laccase/PS system in absence 
of oxygen, thus indicating the significance of active laccase in an integrated laccase/PS 
treatment system. Based on the above observations, PS activation may have caused by both the 
structural components of laccase as well as the possibility of PS acting as a final acceptor of 
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Figure 6.2. Degradation of the selected TrOCs by laccase and laccase/PS in batch tests for 
understanding the PS activation pathways. PS (potassium persulfate) was added at 5 mM 
concentration, while the initial laccase activity was 90-95 µM(DMP)/min. Results presented as 
average ± standard-deviation (n=3).  
6.4.1.2. Effect of PS concentration    
The effects of combining laccase and PS are comprehensively demonstrated in the preceding 
section. For optimization, performance of PS in laccase/PS system was analysed at different 
PS concentrations of 1-10 mM. In this experiment, degradation of the tested TrOC, except for 
oxybenzone that was completely degraded at all the tested concentration of PS, improved by 
increasing the PS concentration from 1 to 10 mM, although the extent of improvement was 
compound-specific. For instance, degradation of sulfamethoxazole was 23, 36, 53 and 72% at 
an initial PS concentration of 1, 2, 5 and 10 mM (Figure 6.3). Similarly, carbamazepine 
degradation increased from 11% (at 1 mM PS) to 40% (at 10 mM PS). Since performance of 
laccase/PS system was studied for the first time, it is not possible to compare the results of this 
chapter with literature. However, the trend in the improvement of TrOCs with increasing PS 
concentration seems to be consistent with available literature. According to the available 
literature, TrOC degradation generally improves with the increase in PS concentration. For 
instance, Ji et al. [26] reported an improvement of approximately 80% in the degradation of 
the pesticide atrazine by heat-activated PS after the increase in concentration from 0.1 to 2 mM. 
In another study, degradation of sulfamethoxazole increased from merely 10 to 70% following 
the increase in the concentration of bicarbonate-activated PS from 1 to 10 mM [36].  
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The best PS concentration for achieving the highest degradation was different for the tested 
TrOCs. It was 1 mM for oxybenzone and 5 mM for bisphenol A, while 10 mM was the most 
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Figure 6.3. Effect of PS concentrations on TrOC degradation in batch laccase/PS system. PS 
concentration ranged from 1-10 mM, while the initial laccase activity was 90-95 
µM(DMP)/min. Results presented as average ± standard-deviation (n=3).  
Laccase inactivation can be a concern during TrOC degradation, requiring intermittent 
replenishment of laccase. Different physicochemical (e.g., salts and heavy metals) and 
biological (e.g., organic acids and humic substances) factors can cause laccase inactivation [3, 
17]. In absence of any known inhibitor, laccase activity did not reduce significantly (~2%) in 
this experiment. However, when PS was added in the enzymatic bioreactor, increase in laccase 
inactivation was observed (Figure 6.4a). At the end of the operation of batch laccase/PS 
system, laccase inactivation was 7% at 1 mM PS concentration, which increased to 16, 18, and 
43% following addition of PS at 2, 5 and 10 mM, respectively (Figure 6.4a). Laccase 
inactivation could also be due to the radicals produced by PS that can interact with the active 
sites of laccase, thereby affecting laccase activity. Previously, redox-mediators were added in 
enzymatic bioreactor for improving the degradation of TrOCs. Despite the TrOC-specific 
improvement in degradation, the radicals produced by redox-mediators has been reported to 
cause rapid laccase inactivation [1, 4, 37]. For instance, laccase was reported to lose 70-80% 
of its initial activity following the addition of violuric acid and 1-hydrozybenzotriazole 
separately at 1 mM concentration. Notably, laccase inactivation caused by PS radicals is 
significantly lower than that reported in presence of redox-mediators.  
194 
 
In addition to laccase inactivation, depletion of PS may occur due to the scavenging reactions 
in which radicals react with other radicals or nontarget compounds. These scavenging reactions 
deplete PS by converting sulphate radicals into sulphate ions [38, 39]. In this experiment, PS 
depletion was insignificant (less than 2%) at a PS concentration of 1-5 mM but increased 
considerably (36%) in presence of 10 mM PS in laccase/PS system after 24 h of batch 
experiment (Figure 6.4b). Thus, it important to consider the concentration of PS for developing 




































































































































Figure 6.4. Laccase inactivation (a) and depletion of PS (b) at the end of batch tests with and 
without the addition PS at different concentrations. Error bars represents the standard deviation 
between duplicate samples. 
6.4.1.3. Effect of incubation time    
Degradation efficiency of the integrated laccase/PS system was assessed at different incubation 
periods (i.e., 2, 4 8 and 24 h). To facilitate the discussion, performance of the integrated systems 
at 2- and 5-mM PS concentration is presented in Figure 6.5. Laccase/PS system achieved rapid 
degradation of both phenolic TrOCs. Complete elimination of oxybenzone was observed after 
an incubation time of 2 h (at 5 mM PS concentration) and 4 h (at 2 mM Ps concentration). On 
the other hand, 5 mM PS achieved 100% degradation of bisphenol A after 8 h in laccase/PS 
system (Figure 6.5). Regardless of PS concentration, the maximum degradation for non-
phenolics was observed within first 8 h of incubation period, and the degradation slowed down 
considerably from 8 to 24 h. These results are consistent with the available literature related to 
the performance of PS for the degradation of an individual TrOC. For instance, when heat-
activated PS at 0.5 mM concentration was investigated for the degradation of an antibiotic 
(penicillin G), its maximum degradation occurred within first 60 min [40]. Similarly, 
degradation of sulfamethoxazole by PS was not observed to increase significantly after an 
incubation period of 6 h in a PS/bicarbonate system [36]. The observations related to the 
incubation time are vital for designing a wastewater treatment system. This is because 
incubation time is an important parameter to estimate the size of the reactor required for 
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Figure 6.5. Effect of incubation time on TrOC degradation in batch laccase/PS system 
assessed separately at 2- and 5-mM PS concentration. Initial laccase activity was 90-95 
µM(DMP)/min. Results presented as average ± standard-deviation (n=3).  
6.4.1.4. Ecotoxicity and Estrogenic evaluation  
Toxicity cannot be estimated by quantifying the actual amount of TrOC in the treated effluent 
before disposal, because the degradation of TrOCs results in the production of transformation 
by-products or metabolites that could cause more toxicity than the parent compound. To predict 
the risk associated with the disposal of treated effluent, bioassays have been developed and 
reported for quantifying the toxicity [17, 41]. In this experiment, toxicity of the treated effluent 
was evaluated by measuring the inhibition of luminescence in the naturally bioluminescent 
bacteria (Photobacterium leiognathi) using the BLT-Screen [42]. Consistent with previous 
studies [13, 41], toxicity following treatment with laccase alone did not increase significantly 
and ranged between less than 1 and 2.3 rTU (Table 6.2). On the other hand, toxicity of reaction 
media increased from 7.6 to 28.8 rTU in batch laccase/PS systems with the increase in PS 
concentration (Table 6.2). This could be attributed to: the reactive radicals generated by PS; 
and/or the generation of toxic transformation by-products. Reduction in toxicity following 
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treatment of a single TrOC by PS has been reported previously [43, 44]. However, toxicity of 
the media following degradation of one TrOC is not comparable to that obtained from the 
media containing a mixture of five TrOCs. Indeed, Kortenkamp et al. [45] observed that the 
toxic effects of the solution containing a mixture of compounds are often higher than the toxic 
effects of individual compound.  
Table 6.2. Estrogenic activity and ecotoxicity of samples collected at the end of different 
treatment options. Number of samples, n = 2. 
Reaction media of different treatment 
options 
Toxicity (rTU) E2-EQ (ng/L) 
4-OHTMX-EQ 
(µg/L) 
TrOCs only <1 9.7 – 13.9 <20 
TrOCs – Laccase <1 – 2.3 < 1.4 <20 
Laccase – TrOCs – Persulfate (1 mM) 7.6 – 11.3 2.3 – 2.6 <20 
Laccase – TrOCs – Persulfate (2 mM) 3.9 – 5.6 1.8 – 2.6 <20 
Laccase – TrOCs – Persulfate (5 mM) 10.3 – 11.2 3.3 – 3.9  <20 
Laccase – TrOCs – Persulfate (10 mM) 24.8 – 28.8 2 – 2.2 <20 
Note: The limit of detection of the toxicity assay was 1 rTU 
The limit of detection for E2-EQ and 4-OHTMX-EQ was 1.4 ng/L and 20 (µg/L), respectively.  
E2-EQ stands for 17β-estradiol equivalent; and 4-OHTMX-EQ stands for 4-hydroxytamoxifen equivalent. 
Estrogenic activity was analysed because the prolonged exposure to TrOCs, particularly 
bisphenol A has been reported to induce endocrine disrupting effects in aquatic life and human 
[41, 46]. In this experiment, the estrogenic activity before and after treatment was evaluated by 
using GeneBLAzer ERα-UAS-bla GripTiteTM cells, and the results are expressed as 17β-
estradiol equivalent (E2-EQ) and 4-hydroxytamoxifen equivalent (4-OHTMX-EQ). E2-EQ 
estrogenic activity of the influent ranged between 9.7 and 13.9 ng/L (n=2) but was observed to 
reduce after the treatments with laccase alone and laccase/PS system (Table 6.2). Importantly, 
laccase-catalysed degradation achieved complete elimination of E2-EQ estrogenic activity 
(i.e., below the detection limit of 1.4 ng/L). Despite the increase in toxicity, reduction in E2-
EQ estrogenic activity in laccase/PS system (Table 6.2) demonstrate that the resultant 
transformation by-products either are not capable of exhibiting estrogenicity or have lower 
estrogenic activity than the parent compound. Regardless of the treatment option, the 4-
OHTMX-EQ (i.e., antiestrogenic activity) of the influent and the treated effluent was below 
the limit of detection (i.e., less than 20 µg/L) as indicated in Table 6.2. Although laccase [41, 
47] or PS [48, 49] treatments have been reported to significantly reduce estrogenic activity 
caused by TrOCs, the combination of both laccase and PS is also effective in reducing 
estrogenic activity. 
6.4.2. Continuous TrOC removal by laccase/PS-NFBR treatment system 
 The laccase/PS-NFBR system was operated continuously for a period of 64 h (i.e., 4 ×HRT) 
at the TrOC loading rate of 0.72 mg/L.d, and laccase activity of 90-95 µM(DMP)/min. PS 
concentration of 5 mM was selected based on the performance of batch laccase/PS system, and 
was added only once at the start of the experiment. Main reason for coupling a membrane with 
an enzymatic bioreactor was to effectively retain laccase, thereby preventing laccase washout 
with treated effluent [14, 15]. To confirm this, permeate samples were collected after regular 
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intervals for monitoring the residual laccase activity as well as PS concentration. In this 
experiment, the NF membrane effectively retained laccase, and PS was also not detected in 
membrane permeate (data not shown). PS concentration may deplete over time due to the 
interaction of secondary radicals with sulphate radicals as explained in the Section 6.4.1.2, 
requiring intermittent addition of PS. Samples were collected after every 12 h for monitoring 
PS concentration in the laccase/PS bioreactor. A gradual reduction in PS concentration was 
observed during the operation of the laccase/PS-NFBR system. PS was not completely depleted 
by the end of continuous experiment (i.e., after 64 h), and total reduction in PS concentration 
was approximately 55%. In the following section, degradation and overall removal of TrOCs 
in laccase/PS-NFBR is discussed separately for elucidating the performance of the developed 
treatment system.   
6.4.2.1. TrOC degradation 
In the continuous-flow laccase/PS-NFBR treatment system, mechanisms of TrOC removal 
include degradation by laccase/PS and membrane retention (discussed in Section 6.4.2.2). 
TrOC degradation by the laccase/PS during continuous treatment ranged between 56 and 100% 
(Figure 6.6a) with >99% degradation achieved for one non-phenolic (diclofenac) and two 
phenolic TrOCs (bisphenol A and oxybenzone). Although the comparison of data obtained 
from batch and continuous experiments may not be appropriate, better degradation of TrOC 
was observed in the laccase/PS-NFBR system as compared to that achieved in the batch 
laccase/PS system (Figure 6.1). Difference in the degradation of TrOCs in batch enzymatic 
bioreactor and continuous-flow EMBR was also reported by Nguyen et al. [13]. They reported 
that the degradation of a few TrOCs such as oxybenzone and diclofenac improved significantly 
by 10 to 60% in a continuous-flow EMBR as compared to the batch enzymatic bioreactor [13]. 
Indeed, in the current experiment, degradation of carbamazepine, sulfamethoxazole, and 
diclofenac by the laccase/PS-NFBR system was 52, 60 and 100%, respectively (Figure 6.6b), 
while their degradation in batch tests under an identical PS concentration of 5 mM was less 
than 55% (Figure 6.1). Previously, simultaneous retention of both laccase and TrOCs has been 
reported to facilitate degradation [33, 50]. In a study by Asif et al. [5], performance of an 
enzymatic bioreactor coupled to either an NF or UF membrane was compared under identical 
operating conditions. Compared to UF-EMBR, degradation of the selected TrOCs, namely 
carbamazepine, sulfamethoxazole, diclofenac, atrazine and oxybenzone improved by 15 to30% 
in NF-EMBR, and it was attributed to the prolonged contact time between laccase and TrOCs 
following their complete retention by the NF membrane [5]. 
It is important to note that the presence of TrOCs containing a phenolic moiety can also 
facilitate the degradation of non-phenolic pollutants by acting as a redox-mediator. In natural 
environmental settings, laccase can only degrade the phenolic components of lignin. This 
results in the formation of secondary radicals (e.g., phenoxyl radical) or cross-coupling agents 
that can degrade the non-phenolic components of lignin [32]. In a recent study, the 
transformation by-products of a phenolic pharmaceutical (acetaminophen) was reported to 
directly oxidize another pharmaceutical carbamazepine [51]. It is possible that the phenolic 
TrOCs (oxybenzone and bisphenol A) that were effectively eliminated (~100%) may have 
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contributed in the degradation of non-phenolic TrOCs. This phenomenon may not be apparent 
in batch experiments probably because the abundance of oxidative cross coupling agents or 
secondary radicals was not high enough as compared to that in the continuous-flow laccase/PS-
NFBR system. Since the NF membrane can achieve effective retention of laccase, PS and 
TrOCs, the transformation by-products will also stay in the bioreactor of the continuous-flow 
laccase/PS-NFBR system to contribute in TrOC degradation via catalytic and non-catalytic 
pathways.  
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Figure 6.6. Performance of the laccase/PS-NFBR treatment system for the degradation of the 
selected TrOCs. Overall TrOC degradation (a) as well as time course of TrOC degradation (b) 
is shown here. PS (potassium persulfate) was added at 5 mM concentration, while the initial 
laccase activity was 90-95 µM(DMP)/min. The laccase/PS-NF treatment system was operated at 
a TrOC loading rate of 0.72 mg/L.d and HRT of 16 h. Results presented as average ± standard-
deviation calculated based on the triplicate samples that were collected at 24, 36, 48 and 64 h.  
The performance of the laccase/PS-NFBR system was regularly monitored over the course of 
its operation for assessing the stability of the developed process. The time course of TrOC 
degradation during continuous operation as presented in Figure 6.6(b) indicates that the 
degradation of both phenolic TrOCs (bisphenol A and oxybenzone) stabilised after an 
operating time of 12 h, while steady state of diclofenac degradation was achieved after 18 h. 
Degradation of sulfamethoxazole and carbamazepine increased up until 36 h, and remained 
almost constant during the operating time of 36-64 h. Thus, it could be concluded that the 
developed system was stable, achieving steady-state TrOC degradation.   
6.4.2.2. Overall TrOC removal 
The benefits of integrating the laccase/PS system with a high retention NF membrane can only 
be realised by assessing the overall TrOC removal (i.e., degradation + membrane retention). 
Despite the appreciable TrOC degradation, sulfamethoxazole and carbamazepine were 
resistant to laccase/PS system and were moderately degraded (52-60%). The NF membrane 
effectively retained the TrOCs not completely degraded by laccase/PS, producing a TrOC-free 
stream with >95% overall removal (Figure 6.7). The NF membrane can effectively retain a 
wide range of TrOCs via a combination of removal mechanisms. TrOC with molecular weight 
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above 200 g/mol has been reported to be effectively retained (above 90%) by size exclusion. 
On the other hand, mechanism of removal for hydrophobic (log D>3) and charged (e.g., 
diclofenac) TrOCs is adsorption on membrane surface and charge repulsion, respectively [52, 
53]. In a previous study, the NF membrane coupled to an enzymatic bioreactor achieved an 
overall removal of 92 to99% [5]. In this study, overall removal of the selected TrOCs ranged 
between 95 and 100%. Since molecular weight of all the selected TrOCs was above 200 g/mol 
(see Table 6.1), size exclusion appears to be the dominant mechanism of TrOC retention by 


























































































Figure 6.7. Overall removal (degradation + membrane retention) of TrOCs by the laccase/PS-
NFBR system. Error bars represents the standard deviation (n=12). Experimental conditions 
are presented in the caption of Figure 6.6. 
As demonstrated above in section 6.4.1.4, toxicity of the treated effluent increased after the 
batch laccase/PS treatment. In a previous study, a high retention membrane distillation process 
coupled to an enzymatic bioreactor was reported to reject TrOCs and their transformation 
products, thus producing a non-toxic permeate [50]. However, toxicity of the NF permeate has 
not been evaluated to date. To confirm this, samples were collected at the end of continuous 
operation, and their toxicity was analysed. Although the toxicity of the bioreactor media was 
96.2 ± 6.7 rTU (n=3), NF permeate samples were non-toxic (i.e., less than 1 rTU). This 
confirmed that the high retention NF membrane not only retained TrOCs but can also retain 
the transformation by-products that may exhibit toxicity.  
Estrogenic activity is another important parameter to evaluate the safety of treated effluent for 
disposal and reuse [29, 54]. The samples collected from laccase/PS bioreactor at the end of 
experiment showed an estrogenic activity of 0.6 ± 0.2 ng/L EE2-EQ, while no estrogenic 
activity was found in NF permeate (i.e., blow the detection limit of 0.35 ng/L EE2-EQ). 
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Importantly, the antiestrogenic activity expressed as 4-OHTMX-EQ in both the laccase/PS 
bioreactor and NF permeate was below the detection limit of 20 µg/L.  
6.4.3. Hydraulic performance of the laccase/PS-NFBR  
Permeate flux was monitored regularly for analysing the hydraulic performance of the NF 
membrane. By the end of the experiment, permeate flux of the NF membrane reduced by almost 
20% (Figure 6.8). The permeate flux reduced by 10% within the first 2 h of operation due to 
the adsorption of the reaction media consisting of TrOCs, laccase and PS. Similar trend was 
observed previously when an enzymatic bioreactor was integrated with the NF membrane [5, 
55]. Notably, the reduction in permeate flux can also be attributed to concentration polarization 
that is caused by the accumulation of the bioreactor media on or near the surface membrane 
[55, 56]. At the end of operation, cleaning the NF membrane with milli-Q water was effective 
to recover the flux by almost 95%. This indicates that the reduction in flux caused due to the 
adsorption of reaction media and/or concentration polarization is reversible.  
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Figure 6.8. Hydraulic performance of the NF membrane expressed as normalised flux during 
the operation of the laccase/PS-NFBR treatment system. 
6.5. Conclusion 
Performance of an integrated laccase and persulfate (PS) oxidation process in batch and 
continuous modes was systematically investigated for the degradation of five trace organic 
contaminants (TrOCs), namely diclofenac, sulfamethoxazole, carbamazepine, bisphenol A and 
oxybenzone. Degradation of the selected TrOCs by laccase alone in batch experiments ranged 
between 7 (for sulfamethoxazole) and 100% (for oxybenzone) and was governed by the 
physicochemical properties such as chemical structure. Addition of PS at different 
concentration (1-10 mM) in the batch enzymatic bioreactor achieved TrOC-specific 
improvement in degradation, exhibiting the benefits of combining both oxidation processes. 
Among the tested PS concentrations (1-10 mM), the best performance was achieved at 5 mM 
concentration that achieved 100% degradation for two phenolics (bisphenol A and 
oxybenzone) and 25-53% degradation for three non-phenolic (diclofenac, sulfamethoxazole, 
and carbamazepine) TrOCs without significantly causing laccase inactivation and PS 
depletion. However, addition of PS increased the toxicity of the treated effluent to 7.6-28.8 
rTU as compared to the toxicity of <1-2.3 rTU obtained after treatment with laccase alone. All 
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treatment options with and without PS reduced the estrogenic activity measured as 17β-
estradiol equivalent, while antiestrogenic activity (expressed as 4-hydroxytamoxifen 
equivalent) was below the detection limit of 20 µg/L. A treatment system by coupling a 
nanofiltration (NF) membrane with laccase/PS (5 mM) system was also developed, which 
allowed continuous removal of TrOCs without laccase and PS washout. The continuous 
laccase/PS-NFBR treatment system produced a high quality permeate stream due to effective 
TrOC removal (95-100%). In addition, the enhanced degradation (10-65%) of non-phenolic 
was also achieved in laccase/PS-NFBR as compared to that obtained in the batch laccase/PS 
system. On the other hand, degradation of both bisphenol A and oxybenzone remained below 
the limit of detection in the laccase/PS-NFBR system. Although the toxicity of the bioreactor 
reaction media increased, the membrane permeate was non-toxic. The evaluation of the data 
obtained from estrogenic activity assay indicated a reduction in the estrogenic activity of the 
reaction media. Because the NF membrane can reject the residual estrogenic activity, the 
membrane permeate was deemed safe for disposal and reuse. Hydraulic performance of the NF 
membrane was monitored, which showed a reduction of approximately 20% in the permeate 
flux at the end of the experiment. Cleaning the membrane with Milli-Q water helped to recover 
permeate flux by 95%. 
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Acid mine drainage (AMD) originating from different mining activities (such as coal and gold 
mining) has gained global attention in the last decade due to its adverse environmental impacts 
on soil, freshwater and aquatic ecosystem [1, 2]. AMD is generated due to the oxidation of 
sulfides ores during a wide range of mining activities. Among different types of sulfide ores, 
pyrite ore (FeS2) has been recognized as the main mineral ore for AMD generation, because its 
exposure to oxygen and water can easily oxidize the pyrite ore as shown in Equation (1-3) [1, 
3]. Composition of AMD is diverse and is commonly characterized by high concentrations of 
sulphate and iron (II) as well as other trace elements such as calcium and lithium. AMD flows 
into freshwater bodies and can promote the release of different toxic metals following its 
interaction with underground rocks [1, 4, 5]. Thus, an efficient process for the treatment of 
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𝐹𝑒3+ + 3𝐻2𝑂 →  𝐹𝑒(𝑂𝐻)3 +  3H
+ Eq. (3) 
Technologies for the treatment of AMD-impacted water can be divided into two categories, 
namely active and passive treatment processes. The conventional active treatment process 
includes the application of alkaline chemicals (e.g., lime) to precipitate metals by raising the 
pH [6]. However, this process generates toxic sludge that contains high concentrations of 
amorphous ferric oxyhydroxide, and the treated effluent requires additional treatment for 
meeting the water quality guidelines [1, 6]. Bioreactors and wetlands are the passive processes, 
which use natural processes for the treatment AMD-impacted water. For instance, during 
treatment with bioreactors, naturally occurring iron and sulfate reducing bacteria are cultured 
to convert sulfate into hydrogen sulfide, but the pH of AMD-impacted water should be above 
3 for effective metabolization of iron and sulfate ions [7]. During treatment with wetlands, 
natural attenuation processes, lime dosing, and long hydraulic retention time (HRT) allow all 
the solids including heavy metals to settle down [8]. Although conventional active and passive 
processes are effective, large area requirement; large quantities of reagents for neutralization; 
and long HRT as well as process sensitivity to changes in influent chemistry (such as pH and 
temperature) are the major drawbacks [9-11]. Hence, a compact and robust treatment process 
is required for the treatment of AMD-impacted water.  
In addition to AMD contamination, trace organic contamination (TrOCs) such as 
pharmaceuticals and pesticides have been reported to be detected in sewage-impacted 
freshwater bodies [12-14]. This raises significant concern due to their potential harmful impact 
on aquatic organisms and even humans in the case of prolonged ingestion, thus requiring a 
treatment process for effective removal of both the metals and TrOCs. Recently membrane 
distillation (MD) has gained significant attention as an effective separation process [15, 16]. 
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MD is a thermally driven membrane separation process; however, it requires a lower operating 
temperature than conventional distillation processes such as fractional distillation. During the 
MD process, water in vapor form moves via diffusion through a microporous hydrophobic 
membrane from a higher temperature feed solution to a lower temperature permeate solution. 
This occurs due to the vapor pressure gradient developed by the temperature difference 
between the sides of the membrane [17, 18]. Since the water moves across the membrane in 
vapor form, MD can theoretically provide complete removal of non-volatile pollutants [15, 19]. 
Furthermore, the compatibility of the MD process with low-grade waste heat and solar thermal 
energy [17] makes its application attractive in various fields, including water desalination and 
wastewater treatment. 
The MD process has been predominantly assessed for the desalination of sea and brackish 
water, particularly for hyper-saline feed, because, being a thermally driven process, water flux 
in MD is negligibly affected by the feed osmotic pressure as compared to the pressure-driven 
membrane desalination processes (e.g., RO and NF) [16, 20, 21]. In addition, as compared to 
RO and NF membranes, superior performance of MD for the removal of a range of pollutants 
such as pharmaceuticals and metal salts has been reported [22-25]. Despite the potential to 
date, the performance of MD for the removal of TrOCs and metals has been mostly assessed 
separately only in a few short-term batch studies. For instance, Wijekoon et al. [15] investigated 
the removal of TrOCs including pesticides and  pharmaceuticals by MD operated in batch mode 
for 24h. They observed TrOCs removal to be governed by their volatility and hydrophobicity. 
In another short-term study by Han et al. [22], MD achieved 90-95% removal of a nonsteroidal 
anti-inflammatory drug ibuprofen from synthetic wastewaters mimicking surface water or 
reverse-osmosis concentrate. Hull and Zodrow [26] investigated the removal of AMD 
constituents including iron, aluminum and zinc from synthetic by using an MD process. They 
achieved above 99% removal of AMD constituents by MD after a short-term experiment of 
12-24 h [26]. Although these studies provide useful insights, it is important to note that a 
continuous-flow operation is required to analyze and understand process stability. To date, only 
a handful of studies have assessed TrOC removal in continuous-flow mode [16, 27]. The 
authors reported 70 to 99% removal of the investigated TrOCs depending on their 
physicochemical properties. Two particular aspects highlighted in these studies were: (a) 
membrane fouling, significantly reducing permeate flux; and (b) additional requirement of 
treatment and disposal of membrane-concentrate rich in TrOCs as well as other organic and 
inorganic impurities. Notably, a continuous-flow MD process for the treatment of AMD-
impacted water is yet to be studied. 
Accumulation of organic pollutants, particularly TrOCs in MD-concentrate could be reduced 
by integrating either a laccase or a persulfate (PS) oxidation process with the MD process. This 
integration will simultaneously degrade bulk organics and TrOCs, reducing their accumulation 
in MD-concentrate and potentially mitigating membrane fouling. Efficacy of laccase-catalyzed 
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degradation process and PS-assisted oxidation processes for TrOC removal has already been 
discussed in Chapter 6.  
In this chapter, the performance of a direct-contact MD process is discussed for simultaneous 
removal of metal salts and TrOCs from sewage- and AMD-impacted water. For this purpose, 
a synthetic wastewater was prepared, which contains a mixture of 12 TrOCs at an 
environmentally relevant concentration of 5 µg/L, as well as a mixture of four metal ions (iron, 
calcium, magnesium and lithium each at 10 and 100 mg/L concentration). The performance of 
laccase and PS for the degradation of TrOCs was systematically analyzed, and the oxidation 
process showing better stability and TrOC removal was selected for integration with the MD. 
Basic water quality parameters such as total organic carbon (TOC) and total nitrogen (TN) as 
well as membrane water productivity was thoroughly evaluated to determine the fouling 
behavior. At the end of operation, MD membranes were characterized by scanning electron 
microscopy (SEM) - energy dispersion spectrometry (EDS) to gain an in-depth understanding 
of the fouling mitigation. 
7.2. Hypothesis  
▪ The direct-contact MD process can achieve effective removal of TrOCs and metal salts 
from sewage- and AMD-impacted water 
▪ Accumulation of organic and inorganic impurities (such as metal ions) in membrane-
concentrate may affect the hydraulic performance of the MD process by causing 
membrane fouling  
▪ Integration of an oxidation process with MD may achieve TOC and TrOC degradation 
as well as membrane fouling control 
7.3. Materials and methods 
7.3.1. Chemicals 
Potassium persulfate (PS) was purchased from Sigma-Aldrich (Australia). The stock solution 
(100 mM) of PS was prepared in ultrapure Milli-Q water and stored at 4ºC before use. HPLC 
grade acetonitrile, methanol, dichloromethane and formic acid were used for quantification of 
TrOCs as explained in Section 7.3.4.2. As noted in Section 7.3.3.2, analytical grade glucose, 
peptone, urea, monopotassium phosphate, magnesium sulphate, ferrous sulphate, and sodium 
acetate were used to make the synthetic wastewater for MBR. In this experiment, metal salts 
and TrOCs were added in the MBR permeate for making the synthetic wastewater. MBR 
permeate was used to mimic sewage-impacted water.  
Properties of the selected TrOCs including three pesticides and nine PPCPs are presented in 
Table 7.1, and their chemical structures are given in Appendix Table 7-1. These were selected 
based on their widespread occurrence in municipal wastewater and sewage-impacted water 
[12]. These chemicals were also purchased from Sigma-Aldrich (Australia). A combined stock 
solution of TrOCs was prepared in pure methanol and stored at −18ºC in dark. Analytical grade 
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iron sulfate, lithium chloride, magnesium chloride and calcium chloride were purchased from 
Sigma-Aldrich (Australia), and a concentrated stock solution containing the mixture of each 
metal salt was prepared in 100 mL Milli-Q ultrapure water. Laccase from genetically modified 
Aspergillus oryzae obtained from Novozymes Pty Ltd (Australia) was used in this experiment. 
Properties of laccase are presented in Section 3.3.1 (Chapter 3). 
















Acetaminophen 152 0.46 0.52 8.3 
Negative 
 
Bezafibrate 362 -0.93 3.29 - 
Diclofenac 296 1.77 4.18 11.51 
Sulfamethoxazole 253 -0.96 5.18 11.81 
Amitriptyline 277 2.28 9.18 8.18 
Neutral 
Carbamazepine 236 1.89 13.94 9.09 
Primidone 218 0.83 12.26 13.93 
Triclosan 290 5.28 7.8 6.18 
Trimethoprim 290 0.27 7.04 13.62 
Pesticide 
Atrazine 216 2.64 2.27 7.28 
Negative 
Linuron 249 3.12 12.13 8.71 
Pentachlorophenol 266 2.85 4.68 7.59 Neutral 
a molecular weight, log D (water partition coefficient) and pka (acid dissociation coefficient) were 
obtained from the SciFinder Scholar database 
b pKH = - log10 H, where H is Henry’s law constant and defined as vapour pressure×molecular 
weight/water solubility.  
“−”: not available 
7.3.2. Experimental setup 
A laboratory-scale direct contact membrane distillation (DCMD) system was used for the 
treatment of synthetic sewage- and AMD-impacted water (Figure 7.1), due to the ease of 
operation as compared to other MD configurations, e.g., air gap MD [17]. In Chapter 4 and 
5, the MD setup was operated in concentration mode, and is different from that used in this 
experiment. Hence, a brief description of the continuous-flow MD setup is provided here. The 
DCMD setup consisted of a 3 L glass reactor (hereafter referred to as MD feed tank), a 
membrane module, a glass distillate tank (5 L) and two circulation gear pumps (Micropump 
Inc., Vancouver, WA, USA). Operated via a water level controller, a peristaltic pump (Cole-
Parmer, Vernon Hills, IL, USA) supplied wastewater from a storage tank to the MD feed tank. 
The temperature of the MD feed tank, which was covered, was maintained at 40 ± 1.5ºC by 
using a heating immersion circulator (Julabo, Seelbach, Germany), while a chiller (Thermo 
Scientific, Waltham, MA, USA) was used to keep the temperature of the distillate tank at 20 ± 
0.5ºC.  
The MD membrane module was made of acrylic plastic. It was comprised of two identical 
cells, each engraved with flow channels 145 mm long, 95 mm wide and 3 mm deep as described 
previously [28]. A hydrophobic polytetrafluoroethylene (PTFE) membrane with a thickness, 
nominal pore size, and porosity of 60 μm, 0.2 μm, and 80%, respectively, was purchased from 
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Ningbo Porous Membrane Technology (Ningbo, China). The media from the MD feed tank 
and the distillate tank were passed through the opposite membrane cells at a recirculation 
flowrate of 1 L/min (corresponding to a cross flow velocity of 9 cm/s) using two rotameters. 
The partial vapor pressure gradient developed due to difference in temperature allows water to 
move across the membrane as vapor, consequently increasing the volume of water in distillate 
tank. This tank was placed on a precision balance (Mettler-Toledo, Kings Park, NSW, 
Australia). Change in the weight of distillate water was recorded in a computer via BalanceLink 
software (Mettler Toledo) to determine the MD water flux. 
 
Figure 7.1. Schematic representation of the laboratory-scale DCMD setup  
7.3.3. Experimental protocols 
7.3.3.1. MD process characterization  
The MD process was characterized by calculating the mass transfer coefficient (Km) using a 
procedure previously described by Duong et al. [18]. Briefly, the MD system was operated in 
batch mode at different feed temperatures (i.e., 40, 45 and 50 ºC) for 1 h with ultrapure Milli 
Q water. Distillate temperature was kept constant at 20 ºC, and recirculation flow rate of both 
feed and distillate was maintained at 1 L/min. The permeate flux was recorded every 5 min for 
1 h. Permeate flux of MD can be theoretically calculated using Equation 4 as given below: 
𝐽 =  𝐾𝑚  × (𝑃𝑓𝑒𝑒𝑑 − 𝑃𝑑𝑖𝑠𝑡𝑖𝑙𝑙𝑎𝑡𝑒) 
 
Eq. (4) 
where J is the permeate flux (L/m2 h) of DCMD, Km is the mass transfer coefficient (L/m
2 h 
Pa), Pfeed is the vapor pressure of water in MD feed, and Pdistillate is the vapor pressure of water 
in MD distillate. Pfeed and Pdistillate can be determined by using Equation 5 [29]: 
𝑃 =  𝑥𝑤𝑎𝑡𝑒𝑟  ×  𝛼𝑤𝑎𝑡𝑒𝑟  ×  𝑃𝑜 
 
Eq. (5) 
where xwater and αwater are the molar fraction and activity of water, respectively, and Po is the 
vapor pressure of water in MD feed and distillate. Since DCMD was characterised with 
ultrapure Milli-Q water, value of both xwater and αwater is equal to 1. Vapor pressure of water in 
MD feed and distillate can be calculated by using Antoine’s Equation [18, 29] as given below: 
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where T is the absolute temperature of the feed or distillate streams.  
7.3.3.2. Performance of a stand-alone MD process 
In the first part of this experiment, removal of both the TrOCs and metalions from four different 
compositions of synthetic wastewater was studied by operating the stand-alone MD in a 
continuous-flow mode for a period of 5 d, i.e., 6×HRT (Table 7.2). The main aim was to 
understand the interaction of different pollutants on their rejection as well to understand the 
performance governing factors.  
Table 7.2. Description of different wastewater compositions treated by the stand-alone MD 
Run ID Milli-Q water MBR permeate TrOCs Metal salts 
Control run ✓ – ✓ ✓ 
MD-WW0 – ✓ ✓ – 
MD-WW10 – ✓ ✓ ✓ 
MD-WW100 – ✓ ✓ ✓ 
Note: TrOC concentration was kept at 5 µg/L during all experiments. 
The numbers in the sub-script of the run ID indicate the concentration of each metals salt. For 
example, MD-WW0 represents the run with no metal salts, while MD-WW10 indicates that the 
concentration of each salt during this experiment was 10 mg/L. 
As mentioned above, permeate from a lab-scale MBR was collected to make a synthetic 
wastewater mimicking the properties of sewage- and AMD-impacted water. The MBR was 
operated for around one year, while it was continuously fed with synthetic wastewater 
containing 400 mg/L glucose, 100 mg/L peptone, 35 mg/L urea, 17.5 mg/L monopotassium 
phosphate, 17.5 mg/L magnesium sulphate, 10 mg/L ferrous sulphate, and 225 mg/L sodium 
acetate. The wastewater had a chemical oxygen demand (COD), total organic carbon (TOC), 
total nitrogen (TN) and PO4
3--P concentrations of 650, 175, 25, and 15 mg/L, respectively. The 
hydraulic retention time and solids retention time of the MBR was 12 h and 10 d, respectively. 
Characteristics of MBR permeate are given in Table 7.3. 
Table 7.3. Characteristics of MBR permeate used for making the different compositions of 
wastewater to be treated by MD   
Parameter Unit Value (minimum – maximum) 
pH - 6.9 – 7.2 
Conductivity  µS/cm 190 – 220 
Total organic carbon (TOC) mg/L 8.5 – 16 
Total nitrogen (TN) mg/L 6.4 – 7.9 
NH4+-N mg/L 2.4 – 2.9 
PO43--P mg/L 3.4 – 6.1 
Prior to the commencement of this experiment, the MBR-treated effluent was spiked with the 
selected pharmaceuticals and pesticides (at 5 µg/L each) as well as metal salts at either 10 or 
100 mg/L each as illustrated in Table 7.2. Duplicate samples from MD feed tank and distillate 
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tank were collected after every 3×HRT for the quantification of TrOCs and metal ions. In 
addition, samples were collected on daily basis to measure TOC and TN removal by the MD. 
At the start of each run, 1.5 L of Milli-Q was added in the distillate tank that served as the 
initial distillate. Thus, the concentrations of TOC, TN, TrOCs and metals in MD permeate were 
corrected for dilution by considering the initial working volume of the distillate tank. At the 
end of MD operation, MD membranes were collected and characterized by SEM-EDS to gain 
an in-depth understanding of the fouling constituents.  
7.3.3.3. Performance of an integrated MD process 
To choose an oxidation process to be integrated with MD, performance and stability of both 
laccase and PS was assessed in batch experiments. The batch reactors (250 mL) containing the 
wastewater prepared by adding the mixture of TrOCs and iron salt in MBR permeate were 
incubated for a period of 24 h at 20 and 40 °C in separate runs. Initial laccase activity and PS 
concentration was maintained at 95-100 µM/min and 1 mM, respectively. Samples were 
collected at the end for TrOC quantification, laccase activity and residual PS concentration. 
Based on the results achieved (see Section 7.4.3.1), PS exhibited better TrOC removal and 
stability in batch experiments as compared to laccase. Thus, PS-assisted oxidation process was 
selected for integration with MD. PS was directly added to the feed media at a concentration 
of 1 mM after every 2×HRT. Concentration of PS was selected based on a comprehensive 
literature survey [30, 31]. The spiked secondary treated wastewater was treated by PS-assisted 
MD system with (PS-MD-WW10) and without (PS-MD-WW0) the addition of metal salts in 
continuous-flow mode for a period of 5 d (i.e., 6×HRT).  
Duplicate samples from MD feed tank and distillate tank were collected after every 3×HRT for 
the determination of TrOCs and metals. In addition, samples were collected on daily basis to 
measure TOC and TN removal by PS-assisted MD with and without the addition of metal salts. 
Similar to the stand-alone MD, membranes at the end of PS-assisted MD systems were 
collected and characterized by SEM-EDS to gain an in-depth understanding of the fouling 
control achieved by PS.  
7.3.4. Analytical methods 
7.3.4.1. Analysis of basic quality parameters 
Samples from MD feed tank and distillate tank were collected on daily basis for analysis. TOC 
and TN concentrations were measured using a TOC/TN-VCSH analyser (Shimadzu, Japan). 
TOC and TN removal efficiency by the stand-alone and PS-assisted MD were calculated based 
on the method described in Section 7.3.4.2. The pH and conductivity were measured using an 
Orion 4 Star Plus portable pH/conductivity meter (Thermo Scientific, Waltham, MA, USA) 
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7.3.4.2. Analysis of TrOCs and metals 
TrOCs were analysed using a Shimadzu LC-MS system (LC-MS 2020) after solid phase 
extraction (SPE). A detailed description of this method is available elsewhere [32]. Briefly, 
TrOCs were extracted using 6 mL Oasis HLB cartridges (Waters, Milford, MA, USA). The 
HLB cartridges were first pre-conditioned with 5 mL dichloromethane and methanol solution 
(1:1 v/v), 5 mL methanol and 5 mL Milli-Q water. The pH of the samples was adjusted to 2-3 
using 2 M H2SO4, and then loaded onto the cartridges at a flow rate of 1–4 mL/min. The 
cartridges were dried for 30 min under gentle stream of nitrogen. The extracted samples were 
eluted using 7 mL methanol and 7 mL dichloromethane and were dried in a water bath at 40ºC 
for 3-4 h. The residues were redissolved in 400 µL methanol for quantification by LC-MS.  
The LC-MS system was equipped with an electrospray ionization (ESI) interface, and a 
Phenomenex Kinetex C8 chromatography column (50 × 4.6 mm) was used for the separation 
of TrOCs. Milli-Q water buffered with 0.1% (v/v) formic acid, and HPLC grade acetonitrile 
was used as the mobile phase during the analysis. Mobile phase flow rate and sample injection 
volume were 0.5 mL/min and 10 µL, respectively. Quantification of acetaminophen, 
primidone, trimethoprim, sulfamethoxazole, carbamazepine, bezafibrate, atrazine, linuron, and 
amitriptyline was performed under ESI positive ionization [M+H]+ mode, while ESI negative 
ionization [M-H]− mode was adopted for pentachlorophenol, diclofenac and triclosan [32]. 
During the analysis, detector voltage, desolvation line temperature and heating block 
temperature were kept constant at 0.9 kV, 250ºC, and 200ºC, respectively. The analysis was 
conducted in gradient elution mode as shown in Appendix Table 7-2. High purity nitrogen 
that acted as both the nebulizing and drying gas was supplied continuously at a flow rate of 1.5 
and 10 L/min, respectively. The calibration curves were prepared by analyzing the known 
concentrations of analytes that ranged between 0.1 and 20 µg/L. The correlation coefficient of 
all the calibration curves was above 0.99. 
Removal of TrOCs by PS/laccase (R1) and MD (R2) was calculated by using Equation (7) and 
(8), respectively:   
𝑅1 = 100 × (1 −
𝐶𝑆𝑢
𝐶𝑓
) Eq. (7) 
𝑅2 = 100 × (1 −
𝐶𝑝
𝐶𝑓
) Eq. (8) 
where, Cf, Csu and Cp are the concentration (ng/L) of a specific pollutant in MD storage tank 
(Figure 7.1), MD feed and MD permeate, respectively.  
The mass of a TrOCs degraded by PS during PS-assisted MD operation was calculated as 
follows:  
Cf × Vf  = (Csu × Vsu) + (Cp × Vp) + Mass degraded by PS Eq. (9) 
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where, Vf, Vsu and Vp represents the volume of wastewater, MD feed and permeate, 
respectively. 
Concentrations of iron (II), calcium, magnesium and lithium were determined by inductively 
coupled plasma-optical emission spectroscopy (ICP-OES, 7500CS, Agilent Technologies, 
USA). A sample dilution was prepared out with 5% nitric acid. The linear regression 
coefficients for all calibration curves were higher than 0.99 for both elements. Prior to each 
batch of analyses, the ICP-OES was tuned by a using multi-element tuning solution.  
7.3.4.3. Membrane characterization and toxicity of MD permeate 
At the end of DCMD operation with and without PS dosing, MD membranes were collected 
and air-dried in a desiccator. MD membranes were then coated with an ultra-thin gold layer 
with a sputter coater (SPI Module, West Chester, PA, USA), and were characterized with a 
scanning electron microscopy (SEM) coupled with energy dispersion spectrometry (EDS) 
(JCM-600, JEOL, Tokyo, Japan). The method for toxicity assay has already been described in 
Section 5.3.4.3 (Chapter 5). 
7.3.4.4. PS concentration and laccase activity  
The change in PS concentration following its addition to the reaction media was monitored 
during batch experiments as well as during the operation of PS-assisted MD by using a 
previously developed spectrophotometric method [33]. Briefly, two solutions were prepared 
before measuring PS concentration. Solution-1 was the PS stock solution (100 mM). Solution-
2 was prepared by dissolving 0.2 g NaHCO3 and 4 g KI in 40 mL Milli-Q water, mixed well 
and allowed to equilibrate for 15 min. Portions of Solution-1 (i.e., 0.1, 0.2, 0.4, 2 and 4 mL) 
were separately added to Solution-2 to achieve final PS concentration of 0.25, 0.5, 1, 5 and 10 
mM. The standard solutions were incubated on a rotary shaker at 80 rpm for 2 h. Absorbance 
of the standard solutions was measured at a wavelength of 352 nm in 1 cm quartz cuvettes 
using a UV-visible spectrophotometer (DR6000, Hach, Loveland, CO, USA). The coefficient 
of determination (R2) obtained by drawing the calibration curve was >0.98. For determining 
the concentration of PS during the operation of PS-assisted DCMD, 20 mL sample collected 
from MD feed was added to 40 mL Solution-2, and the resulting solution was incubated for 2 
h before measuring its absorbance at 352 nm using a UV-visible spectrophotometer as 
described above. The concentration of the PS was corrected by multiplying it with the dilution 
factor of 3. Laccase activity was measured as described in Section 3.3.4.2 (Chapter 3).  
7.4. Results and discussions 
7.4.1. Mass transfer coefficient (Km) of MD 
The mass transfer coefficient (Km) of the MD system in the current experiment was determined 
experimentally using ultrapure Milli-Q water as feed following Equations 4−6. Mass transfer 
(denoted by Km value) during MD operation can be affected by concentration and temperature 
polarization. Since concentration of salts in Milli-Q water is negligible, the effect of 
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concentration polarization on Km could be ignored. Temperature polarization effect has been 
incorporated in Equations 4−6 for the determination of Km. The significance of temperature 
polarization effect can be assessed by comparing Km values at different feed temperatures [17, 
18]. Despite the increase in permeate flux (Figure 7.2a), Km reduced with the increase of MD 
feed temperature from 40 to 50ºC (Figure 7.2). This indicates that temperature polarization 
effects become severe at high feed temperature, which is consistent with the available literature 
[18, 34, 35]. Therefore, we operated the DCMD system at a feed temperature of 40ºC, resulting 
a Km value 2.7 L/m
2.h.Pa. 





















(b) Mass transfer coefficient of DCMD
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Figure 7.2. Permeate flux (a) and mass transfer coefficient (b) of the MD system determined 
experimentally with Milli-Q water as feed at a temperature of 40, 45 and 50 ºC. Temperature 
of the distillate reservoir was kept at 20 ºC, while the cross-flow velocity was maintained at 1 
L/min.  
7.4.2. Performance of a stand-alone MD system 
7.4.2.1. Removal of TrOCs  
Overall removal of the selected TrOCs by the standalone MD system in absence of metal salts 
is presented in Figure 7.3. In a stand-alone MD process, membrane retention is the only 
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mechanism of TrOC removal. Because water moves across an MD membrane in vapor form, 
the extent of TrOC removal by the membrane is influenced by the water partition coefficient 
(log D) and vapor pressure of the target pollutant [25]. Noting that pKH = -log10 H (where, H 
is the Henry’s Law constant and is equal to vapor pressure × MW/water solubility), in general, 
TrOCs with a low ‘pKH / log D’ ratio (e.g., less than 2.5) are partially removed by the MD 
membrane in a stand-alone MD system [15, 28]. In the current experiment, TrOC removal from 
two different compositions of wastewater (control and MD-WW0) by MD was initially 
assessed. The stand-alone MD achieved TrOC-specific removal that ranged between 86 and 
100% (Figure 7.3). During the control run, out of the 12 selected TrOCs, removal of six 
including four PPCPs (amitriptyline, acetaminophen, trimethoprim and triclosan) and two 
pesticides (pentachlorophenol and linuron) was between 90 and 98%, while removal of four 
PPCPs (primidone, bezafibrate, carbamazepine and sulfamethoxazole) was greater than 98% 
(Figure 7.3). For the remaining two TrOCs, removal of the pesticide atrazine and the 


























































































































































Figure 7.3. Performance of the stand-alone MD for the removal of the selected TrOCs arranged 
based on pKH /log. Two different compositions of the synthetic wastewater were prepared to 
assess the performance of the stand-alone MD. For the control run, synthetic wastewater was 
prepared by adding a mixture of TrOCs in ultrapure Milli-Q water. For the MD-WW0 run, 
synthetic wastewater was prepared by dosing MBR permeate with TrOC mixture. Operating 
conditions: the initial TrOC concentration was 5 µg/L; temperature of the MD feed and the 
distillate (permeate) tank was kept at 40 and 20 ºC, repectivley; and cross-flow rate was 1 
L/min (corresponding to cross-flow velocity of 9 cm/s). Mean removal efficiency and standard 
deviation (n=4 for control run, and n=10 for MD-WW0 run) are presented.  
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During the MD-WW0 run for the treatment of wastewater prepared by dosing MBR permeate 
with TrOC mixture, six including four PPCPs (carbamazepine, trimethoprim, bezafibrate, 
primidone and acetaminophen) and three pesticide (pentachlorophenol) exhibited removal 
greater than 98% (Figure 7.3). For the remaining TrOCs, MD achieved a removal of 86% for 
atrazine, 91% for triclosan, 92% for amitriptyline, 94% for diclofenac, 95% for 
sulfamethoxazole, and 96% for linuron (Figure 7.3). Previously, Song et al. [27] investigated 
the performance of a stand-alone MD system for the treatment of anaerobic-MBR permeate 
containing a mixture of TrOCs. Consistent with the results of the current experiment, they also 
reported good but incomplete removal (80-95%) of a few TrOCs such as atrazine, diclofenac, 
sulfamethoxazole, linuron and triclosan [27]. Due to the adsorption of a few TrOCs onto the 
residual organics present in MBR permeate, TrOC removal from MBR permeate could be 
better than that achieved from milli-Q water [15]. Indeed, comparison of the results indicates 
that removal of two TrOCs (diclofenac and sulfamethoxazole) by the stand-alone MD was 
significantly better (up to 10%) during the MD-WW0 run as compared to that during control 
run (Figure 7.3). 
When the salts of iron, calcium, magnesium and lithium were added at either 10 or 100 mg/L 
in the MBR-permeate, no apparent change in the extent of TrOC removal by the stand-alone 
MD system was observed. TrOC removal ranged from 84 to 100% at a salt concentration of 10 
mg/L each, and 82 to 100% at a salt concentration of 100 mg/L each (Figure 7.4). Comparison 
of the results obtained from this experiment could not be compared with the available literature 
due to unviability of the studies on removal of TrOCs in presence of metal salts. These results 
































































































































































Figure 7.4. Performance of the stand-alone MD for the removal of the selected TrOCs arranged 
based on pKH /log in presence of metal salts at 10 (MD-WW10) and 100 mg/L (MD-WW100). 
Mean removal efficiency and standard deviation (n=4) are presented. Operating conditions are 
presented in the caption of Figure 7.3. 
7.4.2.2. Removal of TOC, TN and metal ions 
Overall removal of bulk organics was monitored via TOC and TN concentration in the MD 
permeate (distillate) for different wastewater compositions (Table 7.4). TN and TOC removal 
by the stand-alone MD was consistently above 95% and 98%, respectively, as shown in Table 
7.4, thus ensuring high quality treated effluent. However, effective retention of TOC and TN 
during continuous feeding also means their accumulation in MD feed tank (i.e,, MD reactor), 
which may cause severe membrane fouling [27]. This aspect is more comprehensively 
discussed in Section 7.4.4. 
Table 7.4. Removal of different pollutants during the treatment of wastewater by the stand-
alone MD system 
Parameters Removal efficiency (%) 
 Control MD-WW0 MD-WW10 MD-WW100 
TOC – 99 98 99 
TN – 96 98 98 
Conductivity  99 99 99 99 
Iron (II) 100 – 99 99 
Magnesium  99 – 99 100 
Calcium  99 – 100 99 
Lithium  99 – 100 100 
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n=5 for TOC and TN, and n=4 for metal ions. Standard deviation during all analysis was below 
5%. ‘–‘ indicates that metal ions were not added during that run. TrOC concentration was kept at 
5 µg/L during all experiments. 
The numbers in the sub-script of the run ID indicate the concentration of each metals salt. For 
example, MD-WW0 represents the run with no metal salts, while MD-WW10 indicates that the 
concentration of each salt during this experiment was 10 mg/L.  
 
Composition of AMD-impacted water is diverse and is commonly characterized by high 
concentrations of iron (II) as well as other trace elements such as calcium and lithium [1, 4, 5]. 
The MD performance was assessed for the removal of metal ions at different concentration to 
check process stability. According to the results presented in Table 7.4, removal of all metal 
ions was greater than 99% during all experiments. Since the water moves across the membrane 
in vapor form, MD can provide effective removal of non-volatile metal ions [15, 19]. However, 
high concentrations of metal ions can cause severe scaling, affecting membrane permeability 
[36] as discussed in Section 7.4.4. 
7.4.3. Performance of an integrated MD system 
7.4.3.1. Degradation of TrOCs in batch tests 
To choose an oxidation process to be integrated with MD, performance and stability of both 
laccase and PS was assessed in batch experiments. The batch reactors (250 mL) containing the 
wastewater prepared by adding the mixture of TrOCs and iron salt in MBR permeate were 
incubated for a period of 24 h at 20 and 40 °C in separate runs. Oxidation of TrOCs by laccase 
is principally controlled by two factors: (i) the nature of functional groups attached to the core 
part of the molecule; and (ii) relative redox potential of laccase and TrOCs. Laccase can 
efficiently degrade phenolic compound, but the oxidation of non-phenolic compounds may be 
restricted by kinetic limitations [37, 38]. In this experiment, all the tested TrOCs except 
triclosan, pentachlorophenol and acetaminophen were non-phenolic, and their degradation by 
laccase ranged from 6 to 75% at 20°C, and 6 to 90% at 40°C (Figure 7.5). Out the 12 tested 
TrOCs, degradation of one non-phenolic compound (bezafibrate) and two phenolic TrOCs 
(triclosan, and acetaminophen) was above 75% and 90%, respectively. When the temperature 
of the bioreactor was increased from 20 to 40°C to assess laccase performance at the operating 
temperature of MD feed, degradation of three trimethoprim, diclofenac, triclosan, 
pentachlorophenol and acetaminophen improved significantly by 10-25%. This is because the 
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Figure 7.5. Performance of laccase and persulfate (PS) for degradation of the selected TrOCs 
in batch experiments. The performance of both laccase (95-100 µM/min) and PS (1 mM) was 
assessed for an incubation period of 24 h in presence of iron salt (10 mg/L) at 20 and 40 °C. 
Mean removal efficiency and standard deviation (n=2) are presented. 
PS is stable at room temperature, but can be activated by various agents such as transition 
metals (e.g., iron), heat, and ultraviolet (UV) light to form one or more sulphate radicals (SO4
– 
•), which are highly reactive [30]. PS activation by heat and UV light produce two SO4
– • 
radicals (Equation 10), while only one SO4
– • radical is generated following activation by 
transition metals such as Fe2+ (Equation 11). This indicates that activation by heat or UV light 
may provide more efficient treatment compared to activation by a transition metal [30, 40].  
𝑆2𝑂8 
2− + ℎ𝑒𝑎𝑡 𝑜𝑟 𝑈𝑉 𝑙𝑖𝑔ℎ𝑡 →  2 𝑆𝑂4 








In this experiment, ability of PS for TrOC degradation studied at 20 and 40°C to show that both 
heat and iron (II) can activate PS. Previously, a combined peroxymonosulfate (50 µM) – Fe2+ 
(50 µM) process achieved above 99% degradation of atrazine, outperforming atrazine removal 
by coagulation [41]. Heat-activated PS has been also reported to achieve 40-100% removal of 
a few investigated TrOCs such as atrazine, aniline, monochlorobenzene and 
2,4-dichlorophenol [30]. In the current experiment, degradation of 10-85% was achieved by 
Fe-activated PS at 20°C (Figure 7.5), and the degradation of nine out of 12 TrOCs was less 
than 50%. This indicates that iron can cause activation because PS is stable at room temperature 
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of 20°C [30]. Notably, at 40°C, the spectrum of significantly degraded TrOC broadened as the 
degradation of 10 out of the 12 tested TrOCs was above 60% (Figure 7.5). Compared to 
laccase, performance of activated-PS was superior for eight TrOCs, while the degradation of 
three TrOCs (acetaminophen, diclofenac and bezafibrate) by both laccase and activated-PS was 
comparable. Notably, degradation of a phenolic PPCP triclosan by laccase was almost 20-30% 
higher than activated-PS (Figure 7.5).  
Increasing the temperature from 20 to 40°C caused laccase inhibition. The initial laccase 
activity reduced by less than 5% at 20°C, while a reduction of 45% in laccase activity was 
observed at 40°C. On the other hand, depletion of PS was 2% at 20°C and 12% at 40°C. Thus, 
PS-assisted oxidation process was selected for integration with MD.  
7.4.3.2. Degradation of TrOCs by PS-assisted MD system 
In a stand-alone MD, TrOCs accumulate within the feed following their retention by the MD 
membrane. Over time, this may affect TrOC retention. This also requires additional intensive 
treatment of MD-concentrate that needs to be periodically purged from the system. Thus, 
intermittent PS dosing was investigated for TrOC degradation to reduce their accumulation in 
feed (with and without metal salts) during MD operation.  
Following the absorption of heat, breaking of the peroxide bond (O–O) that bridges the sulphur 
atoms in persulfate occurs, resulting in the formation of two SO4
– • radicals as shown in 
Equation 10 [30]. Depending on wastewater characteristics, persulfate or SO4
–• radicals may 
react with water and/or organics to form secondary radicals that can also contribute to 
degradation of  organic impurities [30, 42]. SO4
–• radicals can react with water to form hydroxyl 
(OH–•) radicals, but the abundance of the SO4
–• and OH–• radicals is governed by the pH of 
reaction media (Equation 12 and 13). Under acidic conditions (pH<7), SO4
–• radicals are the 
dominant species, while OH–• is the primary reactive species under basic conditions (pH>7). 
At neutral pH, both SO4
–• and OH–• radicals contribute equally to pollutant degradation [43]. 
Since the pH of the secondary treated effluent in this experiment ranged between 6.9 and 7.2, 
both SO4
–• and OH–• radicals were responsible for the degradation of TrOCs. 
 𝑆𝑂4 
2−. +  𝐻2𝑂 →  𝑆𝑂4 




2−. +  𝑂𝐻− →  𝑆𝑂4 
2− + 𝑂𝐻.           (𝑝𝐻 > 7) Eq. (13) 
A mass balance (Equation 9) reveals that heat-activated PS achieved 25-100% degradation of 
the TrOCs (Figure 7.6) and above 99% overall removal (i.e., degradation+membrane 
retention). During treatment without the addition of metal salts (MD-WW0), degradation of 
TrOCs can be divided into three categories: (i) 90-100% degradation of four PPCPs, namely 
amitriptyline, trimethoprim, bezafibrate and acetaminophen; (ii) 60-90% degradation of three 
pesticides (atrazine, linuron and pentachlorophenol) and four PPCPs (carbamazepine, triclosan, 
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sulfamethoxazole and primidone); and (iii) less than 25% degradation of the pharmaceutical 
compound diclofenac (Figure 7.6). Similar to biodegradation [37, 38, 44], degradation of 
TrOCs by the heat-activated PS appears to be governed by their chemical structure (e.g., 
presence of EWGs and/or EDGs). For instance, TrOCs such as amitriptyline, trimethoprim and 
bezafibrate that contain amine (– NH2), alkyl (–R) or acyl (– COR) EDGs were readily 
degraded (Figure 7.6). This is because sulphate radicals are electrophilic and can achieve faster 
degradation of pollutants containing strong EDGs [45]. However, even some of the compounds 
with strong EWGs underwent significant degradation. Of particular interest was the 
significantly higher PS-mediated degradation of pesticides, particularly atrazine and linuron, 
compared to biodegradation by conventional activated sludge and fungal enzymes [37, 38, 44].  
Literature on the degradation of TrOCs by heat-activated PS is scarce, and to date has been 
generally focused on PS activation routes in the presence of a single TrOCs. For instance, Deng 
et al. [46] reported only 12% degradation of carbamazepine following 2 h treatment with heat-
activated-PS at a PS concentration and operating temperature of 1 mM and 40ºC, respectively. 
In a study by Ji et al. [47], PS (1 mM) activated by heat at 40ºC achieved 20% atrazine 
degradation after an incubation time of 120 h. Ji et al. [48] observed complete degradation of 
the antibiotic sulfamethoxazole within 8 h at 50ºC. These previous experiments were done in 
batch mode. Instead of a single TrOCs, this chapter presents the performance of activated PS 
for the degradation of a dozen of TrOCs in their mixture for the first time. Furthermore, this is 
the first set of data from a reactor operated in continuous-feeding mode. Although a direct 
comparison with previous data [46, 47] is not recommended due to the differences in 

























































































































Figure 7.6. Degradation of the selected TrOCs by PS (1 mM)-assisted MD system during the 
treatment of wastewater with (MD-WW10) and without (MD-WW0) the addition metal salts. 
Data is presented as average ± standard deviation (n=4 for MD-WW10 and n=10 for MD-WW0). 
Operating conditions are presented in the caption of Figure 7.3. 
Notably, when metals salts each at 10 mg/L were added in MBR-permeate (MD-WW10), the 
extent of degradation of the selected TrOC was comparable to that achieved in absence of metal 
salts. Importantly, degradation of a nonsteroidal anti-inflammatory drug diclofenac was 
increased from 25 to 52% (Figure 7.6). Compared to an integrated activated sludge-MD 
system, degradation of a few TrOCs in the PS-assisted MD system was more efficient. For 
instance, Wijekoon [49] reported less than 30% removal for diclofenac, atrazine and 
carbamazepine in an activated sludge-MD system. In the current experiment, PS-assisted MD 
system achieved 55-64% degradation of carbamazepine, and 76-85% degradation of atrazine 
(Figure 7.6). Future studies are recommended to systematically compare biodegradation vs. 
advanced oxidation-assisted MD process. However, that is beyond the scope of this chapter. 
The concentration of the PS added to the MD reactor was monitored to determine if recurrent 
dosing of PS was required. Only a few studies have investigated the depletion of sulphate 
radicals during TrOC degradation [42, 50-52]. The radicals (e.g., SO4
– • and OH•) formed 
following PS activation by heat and/or iron (II) not only can react with the target pollutants but 
can also react with other radicals and non-target pollutants. The scavenging reactions (i.e., 
radical-radical and radical-nontarget) produce secondary radicals that can take part in the 




radicals into sulphate ions [42, 45]. Depletion of PS necessitates its intermittent dosing to 
maintain the performance of the oxidation process. In this experiment, the concentration of 
persulfate was observed to be reduced by 50-70% over a period of 2×HRT. Thus, intermittent 
dosing of PS after every 2×HRT was applied to reinstate PS concentration to 1 mM and 
maintain PS-mediated degradation. Although the addition of PS would increase the operating 
cost of the treatment system, it is compensated generously by: (i) achieving improved TrOC 
removal in MD; (ii) reducing the accumulation of organic impurities in the feed of MD (See 
Section 7.4.3.3); and (iii) significantly mitigating membrane fouling (See section 7.4.4).  
7.4.3.3. TOC and TN degradation by PS-assisted MD system 
Overall removal of bulk organics was monitored via TOC and TN concentration in the PS-
assisted MD feed and permeate (distillate). Removal of TOC, TN and metal ions by the PS-
assisted MD was consistently above 99% as shown in Table 7.5, thus ensuring high quality 
treated effluent. However, effective retention of TOC and TN during continuous feeding also 
means their accumulation in MD feed tank (i.e., MD reactor), which may cause severe 
membrane fouling [27].  
Table 7.5. Removal of pollutants during the treatment of wastewater by the PS-assisted MD 
system 








TOC 66±4 99±0.5 71±7 99±0.5 
TN 39±2 99±1 51±3 99±0.5 
Iron (II) – 100±0 – 99±1 
Magnesium  – 100±0 – 100±0 
Calcium  – 99±1 – 100±0 
Lithium  – 99±2 – 99±1 
n=5 for TOC and TN, and n=4 for metal ions.  
Persulfate and SO4
–• radicals can directly react with organic impurities (e.g., humic substances) 
to either degrade them or form organic radicals. The complex combination of SO4
–• chain 
propagation and termination reactions govern the overall degradation of organic impurities [30, 
53, 54]. In a previous study, dissolved organic carbon removal by UV-activated PS (0.6 mM) 
was reported to be 80% after an irradiation time of 3 h [55]. Depending on the dose of PS, 
Deng and Ezyske [56] achieved chemical oxygen demand and ammonia-nitrogen removal of 
up to 95 and 80%, respectively, from landfill leachate. Consistent with previous studies, this 
chapter shows significant TOC and TN removal by activated-PS.  
Following effective retention by MD membrane in this chapter, up to 66-71% and 39-51% 
degradation of TN and TOC, respectively, was achieved by the PS-assisted MD with and 
without the presence of metal salts (Table 7.5). This significantly reduced the accumulation of 
these impurities in the MD reactor. The advantages of combining PS oxidation with the MD 
process is demonstrated for the first time in this chapter. Particularly, operating the MD system 
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in a continuous flow (i.e., continuous feeding) mode helped demonstrate the effectiveness of 
PS in significantly reducing the accumulation of organics within the reactor.  
7.4.4. Hydraulic performance of the stand-alone and PS-assisted MD  
Permeate flux of the stand-alone MD system during treatment of different wastewater 
compositions was monitored continuously throughout their operation in continuous-flow mode 
(Figure 7.7). Permeate flux of the stand-alone MD reduced during all experiments and was 
dependent on the composition of the wastewater. During the control run (Milli-Q water, 5 µg/L 
TrOCs and 100 mg/L metal salts), the permeate flux reduced gradually at a rate of 1.5 L/m2.h/d, 
dropping to 55% of the initial flux within 5 days (i.e., 6×HRT) of operation. On the hand, 
addition of metal salts each at 100 mg/L and TrOCs each at 5 µg/L in MBR-permeate (i.e., 
MD-WW100) significantly affected the permeability of the MD membrane by reducing the 
permeate flux by 76% of the initial flux (Figure 7.7). Based on the comparison of the permeate 
flux achieved by the MD membrane for different wastewater compositions, it can be concluded 
that the presence of metal salts affected the membrane permeability during treatment in 
presence of metal salts as compared to that in absence of metal salts. For instance, reduction in 
permeate flux was only 20% during treatment of MD-permeate without metal salts, while metal 
salts at 100 mg/L concentrations reduced permeate flux by 76%, respectively (Figure 7.7).  



































Figure 7.7. Variations in the permeate flux of the stand-alone and PS-assisted MD systems as 
a function of time. TrOC retention by MD during each experiment was TrOC-specific and 
ranged from 85 to 98% and 95 to 99% for standalone MD and integrated MD systems, 
respectively. Operating conditions are given in the caption of Figure 7.3. 
Reduction in permeate flux during the stand-alone MD operation can be attributed to scaling 
and membrane fouling. A fouling layer formed on the membrane surface can significantly 
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affect permeate flux by reducing the active area of membrane surface for effective mass transfer 
[27, 57]. The comparatively lower flux reduction for the PS-assisted MD system can be 
attributed to the degradation of TOC (up to 70%, Table 7.5) achieved by activated PS, which 
reduced TOC accumulation in the feed of the PS-assisted MD system. 
To derive deeper insights into the fouling phenomenon, the fouling layer formed on the 
membrane surface was characterized by SEM-EDS. As shown in Figure 7.8, during the 
standalone MD operation for the treatment without metal salts, a dense fouling layer formed 
on the membrane that almost uniformly covered the surface. On the other hand, during the PS-
assisted MD operation without salt addition, the fouling layer on the membrane was distributed 
unevenly and covered a significantly smaller surface area (Figure 7.8).  
 
Figure 7.8. SEM images and EDS spectra of pristine MD membrane (a) and fouled membrane 
collected at the end of experiment with the stand-alone MD (b) and PS-assisted MD (c) 
systems. The membranes were used for the treatment of wastewater without the addition of 
metal salts.  
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The EDS spectra revealed that the fouling layers were mainly composed of carbon, oxygen, 
iron and calcium. However, the comparison of EDS spectra suggests that the abundance of 
carbon and oxygen (main constituents of organic impurities) was significantly higher (almost 
double) in the fouling layer of the membrane collected from the standalone MD system. A 
similar composition of fouling layer was reported when a standalone MD was operated for the 
treatment of anaerobic-MBR permeate [27]. Song et al. [27] additionally observed the 
deposition of phosphorous on the MD membrane. However, in this experiment, phosphorous 
was not detected in the membrane fouling layer. This can be due to the low concentration (i.e., 
3.4 – 6.1 mg PO4
3--P/L) of phosphorous in wastewater used in the current experiment as 
compared to that reported for anaerobically treated effluent in the study by Song et al. [27], 
i.e., approximately 200 mg PO4
3--P/L. 
MD membrane flux reduction can be also caused by accumulation of salts leading to 
concentration polarization and membrane scaling [17]. However, in this experiment, at the end 
of the operation, the conductivity of the feed increased from 200 to 2050 µS/cm in case of the 
standalone MD system in absence of additional metal salts, which is comparable to the increase 
observed for the PS-assisted MD system (i.e., from 190 to 2940 µS/cm), and did not affect 
permeate flux during MD-WW0 and PS-MD-WW0 run. However, when metal salts were added 
at different concentrations, the composition of fouling layer completely changed (Figure 7.9). 
The EDS spectra revealed that the fouling layers were mainly composed of carbon, oxygen, 
iron and calcium, but the percentage of iron is significantly higher than other components of 
the fouling layer. It is evident that under the operating conditions of this experiment, salt 
accumulation affected the permeate flux when additional metal salts were added to the MD 
feed. Notably, membrane pore wetting phenomenon did not occur for any of the membranes, 
which is evident from the effective conductivity removal (above 99%) by MD membrane in all 
experiments. 
It is noteworthy that the fouling layer on the membrane could potentially influence the degree 
of removal of dissolved constituents including TrOCs. For example, for nanofiltration, 
membrane fouling may cause different changes in hydrophobicity, surface charge, and 
effective pore size of the membrane, which may lead to reduced rejection depending on the 
membrane evaluated and the charge of the compound [58]. Also, in the presence of a fouling 
layer, polymeric forward osmosis membranes may swell due to elevated electroneutrality, 
reducing rejection of hydrophilic non-ionic TrOCs [59]. However, results shows that despite 
significant fouling, removal of TrOCs, TOC, TN and metal ions by the MD membrane was 




Figure 7.9. SEM images and EDS spectra of the MD membrane. (a) PS-assisted MD 
membrane at the end of MD-WW10 run; (b) MD membrane at the end of MD-WW10 run (c) 
MD membrane at the end of MD-WW100 run; and (d) MD membrane at the end of control run. 
7.4.5. Toxicity of treated effluent  
The bioluminescent bacteria Photobacterium leiognathi was used to monitor effluent toxicity. 
Our analysis indicates that the reactor media toxicity for both the stand-alone and PS-assisted 
MD slightly increased at the end of their operation (Table 7.6), and that the toxicity of the PS-
assisted MD reactor media in absence of metal salts (6.3-6.5 rTU, n=2) was higher than that of 
the stand-alone MD (3.4-3.9 rTU, n=2). This suggests that PS itself and/or the transformation 
products originating from PS-mediated degradation of the organics present in the feed (i.e., 
effluent organic matter and spiked TrOCs) was slightly more toxic than the feed. Whatever 
those compounds (whether PS, or intermediate TrOC transformation products) were, they did 
not pass into the permeate, and the MD permeate (i.e., the final effluent) was not toxic to 




Table 7.6. Toxicity, expressed as relative toxic unit (rTU), of different samples. The limit of 
detection of the toxicity assay was 1 rTU. Number of samples, n = 2.  
Sample description Toxicity (rTU) 
MD feed (i.e., Secondary treated effluent + TrOCs) <1 – 2.4 
Reactor media of the stand-alone MD system 3.4 – 3.9 
Reactor media of the PS-assisted MD system 6.3 – 6.5 
MD permeate  <1 
 
7.5. Conclusions 
This chapter aims to elucidate the performance of a direct-contact MD process for simultaneous 
removal of metals and TrOCs from sewage- and AMD-impacted water. The results in this 
chapter indicate that the stand-alone MD can achieve effective retention of both TrOCs (80-
100%) and metal ions (>99%). Notably, addition of metal salts did not affect the removal of 
TrOCs and metal ions but caused significant fouling due to the accumulation of organic and 
inorganic impurities in the MD reactor. To reduce the accumulation of bulk organics and 
TrOCs, performance of laccase and persulfate (PS) was assessed. Based on the results of this 
chapter, PS exhibited better TrOC removal and stability in batch experiments as compared to 
laccase. Thus, PS-assisted oxidation process was selected for integration with MD. Depending 
on the molecular structure and hydrophobicity of the TrOCs, PS dosing at a concentration of 1 
mM achieved 25 to >99% TrOC degradation with and without the addition of metal salts. This 
led to the consistent removal of above 99% for all the TrOCs from the MD permeate (i.e., final 
effluent), without the production of toxic transformation products in the MD permeate. 
Activated PS degraded other organic impurities, along with TrOCs present in MD feed. 
Accordingly, during continuous operation of the PS-assisted MD system, organics 
accumulation in the reactor media was significantly reduced. This in turn helped minimize 
membrane fouling to some extent. However, when metal salts were added, performance of MD 
membrane was still affected due to the formation of scaling layer. 
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Chapter 8: Conclusions and recommendations for 
future work 
8.1. Conclusions 
This thesis systematically investigates the performance of a novel high retention (HR) – 
enzymatic membrane bioreactor (EMBR) for effective degradation of a broad spectrum of trace 
organic contaminants (TrOCs) ubiquitously detected either in sewage-impacted water or in 
wastewater treatment plant effluent. In nutshell, two different configurations of HR-EMBRs 
viz nanofiltration (NF)-EMBR and membrane distillation (MD)-EMBR are developed and 
explored for the first time. The impacts of (i) laccase source; and (ii) redox-mediator (low 
molecular weight chemicals added to improve laccase-catalyzed degradation) type and 
concentration on membrane retention, TrOC degradation and effluent ecotoxicity are 
systematically analyzed and elucidated. In addition to redox-mediator dosing, a combined 
laccase/persulfate (PS)-assisted oxidation process is envisaged, and its efficacy for TrOC 
degradation as well as estrogenicity and ecotoxicity reduction is assessed for understanding the 
stability of the developed process. Simultaneous removal of both TrOCs and the metal ions by 
a high retention MD process is comprehensively studied by assessing the effects of organic and 
inorganic impurities on membrane retention and fouling. 
In Chapter 3, integration of an enzymatic bioreactor (3 L) with a high retention NF membrane 
(0.2 kDa), which will retain both laccase and TrOCs, and a conventional UF membrane (30 
kDa), which will only retain laccase but not TrOCs, was investigated to assess the fate of a 
diverse set of 29 TrOCs. The operation of both EMBRs under full recirculation mode 
confirmed effective retention (95% for UF membrane and 100% for NF membrane) of a 
commercially available laccase from genetically modified Aspergillus oryzae. However, 
during the operation of EMBRs, laccase activity may diminish due to various physical, 
chemical and biological inhibitors such as shear stress caused by membrane filtration. The 
laccase activity was maintained by re-injecting a small dose of laccase (250 µL per litre of 
bioreactor media). The continuous-flow NF-EMBR was observed to produce high quality 
effluent due to effective TrOC retention (90-99%). NF-EMBR achieved TrOC-specific 
improvement in the extent of degradation (up to 65%) as compared to that achieved by UF-
EMBR. It is noteworthy that membrane retention and laccase-catalyzed degradation were the 
removal mechanism, and their contribution was dependent on TrOC properties. For instance, 
laccase-catalyzed degradation was the main mechanism of removal for TrOCs containing 
strong electron donating functional groups (EDGs), while TrOCs containing strong electron 
withdrawing functional groups (EWGs) were mainly removed via membrane retention 
mechanism. Although degradation is the only expected mechanism of removal in UF-EMBR, 
anionic and hydrophobic (log D>3) TrOCs were partially retained by the UF membrane via 
charge repulsion by UF membrane and adsorption on the enzyme gel-layer visible to the naked 
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eye. Change in membrane properties due to laccase adsorption along with concentration 
polarization reduced the permeate flux of the UF and NF membrane, but the flux can be 
recovered effectively by cleaning the membrane with water.  
In Chapter 4, MD, which is another format of the high retention membrane separation process 
with a completely different working principle as compared to the pressure-driven NF, was 
integrated with an enzymatic bioreactor. Degradation of TrOCs by two commercially laccases 
from: (i) genetically modified Aspergillus oryzae; and (ii) Trametes versicolor was examined 
and elucidated. The MD system ensured complete retention (>99%) of both laccases and 
selected TrOCs. Laccase from T. versicolor and A. oryzae achieved 40-80% and 45-99% TrOC 
degradation, respectively. Laccase from A. oryzae demonstrated better overall performance 
possibly due to its higher redox-potential (up to 15%). Notably, during MD-EMBR operation, 
degradation of TrOCs was achieved within first 9 h regardless of laccase type. Cease of TrOC 
oxidation at the later end was apparently due to laccase inactivation. Hydraulic performance of 
MD-EMBR monitored by recording the permeate flux was stable during all experiments. 
Importantly, like NF-EMBR, the complete retention of the TrOCs resulted in improved TrOC 
degradation by both laccases as compared to previously developed UF-EMBRs. In addition to 
the prolonged contact time ensured by the MD process, TrOCs containing phenolic moiety 
such as oxybenzone and bisphenol A can improve laccase-catalyzed degradation by acting as 
redox-mediators. The secondary radicals or coupling agents, which are formed following the 
oxidation of phenolic TrOCs, are highly reactive and could directly oxidize or polymerize other 
TrOCs. 
Chapter 5 elucidates the factors governing the performance of redox-mediators following their 
addition in the enzymatic bioreactor of MD-EMBR. Two N=OH type redox-mediators, namely 
1-hydroxybenzotriazole (HBT) and violuric acid (VA), and one phenolic redox-mediator, 
namely syringaldehyde (SA), were assessed at different concentrations. The selected redox-
mediators can improve TrOC degradation by following a hydrogen atom transfer pathway. 
Degradation of phenolic compounds and non-phenolic compounds by the MD-EMBR was 
improved by 20–30% and 10–50%, respectively, following the addition of redox-mediators. 
Improved TrOC degradation after the addition of redox-mediators is possibly due to the 
generation of aminoxyl and phenoxyl radicals that have significantly higher redox-potential 
than that of laccase only. Since SA and VA showed different patterns of TrOC-specific 
degradation-improvement during MD-EMBR, it was envisaged that a mediator-mixture would 
have further beneficial effects. Instead of inducing a synergistic effect, degradation of at least 
six pharmaceutically active TrOCs reduced in presence of SA-VA mixture. This is because, in 
mixtures, some mediators can: (i) chemically interact with each other instead of acting as an 
electron shuttle for laccase; and/or (ii) reversibly inhibit laccase, thereby inhibiting electron 
transfer between laccase and TrOCs. Indeed, laccase activity reduced by up to 80% in laccase-
mediator system, indicating frequent replenishment of laccase. Mediator addition increased the 
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toxicity of the reaction media, but MD permeate remained non-toxic. This is an added 
advantage of coupling an enzymatic bioreactor with a high retention MD membrane. 
Chapter 6 details the performance of an integrated laccase- and persulfate (PS)- assisted 
oxidation process for the first time. To date, only redox-mediators have been assessed to 
improve the extent of laccase-catalyzed degradation. However, they achieve TrOC degradation 
at the expense of laccase activity and could increase the toxicity of the treated effluent. Thus, 
PS-assisted oxidation process was studied as an alternative to the redox-mediators. A series of 
batch tests were performed at different PS concentrations ranging from 1 to 10 mM to 
investigate the impact of PS concentration and incubation time on TrOC degradation. Among 
the tested PS concentrations (1-10 mM), the best performance was achieved at 5 mM 
concentration. PS at 5 mM achieved 100% degradation for two phenolics (bisphenol A and 
oxybenzone) and 25-53% degradation for three non-phenolic (diclofenac, sulfamethoxazole, 
and carbamazepine) TrOCs. A continuous treatment system developed by integrating a 
nanofiltration (NF) membrane with laccase/PS process was hydraulically stable and achieved 
steady-state degradation within 24 h for all TrOCs. Importantly, degradation of non-phenolics 
further improved by 10 to 65% in laccase/PS-NFBR system as compared to laccase only. This 
could be attributed to the prolonged contact time between laccase/PS and TrOCs; as well as 
the contribution of oxidative coupling agents in degradation. The NF membrane not only 
retained the moderately degraded carbamazepine and sulfamethoxazole effectively but was 
also effective for the removal of the toxic transformation by-products and residual estrogenic 
activity as evaluated by ecotoxicity and estrogenicity assays, respectively. 
Chapter 7 reports the performance of a direct-contact MD process for simultaneous removal 
of metal ions and TrOCs from sewage- and AMD-impacted water for a period of 6×HRT (i.e., 
5 d). For this purpose, different compositions of wastewater was prepared by adding a mixture 
of structurally diverse TrOCs as well as a mixture of four metal ions (iron, calcium, magnesium 
and lithium each at 10 and 100 mg/L concentration). The stand-alone MD process achieved 
80-100% and >99% removal (via membrane retention) for the selected TrOCs and the metals, 
respectively. Based on the performance achieved by the MD membrane, addition of salts did 
not affect the extent of pollutant removal. Effective retention of bulk organics, TrOCs and 
metal ions during continuous feeding also means their accumulation in MD feed tank (i.e., MD 
reactor). This caused severe membrane fouling as evident from flux reduction. Accumulation 
of bulk organics could be reduced by combining a laccase or activated-PS oxidation process 
with the MD system. The integration of PS-assisted oxidation process reduced the 
accumulation of bulk organics and TrOCs, but a gradual decline in permeate flux was still 
observed due to membrane scaling mainly caused by iron. Nevertheless, the MD membrane 




Two different configurations of HR-EMBR are assessed for enhanced degradation of TrOCs 
in this thesis. Both NF- and MD-EMBRs achieved TrOC-specific improvement in degradation 
by laccase, but it is not appropriate to compare their performances due to difference in their 
working principles (temperature gradient-driven vs. pressure-driven) and operating conditions 
such as temperature and operating mode (concentration mode in MD and continuous-flow 
mode in NF). Both EMBR configurations have its own pros and cons. For instance, MD-EMBR 
achieved better extent of TrOC degradation, while laccase showed significantly better stability 
in NF-EMBR.  
8.2. Recommendations for future research 
This thesis provides an in-depth understanding of the TrOC removal in HR-EMBRs by 
elucidating the performance of laccase-catalyzed degradation, role of membrane removal 
mechanism, synergistic impacts of the combined laccase/mediators- and laccase/PS systems. 
However, few new research questions emerged during the course of this research and are worth 
exploring in future. 
In this study, two different configurations of HR-EMBR, namely NF-EMBR and MD-EMBR 
are examined for improved degradation of TrOCs. Forward osmosis (FO) is another format of 
high retention membrane separation process and is recommended to be integrated with an 
enzymatic bioreactor. During the development and assessment of FO-EMBR performance, 
preliminary focus could be on the selection of a suitable draw solute that will not inhibit 
laccase. In addition, FO permeate is saline, and the selection of an appropriate process for the 
treatment saline product water will be critical. 
TrOCs containing phenolic moiety can improve laccase-catalyzed degradation by acting as 
redox-mediators. The secondary radicals or coupling agents, which are formed following the 
oxidation of phenolic TrOCs, are highly reactive and could directly oxidize or polymerize other 
TrOCs. To date, only two TrOCs, namely bisphenol A and acetaminophen were demonstrated 
to act as redox-mediators. More phenolic TrOCs with the ability to facilitate degradation are 
required to be identified and examined in future studies.  
Since intermittent replenishment is required to maintain enzymatic activity, use of crude 
enzymes can reduce the cost of the treatment system if renewable waste products such as 
agricultural residues are used for fungal growth. Because crude enzyme extract may contain a 
cocktail of enzymes and natural redox-mediators, their use can enhance the spectrum of 
significantly degradable TrOCs. The presence of unspent growth media in enzyme solution can 
increase organic loading in enzymatic treatment systems. Simple and robust enzyme 
purification processes should be developed in future studies. 
For full-scale applications of HR-EMBRs for real wastewater treatment, laccase stability needs 
to be improved. One approach could be to use stabilizers. For instance, polyvinyl alcohol, 
polyethylene glycol (PEG), polythene and polysaccharide (e.g., Ficoll) were able to improve 
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the stability of laccase during the treatment of bisphenol A. However, effluent toxicity may 
increase in the presence of PEG. Another option is to use encapsulation or carrier materials to 
improve laccase stability. In this regard, inert carrier materials may be preferred to avoid 
adsorption of denaturants. Efficacy of stabilizers and carriers needs to be assessed 
systematically in future studies in HR-EMBR. 
Fungal species secrete different organic compounds (e.g., oxalates) that can protect them from 
metal-induced toxicity, their presence in the crude enzyme preparation may enhance the 
stability of ligninolytic enzymes. However, there is a dearth of information regarding this. 
Toxicity of the reaction media, particularly following the addition of redox-mediators increase 
significantly, indicating that transformation by-products are more toxic than the parent 
compound. It is recommended to identify and elucidate the formation of transformation by-
products during laccase only and/or laccase/mediator treatment process. This will explain the 
quantitative and qualitative difference between the transformation by-products formed in 
laccase-catalyzed degradation process and laccase/mediator process. 
Combining laccase with a PS-assisted oxidation was observed to improve TrOC degradation 
without significantly inactivating laccase. Combination of other advanced oxidation processes 
















































































250.33 4.30 ± 0.32 1 
 
Amitriptyline 
C20 H23 N 
(50-48-6) 
























182.22 3.21 ± 0.29 5 
 
Oxybenzone 
C14 H12 O3 
(131-57-7) 
228.24 3.99±0.36 5 
 
Octocrylene 
C24 H27 N O2 
(6197-30-4) 




































2.967± 0.12 10 
 
Clofibric acid  
(C10H11ClO3) 
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C18 H18 O4 
(78473-71-9) 
298.33 1.89± 0.37 10 
 
a Source: SciFinder database  https://scifinder.cas.org/scifinder/view/scifinder/scifinderExplore.jsf 
Log D is logarithm of the distribution coefficient which is the ratio of the sum of concentrations of all forms of 
the compound (ionised and unionised) in octanol and water at a given pH. 
bLimit of detection (LOD) of the compounds during GC-MS analysis as described in Section 2.5.2. LOD is 
defined as the concentration of an analyte giving a signal to noise (S/N) ratio greater than 3. The limit of 











































































Figure 3-3. Laccase activity profiles in UF-EMBR (a) and NF-EMBR (b). Laccase activity was 




Figure 3-4. Enzyme-gel layer formed on the active side of the UF and NF membrane during 
the operation of UF- and NF-EMBRs. 
 
 
Figure 3-5. Rejection of TrOCs by the UF and NF membrane during the operation of EMBRs 
in full recirculation mode. Error bars show average± standard deviation (n=8).  
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Figure 3-6. Confirmation of effective laccase retention by the NF and UF membrane. Laccase 
retention of >99% and 95% was achieved by the NF and UF membrane respectively. UF/NF-EMBR 



































































































































































































































































Figure 3-7. Removal of TrOC by the NF membrane to confirm their effective retention. NF-EMBR 
were operated for a period of 32 h in continuous mode without the addition of laccase. The UF-EMBR 
was not operated because the UF membrane was not expected to retain TrOCs. Data presented as 












































































































































 T. Versicolor  Novozym  T. Versicolor+HBT
 Novozym+HBT  T. Versicolor+VA  Novozym+VA
 
Figure 4-1. Enzymatic Activity profiles with and without the addition of redox mediator(s) in 
enzymatic membrane distillation system. Two N–OH type redox mediators namely, 1-

















































































Figure 4-2. Variations in permeate flux during the operation of MD and MD-EMR systems. Feed and 
distillate temperature were controlled at 30 and 10 °C, respectively. The cross-flow rate of both feed 
and distillate side was set at 1 L/min (corresponding to a cross-flow velocity of 9 cm/s). Concentration 






















































































































































































Figure 5-1. Impact of mediator concentration (0.25 and 0.5 mM) on the degradation of after an 
incubation time of 12 h in the MD-EMBR. Error bars indicate the standard deviation of 












































































































































































































































































 Laccase  Laccase+SA(0.5 mM)  Laccase+VA (0.5 mM)  Laccase+0.25 mM VA + 0.25 mM SA
 Phenolic TrOCsNon-phenolic TrOCs
 
Figure 5-2. Comparison of the degradation capacity of laccase, SA, VA and SA-VA mixture in MD-

























































Figure 5-3. Enzymatic activity profiles with and without the addition of redox mediator(s) in 





























































Figure 5-4. Permeate flux obtained during the preliminary operation (12 h) of enzymatic 
membrane distillation (MD-EMBR) with and without the addition of redox mediators. Feed 
and distillate temperature were controlled at 30 and 10 °C, respectively during all experiments. 
The cross-flow rate of both feed and distillate side was set at 1 L/min (corresponding to a cross-
























































Figure 5-5. Permeate flux obtained during the long-term operation (60 h) of enzymatic 
membrane distillation (MD-EMR) with and without the addition of mediators. Feed and 
distillate temperature were controlled at 30 and 10 °C, respectively during all experiments. The 
cross-flow rate of both feed and distillate side was set at 1 L/min (corresponding to a cross-




Table 7-1. Chemical formula and structures of the selected micropollutants 
Type Name Chemical Formula MW (g/mol) Chemical structure 
Pharmaceuticals 
and personal care 
products (PPCPs) Acetaminophen C8H9NO2 152 
 





Sulfamethoxazole C10H11N3O3S 253 
 
Amitriptyline C20 H23 N 277 
 
Carbamazepine C15H12N2O 236 
 
Primidone C12H14N2O2 218 
 
Triclosan C12H7Cl3O2 290 
 





























Table 7-2: LC-MS analysis eluent gradient time program. adapted from (Xie et al., 2013) 











* Eluent A contains 0.1% (v/v) formic acid in Milli-Q water; eluent B is acetonitrile. 
 
 
